SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain and Structure information: based on WT protein Annotated databases Deep learning-based pathogenicity predictions Folding stability-based pathogenicity predictions Sequence/structure-based pathogenicity predictions Phase Separation Evolutionary/physical properties Molecular Dynamics-based analysis DOI
Domain IUPred2 ANCHOR2 AlphaFold MobiDB PhosphoSitePlus ClinVar gnomAD ESM1b AlphaMissense FoldX Rosetta Foldetta PremPS REVEL PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PSMutPred PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation
Score Prediction Score Prediction pLDDT disorder disorder LTP HTP KL PTM Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences IP RF SP RF Prediction PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.745G>C
A249P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A249P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. All other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. The SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is therefore pathogenic (3 pathogenic vs. 1 benign). High‑accuracy assessments are consistent: AlphaMissense‑Optimized indicates pathogenicity; the SGM‑Consensus (majority vote) is pathogenic; and Foldetta, integrating FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. **Based on the collective predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.505461Disordered0.255452Uncertain0.8100.3360.125-10.727Likely Pathogenic1.000Likely PathogenicLikely Pathogenic2.76Destabilizing0.48.40Destabilizing5.58Destabilizing1.04Destabilizing0.756Likely Pathogenic-3.32Deleterious0.176Benign0.039Benign5.57Benign0.03Affected0.14290.35371-1-3.426.04
c.745G>T
A249S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A249S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. Protein‑stability assessments are mixed: FoldX indicates a benign effect, while Rosetta and Foldetta are uncertain. High‑accuracy predictions show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the preponderance of evidence—including the high‑accuracy tools—suggests that A249S is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.505461Disordered0.255452Uncertain0.8100.3360.125-5.707Likely Benign0.634Likely PathogenicLikely Benign0.48Likely Benign0.30.84Ambiguous0.66Ambiguous0.33Likely Benign0.465Likely Benign-1.40Neutral0.990Probably Damaging0.681Possibly Damaging5.63Benign0.19Tolerated0.19620.339311-2.616.00
c.746C>A
A249E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A249E has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are SIFT and FATHMM. The majority of other in‑silico predictors (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the variant as pathogenic; FoldX is uncertain and is not counted as evidence for either side. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.505461Disordered0.255452Uncertain0.8100.3360.125-13.519Likely Pathogenic0.991Likely PathogenicLikely Pathogenic1.60Ambiguous1.22.59Destabilizing2.10Destabilizing1.02Destabilizing0.818Likely Pathogenic-3.29Deleterious0.997Probably Damaging0.879Possibly Damaging5.64Benign0.09Tolerated0.07990.15090-1-5.358.04
c.746C>G
A249G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A249G is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: pathogenic calls come from SGM‑Consensus (Likely Pathogenic), REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Only FATHMM predicts a benign outcome. Uncertain results are reported by FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show SGM‑Consensus as Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta remain inconclusive. Overall, the preponderance of evidence supports a pathogenic classification for A249G, and this conclusion does not conflict with ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.505461Disordered0.255452Uncertain0.8100.3360.125-9.678Likely Pathogenic0.947Likely PathogenicAmbiguous1.04Ambiguous0.22.02Destabilizing1.53Ambiguous1.19Destabilizing0.607Likely Pathogenic-2.97Deleterious0.990Probably Damaging0.760Possibly Damaging5.59Benign0.04Affected0.16670.267510-2.2-14.03
c.746C>T
A249V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A249V missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include premPS, PROVEAN, and FATHMM, while those that agree on a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy methods are likewise inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Consequently, no high‑accuracy tool provides a definitive pathogenic or benign verdict. Overall, the majority of available predictions (seven pathogenic vs. three benign) lean toward a pathogenic interpretation. This assessment does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.505461Disordered0.255452Uncertain0.8100.3360.125-9.417Likely Pathogenic0.856Likely PathogenicAmbiguous1.48Ambiguous0.60.51Ambiguous1.00Ambiguous0.41Likely Benign0.652Likely Pathogenic-2.47Neutral0.990Probably Damaging0.760Possibly Damaging5.76Benign0.03Affected0.07370.4677002.428.05
c.748G>A
V250I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V250I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). All evaluated in silico predictors classify the change as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). The high‑accuracy tools likewise predict a benign effect: AlphaMissense‑Optimized is benign, the SGM Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. No pathogenic predictions are present. Therefore, based on the available computational evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.447574Structured0.244075Uncertain0.7780.3240.125-6.696Likely Benign0.085Likely BenignLikely Benign-0.44Likely Benign0.1-0.01Likely Benign-0.23Likely Benign0.35Likely Benign0.362Likely Benign-0.79Neutral0.384Benign0.070Benign6.09Benign0.13Tolerated0.05710.3644430.314.03
c.748G>C
V250L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V250L variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include FoldX, PROVEAN, FATHMM, AlphaMissense‑Optimized, and polyPhen2_HumVar. Those that predict pathogenicity are REVEL, polyPhen2_HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. Tools with inconclusive results—Foldetta and premPS—are noted as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is ambiguous (two pathogenic vs. two benign votes), and Foldetta remains uncertain. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic effect, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.447574Structured0.244075Uncertain0.7780.3240.125-11.649Likely Pathogenic0.587Likely PathogenicLikely Benign-0.23Likely Benign0.12.47Destabilizing1.12Ambiguous0.66Ambiguous0.690Likely Pathogenic-2.47Neutral0.767Possibly Damaging0.344Benign5.81Benign0.04Affected0.06980.422921-0.414.03
c.748G>T
V250L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V250L variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include FoldX, PROVEAN, FATHMM, AlphaMissense‑Optimized, and polyPhen2_HumVar. Those that predict pathogenicity are REVEL, polyPhen2_HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. Tools with inconclusive results—Foldetta and premPS—are noted as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is ambiguous (two pathogenic vs. two benign votes), and Foldetta remains uncertain. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic effect, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.447574Structured0.244075Uncertain0.7780.3240.125-11.649Likely Pathogenic0.587Likely PathogenicLikely Benign-0.23Likely Benign0.12.47Destabilizing1.12Ambiguous0.66Ambiguous0.690Likely Pathogenic-2.47Neutral0.767Possibly Damaging0.344Benign5.81Benign0.04Affected0.06980.422921-0.414.03
c.749T>A
V250E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V250E is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign predictions are limited to FATHMM, whereas the remaining 12 tools (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify the change as pathogenic. The high‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. No prediction or stability result is inconclusive. Consequently, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.447574Structured0.244075Uncertain0.7780.3240.125-15.723Likely Pathogenic0.983Likely PathogenicLikely Pathogenic1.85Ambiguous0.13.34Destabilizing2.60Destabilizing2.01Destabilizing0.906Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.916Probably Damaging5.74Benign0.00Affected0.07870.1564-2-2-7.729.98
c.749T>C
V250A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V250A missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a pathogenic effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default all indicate pathogenicity, whereas ESM1b and FATHMM predict a benign outcome. Stability‑based methods (FoldX, Rosetta, Foldetta) and AlphaMissense‑Optimized return uncertain results and are treated as unavailable. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain, the SGM consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is balanced and therefore unavailable, and Foldetta is uncertain. Overall, the preponderance of evidence points to a pathogenic effect for V250A, and this assessment does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.447574Structured0.244075Uncertain0.7780.3240.125-6.385Likely Benign0.852Likely PathogenicAmbiguous0.82Ambiguous0.11.22Ambiguous1.02Ambiguous1.48Destabilizing0.818Likely Pathogenic-3.11Deleterious0.930Possibly Damaging0.584Possibly Damaging5.82Benign0.02Affected0.24910.215100-2.4-28.05
c.749T>G
V250G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V250G missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (both HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default, while only FATHMM predicts a benign outcome. Uncertain results are reported by FoldX and AlphaMissense‑Optimized. High‑accuracy assessments reinforce the pathogenic signal: the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, AlphaMissense‑Optimized remains uncertain, and Foldetta is pathogenic. Taken together, the overwhelming majority of evidence indicates a pathogenic effect. This conclusion is consistent with the absence of a ClinVar classification; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.447574Structured0.244075Uncertain0.7780.3240.125-11.255Likely Pathogenic0.917Likely PathogenicAmbiguous1.65Ambiguous0.33.18Destabilizing2.42Destabilizing2.08Destabilizing0.900Likely Pathogenic-5.90Deleterious0.879Possibly Damaging0.997Probably Damaging5.75Benign0.00Affected0.18840.1996-1-3-4.6-42.08
c.74G>C
R25P
2D
AIThe SynGAP1 missense variant R25P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT uniformly predict a pathogenic outcome. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.461924Structured0.438941Uncertain0.3730.8900.375-3.394Likely Benign0.424AmbiguousLikely Benign0.155Likely Benign-1.56Neutral0.841Possibly Damaging0.809Possibly Damaging3.94Benign0.00Affected0.22170.45710-22.9-59.07
c.74G>T
R25L
2D
AIThe SynGAP1 missense variant R25L is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in‑silico predictors shows a predominance of benign calls: REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized all predict a benign effect, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates a likely benign outcome. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT each predict a pathogenic impact. AlphaMissense‑Default remains uncertain, and no Foldetta stability assessment is available. High‑accuracy tools specifically highlight a benign prediction: AlphaMissense‑Optimized is benign, the SGM‑Consensus is likely benign, and Foldetta data are missing. Taken together, the majority of robust predictors and the consensus analysis support a benign classification for R25L. This conclusion is consistent with the lack of ClinVar evidence and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.461924Structured0.438941Uncertain0.3730.8900.375-3.443Likely Benign0.484AmbiguousLikely Benign0.121Likely Benign-1.59Neutral0.686Possibly Damaging0.630Possibly Damaging3.97Benign0.00Affected0.20450.4792-3-28.3-43.03
c.751A>C
K251Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K251Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and polyPhen‑2 HumVar, while premPS and AlphaMissense‑Default are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Taken together, the majority of evidence supports a benign classification for K251Q, and this conclusion does not contradict the absence of a ClinVar entry. Based on the aggregate predictions, K251Q is most likely benign, and this is consistent with its absence from ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.447574Structured0.226632Uncertain0.7580.3120.125-5.869Likely Benign0.362AmbiguousLikely Benign0.36Likely Benign0.10.42Likely Benign0.39Likely Benign-0.62Ambiguous0.465Likely Benign0.55Neutral0.997Probably Damaging0.879Possibly Damaging5.86Benign0.63Tolerated0.44660.1085110.4-0.04
c.751A>G
K251E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K251E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS, PROVEAN, SIFT, and FATHMM, while those that agree on a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The remaining tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) give uncertain results. High‑accuracy methods are likewise inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie, and Foldetta is uncertain. Overall, the majority of available predictions lean toward pathogenicity, with a small but notable benign signal. Therefore, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.447574Structured0.226632Uncertain0.7580.3120.125-12.812Likely Pathogenic0.906Likely PathogenicAmbiguous0.88Ambiguous0.20.99Ambiguous0.94Ambiguous0.40Likely Benign0.571Likely Pathogenic-0.54Neutral0.970Probably Damaging0.584Possibly Damaging5.80Benign0.46Tolerated0.39290.0860010.40.94
c.752A>C
K251T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K251T is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include premPS, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Tools with uncertain or inconclusive results are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) supports a pathogenic prediction, while AlphaMissense‑Optimized and Foldetta remain uncertain. Overall, the balance of evidence favors a pathogenic effect for K251T, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.447574Structured0.226632Uncertain0.7580.3120.125-10.552Likely Pathogenic0.841Likely PathogenicAmbiguous1.21Ambiguous0.40.50Ambiguous0.86Ambiguous0.46Likely Benign0.742Likely Pathogenic-2.72Deleterious0.970Probably Damaging0.749Possibly Damaging5.76Benign0.28Tolerated0.23530.28520-13.2-27.07
c.752A>G
K251R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K251R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Rosetta and Foldetta give uncertain results. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.447574Structured0.226632Uncertain0.7580.3120.125-4.355Likely Benign0.123Likely BenignLikely Benign-0.37Likely Benign0.0-0.64Ambiguous-0.51Ambiguous0.14Likely Benign0.531Likely Pathogenic-0.61Neutral0.970Probably Damaging0.681Possibly Damaging5.92Benign0.34Tolerated0.47560.104932-0.628.01
c.752A>T
K251M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K251M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, premPS, PROVEAN, and FATHMM. Those that predict pathogenicity are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessment shows AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a benign effect. Overall, the evidence is evenly split between benign and pathogenic predictions, with the most reliable high‑accuracy tools leaning toward a benign outcome. Thus, the variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.447574Structured0.226632Uncertain0.7580.3120.125-10.678Likely Pathogenic0.796Likely PathogenicAmbiguous0.14Likely Benign0.10.10Likely Benign0.12Likely Benign0.05Likely Benign0.751Likely Pathogenic-2.36Neutral0.999Probably Damaging0.970Probably Damaging5.73Benign0.05Affected0.12710.34750-15.83.02
c.753G>C
K251N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K251N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM (nine tools). Only AlphaMissense‑Default predicts a pathogenic outcome, while ESM1b and AlphaMissense‑Optimized are uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign consensus; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the preponderance of evidence indicates that K251N is most likely benign, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.447574Structured0.226632Uncertain0.7580.3120.125-7.978In-Between0.930Likely PathogenicAmbiguous0.29Likely Benign0.10.21Likely Benign0.25Likely Benign0.32Likely Benign0.298Likely Benign-1.29Neutral0.384Benign0.070Benign5.73Benign0.39Tolerated0.38480.1196100.4-14.07
c.753G>T
K251N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K251N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM (nine tools). Only AlphaMissense‑Default predicts a pathogenic outcome, while ESM1b and AlphaMissense‑Optimized are uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign consensus; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the preponderance of evidence indicates that K251N is most likely benign, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.447574Structured0.226632Uncertain0.7580.3120.125-7.978In-Between0.930Likely PathogenicAmbiguous0.29Likely Benign0.10.21Likely Benign0.25Likely Benign0.32Likely Benign0.298Likely Benign-1.29Neutral0.384Benign0.070Benign5.73Benign0.39Tolerated0.38480.1196100.4-14.07
c.754C>A
P252T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P252T is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include polyPhen‑2 HumDiv, polyPhen‑2 HumVar and FATHMM. Those that predict a pathogenic effect are REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized and the SGM‑Consensus score (Likely Pathogenic). Four tools (FoldX, Rosetta, Foldetta, premPS) give uncertain results and are treated as unavailable. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; Foldetta’s stability assessment is uncertain. Overall, the majority of evidence points to a pathogenic effect, and this is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.461924Structured0.211606Uncertain0.7530.3040.250-11.824Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.24Ambiguous0.11.89Ambiguous1.57Ambiguous0.71Ambiguous0.828Likely Pathogenic-7.35Deleterious0.384Benign0.177Benign5.78Benign0.01Affected0.15140.48420-10.93.99
c.754C>G
P252A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 P252A is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: a single benign call from FATHMM, and a majority of pathogenic calls from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as pathogenic, and Foldetta as inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for P252A, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.461924Structured0.211606Uncertain0.7530.3040.250-10.587Likely Pathogenic0.977Likely PathogenicLikely Pathogenic0.97Ambiguous0.11.74Ambiguous1.36Ambiguous0.69Ambiguous0.831Likely Pathogenic-7.35Deleterious0.941Possibly Damaging0.607Possibly Damaging5.87Benign0.03Affected0.34900.41611-13.4-26.04
c.754C>T
P252S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P252S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, while the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact. Predictions that are uncertain (FoldX, Rosetta, Foldetta, premPS) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the evidence strongly favors a pathogenic effect for P252S, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.461924Structured0.211606Uncertain0.7530.3040.250-10.926Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.76Ambiguous0.11.81Ambiguous1.29Ambiguous0.79Ambiguous0.840Likely Pathogenic-7.35Deleterious0.941Possibly Damaging0.531Possibly Damaging5.79Benign0.05Affected0.35080.43611-10.8-10.04
c.755C>A
P252H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P252H missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM, while the remaining evaluated algorithms (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. No other high‑confidence stability predictions are available. Overall, the preponderance of evidence indicates that P252H is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.461924Structured0.211606Uncertain0.7530.3040.250-11.991Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.06Ambiguous0.21.96Ambiguous1.51Ambiguous0.82Ambiguous0.845Likely Pathogenic-8.27Deleterious0.999Probably Damaging0.936Probably Damaging5.76Benign0.00Affected0.15920.41280-2-1.640.02
c.755C>G
P252R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P252R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Computational predictors that classify the variant as benign are FoldX and FATHMM, whereas the majority of tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. Predictions that are inconclusive are Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; Foldetta remains uncertain. Overall, the preponderance of evidence indicates that P252R is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.461924Structured0.211606Uncertain0.7530.3040.250-14.648Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.40Likely Benign0.11.23Ambiguous0.82Ambiguous0.81Ambiguous0.890Likely Pathogenic-8.27Deleterious0.997Probably Damaging0.916Probably Damaging5.80Benign0.00Affected0.14130.28480-2-2.959.07
c.755C>T
P252L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P252L missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify the variant as benign are premPS and FATHMM, while the majority of other in silico predictors (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a pathogenic effect. Predictions from FoldX, Rosetta, and Foldetta are uncertain and therefore do not contribute to the overall assessment. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.461924Structured0.211606Uncertain0.7530.3040.250-10.181Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.93Ambiguous0.01.56Ambiguous1.25Ambiguous0.47Likely Benign0.794Likely Pathogenic-9.19Deleterious0.991Probably Damaging0.781Possibly Damaging5.81Benign0.00Affected0.20270.6475-3-35.416.04
c.757A>C
N253H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N253H is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include FoldX, FATHMM, and premPS, whereas a larger group predicts pathogenicity: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show that the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome, while AlphaMissense‑Optimized and Foldetta provide inconclusive results and are treated as unavailable. No contradictory evidence is present in ClinVar. Overall, the preponderance of evidence from multiple in‑silico predictors points to a pathogenic effect for the variant, and this conclusion does not conflict with the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.201744Uncertain0.7710.2980.250-12.199Likely Pathogenic0.899Likely PathogenicAmbiguous0.31Likely Benign0.10.76Ambiguous0.54Ambiguous-0.06Likely Benign0.832Likely Pathogenic-4.39Deleterious0.998Probably Damaging0.991Probably Damaging5.51Benign0.01Affected0.19360.8033210.323.04
c.757A>G
N253D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N253D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on benign effects include FoldX, Rosetta, Foldetta, premPS, SIFT, and FATHMM, while those that predict pathogenicity are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicating likely pathogenic, whereas Foldetta predicts a benign effect on protein stability. Overall, the majority of tools (8/15) favor a pathogenic outcome, with no conflict with ClinVar status because the variant is not yet catalogued. Thus, the variant is most likely pathogenic based on current computational predictions, and this assessment does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.201744Uncertain0.7710.2980.250-14.105Likely Pathogenic0.977Likely PathogenicLikely Pathogenic0.25Likely Benign0.00.37Likely Benign0.31Likely Benign0.09Likely Benign0.742Likely Pathogenic-4.13Deleterious0.993Probably Damaging0.971Probably Damaging5.60Benign0.09Tolerated0.22480.5186210.00.98
c.757A>T
N253Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N253Y is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include FoldX, FATHMM, and premPS, whereas a larger set—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Because the majority of evidence points to a deleterious impact, the variant is most likely pathogenic; this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.201744Uncertain0.7710.2980.250-14.749Likely Pathogenic0.920Likely PathogenicAmbiguous0.27Likely Benign0.11.13Ambiguous0.70Ambiguous0.29Likely Benign0.896Likely Pathogenic-7.01Deleterious0.998Probably Damaging0.994Probably Damaging5.55Benign0.01Affected0.06420.7055-2-22.249.07
c.758A>C
N253T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N253T is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, and FATHMM, whereas the majority of tools (SGM‑Consensus, REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default) predict a pathogenic outcome. High‑accuracy methods give a consistent pathogenic signal: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta) also predicts pathogenic. AlphaMissense‑Optimized is uncertain and is treated as unavailable. Overall, the preponderance of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.201744Uncertain0.7710.2980.250-11.656Likely Pathogenic0.929Likely PathogenicAmbiguous1.96Ambiguous0.32.67Destabilizing2.32Destabilizing0.16Likely Benign0.739Likely Pathogenic-5.01Deleterious0.993Probably Damaging0.971Probably Damaging5.54Benign0.06Tolerated0.16400.8665002.8-13.00
c.758A>G
N253S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N253S is listed in ClinVar with no submitted interpretation and is present in gnomAD (ID 6‑33435609‑A‑G). Prediction tools that agree on a benign effect include premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. Overall, the evidence is mixed, but the single high‑accuracy tool that is available points to a benign effect. Therefore, the variant is most likely benign based on current predictions, and this assessment does not contradict the ClinVar status, which remains unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.513880Disordered0.201744Uncertain0.7710.2980.2506-33435609-A-G-7.197In-Between0.541AmbiguousLikely Benign0.60Ambiguous0.11.19Ambiguous0.90Ambiguous-0.03Likely Benign0.716Likely Pathogenic-4.26Deleterious0.993Probably Damaging0.956Probably Damaging5.56Benign0.09Tolerated3.39150.39600.7764112.7-27.03
c.759C>A
N253K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N253K resides in the PH domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Functional prediction tools that classify the variant as benign include FoldX, Foldetta, premPS, and FATHMM. In contrast, the majority of predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—label it pathogenic or likely pathogenic. The high‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus also indicates likely pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the preponderance of evidence from standard and high‑accuracy predictors points to a pathogenic effect. This assessment is not contradicted by ClinVar, which currently contains no classification for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.201744Uncertain0.7710.2980.250-15.834Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.05Likely Benign0.00.90Ambiguous0.48Likely Benign0.17Likely Benign0.663Likely Pathogenic-5.21Deleterious0.993Probably Damaging0.979Probably Damaging5.53Benign0.03Affected0.26400.659210-0.414.07
c.759C>G
N253K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N253K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools fall into two groups: benign predictions come from FoldX, FATHMM, premPS, and Foldetta, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Benign. Overall, the majority of tools predict pathogenicity, and the two most reliable predictors also lean pathogenic, whereas only one high‑accuracy tool suggests benign. Therefore, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.201744Uncertain0.7710.2980.250-15.834Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.05Likely Benign0.00.90Ambiguous0.48Likely Benign0.17Likely Benign0.663Likely Pathogenic-5.21Deleterious0.993Probably Damaging0.979Probably Damaging5.53Benign0.03Affected0.26400.659210-0.414.07
c.760A>C
K254Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K254Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Foldetta, SIFT, and FATHMM. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools, Rosetta and premPS, give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. No prediction or folding stability result is missing or inconclusive. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.207751Uncertain0.7990.2850.375-12.332Likely Pathogenic0.979Likely PathogenicLikely Pathogenic0.13Likely Benign0.1-0.61Ambiguous-0.24Likely Benign0.90Ambiguous0.737Likely Pathogenic-3.04Deleterious0.997Probably Damaging0.879Possibly Damaging5.91Benign0.11Tolerated0.37490.1483110.4-0.04
c.760A>G
K254E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K254E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: FATHMM is the sole benign predictor, while the remaining 13 tools (REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and SGM‑Consensus) predict pathogenicity; FoldX and Foldetta are uncertain. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized indicates pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. Overall, the preponderance of evidence supports a pathogenic classification for K254E, and this conclusion does not conflict with ClinVar, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.207751Uncertain0.7990.2850.375-14.745Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.72Ambiguous0.12.34Destabilizing1.53Ambiguous1.17Destabilizing0.860Likely Pathogenic-3.27Deleterious0.970Probably Damaging0.584Possibly Damaging5.87Benign0.05Affected0.32240.1352010.40.94
c.761A>C
K254T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K254T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, PROVEAN, both polyPhen‑2 HumDiv and HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Benign predictions are limited to SIFT and FATHMM. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta’s stability analysis is inconclusive. Overall, the majority of evidence points to a pathogenic effect for K254T, and this conclusion does not conflict with ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.207751Uncertain0.7990.2850.375-13.793Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.51Ambiguous0.01.92Ambiguous1.22Ambiguous0.62Ambiguous0.883Likely Pathogenic-5.14Deleterious0.970Probably Damaging0.749Possibly Damaging5.88Benign0.06Tolerated0.18250.25620-13.2-27.07
c.761A>G
K254R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K254R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools—Rosetta, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority (2 benign vs. 1 pathogenic, 1 uncertain); Foldetta is uncertain. Taken together, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status because the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.513880Disordered0.207751Uncertain0.7990.2850.375-11.064Likely Pathogenic0.528AmbiguousLikely Benign-0.44Likely Benign0.1-1.13Ambiguous-0.79Ambiguous0.76Ambiguous0.604Likely Pathogenic-2.36Neutral0.970Probably Damaging0.681Possibly Damaging5.81Benign0.09Tolerated0.40700.165832-0.628.01
c.761A>T
K254M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K254M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show discordant results: benign predictions come from FoldX, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are reported by SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight the conflict: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No prediction or stability result is missing or inconclusive. Overall, the majority of tools and the high‑accuracy consensus lean toward a pathogenic effect, and this assessment does not contradict ClinVar status, which currently has no entry for it. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.207751Uncertain0.7990.2850.375-12.832Likely Pathogenic0.995Likely PathogenicLikely Pathogenic-0.35Likely Benign0.50.48Likely Benign0.07Likely Benign0.23Likely Benign0.864Likely Pathogenic-5.08Deleterious0.999Probably Damaging0.970Probably Damaging5.78Benign0.00Affected0.10730.35620-15.83.02
c.762G>C
K254N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K254N is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that classify the variant as benign include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The majority of other in silico predictors—REVEL, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—indicate a pathogenic effect. Stability‑based methods FoldX, Rosetta, and Foldetta returned uncertain results and are therefore not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as unavailable. Overall, the preponderance of evidence supports a pathogenic classification, which contradicts the current ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.207751Uncertain0.7990.2850.375Uncertain 1-13.306Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.73Ambiguous0.21.87Ambiguous1.30Ambiguous1.19Destabilizing0.757Likely Pathogenic-4.23Deleterious0.384Benign0.070Benign5.93Benign0.01Affected3.39150.32000.1488100.4-14.07215.3-21.0-1.01.70.20.3XPotentially PathogenicThe amino group of Lys254, located in an α-β loop connecting the PH and C2 domains (res. Lys251-Arg258), forms salt bridges with the carboxylate groups of Glu244 and Asp684. Since the neutral carboxamide group of the Asn254 side chain cannot form salt bridges with acidic residues, the residue swap potentially weakens the tertiary structure assembly and/or influences the loop positioning. Regardless, in both the variant and WT simulations, all hydrogen bonds formed by the residue’s side chain were broken, and the residue rotated outwards. The partially α helical conformation of the loop, which extends to a nearby α helix (res. Met414-Asn426), is dynamic, making it unclear if the mutation affects it.
c.762G>T
K254N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K254N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that classify the variant as benign include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are REVEL, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic” (3 pathogenic vs. 1 benign). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No evidence from FoldX or Rosetta alone is conclusive. Based on the overall pattern of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not currently catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.513880Disordered0.207751Uncertain0.7990.2850.375-13.306Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.73Ambiguous0.21.87Ambiguous1.30Ambiguous1.19Destabilizing0.757Likely Pathogenic-4.23Deleterious0.384Benign0.070Benign5.93Benign0.01Affected3.39150.32000.1488100.4-14.07215.3-21.0-1.01.70.20.3XPotentially PathogenicThe amino group of Lys254, located in an α-β loop connecting the PH and C2 domains (res. Lys251-Arg258), forms salt bridges with the carboxylate groups of Glu244 and Asp684. Since the neutral carboxamide group of the Asn254 side chain cannot form salt bridges with acidic residues, the residue swap potentially weakens the tertiary structure assembly and/or influences the loop positioning. Regardless, in both the variant and WT simulations, all hydrogen bonds formed by the residue’s side chain were broken, and the residue rotated outwards. The partially α helical conformation of the loop, which extends to a nearby α helix (res. Met414-Asn426), is dynamic, making it unclear if the mutation affects it.
c.763G>A
D255N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D255N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS and FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. FoldX, Rosetta, and Foldetta provide uncertain results. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta remains inconclusive. Overall, the consensus of the available predictions points to a pathogenic effect for D255N, and this conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.501700Disordered0.219132Uncertain0.8010.2730.250-12.251Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.86Ambiguous0.11.48Ambiguous1.17Ambiguous0.38Likely Benign0.682Likely Pathogenic-4.30Deleterious0.997Probably Damaging0.989Probably Damaging5.84Benign0.01Affected0.11170.4774210.0-0.98
c.763G>C
D255H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D255H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from premPS and FATHMM, while pathogenic predictions are made by SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy methods reinforce the pathogenic interpretation: AlphaMissense‑Optimized predicts Pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains Uncertain. Overall, the consensus of the available predictions points to a pathogenic effect for D255H, and this conclusion is consistent with the lack of ClinVar annotation (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.501700Disordered0.219132Uncertain0.8010.2730.250-14.645Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.72Ambiguous0.21.17Ambiguous1.45Ambiguous0.44Likely Benign0.808Likely Pathogenic-5.93Deleterious1.000Probably Damaging0.997Probably Damaging5.76Benign0.00Affected0.14470.52111-10.322.05
c.763G>T
D255Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D255Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include premPS and FATHMM, while the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Predictions from FoldX, Rosetta, and Foldetta are uncertain and therefore not used as evidence. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as Uncertain. Based on the overall consensus of the available predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.501700Disordered0.219132Uncertain0.8010.2730.250-13.180Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.25Ambiguous0.20.96Ambiguous1.11Ambiguous0.13Likely Benign0.832Likely Pathogenic-7.77Deleterious1.000Probably Damaging0.997Probably Damaging5.73Benign0.00Affected0.04640.5178-4-32.248.09
c.764A>C
D255A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D255A missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include premPS and FATHMM, while the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus “Likely Pathogenic” vote) predict a pathogenic impact. Predictions from FoldX, Rosetta, and Foldetta are uncertain and therefore do not contribute evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.501700Disordered0.219132Uncertain0.8010.2730.250-11.789Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.48Ambiguous0.21.04Ambiguous1.26Ambiguous0.35Likely Benign0.829Likely Pathogenic-6.85Deleterious0.999Probably Damaging0.994Probably Damaging5.80Benign0.01Affected0.33630.48050-25.3-44.01
c.764A>G
D255G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D255G missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include premPS and FATHMM, while the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive results and are therefore not used as evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.501700Disordered0.219132Uncertain0.8010.2730.250-12.652Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.72Ambiguous0.11.34Ambiguous1.53Ambiguous0.31Likely Benign0.885Likely Pathogenic-6.13Deleterious0.997Probably Damaging0.989Probably Damaging5.86Benign0.01Affected0.32110.51851-13.1-58.04
c.764A>T
D255V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D255V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from premPS and FATHMM, while pathogenic predictions are made by SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy methods reinforce the pathogenic interpretation: AlphaMissense‑Optimized predicts Pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains Uncertain. Overall, the consensus of available predictions points to a pathogenic effect for D255V, and this conclusion is consistent with the lack of ClinVar annotation (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.501700Disordered0.219132Uncertain0.8010.2730.250-13.575Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.76Ambiguous0.21.07Ambiguous1.42Ambiguous0.16Likely Benign0.895Likely Pathogenic-7.77Deleterious0.999Probably Damaging0.996Probably Damaging5.75Benign0.00Affected0.06840.5162-2-37.7-15.96
c.765C>A
D255E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change D255E is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include premPS, SIFT, ESM1b, and FATHMM. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is also inconclusive. Overall, the majority of available predictions (seven pathogenic vs. four benign) point to a likely pathogenic impact. This conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.501700Disordered0.219132Uncertain0.8010.2730.250-6.876Likely Benign0.989Likely PathogenicLikely Pathogenic0.80Ambiguous0.30.90Ambiguous0.85Ambiguous0.15Likely Benign0.508Likely Pathogenic-2.98Deleterious0.994Probably Damaging0.978Probably Damaging5.89Benign0.08Tolerated0.13650.5067320.014.03
c.765C>G
D255E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D255E is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include premPS, SIFT, ESM1b, and FATHMM, whereas those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The remaining tools (FoldX, Rosetta, Foldetta) provide uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign), and Foldetta is also inconclusive. Overall, the majority of available predictions (7 pathogenic vs. 4 benign) indicate a pathogenic effect. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.501700Disordered0.219132Uncertain0.8010.2730.250-6.876Likely Benign0.989Likely PathogenicLikely Pathogenic0.80Ambiguous0.30.90Ambiguous0.85Ambiguous0.15Likely Benign0.509Likely Pathogenic-2.98Deleterious0.994Probably Damaging0.978Probably Damaging5.89Benign0.08Tolerated0.13650.5067320.014.03
c.766A>C
N256H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256H is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include Rosetta, Foldetta, premPS, and FATHMM. Those that predict pathogenicity are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The high‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, whereas Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-8.090Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.56Ambiguous0.30.26Likely Benign0.41Likely Benign0.08Likely Benign0.698Likely Pathogenic-4.06Deleterious0.999Probably Damaging0.994Probably Damaging5.82Benign0.05Affected0.12330.5646210.323.04
c.766A>G
N256D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N256D is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include Rosetta, Foldetta, premPS, and FATHMM, while the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. FoldX is uncertain and therefore not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as benign. Taken together, the overall consensus leans toward a pathogenic effect, with 10 tools supporting pathogenicity versus 4 supporting benignity. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-12.478Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.69Ambiguous0.30.21Likely Benign0.45Likely Benign0.44Likely Benign0.701Likely Pathogenic-4.36Deleterious0.997Probably Damaging0.980Probably Damaging5.81Benign0.03Affected0.18900.3514210.00.98
c.766A>T
N256Y
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that classify the variant as benign include FoldX, Foldetta, premPS, and FATHMM, whereas the majority of tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—label it pathogenic. The high‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the preponderance of evidence from standard predictors and the two high‑accuracy pathogenic calls suggests that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-10.881Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.17Likely Benign0.2-0.80Ambiguous-0.32Likely Benign0.30Likely Benign0.868Likely Pathogenic-6.85Deleterious0.999Probably Damaging0.996Probably Damaging5.83Benign0.00Affected0.04930.5881-2-22.249.07
c.767A>C
N256T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign predictions come from Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The high‑accuracy AlphaMissense‑Optimized model classifies the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, while the Foldetta stability assessment reports a benign effect. No prediction or stability result is missing or inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-12.212Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.88Ambiguous0.1-0.18Likely Benign0.35Likely Benign0.49Likely Benign0.819Likely Pathogenic-5.25Deleterious0.997Probably Damaging0.980Probably Damaging5.85Benign0.01Affected0.12490.5848002.8-13.00
c.767A>G
N256S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256S is listed in ClinVar as Pathogenic (ClinVar ID 2584352.0) and is not reported in gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Rosetta, Foldetta, premPS, and FATHMM, while pathogenic calls come from SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy subset gives AlphaMissense‑Optimized as Uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of predictions support a pathogenic effect, aligning with the ClinVar classification. Therefore, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250Likely Pathogenic 1-10.640Likely Pathogenic0.950Likely PathogenicAmbiguous0.31Likely Benign0.20.36Likely Benign0.34Likely Benign0.48Likely Benign0.707Likely Pathogenic-4.33Deleterious0.997Probably Damaging0.970Probably Damaging5.87Benign0.02Affected3.39150.30240.5864112.7-27.03
c.767A>T
N256I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include Rosetta, premPS, and FATHMM. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy methods give a pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-14.050Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.64Ambiguous0.40.45Likely Benign0.55Ambiguous0.31Likely Benign0.849Likely Pathogenic-7.91Deleterious0.999Probably Damaging0.994Probably Damaging5.87Benign0.00Affected0.05960.6260-2-38.0-0.94
c.768C>A
N256K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256K is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, and FATHMM. Those that predict pathogenicity comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools favor a pathogenic effect, whereas a minority suggest benign. Thus, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-13.814Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.22Likely Benign0.3-0.10Likely Benign0.06Likely Benign0.55Ambiguous0.569Likely Pathogenic-5.02Deleterious0.997Probably Damaging0.986Probably Damaging5.90Benign0.01Affected0.17020.524010-0.414.07
c.768C>G
N256K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N256K is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, and FATHMM. Those that predict pathogenicity comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools support a pathogenic effect, whereas a minority suggest benign. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.234105Uncertain0.8260.2710.250-13.814Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.22Likely Benign0.3-0.10Likely Benign0.06Likely Benign0.55Ambiguous0.569Likely Pathogenic-5.02Deleterious0.997Probably Damaging0.986Probably Damaging5.90Benign0.01Affected0.17020.524010-0.414.07
c.769A>C
S257R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S257R has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FoldX, premPS, SIFT, and FATHMM, whereas a majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; Rosetta and Foldetta are uncertain. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect for S257R. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.258293Uncertain0.8470.2720.250-11.746Likely Pathogenic0.992Likely PathogenicLikely Pathogenic-0.18Likely Benign0.0-1.33Ambiguous-0.76Ambiguous0.29Likely Benign0.754Likely Pathogenic-3.38Deleterious0.998Probably Damaging0.986Probably Damaging5.81Benign0.13Tolerated0.07620.30680-1-3.769.11
c.769A>G
S257G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S257G is not reported in ClinVar (ClinVar status: None) and has no entry in gnomAD (gnomAD status: None). Prediction tools that agree on a benign effect include SIFT, FATHMM, and AlphaMissense‑Optimized. In contrast, a majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments further support this view: AlphaMissense‑Optimized indicates a benign change, whereas the SGM‑Consensus (majority vote) indicates likely pathogenic. The Foldetta stability prediction is unavailable and therefore does not influence the overall assessment. Based on the preponderance of pathogenic predictions and the lack of any ClinVar annotation, the variant is most likely pathogenic, with no contradiction from existing ClinVar data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.258293Uncertain0.8470.2720.250-11.206Likely Pathogenic0.624Likely PathogenicLikely Benign0.61Ambiguous0.30.60Ambiguous0.61Ambiguous0.62Ambiguous0.703Likely Pathogenic-2.95Deleterious0.982Probably Damaging0.952Probably Damaging5.79Benign0.11Tolerated0.20870.3589100.4-30.03
c.769A>T
S257C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S257C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, Rosetta) and pathogenic predictions (REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar). The high‑accuracy consensus methods—AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta—each indicate a benign effect. No folding‑stability assessment is available beyond the benign Foldetta result. Overall, the majority of evidence points to a benign impact, and this conclusion is consistent with the absence of a ClinVar assertion. Thus, the variant is most likely benign, and this is not contradicted by ClinVar status, which has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.384043Structured0.258293Uncertain0.8470.2720.250-3.553Likely Benign0.189Likely BenignLikely Benign0.50Ambiguous0.4-0.33Likely Benign0.09Likely Benign-0.46Likely Benign0.611Likely Pathogenic0.02Neutral0.999Probably Damaging0.993Probably Damaging5.76Benign0.18Tolerated0.08800.51510-13.316.06
c.76G>C
G26R
2D
AIThe SynGAP1 missense variant G26R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of the four high‑accuracy tools) also yields benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence—including the high‑accuracy consensus—indicates that G26R is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.438291Uncertain0.3510.8780.375-2.946Likely Benign0.678Likely PathogenicLikely Benign0.189Likely Benign-2.22Neutral0.994Probably Damaging0.990Probably Damaging3.87Benign0.00Affected4.3210.10970.4407-3-2-4.199.14
c.770G>A
S257N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S257N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split consensus: benign calls come from FoldX, Rosetta, Foldetta, PROVEAN, SIFT, and FATHMM, while pathogenic calls come from REVEL, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments give an inconclusive SGM Consensus (a tie between AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), an uncertain AlphaMissense‑Optimized result, and a benign Foldetta prediction. No evidence of pathogenicity is supported by the protein‑stability analysis, which indicates a benign effect. Overall, the predictions are mixed, but the majority of high‑accuracy tools lean toward a benign interpretation. This assessment does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.384043Structured0.258293Uncertain0.8470.2720.250-10.508Likely Pathogenic0.820Likely PathogenicAmbiguous0.25Likely Benign0.1-0.18Likely Benign0.04Likely Benign0.85Ambiguous0.533Likely Pathogenic-2.30Neutral0.993Probably Damaging0.968Probably Damaging5.82Benign0.16Tolerated0.09850.359611-2.727.03
c.770G>C
S257T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S257T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b predict pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority benign) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. No prediction or stability result is missing or inconclusive. Overall, the preponderance of evidence indicates that S257T is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.384043Structured0.258293Uncertain0.8470.2720.250-8.603Likely Pathogenic0.243Likely BenignLikely Benign0.42Likely Benign0.1-0.16Likely Benign0.13Likely Benign0.06Likely Benign0.472Likely Benign-1.58Neutral0.982Probably Damaging0.952Probably Damaging5.83Benign0.48Tolerated0.10730.4898110.114.03
c.770G>T
S257I
2D
AIThe SynGAP1 missense variant S257I is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and Foldetta. Those that predict a pathogenic effect comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicating likely pathogenic, and Foldetta predicting a benign outcome. FoldX and Rosetta results are uncertain and therefore not considered. Overall, the balance of evidence leans toward a pathogenic interpretation, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.258293Uncertain0.8470.2720.250-12.126Likely Pathogenic0.595Likely PathogenicLikely Benign0.78Ambiguous1.0-1.17Ambiguous-0.20Likely Benign0.30Likely Benign0.739Likely Pathogenic-2.97Deleterious0.998Probably Damaging0.991Probably Damaging5.81Benign0.07Tolerated0.06810.5209-1-25.326.08
c.771C>A
S257R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S257R is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools show a split: benign calls come from FoldX, premPS, SIFT, and FATHMM, whereas pathogenic calls are made by REVEL, PROVEAN, both polyPhen‑2 versions, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools with uncertain outcomes include Rosetta and Foldetta. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic,” and Foldetta’s stability analysis is inconclusive. Overall, the majority of reliable predictors indicate a pathogenic impact, and this conclusion does not conflict with the absence of a ClinVar classification. Therefore, the variant is most likely pathogenic, and this assessment is consistent with its lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.258293Uncertain0.8470.2720.250-11.746Likely Pathogenic0.992Likely PathogenicLikely Pathogenic-0.18Likely Benign0.0-1.33Ambiguous-0.76Ambiguous0.29Likely Benign0.707Likely Pathogenic-3.38Deleterious0.998Probably Damaging0.986Probably Damaging5.81Benign0.13Tolerated0.07620.30680-1-3.769.11
c.771C>G
S257R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S257R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, premPS, SIFT, and FATHMM, whereas those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; Rosetta and Foldetta are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evaluated tools (7 pathogenic vs. 4 benign) indicate a pathogenic impact. Thus, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.258293Uncertain0.8470.2720.250-11.746Likely Pathogenic0.992Likely PathogenicLikely Pathogenic-0.18Likely Benign0.0-1.33Ambiguous-0.76Ambiguous0.29Likely Benign0.707Likely Pathogenic-3.38Deleterious0.998Probably Damaging0.986Probably Damaging5.81Benign0.13Tolerated0.07620.30680-1-3.769.11
c.772C>A
R258S
2D
AIThe SynGAP1 missense variant R258S is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect are limited to FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the preponderance of evidence points to a pathogenic effect for R258S, and this conclusion is consistent with the absence of ClinVar annotation or gnomAD frequency data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250-14.336Likely Pathogenic0.990Likely PathogenicLikely Pathogenic2.11Destabilizing0.81.29Ambiguous1.70Ambiguous1.14Destabilizing0.796Likely Pathogenic-4.92Deleterious0.997Probably Damaging0.987Probably Damaging5.89Benign0.01Affected0.30570.38810-13.7-69.11
c.772C>G
R258G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R258G is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while the remaining twelve tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify the variant as pathogenic; premPS remains uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. No prediction is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250-14.239Likely Pathogenic0.980Likely PathogenicLikely Pathogenic2.42Destabilizing0.52.33Destabilizing2.38Destabilizing0.94Ambiguous0.788Likely Pathogenic-5.83Deleterious0.997Probably Damaging0.987Probably Damaging5.78Benign0.04Affected0.31660.3447-3-24.1-99.14
c.773G>C
R258P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R258P is not reported in ClinVar and has no entries in gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while only FATHMM predicts a benign outcome. Predictions of uncertain status come from FoldX, Rosetta, and Foldetta. High‑accuracy tools reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta remains inconclusive. Overall, the preponderance of evidence supports a pathogenic classification for R258P, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250-14.293Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.26Ambiguous0.40.92Ambiguous1.09Ambiguous1.00Destabilizing0.924Likely Pathogenic-5.83Deleterious0.999Probably Damaging0.995Probably Damaging5.79Benign0.01Affected0.21480.45570-22.9-59.07
c.775C>G
R259G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R259G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, whereas the remaining 13 tools—including SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. The high‑accuracy subset reinforces this assessment: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. Rosetta alone is uncertain and is treated as unavailable. Overall, the consensus of available predictions indicates that R259G is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.338208Uncertain0.8850.2550.250-15.389Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.17Destabilizing0.61.53Ambiguous2.35Destabilizing1.14Destabilizing0.762Likely Pathogenic-6.43Deleterious0.997Probably Damaging0.987Probably Damaging5.78Benign0.00Affected0.33420.4139-3-24.1-99.14
c.775C>T
R259W
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R259W is listed in ClinVar with an uncertain significance (ClinVar ID 2014570.0) and is not reported in gnomAD. Functional prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining evaluated algorithms—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—consistently predict a pathogenic impact. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, remains inconclusive. Overall, the preponderance of evidence indicates that R259W is most likely pathogenic, a conclusion that does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.338208Uncertain0.8850.2550.250Uncertain 1-12.186Likely Pathogenic0.985Likely PathogenicLikely Pathogenic1.95Ambiguous0.80.51Ambiguous1.23Ambiguous0.51Ambiguous0.691Likely Pathogenic-7.35Deleterious1.000Probably Damaging0.993Probably Damaging5.76Benign0.00Affected3.39150.12210.42692-33.630.03254.040.00.20.20.20.4XXXPotentially PathogenicThe guanidinium group of Arg259, located at the beginning of an anti-parallel β sheet strand (res. Arg259-Arg272), forms salt bridges with the carboxylate groups of Asp684 at the end of an α helix (res. Ile683-Gln702, GAP domain) and Asp261 on the same β strand. The Arg259 side chain also frequently forms hydrogen bonds with the backbone carbonyl groups of Ser257, Asn256, and Asp255. In the variant simulations, the indole ring of the Trp259 side chain cannot form salt bridges or maintain hydrogen bonding with the carboxylate group of Asp684 or other nearby residues. Notably, the amino group of the Lys254 side chain maintains a salt bridge with Asp684 and Glu244 throughout the variant simulations, while it forms a cation-π bond with the indole ring of Trp259 in the variant. This salt bridge is not maintained in the WT simulations. Additionally, the partially or loosely α helical conformation of a lysine-containing loop (res. Lys251-Ser257), which extends to a nearby α helix (res. Met414-Asn426), could be stabilized due to the residue swap. Moreover, the bulky size of the Trp259 side chain requires nearby residues to adjust their positioning to accommodate the introduced residue, weakening the tertiary structure assembly between the C2, PH, and GAP domains. The residue swap potentially causes more severe effects during protein folding or for the SynGAP-membrane interaction than the solvent-only simulations imply.
c.776G>C
R259P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R259P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods further support this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic effect. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic based on the collective computational evidence, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.338208Uncertain0.8850.2550.250-14.876Likely Pathogenic0.999Likely PathogenicLikely Pathogenic6.34Destabilizing1.63.78Destabilizing5.06Destabilizing1.16Destabilizing0.902Likely Pathogenic-6.43Deleterious0.999Probably Damaging0.995Probably Damaging5.84Benign0.00Affected0.20510.52490-22.9-59.07
c.776G>T
R259L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R259L is not reported in ClinVar and is absent from gnomAD. Among the available in‑silico predictors, the benign‑predicted tools are Rosetta and FATHMM, while the pathogenic‑predicted tools include SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; Foldetta and premPS are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the majority of predictions support a pathogenic effect, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.338208Uncertain0.8850.2550.250-14.185Likely Pathogenic0.991Likely PathogenicLikely Pathogenic2.84Destabilizing1.10.16Likely Benign1.50Ambiguous0.64Ambiguous0.894Likely Pathogenic-6.43Deleterious0.997Probably Damaging0.987Probably Damaging5.87Benign0.00Affected0.19340.5499-3-28.3-43.03
c.778G>A
V260I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260I missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome, while ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts benign. Overall, the consensus of the majority of tools, including the high‑accuracy methods, points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.254060Structured0.382651Uncertain0.8880.2590.250-7.525In-Between0.104Likely BenignLikely Benign-0.16Likely Benign0.10.27Likely Benign0.06Likely Benign-0.14Likely Benign0.404Likely Benign-0.85Neutral0.994Probably Damaging0.970Probably Damaging5.83Benign0.19Tolerated0.05590.3704430.314.03
c.778G>C
V260L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260L missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from FoldX, Rosetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, polyPhen‑2 (HumDiv and HumVar) and ESM1b. The high‑accuracy assessment shows AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, and Foldetta predicts a benign effect on protein stability. No prediction is missing or inconclusive. Overall, the evidence points to a benign effect for V260L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-8.785Likely Pathogenic0.416AmbiguousLikely Benign-0.26Likely Benign0.10.15Likely Benign-0.06Likely Benign0.25Likely Benign0.532Likely Pathogenic-1.84Neutral0.994Probably Damaging0.970Probably Damaging5.90Benign0.11Tolerated0.07300.436021-0.414.03
c.778G>T
V260L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the aggregate predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-8.785Likely Pathogenic0.416AmbiguousLikely Benign-0.26Likely Benign0.10.15Likely Benign-0.06Likely Benign0.25Likely Benign0.532Likely Pathogenic-1.84Neutral0.994Probably Damaging0.970Probably Damaging5.90Benign0.11Tolerated0.07300.436021-0.414.03
c.779T>A
V260E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V260E is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include FoldX, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign impact on protein stability. Overall, the majority of computational evidence points toward a pathogenic interpretation, and this conclusion is not contradicted by the ClinVar status. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.254060Structured0.382651Uncertain0.8880.2590.250-9.516Likely Pathogenic0.667Likely PathogenicLikely Benign-0.02Likely Benign0.10.32Likely Benign0.15Likely Benign1.10Destabilizing0.848Likely Pathogenic-3.66Deleterious0.999Probably Damaging0.991Probably Damaging5.79Benign0.09Tolerated0.08460.1636-2-2-7.729.98
c.779T>C
V260A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260A missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, the SGM‑Consensus (majority vote), and Foldetta. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Two tools (premPS and AlphaMissense‑Default) give uncertain results. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus, and Foldetta—all indicate a benign outcome. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.254060Structured0.382651Uncertain0.8880.2590.250-3.271Likely Benign0.407AmbiguousLikely Benign0.38Likely Benign0.00.02Likely Benign0.20Likely Benign0.81Ambiguous0.487Likely Benign-1.41Neutral0.994Probably Damaging0.970Probably Damaging5.87Benign0.33Tolerated0.26760.190300-2.4-28.05
c.779T>G
V260G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260G missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FATHMM and AlphaMissense‑Optimized, while the majority of tools (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. FoldX, Rosetta, and Foldetta are uncertain and therefore not considered evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans pathogenic (3 pathogenic vs. 1 benign). Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for V260G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-9.300Likely Pathogenic0.644Likely PathogenicLikely Benign1.00Ambiguous0.31.86Ambiguous1.43Ambiguous1.40Destabilizing0.817Likely Pathogenic-4.20Deleterious0.991Probably Damaging0.999Probably Damaging5.76Benign0.00Affected0.18440.1949-1-3-4.6-42.08
c.77G>A
G26E
2D
AIThe SynGAP1 missense variant G26E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.438291Uncertain0.3510.8780.375-3.966Likely Benign0.481AmbiguousLikely Benign0.199Likely Benign-2.08Neutral0.994Probably Damaging0.986Probably Damaging3.90Benign0.00Affected0.16230.42380-2-3.172.06
c.77G>C
G26A
2D
AIThe SynGAP1 missense variant G26A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for G26A, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.438291Uncertain0.3510.8780.375-3.308Likely Benign0.135Likely BenignLikely Benign0.062Likely Benign-1.25Neutral0.953Possibly Damaging0.952Probably Damaging4.02Benign0.00Affected0.40930.5251102.214.03
c.781G>A
D261N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261N is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include premPS, FATHMM, and AlphaMissense‑Optimized, while the majority of tools predict a pathogenic outcome: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-11.804Likely Pathogenic0.746Likely PathogenicLikely Benign1.58Ambiguous0.71.28Ambiguous1.43Ambiguous0.23Likely Benign0.579Likely Pathogenic-2.94Deleterious0.997Probably Damaging0.989Probably Damaging5.82Benign0.02Affected0.07670.4745210.0-0.98
c.781G>C
D261H
2D
AIThe SynGAP1 missense variant D261H is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are premPS and FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; Rosetta is uncertain and is treated as unavailable. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic (3 pathogenic vs. 1 benign); and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Thus, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-13.688Likely Pathogenic0.961Likely PathogenicLikely Pathogenic4.33Destabilizing3.20.93Ambiguous2.63Destabilizing0.33Likely Benign0.780Likely Pathogenic-3.67Deleterious1.000Probably Damaging0.997Probably Damaging6.04Benign0.01Affected0.09370.54651-10.322.05
c.781G>T
D261Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D261Y missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are premPS and FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic effect; and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. No prediction or folding stability result is missing or inconclusive beyond the stated uncertainties. Overall, the preponderance of evidence points to a pathogenic effect for D261Y, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-14.961Likely Pathogenic0.955Likely PathogenicAmbiguous2.93Destabilizing2.10.81Ambiguous1.87Ambiguous-0.12Likely Benign0.886Likely Pathogenic-5.50Deleterious1.000Probably Damaging0.997Probably Damaging5.73Benign0.01Affected0.04740.5476-4-32.248.09
c.782A>C
D261A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D261A missense variant is not reported in ClinVar (status: None) and has no entries in gnomAD. Prediction tools that agree on a benign effect include premPS and FATHMM, while the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Given the preponderance of pathogenic predictions and the lack of conflicting evidence, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status (which is currently unreported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-11.426Likely Pathogenic0.913Likely PathogenicAmbiguous1.70Ambiguous0.31.46Ambiguous1.58Ambiguous0.04Likely Benign0.839Likely Pathogenic-4.59Deleterious0.999Probably Damaging0.994Probably Damaging5.80Benign0.04Affected0.27850.45770-25.3-44.01
c.782A>G
D261G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261G is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include premPS and FATHMM, while the remaining tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-10.847Likely Pathogenic0.945Likely PathogenicAmbiguous2.81Destabilizing0.52.96Destabilizing2.89Destabilizing0.21Likely Benign0.850Likely Pathogenic-4.77Deleterious0.997Probably Damaging0.989Probably Damaging5.81Benign0.02Affected0.29240.45621-13.1-58.04
c.782A>T
D261V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, and FATHMM, while those that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of available predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-12.138Likely Pathogenic0.923Likely PathogenicAmbiguous1.72Ambiguous0.6-0.68Ambiguous0.52Ambiguous-0.01Likely Benign0.869Likely Pathogenic-5.50Deleterious0.999Probably Damaging0.996Probably Damaging5.73Benign0.08Tolerated0.05530.4734-2-37.7-15.96
c.783C>A
D261E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The high‑accuracy consensus from AlphaMissense‑Optimized and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) both indicate a benign outcome, while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is inconclusive. Overall, the majority of evidence points to a benign impact. This assessment is consistent with the absence of ClinVar annotation and does not contradict any existing database status. Based on the predictions, the variant is most likely benign, and this does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.422514Uncertain0.8830.2640.125-2.646Likely Benign0.268Likely BenignLikely Benign1.44Ambiguous0.80.79Ambiguous1.12Ambiguous-0.03Likely Benign0.377Likely Benign0.20Neutral0.994Probably Damaging0.978Probably Damaging5.88Benign1.00Tolerated0.09630.4359320.014.03
c.783C>G
D261E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Protein‑stability calculations from FoldX and Rosetta are uncertain. Overall, the majority of evidence points to a benign impact, which is consistent with the absence of a ClinVar claim and gnomAD observation. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.422514Uncertain0.8830.2640.125-2.646Likely Benign0.268Likely BenignLikely Benign1.44Ambiguous0.80.79Ambiguous1.12Ambiguous-0.03Likely Benign0.377Likely Benign0.20Neutral0.994Probably Damaging0.978Probably Damaging5.88Benign1.00Tolerated0.09630.4359320.014.03
c.784A>C
N262H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. FoldX and Foldetta results are uncertain, providing no clear direction. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.399879Uncertain0.9120.2400.000-6.932Likely Benign0.154Likely BenignLikely Benign1.82Ambiguous0.50.41Likely Benign1.12Ambiguous0.33Likely Benign0.694Likely Pathogenic-3.44Deleterious0.999Probably Damaging0.994Probably Damaging5.81Benign0.41Tolerated0.11220.4860210.323.04
c.784A>T
N262Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of predictions (seven pathogenic vs. three benign) lean toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-12.177Likely Pathogenic0.490AmbiguousLikely Benign1.86Ambiguous0.50.52Ambiguous1.19Ambiguous0.36Likely Benign0.858Likely Pathogenic-6.48Deleterious0.999Probably Damaging0.996Probably Damaging5.85Benign0.01Affected0.04450.3877-2-22.249.07
c.785A>C
N262T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262T has no ClinVar record and is not reported in gnomAD. Functional prediction tools cluster into three groups: benign predictions come from SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b; the remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta’s stability analysis is uncertain. Overall, the balance of evidence leans toward pathogenicity, with no conflict with ClinVar status (which is absent). Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-11.478Likely Pathogenic0.544AmbiguousLikely Benign1.40Ambiguous0.31.44Ambiguous1.42Ambiguous0.74Ambiguous0.723Likely Pathogenic-5.23Deleterious0.997Probably Damaging0.980Probably Damaging5.88Benign0.19Tolerated0.10550.5164002.8-13.00
c.785A>G
N262S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N262S is not listed in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools cluster into two groups: benign predictions come from SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is uncertain. Consequently, the overall evidence is mixed, with a slight tilt toward pathogenicity because five tools predict pathogenic while four predict benign. The variant is most likely pathogenic based on the current predictions, and this assessment does not contradict ClinVar status, as the variant is not yet reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-8.841Likely Pathogenic0.182Likely BenignLikely Benign0.91Ambiguous0.20.90Ambiguous0.91Ambiguous0.69Ambiguous0.638Likely Pathogenic-4.31Deleterious0.997Probably Damaging0.970Probably Damaging5.84Benign0.16Tolerated0.31010.5158112.7-27.03
c.785A>T
N262I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262I is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include premPS and FATHMM, whereas the majority of tools predict a pathogenic outcome: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. Predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are uncertain and therefore treated as unavailable. High‑accuracy methods give an uncertain result for AlphaMissense‑Optimized, a pathogenic consensus from SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and an uncertain result for Foldetta. Overall, the evidence points to a pathogenic effect for the variant, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-15.203Likely Pathogenic0.868Likely PathogenicAmbiguous1.21Ambiguous0.40.54Ambiguous0.88Ambiguous0.09Likely Benign0.777Likely Pathogenic-7.79Deleterious0.999Probably Damaging0.994Probably Damaging5.88Benign0.01Affected0.04490.4638-2-38.0-0.94
c.786T>A
N262K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262K has no ClinVar entry and is not present in gnomAD. Prediction tools that indicate a benign effect include FoldX, premPS, and FATHMM. Those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are reported by Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as inconclusive. Overall, the majority of evidence points to a pathogenic impact for N262K. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-12.512Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.47Likely Benign0.21.00Ambiguous0.74Ambiguous0.33Likely Benign0.531Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.986Probably Damaging5.84Benign0.02Affected0.17990.341310-0.414.07
c.786T>G
N262K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262K has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely disagree: benign predictions come from FoldX, premPS, and FATHMM, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Rosetta and Foldetta. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as inconclusive. Taken together, the majority of evidence points to a pathogenic effect for N262K. This conclusion is consistent with the absence of a ClinVar classification, as there is no existing report to contradict the prediction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-12.512Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.47Likely Benign0.21.00Ambiguous0.74Ambiguous0.33Likely Benign0.532Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.986Probably Damaging5.84Benign0.02Affected0.17990.341310-0.414.07
c.787G>A
V263M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263M is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT predict a pathogenic impact. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts Benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Benign. No conflicting evidence is present. **Based on the aggregate predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-5.956Likely Benign0.218Likely BenignLikely Benign0.20Likely Benign0.1-0.24Likely Benign-0.02Likely Benign0.43Likely Benign0.444Likely Benign-0.95Neutral0.999Probably Damaging0.994Probably Damaging5.84Benign0.03Affected0.06650.354521-2.332.06
c.787G>C
V263L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are Rosetta (Uncertain) and premPS (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.599Likely Benign0.275Likely BenignLikely Benign-0.16Likely Benign0.1-0.63Ambiguous-0.40Likely Benign0.66Ambiguous0.453Likely Benign-1.26Neutral0.994Probably Damaging0.970Probably Damaging5.85Benign0.18Tolerated0.07590.395021-0.414.03
c.787G>T
V263L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are Rosetta (Uncertain) and premPS (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.599Likely Benign0.275Likely BenignLikely Benign-0.16Likely Benign0.1-0.63Ambiguous-0.40Likely Benign0.66Ambiguous0.453Likely Benign-1.26Neutral0.994Probably Damaging0.970Probably Damaging5.85Benign0.18Tolerated0.07590.395021-0.414.03
c.788T>A
V263E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V263E missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools largely agree on a deleterious effect: FATHMM predicts the variant as benign, while the remaining twelve tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify it as pathogenic. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized remains uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic impact for V263E, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.356141Uncertain0.9180.2570.000-13.498Likely Pathogenic0.809Likely PathogenicAmbiguous2.04Destabilizing0.32.18Destabilizing2.11Destabilizing1.99Destabilizing0.862Likely Pathogenic-3.84Deleterious0.999Probably Damaging0.991Probably Damaging5.96Benign0.01Affected0.08860.1436-2-2-7.729.98
c.788T>C
V263A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from Rosetta, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), and SIFT. Predictions marked “Uncertain” include FoldX, Foldetta, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of evidence points to a benign effect. Thus, the variant is most likely benign based on current predictions, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.877Likely Benign0.530AmbiguousLikely Benign1.40Ambiguous0.10.00Likely Benign0.70Ambiguous1.26Destabilizing0.622Likely Pathogenic-2.17Neutral0.994Probably Damaging0.970Probably Damaging5.97Benign0.04Affected0.25650.182200-2.4-28.05
c.788T>G
V263G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V263G missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are FATHMM and AlphaMissense‑Optimized; those that agree on a pathogenic effect are REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Rosetta and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta’s stability prediction is uncertain. Overall, the preponderance of evidence points to a pathogenic impact for V263G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.268042Structured0.356141Uncertain0.9180.2570.000-10.388Likely Pathogenic0.669Likely PathogenicLikely Benign2.27Destabilizing0.21.63Ambiguous1.95Ambiguous1.88Destabilizing0.820Likely Pathogenic-4.59Deleterious0.991Probably Damaging0.999Probably Damaging6.07Benign0.01Affected0.17900.1868-1-3-4.6-42.08
c.790C>G
L264V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L264V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and AlphaMissense‑Optimized; all other evaluated algorithms (SGM‑Consensus, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic or likely pathogenic outcome, while Rosetta remains uncertain. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) classifies the variant as Pathogenic. Overall, the preponderance of evidence points to a pathogenic effect for L264V, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.323473Uncertain0.9390.2640.000-10.621Likely Pathogenic0.630Likely PathogenicLikely Benign2.55Destabilizing0.11.62Ambiguous2.09Destabilizing1.24Destabilizing0.444Likely Benign-2.76Deleterious0.999Probably Damaging0.994Probably Damaging0.73Pathogenic0.01Affected0.12800.2289210.4-14.03
c.791T>A
L264Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L264Q is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset predicts a benign outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, a conclusion that contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.323473Uncertain0.9390.2640.000Uncertain 1-15.729Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.43Destabilizing0.12.41Destabilizing2.92Destabilizing2.48Destabilizing0.678Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging0.49Pathogenic0.00Affected3.38180.09420.0558-2-2-7.314.97254.7-7.60.00.00.00.3XXXPotentially PathogenicThe iso-butyl branched hydrocarbon side chain of Leu264, located at the end of an anti-parallel β sheet strand (res. Arg259-Arg272), packs against multiple hydrophobic residues such as Leu266, Phe314, Leu317, and Leu323 in the WT simulations. In the variant simulations, the hydrophilic carboxamide group of the Gln264 side chain is not suitable for the hydrophobic niche, causing the hydrophobic residues to make room for the swapped residue. Additionally, the carboxamide group of Gln264 forms hydrogen bonds with the backbone amide groups of Arg405 and Lys256 in the β sheet and the carbonyl group of Val350 in an α helical section of a nearby loop (res. Pro359-Phe358). The residue swap disrupts the packing of the C2 domain, which could adversely affect the C2 domain structure during folding. This disruption could potentially weaken the stability of the SynGAP-membrane association.
c.791T>C
L264P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L264P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset reports a benign outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, a conclusion that contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.323473Uncertain0.9390.2640.000Uncertain 1-12.285Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.73Destabilizing0.36.57Destabilizing6.15Destabilizing2.65Destabilizing0.767Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging0.49Pathogenic0.00Affected0.32390.1053-3-3-5.4-16.04
c.791T>G
L264R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L264R is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Consequently, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.323473Uncertain0.9390.2640.000-16.976Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.25Destabilizing0.33.37Destabilizing3.81Destabilizing2.28Destabilizing0.742Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging0.49Pathogenic0.00Affected0.11320.0558-3-2-8.343.03
c.793A>C
K265Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K265Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Among standard in‑silico predictors, five tools (REVEL, FoldX, PROVEAN, AlphaMissense‑Optimized, Foldetta) predict a benign effect, while five (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM) predict pathogenicity. Three tools (premPS, AlphaMissense‑Default, Rosetta) are inconclusive. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a pathogenic consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and a benign outcome from Foldetta. Overall, the predictions are mixed; the balance of evidence, including the two high‑confidence benign calls, suggests the variant is more likely benign, and this does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.209395Structured0.309758Uncertain0.9360.2750.000-8.533Likely Pathogenic0.505AmbiguousLikely Benign0.35Likely Benign0.1-1.15Ambiguous-0.40Likely Benign0.80Ambiguous0.386Likely Benign-2.46Neutral1.000Probably Damaging0.998Probably Damaging1.85Pathogenic0.05Affected0.44010.1062110.4-0.04
c.793A>G
K265E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K265E missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, and Foldetta. Those that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are AlphaMissense‑Optimized, FoldX, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evaluated tools (eight pathogenic vs. three benign) indicate a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.209395Structured0.309758Uncertain0.9360.2750.000-12.163Likely Pathogenic0.952Likely PathogenicAmbiguous0.63Ambiguous0.20.00Likely Benign0.32Likely Benign0.95Ambiguous0.461Likely Benign-2.79Deleterious0.999Probably Damaging0.995Probably Damaging1.94Pathogenic0.05Affected0.38010.0882010.40.94
c.794A>G
K265R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K265R is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster into two groups: benign predictions include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports benign. No prediction or stability result is missing or inconclusive. Based on the aggregate evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.209395Structured0.309758Uncertain0.9360.2750.000-3.366Likely Benign0.136Likely BenignLikely Benign0.04Likely Benign0.1-0.44Likely Benign-0.20Likely Benign0.30Likely Benign0.223Likely Benign-1.08Neutral0.999Probably Damaging0.995Probably Damaging1.90Pathogenic0.36Tolerated0.47130.097632-0.628.01
c.794A>T
K265M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K265M missense variant is not reported in ClinVar and has no entries in gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all classify it as damaging. Benign predictions are limited to FoldX, Foldetta, and premPS. Uncertain results come from Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments reinforce this view: the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, while Foldetta predicts a benign folding‑stability change. Overall, the preponderance of evidence supports a pathogenic classification for K265M, and this conclusion is not contradicted by the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.209395Structured0.309758Uncertain0.9360.2750.000-10.885Likely Pathogenic0.904Likely PathogenicAmbiguous-0.22Likely Benign0.2-0.63Ambiguous-0.43Likely Benign0.19Likely Benign0.516Likely Pathogenic-3.78Deleterious1.000Probably Damaging0.999Probably Damaging1.79Pathogenic0.01Affected0.10050.36950-15.83.02
c.795G>C
K265N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K265N missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and Rosetta, whereas the majority of algorithms predict a pathogenic outcome: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Uncertain results are reported by FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Based on the overall consensus of the available predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.209395Structured0.309758Uncertain0.9360.2750.000-8.759Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.98Ambiguous0.10.16Likely Benign0.57Ambiguous0.85Ambiguous0.350Likely Benign-3.26Deleterious1.000Probably Damaging0.998Probably Damaging1.86Pathogenic0.03Affected0.36910.1158100.4-14.07
c.795G>T
K265N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K265N missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and Rosetta, while the majority of algorithms predict a pathogenic outcome: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Uncertain or inconclusive results are reported only for FoldX, Foldetta, and premPS, and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Based on the overall consensus of the available predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.209395Structured0.309758Uncertain0.9360.2750.000-8.759Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.98Ambiguous0.10.16Likely Benign0.57Ambiguous0.85Ambiguous0.351Likely Benign-3.26Deleterious1.000Probably Damaging0.998Probably Damaging1.86Pathogenic0.03Affected0.36910.1158100.4-14.07
c.796C>A
L266M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L266M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Two tools remain uncertain: premPS and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of tools (six benign vs. four pathogenic, with two uncertain) lean toward a benign classification, and this conclusion is not contradicted by ClinVar status. Thus, the variant is most likely benign based on the collective predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.232838Structured0.297157Uncertain0.9480.2640.000-9.740Likely Pathogenic0.362AmbiguousLikely Benign0.07Likely Benign0.1-0.47Likely Benign-0.20Likely Benign0.95Ambiguous0.288Likely Benign-1.66Neutral1.000Probably Damaging0.999Probably Damaging1.55Pathogenic0.07Tolerated0.05810.285342-1.918.03
c.796C>G
L266V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L266V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. FoldX, Rosetta, and Foldetta give uncertain results and are therefore considered unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta is also inconclusive. Consequently, the variant is most likely benign based on the current predictions, and this assessment does not contradict ClinVar, which has no reported status for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.232838Structured0.297157Uncertain0.9480.2640.000-8.586Likely Pathogenic0.153Likely BenignLikely Benign1.71Ambiguous0.10.97Ambiguous1.34Ambiguous1.32Destabilizing0.193Likely Benign-2.20Neutral0.999Probably Damaging0.994Probably Damaging2.37Pathogenic0.11Tolerated0.11520.2456210.4-14.03
c.797T>A
L266Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L266Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect: none. Tools that agree on a pathogenic effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). The only tool with an uncertain outcome is Rosetta. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.297157Uncertain0.9480.2640.000-16.672Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.92Destabilizing0.11.49Ambiguous2.21Destabilizing2.21Destabilizing0.563Likely Pathogenic-5.25Deleterious1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.00Affected0.08150.0558-2-2-7.314.97
c.797T>C
L266P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L266P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. No conflicting benign evidence is present. Therefore, the variant is most likely pathogenic, and this conclusion is consistent with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.297157Uncertain0.9480.2640.000-15.752Likely Pathogenic0.999Likely PathogenicLikely Pathogenic7.08Destabilizing0.14.02Destabilizing5.55Destabilizing2.31Destabilizing0.654Likely Pathogenic-6.06Deleterious1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.00Affected0.31580.1021-3-3-5.4-16.04
c.797T>G
L266R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L266R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect, so the benign‑prediction group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.297157Uncertain0.9480.2640.000-17.131Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.97Destabilizing0.22.76Destabilizing3.37Destabilizing2.04Destabilizing0.574Likely Pathogenic-5.32Deleterious1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.00Affected0.10590.0558-3-2-8.343.03
c.799T>A
W267R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W267R has no ClinVar entry and is not reported in gnomAD. Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return pathogenic or likely pathogenic scores. Tools that are inconclusive (FoldX and premPS) are noted as uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No benign predictions are present. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.298060Uncertain0.9430.2740.000-13.868Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.94Ambiguous0.12.47Destabilizing2.21Destabilizing0.51Ambiguous0.672Likely Pathogenic-12.87Deleterious1.000Probably Damaging0.999Probably Damaging2.00Pathogenic0.01Affected0.37630.05712-3-3.6-30.03
c.799T>C
W267R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W267R is not reported in ClinVar (ClinVar status: None) and has no entries in gnomAD (gnomAD ID: None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tools predict a benign outcome. Uncertain predictions are provided by FoldX and premPS. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts Likely Pathogenic; and Foldetta predicts Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.298060Uncertain0.9430.2740.000-13.868Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.94Ambiguous0.12.47Destabilizing2.21Destabilizing0.51Ambiguous0.672Likely Pathogenic-12.87Deleterious1.000Probably Damaging0.999Probably Damaging2.00Pathogenic0.01Affected0.37630.05712-3-3.6-30.03
c.799T>G
W267G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W267G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy methods corroborate this: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Thus, the variant is most likely pathogenic, with no contradiction to its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.298060Uncertain0.9430.2740.000-15.020Likely Pathogenic0.993Likely PathogenicLikely Pathogenic4.40Destabilizing0.23.99Destabilizing4.20Destabilizing1.20Destabilizing0.678Likely Pathogenic-11.95Deleterious0.999Probably Damaging0.996Probably Damaging1.96Pathogenic0.03Affected0.40490.1481-7-20.5-129.16
c.79C>A
P27T
2D
AIThe SynGAP1 missense variant P27T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. Foldetta results are unavailable. Overall, the majority of evidence, including high‑accuracy tools, points to a benign effect for P27T, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.437871Uncertain0.4300.8810.375-3.612Likely Benign0.103Likely BenignLikely Benign0.106Likely Benign-2.07Neutral0.909Possibly Damaging0.901Possibly Damaging3.85Benign0.00Affected0.24300.59230-10.93.99
c.79C>G
P27A
2D
AIThe SynGAP1 missense variant P27A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. Foldetta results are unavailable. Overall, the majority of evidence, including high‑accuracy tools, points to a benign effect for P27A, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.437871Uncertain0.4300.8810.375-3.409Likely Benign0.079Likely BenignLikely Benign0.077Likely Benign-1.98Neutral0.805Possibly Damaging0.857Possibly Damaging3.90Benign0.00Affected0.40410.52191-13.4-26.04
c.7A>G
R3G
2D
AIThe SynGAP1 missense variant R3G is reported in gnomAD (ID 6‑33420271‑A‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts it as pathogenic, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also likely benign; Foldetta results are unavailable. Taken together, the preponderance of evidence points to a benign impact. This conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.538167Disordered0.550331Binding0.3580.9200.8756-33420271-A-G-3.093Likely Benign0.160Likely BenignLikely Benign0.099Likely Benign-0.20Neutral0.115Benign0.018Benign3.99Benign0.00Affected4.3210.35590.4114-2-34.1-99.14
c.7A>T
R3W
2D
AIThe SynGAP1 missense variant R3W is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign. Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for R3W, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.538167Disordered0.550331Binding0.3580.9200.875-5.023Likely Benign0.591Likely PathogenicLikely Benign0.122Likely Benign0.08Neutral0.962Probably Damaging0.363Benign3.94Benign0.00Affected0.14070.46342-33.630.03
c.800G>C
W267S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W267S is not listed in ClinVar and has no allele in gnomAD. Functional prediction tools largely agree on a deleterious effect: SIFT is the sole benign predictor, whereas the remaining 12 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all report pathogenicity; premPS is uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.298060Uncertain0.9430.2740.000-12.833Likely Pathogenic0.993Likely PathogenicLikely Pathogenic3.42Destabilizing0.33.20Destabilizing3.31Destabilizing0.87Ambiguous0.593Likely Pathogenic-12.87Deleterious1.000Probably Damaging0.999Probably Damaging2.03Pathogenic0.09Tolerated0.38090.1415-2-30.1-99.14
c.800G>T
W267L
2D
AIThe SynGAP1 missense variant W267L is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset predicts a benign effect. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS, which are treated as unavailable evidence. High‑accuracy assessments further support a damaging effect: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” while Foldetta’s stability prediction is uncertain. Overall, the evidence strongly indicates that W267L is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.298060Uncertain0.9430.2740.000-13.670Likely Pathogenic0.990Likely PathogenicLikely Pathogenic1.19Ambiguous0.71.31Ambiguous1.25Ambiguous0.75Ambiguous0.628Likely Pathogenic-11.95Deleterious0.999Probably Damaging0.996Probably Damaging1.93Pathogenic0.01Affected0.21220.2843-2-24.7-73.05
c.801G>C
W267C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W267C is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Thus, the variant is most likely pathogenic based on the consensus of all predictions, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.298060Uncertain0.9430.2740.000-12.351Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.81Destabilizing0.22.20Destabilizing2.51Destabilizing1.00Destabilizing0.705Likely Pathogenic-11.95Deleterious1.000Probably Damaging0.999Probably Damaging1.90Pathogenic0.01Affected0.35730.1700-8-23.4-83.07
c.801G>T
W267C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W267C is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Thus, the variant is most likely pathogenic based on the consensus of all predictions, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.298060Uncertain0.9430.2740.000-12.351Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.81Destabilizing0.22.20Destabilizing2.51Destabilizing1.00Destabilizing0.705Likely Pathogenic-11.95Deleterious1.000Probably Damaging0.999Probably Damaging1.90Pathogenic0.01Affected0.35730.1700-8-23.4-83.07
c.802A>C
I268L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Two tools give uncertain results: premPS and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, and Foldetta indicates a benign folding‑stability outcome. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.216401Structured0.314336Uncertain0.9510.2640.000-6.544Likely Benign0.402AmbiguousLikely Benign0.37Likely Benign0.1-0.07Likely Benign0.15Likely Benign0.96Ambiguous0.390Likely Benign-1.84Neutral0.981Probably Damaging0.970Probably Damaging1.65Pathogenic0.03Affected0.06350.303722-0.70.00
c.802A>G
I268V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also as likely benign, while Foldetta’s stability analysis is uncertain. Overall, the majority of reliable predictors indicate a benign impact, and this is consistent with the lack of ClinVar evidence; there is no contradiction with ClinVar status. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.216401Structured0.314336Uncertain0.9510.2640.000-4.553Likely Benign0.147Likely BenignLikely Benign1.46Ambiguous0.00.95Ambiguous1.21Ambiguous0.71Ambiguous0.139Likely Benign-0.56Neutral0.958Probably Damaging0.970Probably Damaging2.15Pathogenic0.71Tolerated0.08450.248943-0.3-14.03
c.802A>T
I268F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the SGM‑Consensus score is “Likely Pathogenic.” No tool in the dataset predicts a benign outcome; only Rosetta and Foldetta are uncertain. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) remains uncertain. Overall, the consensus of available predictions strongly supports a pathogenic classification for I268F, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.314336Uncertain0.9510.2640.000-11.426Likely Pathogenic0.968Likely PathogenicLikely Pathogenic2.85Destabilizing0.70.59Ambiguous1.72Ambiguous1.00Destabilizing0.685Likely Pathogenic-3.68Deleterious0.999Probably Damaging0.996Probably Damaging1.53Pathogenic0.00Affected0.04270.215810-1.734.02
c.803T>A
I268N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.314336Uncertain0.9510.2640.000-13.664Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.48Destabilizing0.13.17Destabilizing3.33Destabilizing2.21Destabilizing0.812Likely Pathogenic-6.26Deleterious0.999Probably Damaging0.998Probably Damaging1.51Pathogenic0.00Affected0.07080.0142-2-3-8.00.94
c.803T>C
I268T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268T is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on pathogenicity include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; no tool predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenicity, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a destabilizing, pathogenic effect. All available predictions are concordant and point to a deleterious impact. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.314336Uncertain0.9510.2640.000-10.753Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.44Destabilizing0.13.19Destabilizing3.32Destabilizing1.93Destabilizing0.828Likely Pathogenic-4.24Deleterious0.997Probably Damaging0.994Probably Damaging1.53Pathogenic0.00Affected0.08820.06380-1-5.2-12.05
c.803T>G
I268S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.314336Uncertain0.9510.2640.000-13.032Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.93Destabilizing0.14.54Destabilizing4.74Destabilizing2.10Destabilizing0.841Likely Pathogenic-5.34Deleterious0.999Probably Damaging0.996Probably Damaging1.53Pathogenic0.00Affected0.20370.0530-1-2-5.3-26.08
c.805A>C
I269L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I269L missense variant is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in silico predictors shows a predominance of benign calls: REVEL, FoldX, Rosetta, premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized all predict benign. Pathogenicity is suggested by polyPhen‑2 (HumDiv and HumVar) and FATHMM, while ESM1b and AlphaMissense‑Default remain uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, Foldetta predicts benign stability, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to an equal split between benign and pathogenic signals. Overall, the balance of evidence favors a benign effect for I269L, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.216401Structured0.343787Uncertain0.9370.2440.125-7.588In-Between0.470AmbiguousLikely Benign0.00Likely Benign0.00.19Likely Benign0.10Likely Benign0.47Likely Benign0.348Likely Benign-1.47Neutral0.981Probably Damaging0.970Probably Damaging1.88Pathogenic0.28Tolerated0.06620.281722-0.70.00
c.805A>G
I269V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I269V missense variant has no ClinVar record (ClinVar ID None) and is not reported in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Predictions that are uncertain or inconclusive are FoldX, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools lean toward a benign interpretation, but the high‑accuracy consensus indicates a pathogenic signal, leaving the variant’s clinical significance uncertain. This assessment does not contradict any existing ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.216401Structured0.343787Uncertain0.9370.2440.125-8.748Likely Pathogenic0.344AmbiguousLikely Benign0.95Ambiguous0.00.49Likely Benign0.72Ambiguous0.71Ambiguous0.393Likely Benign-0.72Neutral0.958Probably Damaging0.970Probably Damaging1.87Pathogenic0.10Tolerated0.08440.285943-0.3-14.03
c.805A>T
I269L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I269L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two consensus groups: eight tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, AlphaMissense‑Optimized) predict a benign effect, while three tools (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM) predict pathogenicity. Two tools (ESM1b, AlphaMissense‑Default) return uncertain results. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized classifies the variant as benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts a benign impact. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields no clear majority and is therefore unavailable as evidence. Overall, the preponderance of evidence supports a benign classification, which is consistent with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.216401Structured0.343787Uncertain0.9370.2440.125-7.588In-Between0.470AmbiguousLikely Benign0.00Likely Benign0.00.19Likely Benign0.10Likely Benign0.47Likely Benign0.348Likely Benign-1.47Neutral0.981Probably Damaging0.970Probably Damaging1.88Pathogenic0.28Tolerated0.06620.281722-0.70.00
c.806T>A
I269K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I269K is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools largely agree on a deleterious effect: SIFT is the sole benign predictor, whereas the remaining methods—SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. FoldX and Rosetta individually report uncertain effects, and Foldetta remains unavailable. Overall, the consensus of the majority of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.343787Uncertain0.9370.2440.125-14.609Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.45Ambiguous0.11.86Ambiguous1.66Ambiguous1.55Destabilizing0.763Likely Pathogenic-5.10Deleterious0.999Probably Damaging0.998Probably Damaging1.76Pathogenic0.06Tolerated0.08780.0713-2-3-8.415.01
c.806T>G
I269R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I269R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: the benign group contains only SIFT, whereas the pathogenic group includes SGM‑Consensus (Likely Pathogenic), REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Rosetta give uncertain results, and Foldetta is also uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as unavailable. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.343787Uncertain0.9370.2440.125-14.567Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.34Ambiguous0.11.99Ambiguous1.67Ambiguous1.50Destabilizing0.765Likely Pathogenic-5.23Deleterious0.999Probably Damaging0.998Probably Damaging1.69Pathogenic0.07Tolerated0.11080.0870-2-3-9.043.03
c.807A>G
I269M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I269M is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include PROVEAN and AlphaMissense‑Optimized, whereas REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default predict it to be pathogenic. Five tools (FoldX, Rosetta, Foldetta, premPS, and ESM1b) give uncertain results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized reports a benign effect, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, and Foldetta remains uncertain. Overall, the majority of predictions support a pathogenic impact, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.216401Structured0.343787Uncertain0.9370.2440.125-7.863In-Between0.715Likely PathogenicLikely Benign0.91Ambiguous0.11.66Ambiguous1.29Ambiguous0.94Ambiguous0.507Likely Pathogenic-2.19Neutral0.999Probably Damaging0.998Probably Damaging1.75Pathogenic0.05Affected0.05800.228321-2.618.03
c.808G>A
E270K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E270K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools give uncertain results: Foldetta (a combined FoldX‑MD/Rosetta stability assessment) and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta remains uncertain. Based on the overall consensus of the available predictions, the variant is most likely pathogenic, which is consistent with the lack of ClinVar reporting and gnomAD absence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-14.466Likely Pathogenic0.995Likely PathogenicLikely Pathogenic-0.06Likely Benign0.22.26Destabilizing1.10Ambiguous0.71Ambiguous0.530Likely Pathogenic-3.68Deleterious0.999Probably Damaging0.995Probably Damaging1.68Pathogenic0.01Affected0.22960.425101-0.4-0.94
c.808G>C
E270Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270Q missense variant is not reported in ClinVar (status: None) and has no entry in gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, and premPS, whereas the majority of tools predict pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates several high‑accuracy predictors, classifies the variant as Likely Pathogenic. High‑accuracy methods give the following results: AlphaMissense‑Optimized is Uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is Uncertain. Rosetta alone is Uncertain, and Foldetta’s uncertainty reflects limited stability change evidence. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-11.096Likely Pathogenic0.886Likely PathogenicAmbiguous0.00Likely Benign0.21.00Ambiguous0.50Ambiguous0.46Likely Benign0.418Likely Benign-2.76Deleterious0.999Probably Damaging0.996Probably Damaging1.65Pathogenic0.03Affected0.10440.4015220.0-0.98
c.809A>C
E270A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270A missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools cluster into three groups: benign predictions are made only by premPS; pathogenic predictions are made by SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; and three tools (FoldX, Rosetta, Foldetta) give uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, while Foldetta remains uncertain. Overall, the majority of evidence points to a deleterious effect. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-13.618Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.64Ambiguous0.20.77Ambiguous0.71Ambiguous0.41Likely Benign0.547Likely Pathogenic-5.52Deleterious0.999Probably Damaging0.995Probably Damaging1.61Pathogenic0.01Affected0.41220.39510-15.3-58.04
c.809A>G
E270G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E270G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Pathogenic. Rosetta also predicts pathogenicity, while FoldX, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. No tool predicts a benign effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-13.759Likely Pathogenic0.968Likely PathogenicLikely Pathogenic1.23Ambiguous0.22.37Destabilizing1.80Ambiguous0.61Ambiguous0.576Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.996Probably Damaging1.63Pathogenic0.00Affected0.32540.38760-23.1-72.06
c.809A>T
E270V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E270V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that assess sequence conservation and structural impact uniformly classify the substitution as pathogenic: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return pathogenic scores. No tool predicts a benign effect. Uncertain results are reported only by FoldX, Rosetta, Foldetta, and premPS, which are not considered evidence for or against pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic”; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is inconclusive. Overall, the consensus of available predictions indicates that E270V is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-15.969Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.38Ambiguous0.61.88Ambiguous1.63Ambiguous-0.52Ambiguous0.574Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.998Probably Damaging1.53Pathogenic0.00Affected0.06720.4498-2-27.7-29.98
c.80C>A
P27H
2D
AIThe SynGAP1 missense variant P27H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for P27H, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.437871Uncertain0.4300.8810.375-4.116Likely Benign0.177Likely BenignLikely Benign0.128Likely Benign-2.46Neutral0.992Probably Damaging0.977Probably Damaging3.79Benign0.00Affected0.23840.52900-2-1.640.02
c.80C>G
P27R
2D
AIThe SynGAP1 missense variant P27R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign effect for P27R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.437871Uncertain0.4300.8810.375-3.260Likely Benign0.268Likely BenignLikely Benign0.146Likely Benign-2.28Neutral0.972Probably Damaging0.954Probably Damaging3.82Benign0.00Affected0.17440.42030-2-2.959.07
c.80C>T
P27L
2D
AIThe SynGAP1 missense variant P27L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. The predictions do not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.437871Uncertain0.4300.8810.375-3.297Likely Benign0.161Likely BenignLikely Benign0.174Likely Benign-2.59Deleterious0.909Possibly Damaging0.927Probably Damaging3.82Benign0.00Affected0.26840.6161-3-35.416.04
c.810G>C
E270D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. The majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Rosetta. Tools with inconclusive results—FoldX, Foldetta, and premPS—are listed as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-11.954Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.52Ambiguous0.12.15Destabilizing1.84Ambiguous0.91Ambiguous0.379Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.60Pathogenic0.02Affected0.19080.2540320.0-14.03
c.810G>T
E270D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E270D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. The majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, and the SGM‑Consensus (which is “Likely Pathogenic”). Predictions that are inconclusive or uncertain are FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus also indicating a likely pathogenic outcome, while Foldetta’s stability analysis is uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E270D, and this conclusion is consistent with the lack of ClinVar annotation (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.382573Uncertain0.9380.2310.125-11.954Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.52Ambiguous0.12.15Destabilizing1.84Ambiguous0.91Ambiguous0.383Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.60Pathogenic0.02Affected0.19080.2540320.0-14.03
c.811G>A
A271T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the remaining evidence—premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—consistently predict pathogenicity. FoldX, Rosetta, and Foldetta are inconclusive, and AlphaMissense‑Optimized also yields an uncertain result. High‑accuracy assessments show that the SGM‑Consensus (majority vote) predicts pathogenicity, while AlphaMissense‑Optimized and Foldetta remain unavailable. Taken together, the overwhelming majority of reliable predictors classify the variant as pathogenic, and this conclusion does not conflict with the ClinVar status, which currently has no entry for A271T.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125-9.564Likely Pathogenic0.934Likely PathogenicAmbiguous0.59Ambiguous0.10.54Ambiguous0.57Ambiguous1.00Destabilizing0.498Likely Benign-3.68Deleterious0.999Probably Damaging0.997Probably Damaging0.66Pathogenic0.01Affected0.10760.469110-2.530.03
c.811G>C
A271P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the substitution as pathogenic. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely pathogenic verdict, and Foldetta (integrating FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125-14.699Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.06Destabilizing0.22.97Destabilizing3.52Destabilizing1.15Destabilizing0.680Likely Pathogenic-4.60Deleterious1.000Probably Damaging0.999Probably Damaging0.62Pathogenic0.01Affected0.17050.32671-1-3.426.04
c.811G>T
A271S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A271S is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive are Foldetta and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact for A271S, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125Uncertain 1-9.552Likely Pathogenic0.629Likely PathogenicLikely Benign0.19Likely Benign0.11.47Ambiguous0.83Ambiguous1.14Destabilizing0.453Likely Benign-2.76Deleterious0.999Probably Damaging0.996Probably Damaging0.64Pathogenic0.03Affected0.22600.331211-2.616.00
c.812C>A
A271D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271D is listed in ClinVar as Pathogenic (ClinVar ID 2019732.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125Pathogenic 1-18.590Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.71Destabilizing0.42.67Destabilizing3.69Destabilizing1.59Destabilizing0.706Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging0.62Pathogenic0.00Affected3.38190.15650.15410-2-5.344.01226.2-63.40.00.00.90.1XXXXPotentially PathogenicThe methyl group of Ala271, located near the end of an anti-parallel β sheet strand (res. Arg259-Arg272), packs against multiple hydrophobic residues such as Val400, Val306, and Leu274 in the WT simulations. In the variant simulations, the carboxylate group of Asp271 is not suitable for the hydrophobic niche, causing the hydrophobic residues to make room for the swapped residue. Additionally, the carboxylate group of the Asp271 side chain forms hydrogen bonds with the backbone amide groups of Arg272 and Ala399 in the β sheet, or even forms a salt bridge with the amino group of the Lys394 side chain. This directly affects the integrity of the anti-parallel β sheet at the end. In short, the residue swap disrupts the C2 domain packing during folding, which could weaken the stability of the SynGAP-membrane association.
c.812C>G
A271G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. FoldX, Rosetta, and Foldetta provide uncertain or unavailable stability results and are not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta as unavailable. Overall, the balance of evidence (seven pathogenic versus three benign predictions) indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125-9.508Likely Pathogenic0.183Likely BenignLikely Benign1.73Ambiguous0.11.43Ambiguous1.58Ambiguous1.31Destabilizing0.434Likely Benign-3.68Deleterious0.999Probably Damaging0.996Probably Damaging0.89Pathogenic0.01Affected0.18690.238810-2.2-14.03
c.812C>T
A271V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, and Foldetta, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains inconclusive; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125-8.185Likely Pathogenic0.940Likely PathogenicAmbiguous-0.22Likely Benign0.20.78Ambiguous0.28Likely Benign0.37Likely Benign0.466Likely Benign-3.68Deleterious0.999Probably Damaging0.996Probably Damaging0.69Pathogenic0.02Affected0.09860.4409002.428.05
c.814C>G
R272G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R272G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions are limited to REVEL, whereas pathogenic predictions are made by FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain results come from Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, and this assessment is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.425620Uncertain0.9250.2150.125-11.540Likely Pathogenic0.831Likely PathogenicAmbiguous3.40Destabilizing0.01.94Ambiguous2.67Destabilizing1.06Destabilizing0.479Likely Benign-4.57Deleterious0.999Probably Damaging0.997Probably Damaging1.75Pathogenic0.01Affected0.30820.3062-3-24.1-99.14
c.814C>T
R272W
2D
AISynGAP1 missense variant R272W is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a predominance of pathogenic calls: FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all predict deleterious effects, while the consensus SGM tool (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports a likely pathogenic outcome. Benign predictions are limited to REVEL, Rosetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, whereas Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the balance of evidence favors a pathogenic impact for R272W, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.425620Uncertain0.9250.2150.125-12.145Likely Pathogenic0.863Likely PathogenicAmbiguous2.98Destabilizing1.60.12Likely Benign1.55Ambiguous0.19Likely Benign0.461Likely Benign-5.49Deleterious1.000Probably Damaging0.998Probably Damaging1.72Pathogenic0.00Affected0.14600.36432-33.630.03
c.815G>C
R272P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R272P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the single uncertain call (premPS) does not alter the overall consensus. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.425620Uncertain0.9250.2150.125-11.812Likely Pathogenic0.984Likely PathogenicLikely Pathogenic5.64Destabilizing0.23.99Destabilizing4.82Destabilizing0.80Ambiguous0.561Likely Pathogenic-3.95Deleterious1.000Probably Damaging0.999Probably Damaging1.74Pathogenic0.01Affected0.20570.41020-22.9-59.07
c.815G>T
R272L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R272L missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, and premPS. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results come from FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta remain uncertain. Overall, the majority of evaluated tools predict a pathogenic impact. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.425620Uncertain0.9250.2150.125-10.796Likely Pathogenic0.796Likely PathogenicAmbiguous1.66Ambiguous0.3-0.46Likely Benign0.60Ambiguous0.41Likely Benign0.470Likely Benign-4.57Deleterious0.999Probably Damaging0.997Probably Damaging1.75Pathogenic0.01Affected0.16910.4230-3-28.3-43.03
c.817G>C
E273Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E273Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of individual predictors (seven benign vs. five pathogenic) lean toward a benign classification, while the SGM Consensus and AlphaMissense‑Optimized provide conflicting signals. Thus, the variant is most likely benign based on the aggregate predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.071867Structured0.398918Uncertain0.8630.1960.125-9.865Likely Pathogenic0.503AmbiguousLikely Benign-0.29Likely Benign0.1-0.29Likely Benign-0.29Likely Benign-0.01Likely Benign0.168Likely Benign-1.84Neutral0.946Possibly Damaging0.671Possibly Damaging1.77Pathogenic0.04Affected0.12200.3130220.0-0.98
c.818A>C
E273A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E273A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, whereas AlphaMissense‑Optimized predicts Benign and Foldetta (combining FoldX‑MD and Rosetta) predicts Benign. Overall, the majority of individual tools are split evenly, but the two high‑accuracy methods favor a benign effect. Thus, the variant is most likely benign based on current computational predictions, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.398918Uncertain0.8630.1960.125-8.851Likely Pathogenic0.422AmbiguousLikely Benign0.29Likely Benign0.2-0.29Likely Benign0.00Likely Benign0.16Likely Benign0.240Likely Benign-3.61Deleterious0.896Possibly Damaging0.492Possibly Damaging1.73Pathogenic0.04Affected0.31600.36150-15.3-58.04
c.818A>G
E273G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E273G missense variant has no ClinVar entry and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, premPS, SIFT, and ESM1b; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. Four tools (FoldX, Rosetta, AlphaMissense‑Default, Foldetta) returned uncertain results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels it pathogenic; Foldetta remains uncertain. Given the split between benign and pathogenic signals and the lack of a ClinVar classification, the variant is best described as of uncertain significance, with a slight inclination toward benign based on the most reliable single‑tool prediction. This assessment does not contradict any existing ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.071867Structured0.398918Uncertain0.8630.1960.125-4.784Likely Benign0.373AmbiguousLikely Benign-0.65Ambiguous0.2-0.93Ambiguous-0.79Ambiguous-0.46Likely Benign0.225Likely Benign-2.71Deleterious0.896Possibly Damaging0.519Possibly Damaging1.95Pathogenic0.26Tolerated0.27630.33410-23.1-72.06
c.818A>T
E273V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E273V is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL and premPS. The majority of tools predict a pathogenic impact: Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, SGM‑Consensus (Likely Pathogenic), and Foldetta. Two tools give inconclusive results: AlphaMissense‑Optimized (Uncertain) and FoldX (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as Pathogenic. Overall, the consensus of pathogenic‑predicting tools outweighs the benign predictions, indicating that E273V is most likely pathogenic; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.071867Structured0.398918Uncertain0.8630.1960.125-11.671Likely Pathogenic0.814Likely PathogenicAmbiguous1.93Ambiguous0.33.31Destabilizing2.62Destabilizing0.17Likely Benign0.361Likely Benign-4.66Deleterious0.984Probably Damaging0.825Possibly Damaging1.70Pathogenic0.01Affected0.08110.3813-2-27.7-29.98
c.819G>C
E273D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E273D missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools largely agree on a benign effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign or likely benign. Only FATHMM predicts a pathogenic outcome, while premPS remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the majority of evidence supports a benign impact for E273D, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.071867Structured0.398918Uncertain0.8630.1960.125-1.811Likely Benign0.058Likely BenignLikely Benign0.26Likely Benign0.1-0.48Likely Benign-0.11Likely Benign-0.63Ambiguous0.094Likely Benign1.99Neutral0.004Benign0.010Benign2.00Pathogenic1.00Tolerated3.38180.17110.1859320.0-14.03223.122.10.20.00.00.1XPotentially BenignThe negatively charged residue Glu273, located in a β hairpin loop (res. Glu273-Lys278) that connects two anti-parallel β sheet strands, is replaced with another negatively charged residue, aspartate. Because the C2 domain loop faces the membrane surface, the potentially crucial role of the carboxylate group of Glu273 or Asp273 on SynGAP-membrane association cannot be fully explored via solvent-only simulations.As a minor note, the neighboring residue Arg272, which stacks with the indole ring of the Trp362 side chain and directly faces RasGTPase, forms a salt bridge more often with Asp273 than with the non-mutated Glu273 in the simulations. Regardless, due to the similar physicochemical properties of the WT and variant residues at the membrane interface, the residue swap is likely to be well tolerated.
c.820C>A
L274M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Foldetta, PROVEAN, and AlphaMissense‑Optimized, whereas those that agree on a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Three tools (Rosetta, premPS, and ESM1b) returned uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting benign. Overall, the majority of predictions (seven pathogenic vs. four benign) and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.066181Structured0.377483Uncertain0.8660.1950.250-7.386In-Between0.658Likely PathogenicLikely Benign0.24Likely Benign0.20.74Ambiguous0.49Likely Benign0.81Ambiguous0.512Likely Pathogenic-1.77Neutral1.000Probably Damaging0.999Probably Damaging0.04Pathogenic0.01Affected0.08100.220242-1.918.03
c.820C>G
L274V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274V is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while both the SGM‑Consensus and Foldetta (combining FoldX‑MD and Rosetta outputs) predict pathogenicity. No predictions are missing or inconclusive. Overall, the preponderance of evidence from multiple independent tools points to a pathogenic impact for L274V. This conclusion is consistent with the lack of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250-5.634Likely Benign0.593Likely PathogenicLikely Benign2.13Destabilizing0.62.22Destabilizing2.18Destabilizing0.99Ambiguous0.378Likely Benign-2.56Deleterious0.999Probably Damaging0.994Probably Damaging0.10Pathogenic0.02Affected0.14480.1860210.4-14.03
c.821T>A
L274Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274Q is reported in ClinVar with an uncertain significance (ClinVar ID 1810279.0) and is not found in gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while Rosetta remains inconclusive. No tool predicts a benign outcome. High‑accuracy assessments corroborate this trend: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250Uncertain 1-15.518Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.54Destabilizing0.31.74Ambiguous2.14Destabilizing1.97Destabilizing0.774Likely Pathogenic-5.42Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected3.38190.11280.0688-2-2-7.314.97245.91.80.00.00.10.2XXXPotentially PathogenicThe aliphatic side chain of Leu274, located in a β hairpin loop (res. Glu273-Lys278) connecting two anti-parallel β sheet strands, packs against multiple hydrophobic residues facing the β sheet (e.g., Ala271, Leu327, Tyr280, Val306). The hydrophilic carboxamide group of the Gln274 side chain is not suitable for this hydrophobic niche, causing nearby residues to adjust to make room for the hydrophilic glutamine. Additionally, a new hydrogen bond forms with the backbone carboxyl group of Arg272 in another β strand (res. Glu273-Arg259).As a result, the backbone amide group of Ala399 and the carbonyl group of Arg272, which connect two β strands at the β sheet end, form fewer hydrogen bonds in the variant than in the WT simulations. Although no major secondary structure disruption is observed in the variant simulations, the residue swap could profoundly affect the C2 domain folding, as the hydrophobic packing of Leu274 is crucial for maintaining the loop's contact with the rest of the C2 domain. Lastly, because the Leu274-containing loop faces the membrane surface, the residue swap could also negatively impact the SynGAP-membrane association.
c.821T>C
L274P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool in the dataset predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic impact. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250-14.667Likely Pathogenic0.997Likely PathogenicLikely Pathogenic5.62Destabilizing1.54.49Destabilizing5.06Destabilizing1.66Destabilizing0.804Likely Pathogenic-6.30Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected0.35350.0625-3-3-5.4-16.04
c.821T>G
L274R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274R is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. All available predictions and stability analyses are concordant and indicate a likely pathogenic impact. Thus, based on the current computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250-17.691Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.61Destabilizing0.83.15Destabilizing3.38Destabilizing1.56Destabilizing0.807Likely Pathogenic-5.45Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected0.14040.0488-3-2-8.343.03
c.824C>A
P275H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P275H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a deleterious effect include SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default, all of which classify the change as pathogenic. Tools that are inconclusive or uncertain are Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Taken together, the majority of evidence points to a pathogenic impact, and this conclusion is consistent with the lack of ClinVar annotation (no contradiction). Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.059222Structured0.353469Uncertain0.8110.2080.250-13.157Likely Pathogenic0.804Likely PathogenicAmbiguous2.34Destabilizing0.80.87Ambiguous1.61Ambiguous0.88Ambiguous0.585Likely Pathogenic-6.54Deleterious1.000Probably Damaging1.000Probably Damaging1.73Pathogenic0.01Affected0.20690.30740-2-1.640.02
c.824C>G
P275R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P275R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all classify the change as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments further support this view: the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic effect. AlphaMissense‑Optimized remains uncertain, but its result does not counter the overall consensus. Consequently, the variant is most likely pathogenic, and this conclusion is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.059222Structured0.353469Uncertain0.8110.2080.250-13.557Likely Pathogenic0.915Likely PathogenicAmbiguous2.10Destabilizing0.62.11Destabilizing2.11Destabilizing0.82Ambiguous0.645Likely Pathogenic-6.36Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.01Affected0.16370.30390-2-2.959.07
c.824C>T
P275L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P275L is not reported in ClinVar and is absent from gnomAD. In silico predictions cluster into two groups: benign predictions come from REVEL, premPS, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No evidence from FoldX or Rosetta alone is conclusive. Overall, the majority of tools predict pathogenicity, and the high‑accuracy consensus supports a likely pathogenic classification. This prediction does not contradict any ClinVar status, as the variant is currently unreported in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.059222Structured0.353469Uncertain0.8110.2080.250-9.785Likely Pathogenic0.304Likely BenignLikely Benign1.63Ambiguous0.21.22Ambiguous1.43Ambiguous0.29Likely Benign0.430Likely Benign-6.81Deleterious1.000Probably Damaging0.999Probably Damaging1.83Pathogenic0.00Affected0.21390.5056-3-35.416.04
c.826C>A
P276T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P276T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Uncertain or inconclusive results come from Rosetta, Foldetta, and premPS. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two benign, two pathogenic), and Foldetta is uncertain. Overall, the majority of tools (six pathogenic vs. four benign) indicate a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.037156Structured0.338937Uncertain0.7240.2300.250-5.793Likely Benign0.146Likely BenignLikely Benign2.61Destabilizing0.10.75Ambiguous1.68Ambiguous0.63Ambiguous0.293Likely Benign-3.53Deleterious0.961Probably Damaging0.721Possibly Damaging1.87Pathogenic0.03Affected0.16010.46760-10.93.99
c.826C>T
P276S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P276S missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign calls from REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic calls from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Four tools predict benign while five predict pathogenic, and four additional methods (FoldX, Rosetta, Foldetta, premPS) return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—yields a tie and is therefore inconclusive; Foldetta also reports an uncertain stability change. Taken together, the preponderance of evidence leans toward a pathogenic effect, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.037156Structured0.338937Uncertain0.7240.2300.250-5.946Likely Benign0.142Likely BenignLikely Benign1.78Ambiguous0.20.96Ambiguous1.37Ambiguous0.65Ambiguous0.205Likely Benign-3.25Deleterious0.835Possibly Damaging0.468Possibly Damaging1.92Pathogenic0.05Affected0.31910.37361-10.8-10.04
c.827C>T
P276L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P276L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. FoldX, Rosetta, and Foldetta provide uncertain or unavailable stability results and are therefore not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta remains unavailable. Overall, the predictions are mixed, with an equal split between benign and pathogenic calls, and the high‑accuracy tools do not yield a definitive verdict. Consequently, the variant is most likely benign based on the current evidence, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.037156Structured0.338937Uncertain0.7240.2300.250-6.687Likely Benign0.196Likely BenignLikely Benign1.64Ambiguous0.10.87Ambiguous1.26Ambiguous0.33Likely Benign0.439Likely Benign-4.92Deleterious0.961Probably Damaging0.655Possibly Damaging1.87Pathogenic0.01Affected0.21790.5650-3-35.416.04
c.829A>G
K277E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K277E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, and Foldetta. Tools that agree on a pathogenic effect include SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No predictions are missing or inconclusive. Overall, the majority of tools (10/13) predict pathogenicity, whereas only three predict benign. Therefore, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.061840Structured0.321811Uncertain0.6490.2470.250-14.886Likely Pathogenic0.994Likely PathogenicLikely Pathogenic-0.14Likely Benign0.10.18Likely Benign0.02Likely Benign0.51Ambiguous0.694Likely Pathogenic-3.68Deleterious0.999Probably Damaging0.995Probably Damaging1.85Pathogenic0.01Affected0.34620.0492010.40.94
c.82T>A
S28T
2D
AIThe SynGAP1 missense variant S28T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of all available predictions is that the variant is most likely benign, and this conclusion is consistent with the lack of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.438157Uncertain0.3540.8840.125-3.810Likely Benign0.081Likely BenignLikely Benign0.054Likely Benign-0.21Neutral0.000Benign0.000Benign4.20Benign0.64Tolerated0.18740.6140110.114.03
c.82T>C
S28P
2D
AIThe SynGAP1 missense variant S28P is listed in ClinVar (ID 1500161.0) with an uncertain significance designation and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while only SIFT indicates a pathogenic effect. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta stability analysis is unavailable. Overall, the collective evidence points to a benign classification for S28P, which is consistent with the ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.438157Uncertain0.3540.8840.125Uncertain 1-3.309Likely Benign0.051Likely BenignLikely Benign0.047Likely Benign1.37Neutral0.000Benign0.000Benign4.53Benign0.00Affected4.3210.24320.54991-1-0.810.04
c.82T>G
S28A
2D
AIThe SynGAP1 missense variant S28A is not reported in ClinVar and is absent from gnomAD. In silico prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. No pathogenic predictions are present among the evaluated tools. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates likely benign; Foldetta results are unavailable. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.438157Uncertain0.3540.8840.125-3.517Likely Benign0.063Likely BenignLikely Benign0.039Likely Benign0.09Neutral0.000Benign0.000Benign4.27Benign1.00Tolerated0.51940.4958Weaken112.6-16.00
c.830A>C
K277T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K277T missense variant is not reported in ClinVar (status: None) and has no entry in gnomAD. Prediction tools that agree on a benign effect are Rosetta and premPS, while the remaining tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict pathogenicity. FoldX and Foldetta return uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also pathogenic; Foldetta remains uncertain. Overall, the preponderance of evidence indicates that K277T is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.061840Structured0.321811Uncertain0.6490.2470.250-11.688Likely Pathogenic0.981Likely PathogenicLikely Pathogenic1.46Ambiguous0.10.14Likely Benign0.80Ambiguous0.17Likely Benign0.573Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.998Probably Damaging2.02Pathogenic0.01Affected0.18370.22200-13.2-27.07
c.830A>G
K277R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K277R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Foldetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. Rosetta gives an uncertain result. High‑accuracy methods give a benign prediction from AlphaMissense‑Optimized and from Foldetta; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it is a 2‑vs‑2 split. Overall, the majority of evidence (7 benign vs. 5 pathogenic) supports a benign classification. This consensus does not contradict any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.061840Structured0.321811Uncertain0.6490.2470.250-6.652Likely Benign0.156Likely BenignLikely Benign-0.01Likely Benign0.10.53Ambiguous0.26Likely Benign0.06Likely Benign0.518Likely Pathogenic-2.76Deleterious0.999Probably Damaging0.995Probably Damaging1.83Pathogenic0.06Tolerated0.42320.067832-0.628.01
c.830A>T
K277M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K277M missense variant is not reported in ClinVar and has no entries in gnomAD. Prediction tools cluster into two groups: benign predictions come from FoldX and premPS, while the majority of tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—label the change as pathogenic. High‑accuracy methods reinforce this trend: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. Overall, the preponderance of evidence points to a pathogenic effect, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.061840Structured0.321811Uncertain0.6490.2470.250-13.918Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.18Likely Benign0.01.14Ambiguous0.66Ambiguous0.15Likely Benign0.712Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.80Pathogenic0.00Affected0.09450.25840-15.83.02
c.831G>C
K277N
2D
AIThe SynGAP1 missense variant K277N is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, and premPS. Tools that predict pathogenicity are SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as Benign. No predictions are missing or inconclusive. Overall, the majority of tools (10/14) predict pathogenicity, whereas four tools predict benign. Therefore, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.061840Structured0.321811Uncertain0.6490.2470.250-9.646Likely Pathogenic0.995Likely PathogenicLikely Pathogenic-0.07Likely Benign0.40.08Likely Benign0.01Likely Benign0.46Likely Benign0.572Likely Pathogenic-4.60Deleterious1.000Probably Damaging0.998Probably Damaging1.83Pathogenic0.03Affected0.32650.0568100.4-14.07
c.831G>T
K277N
2D
AIThe SynGAP1 missense variant K277N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include FoldX, Rosetta, Foldetta, and premPS. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is also likely pathogenic; Foldetta, a protein‑folding stability predictor, reports a benign effect. Overall, the preponderance of evidence (10 pathogenic vs. 4 benign predictions) points to a pathogenic classification. This conclusion is not contradicted by ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.061840Structured0.321811Uncertain0.6490.2470.250-9.646Likely Pathogenic0.995Likely PathogenicLikely Pathogenic-0.07Likely Benign0.40.08Likely Benign0.01Likely Benign0.46Likely Benign0.572Likely Pathogenic-4.60Deleterious1.000Probably Damaging0.998Probably Damaging1.83Pathogenic0.03Affected0.32650.0568100.4-14.07
c.832A>C
K278Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K278Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and Foldetta. Those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts a likely pathogenic outcome, whereas Foldetta (combining FoldX‑MD and Rosetta stability outputs) predicts a benign effect, and AlphaMissense‑Optimized remains uncertain. Overall, the majority of evidence points to a pathogenic impact for K278Q, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.120615Structured0.310130Uncertain0.7480.2530.125-11.107Likely Pathogenic0.902Likely PathogenicAmbiguous0.23Likely Benign0.10.25Likely Benign0.24Likely Benign0.73Ambiguous0.387Likely Benign-3.63Deleterious1.000Probably Damaging0.998Probably Damaging1.71Pathogenic0.05Affected0.37700.0672110.4-0.04
c.832A>G
K278E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K278E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and SIFT, all of which score the substitution as tolerated. In contrast, a majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as damaging. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic verdict. Foldetta, a protein‑folding stability method that combines FoldX‑MD and Rosetta outputs, predicts a benign effect. premPS is inconclusive and therefore not considered evidence. High‑accuracy assessments therefore show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as pathogenic, and Foldetta as benign. Overall, the preponderance of evidence from multiple independent predictors indicates that K278E is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.120615Structured0.310130Uncertain0.7480.2530.125-14.047Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.40Likely Benign0.10.39Likely Benign0.40Likely Benign0.68Ambiguous0.463Likely Benign-3.64Deleterious0.999Probably Damaging0.995Probably Damaging1.76Pathogenic0.06Tolerated0.31890.0492010.40.94
c.833A>C
K278T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K278T is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, Rosetta, Foldetta, and premPS. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict any ClinVar annotation because the variant is not yet classified in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.120615Structured0.310130Uncertain0.7480.2530.125-11.227Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.85Ambiguous0.2-0.08Likely Benign0.39Likely Benign0.46Likely Benign0.484Likely Benign-5.40Deleterious1.000Probably Damaging0.998Probably Damaging1.70Pathogenic0.04Affected0.17750.22200-13.2-27.07
c.833A>G
K278R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K278R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields an equal split of benign and pathogenic calls. Overall, the majority of evidence points to a benign impact. Thus, the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.120615Structured0.310130Uncertain0.7480.2530.125-5.313Likely Benign0.216Likely BenignLikely Benign-0.05Likely Benign0.00.18Likely Benign0.07Likely Benign0.13Likely Benign0.282Likely Benign-2.66Deleterious0.999Probably Damaging0.995Probably Damaging1.73Pathogenic0.10Tolerated0.39260.048932-0.628.01
c.833A>T
K278M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K278M is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that indicate a benign effect include FoldX, Foldetta, and premPS, whereas the majority of tools predict a pathogenic effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of evidence points to a pathogenic impact for K278M, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.120615Structured0.310130Uncertain0.7480.2530.125-12.861Likely Pathogenic0.989Likely PathogenicLikely Pathogenic-0.15Likely Benign0.1-0.59Ambiguous-0.37Likely Benign0.25Likely Benign0.526Likely Pathogenic-5.47Deleterious1.000Probably Damaging0.999Probably Damaging1.67Pathogenic0.01Affected0.09750.25840-15.83.02
c.834G>C
K278N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K278N is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Rosetta, premPS, and SIFT, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy methods give mixed results: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) predicts benign. Overall, the majority of tools support a pathogenic effect, so the variant is most likely pathogenic; this is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.120615Structured0.310130Uncertain0.7480.2530.125-10.611Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.40Likely Benign0.00.05Likely Benign0.23Likely Benign0.44Likely Benign0.255Likely Benign-4.51Deleterious1.000Probably Damaging0.998Probably Damaging1.81Pathogenic0.07Tolerated0.30710.0568100.4-14.07
c.834G>T
K278N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K278N is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, premPS, and SIFT, whereas tools that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. With a majority of evidence pointing to deleterious effects and no ClinVar annotation to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.120615Structured0.310130Uncertain0.7480.2530.125-10.611Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.40Likely Benign0.00.05Likely Benign0.23Likely Benign0.44Likely Benign0.255Likely Benign-4.51Deleterious1.000Probably Damaging0.998Probably Damaging1.81Pathogenic0.07Tolerated0.30710.0568100.4-14.07
c.835C>G
R279G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R279G is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote) which labels it “Likely Pathogenic.” AlphaMissense‑Optimized is uncertain, providing no definitive evidence. High‑accuracy assessments further support pathogenicity: the SGM‑Consensus remains “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Based on the overwhelming majority of predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.155435Structured0.309382Uncertain0.8870.2570.125-9.941Likely Pathogenic0.920Likely PathogenicAmbiguous3.10Destabilizing0.72.85Destabilizing2.98Destabilizing1.11Destabilizing0.442Likely Benign-5.37Deleterious0.999Probably Damaging0.997Probably Damaging1.92Pathogenic0.02Affected0.29610.2209-3-24.1-99.14
c.835C>T
R279W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R279W is listed in ClinVar with an uncertain significance (ClinVar ID 1204186.0) and is not reported in gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining pathogenic‑predicating tools—FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—consistently predict a deleterious impact. Uncertain or inconclusive results come from Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for R279W, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.155435Structured0.309382Uncertain0.8870.2570.125Uncertain 1-11.417Likely Pathogenic0.942Likely PathogenicAmbiguous2.00Destabilizing0.81.47Ambiguous1.74Ambiguous0.80Ambiguous0.485Likely Benign-6.29Deleterious1.000Probably Damaging0.998Probably Damaging1.88Pathogenic0.00Affected3.39180.12000.25192-33.630.03270.038.30.10.00.30.0UncertainThe guanidinium group of Arg279, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), can form hydrogen bond with the backbone carbonyl groups of nearby loop residues (e.g., Ser296, Ser331, and As332) and form salt bridges with the carboxylate groups of Asp330 and Asp332. In the WT simulations, Arg279 sporadically forms a salt bridge even with the carboxylate group of Glu613, loosely connecting the C2 domain and GAP domain. Meanwhile, the indole ring of the Trp279 side chain is unable to hydrogen bond with the loop residues in the variant simulations. The lack of hydrogen bond or salt bridge formation with the loop residues could be significant, as Arg279 and the loops face the polar head group region of the membrane. Thus, although Trp279 could interact with the membrane surface as a “lipid anchor,” any changes to the wider loop dynamics could still adversely affect the formation of a stable SynGAP-membrane association. However, no definite conclusions on the effect of the residue swap on the SynGAP-membrane association can be drawn from solvent-only simulations.
c.836G>C
R279P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R279P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as pathogenic. No tool predicts a benign effect. FoldX reports an uncertain outcome, but Rosetta, Foldetta, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) all predict pathogenicity. High‑accuracy assessments further support this view: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus, based on a majority vote of the aforementioned predictors, is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.155435Structured0.309382Uncertain0.8870.2570.125-14.926Likely Pathogenic0.971Likely PathogenicLikely Pathogenic1.42Ambiguous0.94.27Destabilizing2.85Destabilizing1.21Destabilizing0.626Likely Pathogenic-5.01Deleterious1.000Probably Damaging0.999Probably Damaging1.90Pathogenic0.02Affected0.21790.32810-22.9-59.07
c.838T>A
Y280N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y280N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only SIFT, whereas all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Based on the overwhelming consensus of pathogenic predictions and the absence of any benign consensus, the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for Y280N.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.161087Structured0.321243Uncertain0.9170.2480.125-13.090Likely Pathogenic0.995Likely PathogenicLikely Pathogenic4.26Destabilizing0.24.18Destabilizing4.22Destabilizing1.82Destabilizing0.589Likely Pathogenic-8.27Deleterious1.000Probably Damaging0.999Probably Damaging1.95Pathogenic0.06Tolerated0.19020.0212-2-2-2.2-49.07
c.838T>C
Y280H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y280H is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Among the available in‑silico predictors, none indicate a benign effect; all 14 tools that produced a classification predict pathogenicity: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are inconclusive or missing. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status (which is currently unreported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.161087Structured0.321243Uncertain0.9170.2480.125-9.970Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.01Destabilizing0.32.58Destabilizing2.80Destabilizing1.95Destabilizing0.588Likely Pathogenic-4.60Deleterious1.000Probably Damaging0.999Probably Damaging1.94Pathogenic0.01Affected0.20210.021202-1.9-26.03
c.838T>G
Y280D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y280D is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic outcome. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. With all available evidence pointing to a damaging effect and no ClinVar entry to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.161087Structured0.321243Uncertain0.9170.2480.125-16.885Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.91Destabilizing0.25.89Destabilizing5.90Destabilizing2.00Destabilizing0.580Likely Pathogenic-9.19Deleterious1.000Probably Damaging0.999Probably Damaging1.94Pathogenic0.02Affected0.35930.0212-4-3-2.2-48.09
c.839A>C
Y280S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y280S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; all evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the substitution as pathogenic. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely pathogenic verdict, and Foldetta (integrating FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic, and this prediction is consistent with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.161087Structured0.321243Uncertain0.9170.2480.125-13.491Likely Pathogenic0.994Likely PathogenicLikely Pathogenic4.63Destabilizing0.34.80Destabilizing4.72Destabilizing2.03Destabilizing0.635Likely Pathogenic-8.27Deleterious1.000Probably Damaging0.998Probably Damaging2.00Pathogenic0.05Affected0.39930.1227-3-20.5-76.10
c.839A>G
Y280C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y280C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; all evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the change as pathogenic or likely pathogenic. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely pathogenic verdict, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports a pathogenic effect on protein stability. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.161087Structured0.321243Uncertain0.9170.2480.125-10.645Likely Pathogenic0.982Likely PathogenicLikely Pathogenic3.85Destabilizing0.24.45Destabilizing4.15Destabilizing1.68Destabilizing0.629Likely Pathogenic-8.24Deleterious1.000Probably Damaging0.999Probably Damaging1.96Pathogenic0.01Affected0.28770.12960-23.8-60.04
c.839A>T
Y280F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y280F is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The remaining tools—premPS, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive and therefore unavailable. Overall, the majority of available predictions favor a pathogenic impact, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.161087Structured0.321243Uncertain0.9170.2480.125-7.844In-Between0.414AmbiguousLikely Benign0.49Likely Benign0.20.03Likely Benign0.26Likely Benign0.87Ambiguous0.544Likely Pathogenic-3.68Deleterious0.999Probably Damaging0.992Probably Damaging1.98Pathogenic0.02Affected0.22630.2398734.1-16.00
c.83C>A
S28Y
2D
AIThe SynGAP1 missense variant S28Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect. There is no conflict with ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.438157Uncertain0.3540.8840.125-4.521Likely Benign0.270Likely BenignLikely Benign0.041Likely Benign-0.94Neutral0.009Benign0.001Benign4.13Benign0.05Affected0.08950.5067-3-2-0.576.10
c.83C>G
S28C
2D
AIThe SynGAP1 missense variant S28C is not reported in ClinVar and is absent from gnomAD. In silico prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. No pathogenic predictions are present among the evaluated tools. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates likely benign; Foldetta results are unavailable. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.438157Uncertain0.3540.8840.125-4.800Likely Benign0.107Likely BenignLikely Benign0.021Likely Benign-0.26Neutral0.022Benign0.004Benign4.13Benign0.11Tolerated0.13870.57410-13.316.06
c.83C>T
S28F
2D
AIThe SynGAP1 missense variant S28F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Benign, and AlphaMissense‑Optimized also reports a benign prediction. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.438157Uncertain0.3540.8840.125-4.548Likely Benign0.255Likely BenignLikely Benign0.045Likely Benign-1.13Neutral0.009Benign0.002Benign4.13Benign0.05Affected0.07480.5340-3-23.660.10
c.841T>A
Y281N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y281N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions are provided only by SIFT, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict pathogenicity. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized remains inconclusive, SGM‑Consensus is labeled Likely Pathogenic, and Foldetta predicts a destabilizing, pathogenic outcome. Overall, the collective evidence indicates that Y281N is most likely pathogenic, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.337647Uncertain0.9270.2540.000-11.620Likely Pathogenic0.941Likely PathogenicAmbiguous3.29Destabilizing0.22.49Destabilizing2.89Destabilizing1.71Destabilizing0.713Likely Pathogenic-6.20Deleterious1.000Probably Damaging0.999Probably Damaging0.99Pathogenic0.09Tolerated0.24940.1503-2-2-2.2-49.07
c.841T>C
Y281H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y281H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: SIFT classifies it as benign, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) predict pathogenicity. High‑accuracy methods provide a clearer picture: AlphaMissense‑Optimized is uncertain, SGM‑Consensus indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic folding instability. With the overwhelming consensus from most predictors and the high‑accuracy tools supporting a damaging effect, the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.337647Uncertain0.9270.2540.000-8.522Likely Pathogenic0.884Likely PathogenicAmbiguous2.65Destabilizing0.22.05Destabilizing2.35Destabilizing1.63Destabilizing0.717Likely Pathogenic-3.82Deleterious1.000Probably Damaging0.999Probably Damaging0.99Pathogenic0.16Tolerated0.26510.150302-1.9-26.03
c.841T>G
Y281D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y281D is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: SIFT classifies it as benign, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict it to be pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts pathogenic. No tool yields an inconclusive result. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.337647Uncertain0.9270.2540.000-15.506Likely Pathogenic0.990Likely PathogenicLikely Pathogenic4.27Destabilizing0.04.53Destabilizing4.40Destabilizing1.48Destabilizing0.813Likely Pathogenic-6.73Deleterious1.000Probably Damaging0.999Probably Damaging0.98Pathogenic0.06Tolerated0.41730.1175-4-3-2.2-48.09
c.842A>C
Y281S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y281S is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools cluster into two groups: the single benign prediction comes from SIFT, while the remaining tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—predict pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. With the overwhelming majority of evidence indicating pathogenicity and no ClinVar annotation to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.337647Uncertain0.9270.2540.000-9.541Likely Pathogenic0.847Likely PathogenicAmbiguous3.24Destabilizing0.33.02Destabilizing3.13Destabilizing1.59Destabilizing0.642Likely Pathogenic-5.68Deleterious1.000Probably Damaging0.998Probably Damaging1.02Pathogenic0.12Tolerated0.42030.2543-3-20.5-76.10
c.842A>G
Y281C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y281C is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized. All other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized indicates a benign outcome, whereas the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. Consequently, the variant is most likely pathogenic based on the overwhelming majority of predictions, and this assessment does not contradict the ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.337647Uncertain0.9270.2540.000-8.528Likely Pathogenic0.752Likely PathogenicLikely Benign3.00Destabilizing0.12.71Destabilizing2.86Destabilizing1.48Destabilizing0.615Likely Pathogenic-5.55Deleterious1.000Probably Damaging0.999Probably Damaging0.99Pathogenic0.05Affected0.29490.21760-23.8-60.04
c.842A>T
Y281F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y281F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign; Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. No evidence from the uncertain FoldX result is considered. Overall, the consensus of high‑confidence tools points to a benign classification, which is consistent with the absence of ClinVar evidence and gnomAD data. Thus, the variant is most likely benign, and this conclusion does not contradict ClinVar status, which has no reported pathogenicity.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.098513Structured0.337647Uncertain0.9270.2540.000-3.991Likely Benign0.146Likely BenignLikely Benign0.75Ambiguous0.2-0.26Likely Benign0.25Likely Benign-0.37Likely Benign0.372Likely Benign-0.32Neutral0.999Probably Damaging0.992Probably Damaging1.17Pathogenic0.54Tolerated0.23800.3885734.1-16.00
c.844T>A
C282S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282S is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, whereas the majority of other in‑silico predictors (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all classify the variant as pathogenic. Stability‑based methods (FoldX, Rosetta, and Foldetta) return uncertain results and are therefore not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000Uncertain 1-11.846Likely Pathogenic0.958Likely PathogenicLikely Pathogenic1.55Ambiguous0.11.23Ambiguous1.39Ambiguous1.62Destabilizing0.460Likely Benign-9.19Deleterious0.997Probably Damaging0.994Probably Damaging1.64Pathogenic0.03Affected3.39180.50090.1286Weaken0-1-3.3-16.06233.214.8-0.10.0-0.20.3XPotentially BenignThe thiol-containing side chain of Cys282, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), packs against multiple hydrophobic residues (e.g., Ile268, Leu284, Trp308, Leu327). In the variant simulations, the hydroxyl-containing side chain of Ser282 is more hydrophilic and, hence, not as favorable as Cys282 for this hydrophobic niche. Due to this polarity difference, the residue swap could potentially weaken the hydrophobic packing of the C2 domain during the folding process.Moreover, because the C2 domain interacts with the membrane, there could also be a negative effect on the stability of the SynGAP-membrane association. However, no large-scale structural changes were observed during the variant simulations. The hydroxyl group of Ser282 forms a hydrogen bond with the backbone carbonyl group of His326 in another β strand (res. Ala322-Arg329), which competes directly with the backbone amide group of Glu283 within the secondary structure element.
c.844T>C
C282R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282R is listed in ClinVar as Pathogenic (ClinVar ID 635755.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to REVEL, which scores the variant as benign. All other evaluated algorithms predict a pathogenic outcome: FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Rosetta’s output is uncertain and is therefore not counted as evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) also predicts pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, which aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000Pathogenic 2-16.378Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.13Destabilizing0.61.58Ambiguous2.36Destabilizing1.70Destabilizing0.466Likely Benign-11.03Deleterious0.999Probably Damaging0.998Probably Damaging1.63Pathogenic0.00Affected3.39180.16960.1557-4-3-7.053.05297.4-98.2-0.10.10.50.0XXXPotentially PathogenicThe thiol-containing side chain of Cys282, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), is packed against multiple hydrophobic residues (e.g., Ile268, Leu284, Trp308, Leu327). In the variant simulations, the bulky side chain of Arg282 with its positively charged guanidinium group is not suitable for this hydrophobic niche. Consequently, the hydrophobic residues must either make room to accommodate Arg282 or it must escape the hydrophobic C2 domain core.As a result, new hydrogen bonds are formed with the backbone carbonyl groups of the surrounding β sheet residues Ala399, Leu325, and His326, which decreases the unity of the secondary structure elements. Notably, it is likely that the residue swap causes major problems during the C2 domain folding that are not visible in the variant simulations. In fact, even increased lability in the C2 domain could adversely affect the establishment of a stable SynGAP-membrane association.
c.844T>G
C282G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282G is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). The high‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; SGM‑Consensus is pathogenic; Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the overwhelming agreement among pathogenic predictors and the high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000-15.830Likely Pathogenic0.837Likely PathogenicAmbiguous2.60Destabilizing0.12.83Destabilizing2.72Destabilizing1.60Destabilizing0.482Likely Benign-11.03Deleterious0.999Probably Damaging0.996Probably Damaging1.64Pathogenic0.04Affected0.32290.2238-3-3-2.9-46.09
c.845G>A
C282Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282Y resides in the C2 domain. ClinVar has no entry for this variant, and it is not listed in gnomAD. Prediction tools that indicate a benign effect are REVEL and premPS. All other evaluated algorithms—FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000-13.438Likely Pathogenic0.999Likely PathogenicLikely Pathogenic8.50Destabilizing1.12.91Destabilizing5.71Destabilizing0.41Likely Benign0.419Likely Benign-10.11Deleterious0.999Probably Damaging0.998Probably Damaging1.63Pathogenic0.00Affected0.10690.30890-2-3.860.04
c.845G>C
C282S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Predictions from FoldX, Rosetta, and Foldetta are inconclusive and are treated as unavailable. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, while Foldetta remains uncertain. Based on the preponderance of pathogenic predictions and the lack of benign evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000-11.846Likely Pathogenic0.958Likely PathogenicLikely Pathogenic1.55Ambiguous0.11.23Ambiguous1.39Ambiguous1.62Destabilizing0.436Likely Benign-9.19Deleterious0.997Probably Damaging0.994Probably Damaging1.64Pathogenic0.03Affected3.39180.50090.1286Weaken0-1-3.3-16.06233.214.8-0.10.0-0.20.3XPotentially BenignThe thiol-containing side chain of Cys282, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), packs against multiple hydrophobic residues (e.g., Ile268, Leu284, Trp308, Leu327). In the variant simulations, the hydroxyl-containing side chain of Ser282 is more hydrophilic and, hence, not as favorable as Cys282 for this hydrophobic niche. Due to this polarity difference, the residue swap could potentially weaken the hydrophobic packing of the C2 domain during the folding process.Moreover, because the C2 domain interacts with the membrane, there could also be a negative effect on the stability of the SynGAP-membrane association. However, no large-scale structural changes were observed during the variant simulations. The hydroxyl group of Ser282 forms a hydrogen bond with the backbone carbonyl group of His326 in another β strand (res. Ala322-Arg329), which competes directly with the backbone amide group of Glu283 within the secondary structure element.
c.845G>T
C282F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282F is not listed in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are provided by REVEL and premPS, whereas the remaining 13 tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all indicate pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is labeled Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a pathogenic outcome. Taken together, the overwhelming majority of evidence points to a pathogenic impact for C282F. This conclusion is consistent with the absence of a ClinVar entry, which does not contradict the prediction. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000-13.288Likely Pathogenic0.983Likely PathogenicLikely Pathogenic6.22Destabilizing1.42.38Destabilizing4.30Destabilizing0.42Likely Benign0.430Likely Benign-10.11Deleterious0.999Probably Damaging0.998Probably Damaging1.65Pathogenic0.00Affected0.12670.3607-4-20.344.04
c.846T>G
C282W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change C282W is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to REVEL, which scores the variant as benign. All other evaluated predictors—FoldX, Foldetta, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. Uncertain results come only from premPS and Rosetta, which are treated as unavailable. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports a likely pathogenic status; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts pathogenic. **Thus, the variant is most likely pathogenic based on the collective predictions, and this conclusion is not contradicted by any ClinVar annotation.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000-15.392Likely Pathogenic1.000Likely PathogenicLikely Pathogenic10.69Destabilizing1.7-1.05Ambiguous4.82Destabilizing0.70Ambiguous0.418Likely Benign-10.11Deleterious1.000Probably Damaging0.998Probably Damaging1.63Pathogenic0.03Affected0.14570.2978-8-2-3.483.07
c.847G>A
E283K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E283K is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL and FoldX, whereas the majority of algorithms predict it to be pathogenic: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Uncertain results come from Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.358602Uncertain0.9500.2490.000-14.350Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.30Likely Benign0.10.82Ambiguous0.56Ambiguous0.62Ambiguous0.443Likely Benign-3.68Deleterious0.999Probably Damaging0.995Probably Damaging1.92Pathogenic0.01Affected0.29890.571401-0.4-0.94
c.847G>C
E283Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E283Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and Foldetta. Those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). The premPS score is uncertain and does not contribute to the consensus. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of tools (nine pathogenic vs. four benign) predict a pathogenic impact. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.358602Uncertain0.9500.2490.000-10.650Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.48Likely Benign0.1-0.01Likely Benign0.24Likely Benign0.61Ambiguous0.372Likely Benign-2.76Deleterious0.999Probably Damaging0.996Probably Damaging1.67Pathogenic0.01Affected0.14320.5389220.0-0.98
c.848A>G
E283G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E283G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the single uncertain call from premPS is treated as unavailable. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.358602Uncertain0.9500.2490.000-13.937Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.13Destabilizing0.12.74Destabilizing2.94Destabilizing0.55Ambiguous0.559Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.996Probably Damaging1.63Pathogenic0.01Affected0.31230.48420-23.1-72.06
c.848A>T
E283V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E283V missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are FoldX and premPS, while the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools give inconclusive results: Rosetta (Uncertain) and Foldetta (Uncertain). High‑accuracy methods specifically indicate that AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM‑Consensus (a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely pathogenic, whereas Foldetta’s stability assessment is uncertain. Taken together, the preponderance of evidence from both general and high‑accuracy predictors points to a pathogenic effect for E283V. This conclusion is consistent with the absence of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.358602Uncertain0.9500.2490.000-13.602Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.44Likely Benign0.20.56Ambiguous0.50Ambiguous0.36Likely Benign0.558Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.998Probably Damaging1.83Pathogenic0.00Affected0.08740.6011-2-27.7-29.98
c.849G>C
E283D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E283D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and SIFT, whereas pathogenic predictions are made by AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and FoldX. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a pathogenic change, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic. The Foldetta stability analysis is inconclusive and therefore treated as unavailable. Overall, the majority of evidence points to a pathogenic effect for E283D, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.358602Uncertain0.9500.2490.000-10.190Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.25Destabilizing0.20.94Ambiguous1.60Ambiguous0.60Ambiguous0.280Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.63Pathogenic0.06Tolerated0.20080.3480320.0-14.03
c.849G>T
E283D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E283D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and SIFT, whereas a majority of tools predict a pathogenic impact: AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and FoldX. Predictions that remain inconclusive are Foldetta, Rosetta, and premPS. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta’s stability analysis is uncertain. Overall, the preponderance of evidence indicates that E283D is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.358602Uncertain0.9500.2490.000-10.190Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.25Destabilizing0.20.94Ambiguous1.60Ambiguous0.60Ambiguous0.280Likely Benign-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.63Pathogenic0.06Tolerated0.20080.3480320.0-14.03
c.850C>A
L284I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L284I missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No evidence from FoldX or Rosetta alone is conclusive. Overall, the majority of predictions, including the high‑accuracy methods, support a benign classification. This consensus does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.094817Structured0.371601Uncertain0.9500.2550.000-5.853Likely Benign0.293Likely BenignLikely Benign0.50Ambiguous0.01.22Ambiguous0.86Ambiguous0.49Likely Benign0.364Likely Benign-1.51Neutral0.999Probably Damaging0.994Probably Damaging1.88Pathogenic0.13Tolerated0.07380.3006220.70.00
c.850C>G
L284V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L284V missense variant has no ClinVar entry and is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are Rosetta, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Predictions that are uncertain or inconclusive are FoldX, AlphaMissense‑Default, and Foldetta. High‑accuracy methods give a benign consensus: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, while Foldetta remains uncertain. Overall, the balance of evidence leans toward a pathogenic effect, and this assessment does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.094817Structured0.371601Uncertain0.9500.2550.000-6.726Likely Benign0.347AmbiguousLikely Benign1.65Ambiguous0.22.08Destabilizing1.87Ambiguous1.38Destabilizing0.248Likely Benign-2.32Neutral0.999Probably Damaging0.994Probably Damaging2.18Pathogenic0.03Affected0.12590.2456210.4-14.03
c.850C>T
L284F
2D
AIThe SynGAP1 missense variant L284F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while Rosetta, Foldetta, and premPS are inconclusive. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels the variant as Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Taken together, the overwhelming majority of evidence indicates that the variant is most likely pathogenic, and this conclusion is consistent with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.094817Structured0.371601Uncertain0.9500.2550.000-11.656Likely Pathogenic0.970Likely PathogenicLikely Pathogenic2.04Destabilizing1.91.05Ambiguous1.55Ambiguous0.62Ambiguous0.654Likely Pathogenic-3.51Deleterious1.000Probably Damaging0.998Probably Damaging1.69Pathogenic0.01Affected0.05150.277920-1.034.02
c.851T>A
L284H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L284H is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts a pathogenic impact. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.094817Structured0.371601Uncertain0.9500.2550.000-16.581Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.26Destabilizing0.13.06Destabilizing3.16Destabilizing2.57Destabilizing0.772Likely Pathogenic-6.22Deleterious1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.00Affected0.09540.0726-2-3-7.023.98
c.851T>C
L284P
2D
AIThe SynGAP1 missense variant L284P is listed in ClinVar as Pathogenic (ClinVar ID 3344808.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.094817Structured0.371601Uncertain0.9500.2550.000Likely Pathogenic1-15.588Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.83Destabilizing0.25.81Destabilizing5.82Destabilizing1.89Destabilizing0.794Likely Pathogenic-6.17Deleterious1.000Probably Damaging0.999Probably Damaging1.64Pathogenic0.00Affected0.35400.1021-3-3-5.4-16.04
c.851T>G
L284R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L284R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. With all available evidence pointing to a damaging effect and no ClinVar entry to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.094817Structured0.371601Uncertain0.9500.2550.000-17.698Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.05Destabilizing0.54.29Destabilizing4.67Destabilizing2.14Destabilizing0.797Likely Pathogenic-5.38Deleterious1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.00Affected0.11750.0600-3-2-8.343.03
c.853T>A
C285S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285S has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas a majority of the remaining predictors (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default) indicate a pathogenic impact. The remaining tools (FoldX, Rosetta, Foldetta, ESM1b, AlphaMissense‑Optimized) return uncertain results, which are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-7.149In-Between0.868Likely PathogenicAmbiguous0.73Ambiguous0.10.75Ambiguous0.74Ambiguous1.20Destabilizing0.507Likely Pathogenic-8.09Deleterious0.997Probably Damaging0.994Probably Damaging1.90Pathogenic0.08Tolerated0.52100.2038Weaken0-1-3.3-16.06
c.853T>C
C285R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, which scores the variant as benign. All other evaluated predictors—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus confirms a likely pathogenic status, while Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. Consequently, the preponderance of evidence points to a pathogenic effect for C285R, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.127Likely Pathogenic0.981Likely PathogenicLikely Pathogenic-0.47Likely Benign0.2-0.63Ambiguous-0.55Ambiguous1.53Destabilizing0.583Likely Pathogenic-9.66Deleterious0.999Probably Damaging0.998Probably Damaging1.83Pathogenic0.04Affected0.19470.1453-4-3-7.053.05
c.853T>G
C285G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a pathogenic interpretation: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all predict deleterious effects. Tools that assess protein stability (FoldX, Rosetta, Foldetta) and AlphaMissense‑Optimized return uncertain results, providing no clear evidence for or against pathogenicity. High‑accuracy assessments further support a likely pathogenic verdict: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta remain inconclusive. Overall, the consensus of the majority of predictors indicates that the variant is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.937Likely Pathogenic0.859Likely PathogenicAmbiguous1.26Ambiguous0.01.57Ambiguous1.42Ambiguous1.50Destabilizing0.564Likely Pathogenic-9.86Deleterious0.999Probably Damaging0.996Probably Damaging1.78Pathogenic0.04Affected0.35090.2922-3-3-2.9-46.09
c.854G>A
C285Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and Rosetta. Those that agree on a pathogenic effect include SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive are Foldetta, premPS, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact for C285Y. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-7.210In-Between0.895Likely PathogenicAmbiguous3.66Destabilizing1.1-2.33Stabilizing0.67Ambiguous0.53Ambiguous0.484Likely Benign-8.67Deleterious0.999Probably Damaging0.998Probably Damaging1.88Pathogenic0.18Tolerated0.14130.36890-2-3.860.04
c.854G>C
C285S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285S is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and SIFT, whereas premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. Predictions from FoldX, Rosetta, ESM1b, AlphaMissense‑Optimized, and Foldetta are inconclusive. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic classification; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. Overall, the preponderance of evidence points to a pathogenic effect for C285S, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-7.149In-Between0.868Likely PathogenicAmbiguous0.73Ambiguous0.10.75Ambiguous0.74Ambiguous1.20Destabilizing0.499Likely Benign-8.09Deleterious0.997Probably Damaging0.994Probably Damaging1.90Pathogenic0.08Tolerated0.52100.2038Weaken0-1-3.3-16.06
c.854G>T
C285F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285F is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, and AlphaMissense‑Optimized, whereas a majority of tools (SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic outcome; Foldetta is uncertain. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence (12 pathogenic vs. 3 benign predictions) indicates that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.397Likely Pathogenic0.716Likely PathogenicLikely Benign3.27Destabilizing1.1-1.72Ambiguous0.78Ambiguous0.35Likely Benign0.500Likely Pathogenic-8.84Deleterious0.999Probably Damaging0.998Probably Damaging1.81Pathogenic0.12Tolerated0.16260.4007-4-20.344.04
c.855C>G
C285W
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant C285W is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and Rosetta, whereas pathogenic predictions are made by SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy subset confirms this trend: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenicity, and Foldetta remains uncertain. No prediction tool is missing or inconclusive enough to alter the overall assessment. Consequently, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.017Likely Pathogenic0.969Likely PathogenicLikely Pathogenic3.35Destabilizing1.1-2.28Stabilizing0.54Ambiguous0.61Ambiguous0.327Likely Benign-8.97Deleterious1.000Probably Damaging0.998Probably Damaging1.78Pathogenic0.11Tolerated0.19340.3697-8-2-3.483.07
c.856C>A
L286M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L286M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, PROVEAN, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Two tools (premPS and ESM1b) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions (seven pathogenic vs. five benign) and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.122885Structured0.385647Uncertain0.9320.2600.000-7.998In-Between0.781Likely PathogenicLikely Benign-0.06Likely Benign0.10.17Likely Benign0.06Likely Benign0.98Ambiguous0.663Likely Pathogenic-1.84Neutral1.000Probably Damaging0.999Probably Damaging1.54Pathogenic0.02Affected0.07890.337142-1.918.03
c.856C>G
L286V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L286V is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—consistently predict a pathogenic impact; AlphaMissense‑Default and Rosetta are uncertain. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized indicates benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-9.986Likely Pathogenic0.500AmbiguousLikely Benign2.44Destabilizing0.51.63Ambiguous2.04Destabilizing1.26Destabilizing0.676Likely Pathogenic-2.76Deleterious0.999Probably Damaging0.994Probably Damaging1.71Pathogenic0.01Affected0.14920.3007210.4-14.03
c.857T>A
L286Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L286Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a deleterious effect. No tool predicts a benign outcome. Two tools, Rosetta and Foldetta, return uncertain results. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts pathogenic; SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-13.056Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.37Destabilizing0.31.42Ambiguous1.90Ambiguous2.06Destabilizing0.852Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.48Pathogenic0.00Affected0.11230.0958-2-2-7.314.97
c.857T>C
L286P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L286P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-14.982Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.43Destabilizing0.96.38Destabilizing5.91Destabilizing2.10Destabilizing0.878Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.47Pathogenic0.00Affected0.37190.1182-3-3-5.4-16.04
c.857T>G
L286R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L286R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while Rosetta remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity; the SGM‑Consensus (majority vote) is likely pathogenic; and Foldetta, which integrates FoldX‑MD (pathogenic) and Rosetta (uncertain), reports a pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-15.563Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.90Destabilizing0.31.80Ambiguous2.35Destabilizing1.97Destabilizing0.868Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.49Pathogenic0.00Affected0.13700.0600-3-2-8.343.03
c.859G>A
D287N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D287N missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions (REVEL, FoldX, premPS, SIFT) and pathogenic predictions (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default). Two tools give uncertain results (Rosetta, AlphaMissense‑Optimized). High‑accuracy assessments further separate the evidence: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign impact. Overall, the majority of conventional predictors lean toward pathogenicity, while the most accurate stability‑based method suggests benign. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-10.167Likely Pathogenic0.944Likely PathogenicAmbiguous0.16Likely Benign0.3-0.54Ambiguous-0.19Likely Benign0.05Likely Benign0.372Likely Benign-4.60Deleterious0.999Probably Damaging0.997Probably Damaging1.62Pathogenic0.06Tolerated0.13380.8194210.0-0.98
c.859G>C
D287H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D287H missense variant is listed in ClinVar as Pathogenic (ClinVar ID 1700054.0) and is not reported in gnomAD. Functional prediction tools that assess the variant’s effect on protein function largely agree on a deleterious outcome. Benign predictions come from FoldX, Rosetta, and Foldetta, whereas pathogenic predictions are reported by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS remains uncertain. High‑accuracy assessments further support a pathogenic classification: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of evidence points to a pathogenic effect, consistent with the ClinVar designation and not contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000Likely Pathogenic 1-14.518Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.48Likely Benign0.30.32Likely Benign0.40Likely Benign0.63Ambiguous0.589Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.51Pathogenic0.00Affected3.38230.16200.84871-10.322.05235.63.80.11.20.10.1XXPotentially PathogenicThe carboxylate group of Asp287, located at the beginning of a β hairpin loop connecting two anti-parallel β sheet strands (res. Arg279-Leu286, res. Met289-Pro298), maintains a salt bridge with the guanidinium group of Arg324 in the β sheet during the WT simulations. In the variant simulations, the imidazole ring of the His287 side chain is unable to form a salt bridge with Arg324 or establish any other stable compensatory interactions, which could weaken the beta sandwich assembly of the C2 domain. This destabilization of the C2 domain could adversely affect the stability of the SynGAP-membrane association.
c.859G>T
D287Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D287Y missense variant is reported in ClinVar as Pathogenic (ClinVar ID 2263930.0) and is not found in gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Rosetta, Foldetta, and premPS, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus. High‑accuracy assessments give a pathogenic verdict from AlphaMissense‑Optimized, a Likely Pathogenic consensus from SGM, and a benign outcome from Foldetta. Overall, the majority of evidence points to a deleterious effect. Therefore, the variant is most likely pathogenic, in agreement with its ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000Likely Pathogenic 1-12.877Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.21Likely Benign0.20.48Likely Benign0.35Likely Benign0.27Likely Benign0.663Likely Pathogenic-8.27Deleterious1.000Probably Damaging0.999Probably Damaging1.51Pathogenic0.00Affected3.38230.05970.7361-4-32.248.09257.8-44.4-0.61.60.20.3XXPotentially PathogenicThe carboxylate group of Asp287, located at the beginning of a β hairpin loop linking two anti-parallel β sheet strands (res. Arg279-Leu286, res. Met289-Pro298), maintains a salt bridge with the guanidinium group of Arg324 in the β sheet during the WT simulations. In the variant simulations, the phenol group of the Tyr287 side chain is unable to form a salt bridge with the guanidinium group of Arg324, which could weaken the tertiary structure assembly of the C2 domain. However, the phenol group of Tyr287 frequently stacks with the Arg324 guanidinium side chain, which could help maintain the tertiary structure, especially compared to the D287H variant. The destabilization of the C2 domain could adversely affect the stability of the SynGAP-membrane association.
c.85A>C
M29L
2D
AIThe SynGAP1 missense variant M29L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250-1.633Likely Benign0.079Likely BenignLikely Benign0.200Likely Benign-0.49Neutral0.006Benign0.039Benign4.27Benign0.00Affected0.19840.5336421.9-18.03
c.85A>T
M29L
2D
AIThe SynGAP1 missense variant M29L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect; there is no conflict with ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250-1.633Likely Benign0.079Likely BenignLikely Benign0.200Likely Benign-0.49Neutral0.006Benign0.039Benign4.27Benign0.00Affected0.19840.5336421.9-18.03
c.860A>C
D287A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D287A is listed in ClinVar with an Uncertain significance status and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, FoldX, Rosetta, Foldetta, and premPS, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta) as benign. The overall tally favors pathogenicity (8 tools vs 5 benign), but the conflicting high‑accuracy results leave uncertainty. Thus, the variant is most likely pathogenic according to the majority of predictions, which does not contradict its ClinVar Uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000Uncertain 1-14.686Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.30Likely Benign0.1-0.04Likely Benign0.13Likely Benign0.40Likely Benign0.484Likely Benign-7.35Deleterious1.000Probably Damaging0.998Probably Damaging1.58Pathogenic0.01Affected3.38230.44480.7431-205.3-44.01
c.860A>G
D287G
2D
AIThe SynGAP1 missense variant D287G is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include Foldetta, premPS, and Rosetta, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict it to be pathogenic; FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of predictions indicates a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-13.558Likely Pathogenic0.967Likely PathogenicLikely Pathogenic0.61Ambiguous1.10.31Likely Benign0.46Likely Benign0.38Likely Benign0.521Likely Pathogenic-6.43Deleterious0.999Probably Damaging0.997Probably Damaging1.59Pathogenic0.01Affected0.46880.73901-13.1-58.04
c.860A>T
D287V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D287V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only premPS; all other evaluated algorithms (SGM‑Consensus, REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, while FoldX is uncertain and thus not counted as evidence. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-14.418Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.71Ambiguous0.43.94Destabilizing2.83Destabilizing0.25Likely Benign0.516Likely Pathogenic-8.27Deleterious1.000Probably Damaging0.999Probably Damaging1.57Pathogenic0.01Affected0.08840.7788-2-37.7-15.96
c.861T>A
D287E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D287E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, ESM1b, and the protein‑folding stability method Foldetta; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy AlphaMissense‑Optimized tool classifies the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (benign), FATHMM (pathogenic), and PROVEAN (pathogenic), also reports it as pathogenic. In contrast, Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect on protein stability. No evidence is available from Rosetta alone. Overall, the majority of predictions, including the high‑accuracy methods, indicate a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-5.250Likely Benign0.990Likely PathogenicLikely Pathogenic0.35Likely Benign0.20.54Ambiguous0.45Likely Benign0.50Likely Benign0.416Likely Benign-3.68Deleterious0.997Probably Damaging0.994Probably Damaging1.54Pathogenic0.01Affected0.15410.7833320.014.03
c.861T>G
D287E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D287E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, ESM1b, and the protein‑folding stability method Foldetta; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy AlphaMissense‑Optimized tool classifies the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (benign), FATHMM (pathogenic), and PROVEAN (pathogenic), also reports it as pathogenic. In contrast, Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect on protein stability. No evidence is available from Rosetta alone. Overall, the majority of predictions, including the high‑accuracy methods, indicate a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.102787Structured0.389029Uncertain0.9120.2680.000-5.250Likely Benign0.990Likely PathogenicLikely Pathogenic0.35Likely Benign0.20.54Ambiguous0.45Likely Benign0.50Likely Benign0.416Likely Benign-3.68Deleterious0.997Probably Damaging0.994Probably Damaging1.54Pathogenic0.01Affected0.15410.7833320.014.03
c.862G>C
D288H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D288H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, and premPS. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labeling the variant as Likely Pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect on protein folding stability. Overall, the majority of tools (7/12) predict pathogenicity, and the high‑accuracy consensus leans toward pathogenic, with no conflict with ClinVar status. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-12.589Likely Pathogenic0.953Likely PathogenicAmbiguous0.08Likely Benign0.10.36Likely Benign0.22Likely Benign-0.02Likely Benign0.460Likely Benign-5.40Deleterious1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.01Affected0.16390.62541-10.322.05
c.862G>T
D288Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288Y missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, and premPS; pathogenic predictions from SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus confirms Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. No evidence from the available tools suggests a benign effect. Therefore, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-15.269Likely Pathogenic0.979Likely PathogenicLikely Pathogenic0.11Likely Benign0.21.10Ambiguous0.61Ambiguous0.10Likely Benign0.472Likely Benign-7.11Deleterious1.000Probably Damaging0.999Probably Damaging1.64Pathogenic0.00Affected0.06350.5009-4-32.248.09
c.863A>C
D288A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288A missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, and SIFT. Those that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized, Foldetta, and Rosetta give uncertain results and are treated as unavailable for pathogenicity inference. High‑accuracy assessments show that the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, AlphaMissense‑Optimized is uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also uncertain. Overall, seven tools predict pathogenicity while four predict benign, with no conflicting ClinVar evidence. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-13.470Likely Pathogenic0.908Likely PathogenicAmbiguous0.34Likely Benign0.11.27Ambiguous0.81Ambiguous0.10Likely Benign0.451Likely Benign-6.09Deleterious1.000Probably Damaging0.998Probably Damaging1.71Pathogenic0.07Tolerated0.40600.57880-25.3-44.01
c.863A>G
D288G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D288G is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, Rosetta, premPS, SIFT, AlphaMissense‑Optimized, and Foldetta. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. No folding‑stability result is available from FoldX. Overall, the balance of evidence slightly favors a pathogenic interpretation, with one high‑accuracy tool supporting benignity. The prediction does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-8.531Likely Pathogenic0.739Likely PathogenicLikely Benign-0.71Ambiguous0.40.21Likely Benign-0.25Likely Benign-0.15Likely Benign0.436Likely Benign-5.03Deleterious0.999Probably Damaging0.997Probably Damaging2.05Pathogenic0.13Tolerated0.41260.59341-13.1-58.04
c.863A>T
D288V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288V missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are provided by REVEL and premPS, whereas the remaining tools—FoldX (uncertain), Rosetta, Foldetta, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—all indicate a pathogenic effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic based on the aggregate predictions, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.395525Uncertain0.8730.2610.000-15.812Likely Pathogenic0.981Likely PathogenicLikely Pathogenic1.74Ambiguous0.55.44Destabilizing3.59Destabilizing0.13Likely Benign0.481Likely Benign-7.14Deleterious1.000Probably Damaging0.999Probably Damaging1.63Pathogenic0.05Affected0.08380.5545-2-37.7-15.96
c.864C>A
D288E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Two tools give uncertain results: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.125101Structured0.395525Uncertain0.8730.2610.000-6.685Likely Benign0.350AmbiguousLikely Benign0.10Likely Benign0.00.74Ambiguous0.42Likely Benign-0.10Likely Benign0.203Likely Benign-2.84Deleterious0.997Probably Damaging0.994Probably Damaging1.74Pathogenic0.13Tolerated0.15590.5476320.014.03
c.864C>G
D288E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D288E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Two tools give uncertain results: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.125101Structured0.395525Uncertain0.8730.2610.000-6.685Likely Benign0.350AmbiguousLikely Benign0.10Likely Benign0.00.74Ambiguous0.42Likely Benign-0.10Likely Benign0.203Likely Benign-2.84Deleterious0.997Probably Damaging0.994Probably Damaging1.74Pathogenic0.13Tolerated0.15590.5476320.014.03
c.865A>C
M289L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign. Only FATHMM predicts a pathogenic outcome. Grouping by consensus, the benign‑predicting tools outnumber the single pathogenic prediction. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a “Likely Benign” verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign effect. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.127496Structured0.403499Uncertain0.8860.2760.000-5.778Likely Benign0.157Likely BenignLikely Benign0.13Likely Benign0.0-0.10Likely Benign0.02Likely Benign0.39Likely Benign0.070Likely Benign-0.95Neutral0.136Benign0.033Benign1.79Pathogenic0.27Tolerated0.10920.3634421.9-18.03
c.865A>G
M289V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M289V is reported in ClinVar as Benign (ClinVar ID 2122760.0) and is not present in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus all predict benign, while only FATHMM predicts pathogenic. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also indicates benign. No prediction or stability result is inconclusive. Overall, the computational evidence strongly supports a benign classification, consistent with the ClinVar status and showing no contradiction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.127496Structured0.403499Uncertain0.8860.2760.000Benign 1-4.239Likely Benign0.117Likely BenignLikely Benign1.09Ambiguous0.1-0.27Likely Benign0.41Likely Benign0.24Likely Benign0.150Likely Benign-0.36Neutral0.136Benign0.054Benign1.80Pathogenic1.00Tolerated3.38230.22800.2808212.3-32.06204.251.00.00.00.20.0XPotentially BenignThe hydrophobic residue Met289, located in a β hairpin linking two anti-parallel β sheet strands (res. Met289-Arg299, res. Arg272-Leu286), is swapped for another hydrophobic residue, valine. In the variant simulations, the branched hydrocarbon side chain of Val289 packs against the phenol group of the Tyr291 side chain but is unable to form methionine-aromatic interactions. β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. However, based on the simulations, the residue swap does not cause adverse effects on the structure.
c.865A>T
M289L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is benign. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because the variant is not currently listed in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.127496Structured0.403499Uncertain0.8860.2760.000-5.778Likely Benign0.157Likely BenignLikely Benign0.13Likely Benign0.0-0.10Likely Benign0.02Likely Benign0.39Likely Benign0.070Likely Benign-0.95Neutral0.136Benign0.033Benign1.79Pathogenic0.27Tolerated0.10920.3634421.9-18.03
c.866T>A
M289K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 M289K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Because the majority of consensus and individual predictors lean toward pathogenicity, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status since none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.403499Uncertain0.8860.2760.000-12.192Likely Pathogenic0.738Likely PathogenicLikely Benign0.36Likely Benign0.20.60Ambiguous0.48Likely Benign0.94Ambiguous0.229Likely Benign-2.52Deleterious0.891Possibly Damaging0.492Possibly Damaging1.94Pathogenic0.12Tolerated0.12710.08790-1-5.8-3.02
c.866T>C
M289T
2D
AIThe SynGAP1 missense variant M289T is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled likely benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a benign effect. Taken together, the majority of evidence indicates that M289T is most likely benign, and this conclusion does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.127496Structured0.403499Uncertain0.8860.2760.000Uncertain1-4.668Likely Benign0.238Likely BenignLikely Benign0.73Ambiguous0.10.17Likely Benign0.45Likely Benign-0.01Likely Benign0.222Likely Benign-0.47Neutral0.801Possibly Damaging0.315Benign1.83Pathogenic0.57Tolerated0.16570.1534-1-1-2.6-30.09
c.866T>G
M289R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289R has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No predictions or stability results are missing or inconclusive. Overall, the majority of tools lean toward a pathogenic effect, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.403499Uncertain0.8860.2760.000-11.090Likely Pathogenic0.719Likely PathogenicLikely Benign0.04Likely Benign0.10.28Likely Benign0.16Likely Benign1.01Destabilizing0.228Likely Benign-2.84Deleterious0.989Probably Damaging0.767Possibly Damaging1.84Pathogenic0.08Tolerated0.14820.08280-1-6.424.99
c.867G>A
M289I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign prediction; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Overall, the preponderance of evidence indicates that M289I is most likely benign, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.127496Structured0.403499Uncertain0.8860.2760.000-6.010Likely Benign0.505AmbiguousLikely Benign0.62Ambiguous0.1-0.23Likely Benign0.20Likely Benign0.36Likely Benign0.040Likely Benign-0.72Neutral0.005Benign0.018Benign1.78Pathogenic0.31Tolerated0.10010.2758212.6-18.03
c.867G>C
M289I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Overall, the preponderance of evidence indicates that M289I is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.127496Structured0.403499Uncertain0.8860.2760.000-6.010Likely Benign0.505AmbiguousLikely Benign0.62Ambiguous0.1-0.23Likely Benign0.20Likely Benign0.36Likely Benign0.040Likely Benign-0.72Neutral0.005Benign0.018Benign1.78Pathogenic0.31Tolerated0.10010.2758212.6-18.03
c.867G>T
M289I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Overall, the preponderance of evidence indicates that M289I is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.127496Structured0.403499Uncertain0.8860.2760.000-6.010Likely Benign0.505AmbiguousLikely Benign0.62Ambiguous0.1-0.23Likely Benign0.20Likely Benign0.36Likely Benign0.040Likely Benign-0.72Neutral0.005Benign0.018Benign1.78Pathogenic0.31Tolerated0.10010.2758212.6-18.03
c.868C>A
L290M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L290M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, FoldX, and PROVEAN, whereas pathogenic predictions are reported by polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Tools with uncertain outcomes include Foldetta, premPS, AlphaMissense‑Optimized, and Rosetta. High‑accuracy analyses indicate that AlphaMissense‑Optimized is inconclusive, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) classifies the variant as Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Overall, the majority of evidence leans toward a pathogenic effect, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-8.393Likely Pathogenic0.901Likely PathogenicAmbiguous0.48Likely Benign0.20.98Ambiguous0.73Ambiguous0.59Ambiguous0.438Likely Benign-1.84Neutral1.000Probably Damaging0.999Probably Damaging1.92Pathogenic0.02Affected0.08230.416742-1.918.03
c.868C>G
L290V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L290V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and Rosetta, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive or unavailable are FoldX, premPS, ESM1b, AlphaMissense‑Optimized, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple pathogenic‑predicting tools and the SGM Consensus suggests that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-7.392In-Between0.834Likely PathogenicAmbiguous1.17Ambiguous0.10.35Likely Benign0.76Ambiguous0.62Ambiguous0.366Likely Benign-2.76Deleterious0.999Probably Damaging0.994Probably Damaging1.98Pathogenic0.05Affected0.15740.4177210.4-14.03
c.869T>A
L290Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L290Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only SIFT, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which itself is “Likely Pathogenic”). Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, and Foldetta’s stability prediction is unavailable. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-12.776Likely Pathogenic0.993Likely PathogenicLikely Pathogenic1.12Ambiguous0.11.38Ambiguous1.25Ambiguous0.68Ambiguous0.697Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.97Pathogenic0.06Tolerated0.10790.1014-2-2-7.314.97
c.869T>C
L290P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L290P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously favor a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict pathogenicity. No tool in the dataset predicts a benign outcome; the remaining tools (FoldX, Rosetta, Foldetta, premPS) return uncertain results, which are treated as unavailable evidence. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta is inconclusive. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-11.796Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.79Ambiguous0.11.10Ambiguous0.95Ambiguous0.56Ambiguous0.727Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging2.01Pathogenic0.03Affected0.36460.1703-3-3-5.4-16.04
c.869T>G
L290R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L290R is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions are limited to FoldX, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all classify the variant as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus also indicates likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. Overall, the consensus of the majority of evidence points to a pathogenic impact. This conclusion is consistent with the absence of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-13.938Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.48Likely Benign0.10.88Ambiguous0.68Ambiguous0.89Ambiguous0.705Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging2.03Pathogenic0.01Affected0.12150.1056-3-2-8.343.03
c.86T>A
M29K
2D
AIThe SynGAP1 missense variant M29K is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency or clinical annotation. Prediction tools that converge on a benign outcome include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic effect. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the collective predictions point to a benign effect, and this conclusion does not contradict the absence of a ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250-2.514Likely Benign0.287Likely BenignLikely Benign0.197Likely Benign-0.88Neutral0.018Benign0.184Benign4.27Benign0.00Affected0.20190.13120-1-5.8-3.02
c.86T>C
M29T
2D
AIThe SynGAP1 missense variant M29T is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also benign; Foldetta results are unavailable. Overall, the preponderance of evidence indicates that M29T is most likely benign, and this conclusion does not contradict the current ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250Uncertain 1-2.167Likely Benign0.122Likely BenignLikely Benign0.199Likely Benign-0.37Neutral0.018Benign0.184Benign4.33Benign0.00Affected4.3210.26330.2716-1-1-2.6-30.09
c.86T>G
M29R
2D
AIThe SynGAP1 missense variant M29R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250-1.708Likely Benign0.241Likely BenignLikely Benign0.211Likely Benign-0.92Neutral0.042Benign0.184Benign4.23Benign0.00Affected0.20760.12930-1-6.424.99
c.871T>A
Y291N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291N is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the substitution as pathogenic. High‑accuracy methods corroborate this: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely pathogenic verdict, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000-13.599Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.82Destabilizing0.63.37Destabilizing3.10Destabilizing2.16Destabilizing0.533Likely Pathogenic-7.43Deleterious1.000Probably Damaging0.999Probably Damaging1.76Pathogenic0.01Affected0.22550.0499-2-2-2.2-49.07
c.871T>C
Y291H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291H is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: the single benign prediction comes from REVEL, while all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict pathogenicity, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a likely pathogenic verdict; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a destabilizing, pathogenic effect. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000-8.749Likely Pathogenic0.986Likely PathogenicLikely Pathogenic2.13Destabilizing0.22.61Destabilizing2.37Destabilizing1.56Destabilizing0.355Likely Benign-4.04Deleterious1.000Probably Damaging0.999Probably Damaging1.77Pathogenic0.02Affected0.24030.049902-1.9-26.03
c.871T>G
Y291D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291D is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic outcome. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. With all available evidence pointing to a damaging effect and no ClinVar entry to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000-17.570Likely Pathogenic1.000Likely PathogenicLikely Pathogenic4.13Destabilizing0.63.86Destabilizing4.00Destabilizing1.91Destabilizing0.650Likely Pathogenic-8.19Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.01Affected0.43000.0331-4-3-2.2-48.09
c.872A>C
Y291S
2D
AIThe SynGAP1 missense variant Y291S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). All evaluated in silico predictors classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No predictions or stability results are missing or inconclusive. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000-11.928Likely Pathogenic0.992Likely PathogenicLikely Pathogenic3.47Destabilizing0.84.47Destabilizing3.97Destabilizing2.01Destabilizing0.588Likely Pathogenic-7.31Deleterious1.000Probably Damaging0.998Probably Damaging1.83Pathogenic0.02Affected0.48500.2079-3-20.5-76.10
c.872A>G
Y291C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291C is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset predicts a benign outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, a conclusion that contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.383842Uncertain0.9120.2510.000Uncertain 1-8.997Likely Pathogenic0.967Likely PathogenicLikely Pathogenic2.90Destabilizing0.43.51Destabilizing3.21Destabilizing1.35Destabilizing0.505Likely Pathogenic-7.37Deleterious1.000Probably Damaging0.999Probably Damaging1.76Pathogenic0.01Affected3.38230.30530.25270-23.8-60.04205.266.10.10.0-0.40.4XXPotentially PathogenicThe phenol group of the Tyr291 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), packs against hydrophobic residues of the C2 and PH domains (e.g., Leu317, Leu286, Leu284, Pro208, Val209). The phenol ring of Tyr291 also forms favorable Met-aromatic stacking with the methyl group of Met289. In the variant simulation, the thiol group of the Cys291 side chain is not as suitable for the hydrophobic inter-domain space as the phenol ring of Tyr291. Consequently, the structural unity of the PH domain is weakened and ultimately unfolds in the second simulation. Moreover, the residue swap might result in severe detrimental effects on the C2 domain structure and the C2-PH domain tertiary structure assembly during folding.
c.872A>T
Y291F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y291F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign) all predict a neutral impact. In contrast, polyPhen‑2 (HumDiv and HumVar) and FATHMM predict a pathogenic effect, while premPS remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Overall, the majority of evidence supports a benign classification, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.173081Structured0.383842Uncertain0.9120.2510.000-4.095Likely Benign0.305Likely BenignLikely Benign-0.43Likely Benign0.1-0.10Likely Benign-0.27Likely Benign0.71Ambiguous0.148Likely Benign-2.31Neutral0.999Probably Damaging0.992Probably Damaging1.77Pathogenic0.27Tolerated0.23620.3441734.1-16.00
c.874G>A
A292T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A292T is not reported in ClinVar and is absent from gnomAD. Prediction tools largely converge on a deleterious effect: only REVEL classifies it as benign, whereas FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (both HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized returns a pathogenic score, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels it Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a destabilizing, pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.247041Structured0.362042Uncertain0.9290.2560.000-11.039Likely Pathogenic0.985Likely PathogenicLikely Pathogenic2.16Destabilizing0.73.42Destabilizing2.79Destabilizing1.08Destabilizing0.457Likely Benign-3.68Deleterious0.999Probably Damaging0.997Probably Damaging1.68Pathogenic0.01Affected0.16910.737710-2.530.03
c.874G>C
A292P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A292P is not reported in ClinVar and is absent from gnomAD. Prediction tools largely converge on a deleterious effect: only REVEL classifies it as benign, whereas FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (both HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized returns a pathogenic score, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels it Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a destabilizing, pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.247041Structured0.362042Uncertain0.9290.2560.000-16.897Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.37Destabilizing0.39.80Destabilizing7.09Destabilizing1.23Destabilizing0.471Likely Benign-4.60Deleterious1.000Probably Damaging0.999Probably Damaging1.67Pathogenic0.01Affected0.21010.59881-1-3.426.04
c.874G>T
A292S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A292S is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FoldX, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and PROVEAN. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. No prediction or folding‑stability result is missing; uncertain outcomes are treated as unavailable. Overall, the balance of evidence favors a pathogenic classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.247041Structured0.362042Uncertain0.9290.2560.000-8.514Likely Pathogenic0.804Likely PathogenicAmbiguous0.40Likely Benign0.22.13Destabilizing1.27Ambiguous0.70Ambiguous0.364Likely Benign-2.76Deleterious0.999Probably Damaging0.996Probably Damaging1.69Pathogenic0.03Affected0.28500.638911-2.616.00
c.875C>A
A292E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A292E is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support this view: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for A292E.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.247041Structured0.362042Uncertain0.9290.2560.000-14.282Likely Pathogenic0.999Likely PathogenicLikely Pathogenic6.07Destabilizing1.23.82Destabilizing4.95Destabilizing1.54Destabilizing0.475Likely Benign-4.60Deleterious1.000Probably Damaging0.998Probably Damaging1.69Pathogenic0.02Affected0.14440.22050-1-5.358.04
c.875C>G
A292G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A292G is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The high‑accuracy consensus from AlphaMissense‑Optimized is benign, whereas the SGM Consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is uncertain, and individual FoldX and Rosetta predictions are also inconclusive. Overall, the majority of evidence points to a pathogenic impact, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.247041Structured0.362042Uncertain0.9290.2560.000-9.692Likely Pathogenic0.713Likely PathogenicLikely Benign0.88Ambiguous0.11.83Ambiguous1.36Ambiguous1.05Destabilizing0.323Likely Benign-3.68Deleterious0.999Probably Damaging0.996Probably Damaging1.74Pathogenic0.10Tolerated0.21870.505410-2.2-14.03
c.875C>T
A292V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A292V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; premPS is uncertain and therefore not counted. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.247041Structured0.362042Uncertain0.9290.2560.000-11.170Likely Pathogenic0.987Likely PathogenicLikely Pathogenic2.04Destabilizing0.54.60Destabilizing3.32Destabilizing0.85Ambiguous0.430Likely Benign-3.68Deleterious0.999Probably Damaging0.996Probably Damaging1.75Pathogenic0.03Affected0.12720.6253002.428.05
c.877C>A
R293S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R293S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a deleterious effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Tools that are inconclusive or uncertain are Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM‑Consensus indicating a likely pathogenic outcome, while Foldetta’s stability analysis remains uncertain. Taken together, the overwhelming majority of evidence points to a pathogenic impact for R293S. This conclusion is consistent with the lack of ClinVar annotation, as there is no conflicting status to contradict the prediction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125-14.103Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.66Destabilizing0.21.30Ambiguous1.98Ambiguous0.71Ambiguous0.561Likely Pathogenic-5.52Deleterious0.999Probably Damaging0.997Probably Damaging1.51Pathogenic0.01Affected0.27940.50450-13.7-69.11
c.877C>G
R293G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R293G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while premPS remains uncertain. High‑accuracy assessments corroborate this trend: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports a likely pathogenic outcome, and Foldetta (integrating FoldX‑MD and Rosetta stability outputs) also indicates pathogenicity. No tool suggests a benign effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125-15.861Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.70Destabilizing0.22.35Destabilizing3.03Destabilizing0.57Ambiguous0.604Likely Pathogenic-6.43Deleterious0.999Probably Damaging0.997Probably Damaging1.45Pathogenic0.02Affected0.32350.3738-3-24.1-99.14
c.878G>A
R293H
2D
AISynGAP1 missense variant R293H is listed in ClinVar with an uncertain significance (ClinVar ID 3901513.0) and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL and premPS, whereas the remaining 13 tools—FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, classifies the variant as pathogenic. Overall, the preponderance of evidence indicates that R293H is most likely pathogenic, a conclusion that does not contradict the current ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125Uncertain 1-13.009Likely Pathogenic0.973Likely PathogenicLikely Pathogenic4.45Destabilizing2.32.12Destabilizing3.29Destabilizing0.32Likely Benign0.438Likely Benign-4.60Deleterious1.000Probably Damaging0.998Probably Damaging1.45Pathogenic0.04Affected0.31200.2573201.3-19.05
c.878G>C
R293P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R293P is listed in ClinVar as Pathogenic (ClinVar ID 571092.0) and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL and premPS, whereas the remaining tools—FoldX, Rosetta, Foldetta, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as Pathogenic; the SGM Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, classifies it as Pathogenic. Consequently, the variant is most likely pathogenic, and this prediction is concordant with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125Likely Pathogenic 1-16.275Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.62Destabilizing0.49.06Destabilizing6.34Destabilizing0.47Likely Benign0.497Likely Benign-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.45Pathogenic0.01Affected3.38230.21620.47780-22.9-59.07202.3132.00.10.00.10.1XXXPotentially PathogenicThe guanidinium group of the Arg293 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), packs against the phenol ring of the Tyr281 side chain or forms a salt bridge with the carboxylate group of Glu283 on the outer side of the C2 domain. In the WT simulations, the positively charged side chain of arginine remains outside the hydrophobic C2 domain, resulting in a twist in the β strand. The backbone amide bond of Arg293 potentially maintains this twist by forming a hydrogen bond with the carbonyl group of His210 or the hydroxyl group of Ser211 in the anti-parallel β sheet.Although this twist is also maintained in the variant simulations, replacing the positively charged residue with proline, which lacks the backbone amide group altogether, causes the β strand to unfold. Because Arg293 is positioned at the C2 and PH domain interface, the residue swap could significantly impact the tertiary structure assembly. Notably, Arg293 is located at the SynGAP-Ras interface, and its role in complex formation cannot be fully understood through solvent-only simulations.
c.878G>T
R293L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R293L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are made by REVEL and premPS, while the remaining evaluated tools (SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all predict pathogenicity. Uncertain results from FoldX, Rosetta, and Foldetta are treated as unavailable. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta provides no definitive stability change. Consequently, the variant is most likely pathogenic based on the consensus of predictive tools, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125-15.502Likely Pathogenic0.993Likely PathogenicLikely Pathogenic1.56Ambiguous0.20.93Ambiguous1.25Ambiguous0.08Likely Benign0.493Likely Benign-6.43Deleterious0.999Probably Damaging0.997Probably Damaging1.46Pathogenic0.01Affected0.18150.4987-3-28.3-43.03
c.87G>C
M29I
2D
AIThe SynGAP1 missense variant M29I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250-2.425Likely Benign0.185Likely BenignLikely Benign0.067Likely Benign-0.51Neutral0.006Benign0.091Benign4.26Benign0.00Affected4.3210.16800.4385122.6-18.03
c.87G>T
M29I
2D
AIThe SynGAP1 missense variant M29I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250-2.425Likely Benign0.185Likely BenignLikely Benign0.067Likely Benign-0.51Neutral0.006Benign0.091Benign4.26Benign0.00Affected4.3210.16800.4385122.6-18.03
c.880A>C
T294P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T294P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX (Uncertain), Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool reports a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is pathogenic; SGM‑Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-17.477Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.97Ambiguous0.35.18Destabilizing3.58Destabilizing1.15Destabilizing0.741Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.998Probably Damaging-0.19Pathogenic0.01Affected0.19060.44790-1-0.9-3.99
c.880A>G
T294A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T294A missense variant is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tool with an uncertain call is FoldX. High‑accuracy methods give consistent results: AlphaMissense‑Optimized predicts Pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts Likely Pathogenic, and Foldetta predicts Pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-12.371Likely Pathogenic0.971Likely PathogenicLikely Pathogenic1.87Ambiguous0.12.27Destabilizing2.07Destabilizing1.05Destabilizing0.719Likely Pathogenic-4.60Deleterious0.997Probably Damaging0.992Probably Damaging-0.18Pathogenic0.03Affected0.36870.3494102.5-30.03
c.880A>T
T294S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T294S missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). In silico predictors that classify the variant as benign are absent; all available tools that provide a definitive call predict a deleterious effect. Pathogenic predictions come from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results are reported for FoldX, Rosetta, Foldetta, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Uncertain. Overall, the preponderance of pathogenic calls and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which contains no opposing evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-7.785In-Between0.954Likely PathogenicAmbiguous1.12Ambiguous0.21.70Ambiguous1.41Ambiguous1.19Destabilizing0.613Likely Pathogenic-3.68Deleterious0.999Probably Damaging0.992Probably Damaging0.08Pathogenic0.03Affected0.29830.339611-0.1-14.03
c.881C>A
T294N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T294N is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy methods reinforce this assessment: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts pathogenic. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status (no report).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-14.925Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.74Destabilizing0.22.66Destabilizing2.70Destabilizing1.56Destabilizing0.630Likely Pathogenic-4.60Deleterious1.000Probably Damaging0.998Probably Damaging-0.18Pathogenic0.01Affected0.10400.323900-2.813.00
c.881C>G
T294S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T294S missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). In silico predictors that classify the variant as benign are absent; all available tools that provide a definitive call predict a deleterious effect. Pathogenic predictions come from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results are reported for FoldX, Rosetta, Foldetta, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Uncertain. Overall, the preponderance of pathogenic calls and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which contains no opposing evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-7.785In-Between0.954Likely PathogenicAmbiguous1.12Ambiguous0.21.70Ambiguous1.41Ambiguous1.19Destabilizing0.583Likely Pathogenic-3.68Deleterious0.999Probably Damaging0.992Probably Damaging0.08Pathogenic0.03Affected0.29830.339611-0.1-14.03
c.881C>T
T294I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T294I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on pathogenicity include REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools with uncertain or inconclusive results are Rosetta and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Based on the overwhelming agreement among pathogenic predictions and the high‑accuracy tool results, the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-15.302Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.09Destabilizing0.21.33Ambiguous2.71Destabilizing0.54Ambiguous0.768Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.998Probably Damaging-0.19Pathogenic0.01Affected0.08080.54850-15.212.05
c.883A>C
T295P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T295P is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include FoldX and AlphaMissense‑Optimized, whereas the remaining evaluated algorithms (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic outcome. High‑accuracy assessments further show that AlphaMissense‑Optimized classifies the variant as benign, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it as likely pathogenic, and Foldetta reports an uncertain stability change. With the majority of evidence pointing to deleterious effects, the variant is most likely pathogenic, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.401658Structured0.295548Uncertain0.8810.2880.125-9.941Likely Pathogenic0.688Likely PathogenicLikely Benign0.26Likely Benign0.23.30Destabilizing1.78Ambiguous0.60Ambiguous0.531Likely Pathogenic-4.65Deleterious1.000Probably Damaging0.998Probably Damaging1.90Pathogenic0.02Affected0.24420.53270-1-0.9-3.99
c.883A>G
T295A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T295A missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into benign (REVEL, FoldX, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized) and pathogenic (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM). Four tools are uncertain (Rosetta, Foldetta, premPS, ESM1b). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as inconclusive. Overall, the majority of conventional predictors lean toward a benign effect, whereas the SGM Consensus indicates a pathogenic signal. Thus, the variant is most likely benign based on the bulk of evidence, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.401658Structured0.295548Uncertain0.8810.2880.125-7.276In-Between0.336Likely BenignLikely Benign0.22Likely Benign0.11.17Ambiguous0.70Ambiguous0.56Ambiguous0.340Likely Benign-3.51Deleterious0.997Probably Damaging0.992Probably Damaging1.96Pathogenic0.11Tolerated0.46230.4190102.5-30.03
c.883A>T
T295S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T295S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; premPS is inconclusive. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority (3 benign vs. 1 pathogenic); and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.401658Structured0.295548Uncertain0.8810.2880.125-4.904Likely Benign0.335Likely BenignLikely Benign-0.16Likely Benign0.20.28Likely Benign0.06Likely Benign0.54Ambiguous0.218Likely Benign-2.16Neutral0.999Probably Damaging0.992Probably Damaging2.02Pathogenic0.14Tolerated0.39100.447311-0.1-14.03
c.884C>A
T295N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T295N missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, ESM1b, and Foldetta, while those that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, seven tools predict pathogenicity versus four predicting benign, with no ClinVar evidence to contradict this assessment. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.401658Structured0.295548Uncertain0.8810.2880.125-6.588Likely Benign0.793Likely PathogenicAmbiguous0.24Likely Benign0.10.66Ambiguous0.45Likely Benign0.89Ambiguous0.438Likely Benign-3.51Deleterious1.000Probably Damaging0.998Probably Damaging1.93Pathogenic0.03Affected0.15220.445700-2.813.00
c.884C>G
T295S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T295S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; premPS is inconclusive. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority (3 benign vs. 1 pathogenic); and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.401658Structured0.295548Uncertain0.8810.2880.125-4.904Likely Benign0.335Likely BenignLikely Benign-0.16Likely Benign0.20.28Likely Benign0.06Likely Benign0.54Ambiguous0.196Likely Benign-2.16Neutral0.999Probably Damaging0.992Probably Damaging2.02Pathogenic0.14Tolerated0.39100.447311-0.1-14.03
c.886T>A
S296T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 S296T missense variant is not reported in ClinVar and is absent from gnomAD. Consensus from most in silico predictors shows a split: six tools (REVEL, FoldX, Rosetta, premPS, PROVEAN, SIFT) and AlphaMissense‑Optimized predict a benign effect, whereas four tools (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default) predict pathogenicity. ESM1b remains uncertain. High‑accuracy assessments give a more definitive picture: AlphaMissense‑Optimized classifies the variant as benign, the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans toward pathogenicity, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign outcome. Overall, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.444081Structured0.282669Uncertain0.8870.2840.250-7.020In-Between0.645Likely PathogenicLikely Benign0.09Likely Benign0.40.38Likely Benign0.24Likely Benign0.19Likely Benign0.201Likely Benign-2.10Neutral0.992Probably Damaging0.987Probably Damaging2.13Pathogenic0.13Tolerated0.14370.6340110.114.03
c.886T>C
S296P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S296P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, FoldX, Rosetta, and SIFT, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. When predictions are grouped by agreement, four tools predict benign and seven predict pathogenic, with premPS remaining uncertain. High‑accuracy methods give a mixed signal: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus, derived from the unanimous pathogenic vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a benign effect. Thus, the majority of evidence leans toward pathogenicity, and this conclusion is consistent with the lack of ClinVar annotation and gnomAD absence, which do not contradict the prediction. Overall, the variant is most likely pathogenic based on the current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.444081Structured0.282669Uncertain0.8870.2840.250-8.302Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.04Likely Benign0.40.18Likely Benign0.11Likely Benign0.72Ambiguous0.439Likely Benign-3.74Deleterious0.999Probably Damaging0.996Probably Damaging1.92Pathogenic0.12Tolerated0.22730.63201-1-0.810.04
c.886T>G
S296A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S296A (ClinVar ID 469166.0) is listed as ClinVar status Uncertain and is not present in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign or neutral. In contrast, polyPhen‑2 (HumDiv and HumVar) and FATHMM predict pathogenic. Grouping by consensus, the benign‑predicting tools outnumber the pathogenic ones. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a benign effect. No evidence from the available tools suggests a deleterious impact. Therefore, the variant is most likely benign, and this conclusion is consistent with its ClinVar status of Uncertain rather than pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.444081Structured0.282669Uncertain0.8870.2840.250Uncertain 1-6.847Likely Benign0.247Likely BenignLikely Benign0.50Ambiguous0.3-0.26Likely Benign0.12Likely Benign0.35Likely Benign0.209Likely Benign-1.79Neutral0.992Probably Damaging0.987Probably Damaging1.97Pathogenic0.65Tolerated3.40160.49580.5522112.6-16.00182.526.6-0.20.1-0.50.0XPotentially PathogenicThe hydroxyl group of the Ser296 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), stably hydrogen bonds with the carboxylate group of Asp330 in a neighboring β strand (res. Ala322-Asp332). The backbone carbonyl group of Ser296 also hydrogen bonds with the guanidinium group of Arg279 in another nearby β strand (res. Arg279-Cys285). In the variant simulations, the methyl group of the Ala296 side chain cannot hydrogen bond with Asp330, causing the carboxylate group positioning to fluctuate more than in the WT simulations.Although the residue swap does not seem to affect the anti-parallel β sheet assembly during the simulations, it is possible that the Ser296-Asp330 hydrogen bond plays a crucial role in maintaining the C2 domain fold. Notably, because Ser296 is located near the membrane interface, the potential effect of the residue swap on the SynGAP-membrane association cannot be addressed by solvent-only simulations.
c.887C>A
S296Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S296Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and premPS, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Foldetta give uncertain results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact. The variant is most likely pathogenic based on predictions, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.444081Structured0.282669Uncertain0.8870.2840.250-12.148Likely Pathogenic0.992Likely PathogenicLikely Pathogenic1.46Ambiguous0.20.48Likely Benign0.97Ambiguous0.15Likely Benign0.486Likely Benign-4.34Deleterious0.999Probably Damaging0.998Probably Damaging1.93Pathogenic0.05Affected0.08000.5610-3-2-0.576.10
c.887C>G
S296C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S296C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as benign. No predictions or stability results are missing or inconclusive. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.444081Structured0.282669Uncertain0.8870.2840.250-7.842In-Between0.286Likely BenignLikely Benign0.46Likely Benign0.1-0.11Likely Benign0.18Likely Benign0.09Likely Benign0.361Likely Benign-1.46Neutral1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.05Affected0.10520.60520-13.316.06
c.887C>T
S296F
2D
AIThe SynGAP1 missense variant S296F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, and premPS. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive and therefore unavailable as evidence. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant has not been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.444081Structured0.282669Uncertain0.8870.2840.250-11.721Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.29Ambiguous1.60.24Likely Benign0.77Ambiguous0.29Likely Benign0.494Likely Benign-4.34Deleterious0.999Probably Damaging0.998Probably Damaging1.94Pathogenic0.04Affected0.07200.5905-3-23.660.10
c.889A>C
K297Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K297Q missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, Rosetta, and Foldetta. In contrast, the majority of tools predict a pathogenic outcome: SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX is uncertain and is treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as benign. Overall, the preponderance of evidence points to a pathogenic effect for K297Q. This conclusion is not contradicted by ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.422041Structured0.272593Uncertain0.8800.2850.375-8.393Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.66Ambiguous0.30.14Likely Benign0.40Likely Benign1.06Destabilizing0.450Likely Benign-3.48Deleterious1.000Probably Damaging0.998Probably Damaging1.65Pathogenic0.01Affected0.47680.1738110.4-0.04
c.889A>G
K297E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K297E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, while the SGM‑Consensus score is “Likely Pathogenic.” No tool in the dataset predicts a benign outcome; the only inconclusive result is FoldX, which is listed as “Uncertain” and is treated as unavailable. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective predictions, K297E is most likely pathogenic, and this conclusion does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.422041Structured0.272593Uncertain0.8800.2850.375-10.143Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.99Ambiguous0.42.43Destabilizing2.21Destabilizing1.16Destabilizing0.507Likely Pathogenic-3.54Deleterious0.999Probably Damaging0.995Probably Damaging1.61Pathogenic0.02Affected0.40730.1547010.40.94
c.88C>A
H30N
2D
AIThe SynGAP1 missense variant H30N is not reported in ClinVar and is absent from gnomAD. Consensus among most in silico predictors is benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a benign effect, while only SIFT predicts pathogenicity. Grouping the tools, the benign‑predicting set (nine tools) overwhelmingly outweighs the single pathogenic prediction. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely benign. No Foldetta stability analysis is available, so it does not influence the conclusion. Overall, the computational evidence strongly supports a benign classification, and this is consistent with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.438063Uncertain0.3730.8830.250-3.096Likely Benign0.108Likely BenignLikely Benign0.052Likely Benign-1.91Neutral0.273Benign0.380Benign3.92Benign0.00Affected0.26990.381821-0.3-23.04
c.88C>G
H30D
2D
AIThe SynGAP1 missense variant H30D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for H30D, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.438063Uncertain0.3730.8830.250-2.838Likely Benign0.318Likely BenignLikely Benign0.150Likely Benign-2.25Neutral0.462Possibly Damaging0.599Possibly Damaging3.93Benign0.00Affected0.30480.32961-1-0.3-22.05
c.88C>T
H30Y
2D
AIThe SynGAP1 H30Y missense variant (ClinVar ID 972248.0) is listed as “Uncertain” and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumVar and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as “Likely Benign”; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and this is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.438063Uncertain0.3730.8830.250Uncertain 1-3.047Likely Benign0.115Likely BenignLikely Benign0.082Likely Benign-1.84Neutral0.273Benign0.478Possibly Damaging3.99Benign0.00Affected4.3210.15720.4856021.926.03
c.890A>C
K297T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K297T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are none, whereas those that predict a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain predictions come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods specifically show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.422041Structured0.272593Uncertain0.8800.2850.375-10.110Likely Pathogenic0.987Likely PathogenicLikely Pathogenic1.55Ambiguous0.11.19Ambiguous1.37Ambiguous0.59Ambiguous0.551Likely Pathogenic-5.28Deleterious1.000Probably Damaging0.998Probably Damaging1.62Pathogenic0.01Affected0.22940.40240-13.2-27.07
c.890A>G
K297R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K297R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and FATHMM. Predictions that are uncertain or inconclusive are FoldX, Rosetta, premPS, and ESM1b. High‑accuracy methods give a consistent benign signal: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign; and Foldetta, a protein‑folding stability approach combining FoldX‑MD and Rosetta, predicts benign. Based on the aggregate of these predictions, the variant is most likely benign, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.422041Structured0.272593Uncertain0.8800.2850.375-7.877In-Between0.314Likely BenignLikely Benign-0.86Ambiguous0.30.67Ambiguous-0.10Likely Benign0.66Ambiguous0.257Likely Benign-2.36Neutral0.999Probably Damaging0.995Probably Damaging1.66Pathogenic0.19Tolerated0.48280.150632-0.628.01
c.890A>T
K297M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K297M is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include FoldX, Rosetta, Foldetta, and premPS. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized classifies the variant as Pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports Likely Pathogenic; whereas Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, reports a Benign effect. Overall, the preponderance of evidence (10 pathogenic vs. 4 benign predictions) points to the variant being most likely pathogenic, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.422041Structured0.272593Uncertain0.8800.2850.375-11.472Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.09Likely Benign0.10.32Likely Benign0.21Likely Benign0.49Likely Benign0.538Likely Pathogenic-5.20Deleterious1.000Probably Damaging0.999Probably Damaging1.61Pathogenic0.00Affected0.14380.43940-15.83.02
c.891G>C
K297N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K297N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the majority of tools (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results and are therefore not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.422041Structured0.272593Uncertain0.8800.2850.375-11.328Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.08Ambiguous0.11.60Ambiguous1.34Ambiguous1.15Destabilizing0.253Likely Benign-4.31Deleterious1.000Probably Damaging0.998Probably Damaging1.61Pathogenic0.01Affected0.37970.2265100.4-14.07
c.891G>T
K297N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K297N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the majority of tools (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results and are therefore not considered evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Based on the preponderance of pathogenic predictions and the lack of benign consensus, K297N is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.422041Structured0.272593Uncertain0.8800.2850.375-11.328Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.08Ambiguous0.11.60Ambiguous1.34Ambiguous1.15Destabilizing0.253Likely Benign-4.31Deleterious1.000Probably Damaging0.998Probably Damaging1.61Pathogenic0.01Affected0.37970.2265100.4-14.07
c.892C>A
P298T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P298T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar) and FATHMM. The remaining tools—FoldX, Rosetta, Foldetta, and ESM1b—return uncertain results and are treated as unavailable for pathogenicity inference. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, while Foldetta remains uncertain. Overall, the preponderance of evidence points to a benign effect for P298T, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.328603Structured0.268765Uncertain0.8600.2830.500-7.366In-Between0.104Likely BenignLikely Benign1.44Ambiguous0.21.03Ambiguous1.24Ambiguous0.04Likely Benign0.209Likely Benign-0.13Neutral0.939Possibly Damaging0.739Possibly Damaging1.96Pathogenic1.00Tolerated0.15950.63490-10.93.99
c.892C>G
P298A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P298A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No evidence from FoldX or Rosetta alone is conclusive. Based on the preponderance of benign predictions and the lack of pathogenic consensus, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.328603Structured0.268765Uncertain0.8600.2830.500-6.082Likely Benign0.074Likely BenignLikely Benign1.22Ambiguous0.11.17Ambiguous1.20Ambiguous0.50Likely Benign0.191Likely Benign-0.98Neutral0.885Possibly Damaging0.589Possibly Damaging1.94Pathogenic0.66Tolerated0.37610.57871-13.4-26.04
c.893C>A
P298H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P298H missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Remaining tools (AlphaMissense‑Default, FoldX, Rosetta, Foldetta, premPS) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta is uncertain. Overall, the majority of predictions (five pathogenic vs. three benign) and the SGM Consensus support a pathogenic interpretation. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.328603Structured0.268765Uncertain0.8600.2830.500-9.777Likely Pathogenic0.443AmbiguousLikely Benign1.57Ambiguous0.21.49Ambiguous1.53Ambiguous0.83Ambiguous0.313Likely Benign-2.37Neutral0.999Probably Damaging0.964Probably Damaging1.92Pathogenic0.04Affected0.17690.49430-2-1.640.02
c.893C>G
P298R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P298R has no ClinVar entry and is not reported in gnomAD. Computational predictors fall into two consensus groups: benign predictions come from REVEL, FoldX, PROVEAN, SIFT, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain results are reported only by Foldetta and premPS. High‑accuracy tools give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta reports an uncertain stability change. Overall, the majority of evidence points toward a pathogenic effect, and this assessment is not contradicted by ClinVar, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.268765Uncertain0.8600.2830.500-11.427Likely Pathogenic0.733Likely PathogenicLikely Benign0.45Likely Benign0.02.08Destabilizing1.27Ambiguous0.61Ambiguous0.280Likely Benign-1.83Neutral0.997Probably Damaging0.952Probably Damaging2.03Pathogenic0.09Tolerated0.12990.38720-2-2.959.07
c.893C>T
P298L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P298L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The remaining tools—FoldX, Rosetta, Foldetta, and ESM1b—return uncertain or inconclusive results. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign outcome; and Foldetta’s stability prediction is unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.328603Structured0.268765Uncertain0.8600.2830.500-7.334In-Between0.107Likely BenignLikely Benign0.60Ambiguous0.21.53Ambiguous1.07Ambiguous-0.16Likely Benign0.267Likely Benign-0.82Neutral0.885Possibly Damaging0.589Possibly Damaging1.91Pathogenic0.21Tolerated0.21370.6795-3-35.416.04
c.895C>A
R299S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 R299S is not reported in ClinVar and is absent from gnomAD. Among in‑silico predictors, benign calls come from REVEL and SIFT, while pathogenic calls are made by FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. Uncertain results are reported by Rosetta, ESM1b, and AlphaMissense‑Optimized. High‑accuracy methods give a pathogenic verdict: AlphaMissense‑Optimized is inconclusive, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) also predicts pathogenic. Overall, the evidence points to a pathogenic effect, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500-7.276In-Between0.882Likely PathogenicAmbiguous2.86Destabilizing0.31.46Ambiguous2.16Destabilizing1.07Destabilizing0.241Likely Benign-3.20Deleterious0.999Probably Damaging0.997Probably Damaging1.75Pathogenic0.07Tolerated0.27800.50570-13.7-69.11
c.895C>G
R299G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R299G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and AlphaMissense‑Optimized, whereas the remaining 13 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) all predict pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized indicates a benign change, but the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. With the majority of evidence pointing to a damaging effect, the variant is most likely pathogenic. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500-8.354Likely Pathogenic0.629Likely PathogenicLikely Benign3.58Destabilizing0.23.16Destabilizing3.37Destabilizing1.37Destabilizing0.248Likely Benign-3.84Deleterious0.999Probably Damaging0.997Probably Damaging1.79Pathogenic0.02Affected0.33610.4150-3-24.1-99.14
c.896G>C
R299P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R299P is not reported in ClinVar or gnomAD, indicating no publicly available frequency data. Prediction tools cluster into benign and pathogenic groups: benign predictions include REVEL and AlphaMissense‑Optimized, while pathogenic predictions are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen2_HumDiv, polyPhen2_HumVar, SIFT, FATHMM, and AlphaMissense‑Default; ESM1b is uncertain. The SGM‑Consensus label is Likely Pathogenic. High‑accuracy tools give a clear signal: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic, and Foldetta also predicts pathogenic. Overall, the predictions strongly favor a pathogenic interpretation, with no ClinVar status to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500-7.662In-Between0.722Likely PathogenicLikely Benign4.10Destabilizing0.23.01Destabilizing3.56Destabilizing1.19Destabilizing0.295Likely Benign-4.09Deleterious1.000Probably Damaging0.999Probably Damaging1.68Pathogenic0.02Affected0.20720.53790-22.9-59.07
c.896G>T
R299L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R299L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, ESM1b, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Stability‑based methods FoldX, Rosetta, Foldetta, and premPS returned uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of consensus predictions favor a pathogenic effect, and the high‑accuracy tools do not overturn this trend. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for R299L.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500-5.171Likely Benign0.645Likely PathogenicLikely Benign1.37Ambiguous0.60.77Ambiguous1.07Ambiguous0.59Ambiguous0.356Likely Benign-4.03Deleterious0.999Probably Damaging0.997Probably Damaging1.65Pathogenic0.02Affected0.20270.5202-3-28.3-43.03
c.898T>A
S300T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only FATHMM indicates a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM‑Consensus (3 benign vs. 1 pathogenic) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. No prediction or stability result is inconclusive. Overall, the evidence overwhelmingly supports a benign classification, and this conclusion does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.256848Uncertain0.7420.2800.375-4.648Likely Benign0.069Likely BenignLikely Benign0.85Ambiguous0.1-0.30Likely Benign0.28Likely Benign-0.33Likely Benign0.056Likely Benign0.50Neutral0.003Benign0.002Benign1.94Pathogenic0.85Tolerated0.14090.6428110.114.03
c.898T>C
S300P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and FATHMM. The remaining tools—FoldX, Foldetta, and ESM1b—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.356642Structured0.256848Uncertain0.7420.2800.375-7.379In-Between0.110Likely BenignLikely Benign1.24Ambiguous1.00.06Likely Benign0.65Ambiguous0.50Likely Benign0.086Likely Benign-2.46Neutral0.784Possibly Damaging0.390Benign1.54Pathogenic0.02Affected0.21920.55851-1-0.810.04
c.898T>G
S300A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. Rosetta and Foldetta give uncertain results and are therefore not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is also benign (3 benign vs. 1 pathogenic). Foldetta remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.256848Uncertain0.7420.2800.375-5.420Likely Benign0.060Likely BenignLikely Benign0.08Likely Benign0.31.07Ambiguous0.58Ambiguous0.08Likely Benign0.031Likely Benign-1.18Neutral0.139Benign0.060Benign1.56Pathogenic0.20Tolerated0.51350.4949Weaken112.6-16.00
c.899C>A
S300Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300Y has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Foldetta, premPS, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Two tools (AlphaMissense‑Default and Rosetta) are uncertain and do not influence the consensus. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not contradict any ClinVar status (none is available). Thus, based on current predictions, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.356642Structured0.256848Uncertain0.7420.2800.375-10.464Likely Pathogenic0.422AmbiguousLikely Benign-0.08Likely Benign0.40.55Ambiguous0.24Likely Benign0.28Likely Benign0.116Likely Benign-2.52Deleterious0.975Probably Damaging0.686Possibly Damaging1.52Pathogenic0.01Affected0.06780.5395-3-2-0.576.10
c.899C>G
S300C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300C is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33437804‑C‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Rosetta and Foldetta give uncertain results and are therefore not considered evidence for either side. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the majority of reliable predictions indicate a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.256848Uncertain0.7420.2800.3756-33437804-C-G-6.749Likely Benign0.108Likely BenignLikely Benign0.31Likely Benign0.21.45Ambiguous0.88Ambiguous0.34Likely Benign0.129Likely Benign-2.45Neutral0.975Probably Damaging0.815Possibly Damaging1.55Pathogenic0.01Affected3.47190.10050.6493-103.316.06
c.899C>T
S300F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S300F is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. The remaining tool, AlphaMissense‑Default, gives an uncertain result. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions lean toward pathogenicity, while two high‑accuracy methods support a benign effect. Thus, the variant is most likely pathogenic based on the current computational evidence, which does not contradict its ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.356642Structured0.256848Uncertain0.7420.2800.375Uncertain 1-10.222Likely Pathogenic0.353AmbiguousLikely Benign-0.29Likely Benign0.40.16Likely Benign-0.07Likely Benign0.04Likely Benign0.117Likely Benign-2.66Deleterious0.975Probably Damaging0.596Possibly Damaging1.52Pathogenic0.01Affected3.47190.05790.5701-3-23.660.10233.6-67.6-0.10.00.40.2XXPotentially PathogenicThe hydroxyl group of the Ser300 side chain, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), hydrogen bonds with the guanidinium group of Arg299 and the backbone amide group and side chain of Ser302. Thus, in the WT simulations, it contributes to the β hairpin stability. In the variant simulations, the phenol ring of Phe300 cannot form any side chain-related hydrogen bonds, and Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.89A>C
H30P
2D
AIThe SynGAP1 H30P missense variant has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.438063Uncertain0.3730.8830.250-1.933Likely Benign0.077Likely BenignLikely Benign0.202Likely Benign-2.77Deleterious0.676Possibly Damaging0.599Possibly Damaging3.89Benign0.00Affected0.25270.47230-21.6-40.02
c.89A>G
H30R
2D
AIThe SynGAP1 missense variant H30R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.438063Uncertain0.3730.8830.250-2.156Likely Benign0.186Likely BenignLikely Benign0.138Likely Benign-2.17Neutral0.462Possibly Damaging0.599Possibly Damaging3.94Benign0.00Affected0.27620.359020-1.319.05
c.89A>T
H30L
2D
AIThe SynGAP1 H30L missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.438063Uncertain0.3730.8830.250-2.073Likely Benign0.117Likely BenignLikely Benign0.163Likely Benign-2.88Deleterious0.462Possibly Damaging0.599Possibly Damaging3.94Benign0.00Affected0.15230.5793-2-37.0-23.98
c.8G>A
R3K
2D
AIThe SynGAP1 missense variant R3K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta results are not available for this variant. Overall, the majority of evidence points to a benign effect. The prediction is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.538167Disordered0.550331Binding0.3580.9200.875-4.378Likely Benign0.254Likely BenignLikely Benign0.062Likely Benign-0.45Neutral0.001Benign0.000Benign4.09Benign0.00Affected0.58420.4564Weaken320.6-28.01
c.8G>C
R3T
2D
AIThe SynGAP1 missense variant R3T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.538167Disordered0.550331Binding0.3580.9200.875-3.693Likely Benign0.285Likely BenignLikely Benign0.053Likely Benign-0.55Neutral0.208Benign0.018Benign4.01Benign0.00Affected0.18090.5145-1-13.8-55.08
c.8G>T
R3M
2D
AIThe SynGAP1 missense variant R3M is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The high‑accuracy consensus methods give a consistent benign signal: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Benign,” and Foldetta data are unavailable. Overall, the majority of evidence supports a benign classification, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.538167Disordered0.550331Binding0.3580.9200.875-4.655Likely Benign0.618Likely PathogenicLikely Benign0.097Likely Benign0.00Neutral0.872Possibly Damaging0.162Benign3.96Benign0.00Affected0.19060.47950-16.4-24.99
c.901G>C
A301P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A301P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only two tools—polyPhen‑2 HumDiv and polyPhen‑2 HumVar—predict a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.258424Uncertain0.6470.2720.375-3.808Likely Benign0.085Likely BenignLikely Benign-0.47Likely Benign0.1-0.41Likely Benign-0.44Likely Benign0.40Likely Benign0.225Likely Benign-0.83Neutral0.999Probably Damaging0.995Probably Damaging4.11Benign0.06Tolerated0.19070.53711-1-3.426.04
c.901G>T
A301S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A301S is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess sequence conservation and functional impact uniformly indicate a benign effect: SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. High‑accuracy methods corroborate the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports benign. No evidence from these analyses suggests a deleterious effect. Therefore, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.258424Uncertain0.6470.2720.375-2.488Likely Benign0.066Likely BenignLikely Benign0.20Likely Benign0.1-0.32Likely Benign-0.06Likely Benign0.22Likely Benign0.151Likely Benign-0.28Neutral0.992Probably Damaging0.983Probably Damaging4.21Benign0.13Tolerated0.27060.602211-2.616.00
c.902C>A
A301D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A301D is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in‑silico predictors shows a predominance of benign calls: REVEL, FoldX, premPS, PROVEAN, SIFT, and FATHMM all predict benign, whereas polyPhen‑2 (HumDiv and HumVar) and ESM1b predict pathogenic. Tools with uncertain outputs—Rosetta, Foldetta, and AlphaMissense‑Default—do not provide decisive evidence. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized classifies the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also yields a benign verdict; Foldetta remains inconclusive. Taken together, the preponderance of evidence indicates that A301D is most likely benign, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.429200Structured0.258424Uncertain0.6470.2720.375-10.276Likely Pathogenic0.488AmbiguousLikely Benign-0.37Likely Benign0.2-1.15Ambiguous-0.76Ambiguous0.23Likely Benign0.224Likely Benign-0.35Neutral0.999Probably Damaging0.995Probably Damaging4.17Benign0.07Tolerated0.15990.17050-2-5.344.01
c.902C>G
A301G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A301G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as Benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, classifies the variant as Benign. Overall, the consensus of the majority of evidence points to a benign effect, and this is consistent with the absence of a ClinVar claim. Therefore, the variant is most likely benign, and this is not contradictory to ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.258424Uncertain0.6470.2720.375-3.085Likely Benign0.072Likely BenignLikely Benign0.27Likely Benign0.10.34Likely Benign0.31Likely Benign0.37Likely Benign0.128Likely Benign-0.37Neutral0.992Probably Damaging0.983Probably Damaging4.18Benign0.28Tolerated0.24250.505410-2.2-14.03
c.902C>T
A301V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A301V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict pathogenicity. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Thus, the overall evidence supports a benign classification for A301V, and this conclusion is consistent with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.258424Uncertain0.6470.2720.375-2.476Likely Benign0.095Likely BenignLikely Benign0.25Likely Benign0.10.48Likely Benign0.37Likely Benign0.06Likely Benign0.116Likely Benign-0.49Neutral0.997Probably Damaging0.983Probably Damaging4.14Benign0.26Tolerated0.10960.6264002.428.05
c.904T>A
S302T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S302T is not reported in ClinVar and is absent from gnomAD. All available in silico predictors classify the substitution as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). No tool predicts pathogenicity. High‑accuracy assessments concur: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also indicates a benign effect. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.263489Uncertain0.6160.2580.375-4.742Likely Benign0.072Likely BenignLikely Benign0.20Likely Benign0.10.10Likely Benign0.15Likely Benign-0.08Likely Benign0.043Likely Benign-0.55Neutral0.037Benign0.042Benign4.16Benign0.15Tolerated0.17150.6886110.114.03
c.904T>C
S302P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S302P is not reported in ClinVar and is absent from gnomAD. Prediction tools that uniformly indicate a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only Rosetta predicts a pathogenic outcome, while FoldX and Foldetta are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM‑Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also supports a benign classification. Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains inconclusive. Overall, the preponderance of evidence points to a benign impact for S302P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.263489Uncertain0.6160.2580.375-2.485Likely Benign0.121Likely BenignLikely Benign1.19Ambiguous0.42.74Destabilizing1.97Ambiguous0.14Likely Benign0.101Likely Benign-0.89Neutral0.157Benign0.153Benign4.11Benign0.20Tolerated0.25220.62431-1-0.810.04
c.904T>G
S302A
2D
AIThe SynGAP1 missense variant S302A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta. No tool predicts a pathogenic outcome; the only inconclusive result is from Rosetta, which is treated as unavailable. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because the variant is not currently catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.263489Uncertain0.6160.2580.375-2.583Likely Benign0.058Likely BenignLikely Benign0.21Likely Benign0.40.65Ambiguous0.43Likely Benign0.02Likely Benign0.044Likely Benign-0.41Neutral0.000Benign0.001Benign4.16Benign0.20Tolerated0.53580.5407Strenghten112.6-16.00
c.905C>A
S302Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S302Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are SIFT, polyPhen‑2 HumDiv, and ESM1b. Two tools give uncertain results: AlphaMissense‑Default and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.414856Structured0.263489Uncertain0.6160.2580.375-9.674Likely Pathogenic0.355AmbiguousLikely Benign-0.02Likely Benign0.10.56Ambiguous0.27Likely Benign-0.17Likely Benign0.070Likely Benign-1.03Neutral0.801Possibly Damaging0.383Benign4.07Benign0.01Affected0.08820.5990-3-2-0.576.10
c.905C>G
S302C
2D
AIThe SynGAP1 missense variant S302C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, premPS, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Uncertain predictions come from Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact for S302C, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.263489Uncertain0.6160.2580.375-7.290In-Between0.105Likely BenignLikely Benign0.32Likely Benign0.51.24Ambiguous0.78Ambiguous-0.04Likely Benign0.070Likely Benign-0.83Neutral0.833Possibly Damaging0.455Possibly Damaging4.05Benign0.02Affected0.12210.65140-13.316.06
c.905C>T
S302F
2D
AIThe SynGAP1 missense variant S302F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, polyPhen‑2 HumVar, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and ESM1b; Rosetta’s output is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta as Benign. Taken together, the majority of evidence supports a benign impact for S302F, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.263489Uncertain0.6160.2580.375-9.483Likely Pathogenic0.321Likely BenignLikely Benign-0.04Likely Benign0.50.71Ambiguous0.34Likely Benign-0.21Likely Benign0.073Likely Benign-0.92Neutral0.570Possibly Damaging0.383Benign4.06Benign0.01Affected0.07050.6092-3-23.660.10
c.907G>C
G303R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G303R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Only AlphaMissense‑Default predicts a pathogenic outcome. The remaining tools—FoldX, Foldetta, premPS, and ESM1b—return uncertain or inconclusive results. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, while Foldetta remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.450668Structured0.271087Uncertain0.6300.2540.250-7.493In-Between0.724Likely PathogenicLikely Benign1.44Ambiguous0.40.23Likely Benign0.84Ambiguous0.73Ambiguous0.048Likely Benign-1.38Neutral0.001Benign0.003Benign3.99Benign0.06Tolerated3.55180.08390.4490-2-3-4.199.14
c.907G>T
G303W
2D
3DClick to see structure in 3D Viewer
AIClinVar reports no entry for this SynGAP1 G303W variant, and it is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta’s stability prediction is also unavailable. Overall, the evidence is evenly split between benign and pathogenic predictions, providing no clear bias toward either outcome. This balanced prediction does not contradict ClinVar status, which currently has no classification for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.450668Structured0.271087Uncertain0.6300.2540.250-9.041Likely Pathogenic0.579Likely PathogenicLikely Benign1.69Ambiguous0.31.11Ambiguous1.40Ambiguous0.28Likely Benign0.157Likely Benign-1.63Neutral0.983Probably Damaging0.813Possibly Damaging3.93Benign0.00Affected0.06630.4553-7-2-0.5129.16
c.908G>C
G303A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G303A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from FoldX, Rosetta, and Foldetta, which are treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign, while Foldetta’s stability analysis is uncertain. Overall, the variant is most likely benign based on the consensus of predictive tools, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.450668Structured0.271087Uncertain0.6300.2540.250-1.965Likely Benign0.105Likely BenignLikely Benign1.66Ambiguous0.2-0.51Ambiguous0.58Ambiguous0.10Likely Benign0.034Likely Benign-0.90Neutral0.112Benign0.058Benign4.07Benign0.35Tolerated0.37240.5325102.214.03
c.908G>T
G303V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G303V is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster around a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign) all indicate a tolerated change. Pathogenic signals arise only from SIFT and FoldX, while Rosetta and Foldetta are inconclusive. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields Likely Benign, and Foldetta remains uncertain. Overall, the preponderance of evidence points to a benign effect, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.450668Structured0.271087Uncertain0.6300.2540.250-3.046Likely Benign0.198Likely BenignLikely Benign3.06Destabilizing0.6-0.72Ambiguous1.17Ambiguous0.14Likely Benign0.071Likely Benign-1.57Neutral0.011Benign0.017Benign3.96Benign0.01Affected0.10020.4577-1-34.642.08
c.90C>G
H30Q
2D
AIThe SynGAP1 missense variant H30Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT predict pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.438063Uncertain0.3730.8830.250-3.016Likely Benign0.142Likely BenignLikely Benign0.068Likely Benign-2.21Neutral0.462Possibly Damaging0.599Possibly Damaging3.93Benign0.00Affected4.3210.24090.442203-0.3-9.01
c.910G>A
D304N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D304N is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a benign impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250Uncertain 1-6.194Likely Benign0.391AmbiguousLikely Benign0.30Likely Benign0.1-0.08Likely Benign0.11Likely Benign0.21Likely Benign0.345Likely Benign-4.18Deleterious0.999Probably Damaging0.997Probably Damaging1.81Pathogenic0.03Affected3.38230.13530.7205120.0-0.98
c.910G>C
D304H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304H missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into three groups: benign predictions come from REVEL, Rosetta, and premPS; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; the remaining tools (FoldX, Foldetta, AlphaMissense‑Optimized) give uncertain results. High‑accuracy assessments reinforce this pattern: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, which is currently absent. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.285053Uncertain0.7640.2710.250-8.160Likely Pathogenic0.822Likely PathogenicAmbiguous0.89Ambiguous0.10.16Likely Benign0.53Ambiguous0.45Likely Benign0.417Likely Benign-5.67Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.01Affected0.16600.74981-10.322.05
c.910G>T
D304Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304Y missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, Foldetta, and premPS, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also labeled Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. With the majority of evidence pointing toward pathogenicity, the variant is most likely pathogenic; this assessment does not conflict with ClinVar, which contains no entry for D304Y.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.285053Uncertain0.7640.2710.250-10.495Likely Pathogenic0.845Likely PathogenicAmbiguous0.60Ambiguous0.20.14Likely Benign0.37Likely Benign0.37Likely Benign0.468Likely Benign-6.29Deleterious1.000Probably Damaging0.999Probably Damaging1.76Pathogenic0.00Affected0.06230.6566-4-32.248.09
c.911A>C
D304A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304A variant has no ClinVar entry and is not listed in gnomAD. Prediction tools that classify it as benign include premPS, ESM1b, and AlphaMissense‑Optimized, whereas the remaining tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) all predict a pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a pathogenic impact. This prediction does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.285053Uncertain0.7640.2710.250-6.258Likely Benign0.604Likely PathogenicLikely Benign1.00Ambiguous0.10.54Ambiguous0.77Ambiguous0.39Likely Benign0.523Likely Pathogenic-5.97Deleterious1.000Probably Damaging0.998Probably Damaging1.80Pathogenic0.02Affected0.44570.66420-25.3-44.01
c.911A>G
D304G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. AlphaMissense‑Default, FoldX, Rosetta, and Foldetta are uncertain and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting pathogenic, and Foldetta remaining uncertain. Overall, the majority of tools (five pathogenic vs. four benign) and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250-2.713Likely Benign0.546AmbiguousLikely Benign1.02Ambiguous0.20.95Ambiguous0.99Ambiguous0.47Likely Benign0.380Likely Benign-5.32Deleterious0.999Probably Damaging0.997Probably Damaging1.75Pathogenic0.02Affected0.45900.64511-13.1-58.04
c.911A>T
D304V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304V missense variant is not reported in ClinVar (ClinVar status: None) and has no entry in gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include Rosetta and premPS, while the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results come from FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for D304V. This conclusion is not contradicted by ClinVar, which currently has no classification for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.285053Uncertain0.7640.2710.250-8.280Likely Pathogenic0.803Likely PathogenicAmbiguous1.35Ambiguous0.30.14Likely Benign0.75Ambiguous0.35Likely Benign0.541Likely Pathogenic-6.22Deleterious1.000Probably Damaging0.999Probably Damaging1.81Pathogenic0.00Affected0.09710.6999-2-37.7-15.96
c.912C>A
D304E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304E missense variant has no ClinVar entry and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign effect, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250-2.715Likely Benign0.233Likely BenignLikely Benign0.34Likely Benign0.10.21Likely Benign0.28Likely Benign0.48Likely Benign0.186Likely Benign-3.29Deleterious0.997Probably Damaging0.994Probably Damaging1.77Pathogenic0.04Affected0.15040.6998320.014.03
c.912C>G
D304E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304E missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—yields a tie and is therefore inconclusive. Overall, the balance of evidence favors a benign classification, and this conclusion does not conflict with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250-2.715Likely Benign0.233Likely BenignLikely Benign0.34Likely Benign0.10.21Likely Benign0.28Likely Benign0.48Likely Benign0.186Likely Benign-3.29Deleterious0.997Probably Damaging0.994Probably Damaging1.77Pathogenic0.04Affected0.15040.6998320.014.03
c.913A>C
T305P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T305P missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of tools (7 pathogenic vs. 5 benign) lean toward a pathogenic impact, and this assessment does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic based on current predictive evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.359901Structured0.299706Uncertain0.8720.2740.125-5.203Likely Benign0.177Likely BenignLikely Benign3.64Destabilizing1.16.02Destabilizing4.83Destabilizing0.71Ambiguous0.293Likely Benign-2.83Deleterious0.997Probably Damaging0.929Probably Damaging1.72Pathogenic0.06Tolerated0.22060.53330-1-0.9-3.99
c.913A>T
T305S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T305S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions that are inconclusive or uncertain are provided by Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.359901Structured0.299706Uncertain0.8720.2740.125-2.899Likely Benign0.107Likely BenignLikely Benign0.45Likely Benign0.41.21Ambiguous0.83Ambiguous0.55Ambiguous0.135Likely Benign-0.60Neutral0.760Possibly Damaging0.484Possibly Damaging1.86Pathogenic0.54Tolerated0.35790.449611-0.1-14.03
c.914C>A
T305N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T305N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as tolerated or benign, and the SGM‑Consensus score is “Likely Benign.” Only FATHMM predicts a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, and the combined Foldetta) return uncertain or inconclusive results. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also benign, and Foldetta remains uncertain. Overall, the majority of evidence supports a benign impact for T305N, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.359901Structured0.299706Uncertain0.8720.2740.125-3.261Likely Benign0.158Likely BenignLikely Benign1.18Ambiguous0.21.65Ambiguous1.42Ambiguous0.09Likely Benign0.098Likely Benign0.71Neutral0.046Benign0.040Benign2.34Pathogenic0.67Tolerated0.13270.435200-2.813.00
c.914C>G
T305S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T305S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions that are inconclusive or uncertain are provided by Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.359901Structured0.299706Uncertain0.8720.2740.125-2.899Likely Benign0.107Likely BenignLikely Benign0.45Likely Benign0.41.21Ambiguous0.83Ambiguous0.55Ambiguous0.104Likely Benign-0.60Neutral0.760Possibly Damaging0.484Possibly Damaging1.86Pathogenic0.54Tolerated0.35790.449611-0.1-14.03
c.916G>C
V306L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V306L missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Uncertain results come from Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta is inconclusive. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.363090Structured0.315026Uncertain0.8960.2870.125-3.633Likely Benign0.267Likely BenignLikely Benign2.14Destabilizing0.21.47Ambiguous1.81Ambiguous0.75Ambiguous0.161Likely Benign-1.01Neutral0.999Probably Damaging0.996Probably Damaging1.76Pathogenic0.21Tolerated0.08230.411721-0.414.03
c.916G>T
V306F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306F is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, and AlphaMissense‑Optimized, whereas the remaining tools (SGM‑Consensus, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a pathogenic effect. Overall, the majority of evidence supports a pathogenic impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.315026Uncertain0.8960.2870.125-9.311Likely Pathogenic0.700Likely PathogenicLikely Benign13.59Destabilizing1.46.99Destabilizing10.29Destabilizing0.23Likely Benign0.336Likely Benign-3.28Deleterious1.000Probably Damaging0.999Probably Damaging1.74Pathogenic0.01Affected0.05350.3318-1-1-1.448.04
c.917T>A
V306D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306D is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. All available in‑silico predictors that were evaluated return a pathogenic or likely‑pathogenic assessment: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.315026Uncertain0.8960.2870.125Uncertain 1-18.289Likely Pathogenic0.986Likely PathogenicLikely Pathogenic4.40Destabilizing0.34.29Destabilizing4.35Destabilizing2.44Destabilizing0.530Likely Pathogenic-5.44Deleterious1.000Probably Damaging0.999Probably Damaging1.74Pathogenic0.00Affected3.38190.13170.0768-2-3-7.715.96212.3-18.3-0.20.40.00.2XXXPotentially PathogenicThe isopropyl group of Val396, located at the beginning of an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Leu274, Trp308, Ala271) in the WT simulations. However, in the variant simulations, the negatively charged carboxylate group of the Asp306 side chain is not suitable for this hydrophobic niche. Consequently, the side chain moves out to interact with Ser300 in the β strand (res. Met289-Arg299) and the guanidinium group of Arg299 in the β hairpin loop.In the third simulation, the residue swap disrupts the C2 domain secondary structure and tertiary assembly to a large degree when the amino group of the Lys297 side chain rotates to form a salt bridge with Asp306. This drastic effect could potentially reflect the challenge presented by the residue swap during the C2 domain folding. Because the residue swap affects the C2 domain structure, the SynGAP-membrane association could also be impacted. However, this is beyond the scope of the solvent-only simulations to unravel.
c.917T>C
V306A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas the remaining tools (SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) all predict a pathogenic outcome; ESM1b is uncertain and therefore not counted. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a likely pathogenic verdict from the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and a pathogenic prediction from Foldetta. Taken together, the preponderance of evidence indicates that V306A is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.315026Uncertain0.8960.2870.125-7.924In-Between0.599Likely PathogenicLikely Benign2.76Destabilizing0.13.00Destabilizing2.88Destabilizing2.25Destabilizing0.300Likely Benign-2.94Deleterious0.997Probably Damaging0.992Probably Damaging1.77Pathogenic0.05Affected0.26870.198900-2.4-28.05
c.917T>G
V306G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity unanimously classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tool predicts a benign effect. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. All available evidence points to a pathogenic effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.363090Structured0.315026Uncertain0.8960.2870.125-12.313Likely Pathogenic0.795Likely PathogenicAmbiguous4.39Destabilizing0.25.89Destabilizing5.14Destabilizing2.46Destabilizing0.529Likely Pathogenic-5.48Deleterious0.998Probably Damaging1.000Probably Damaging1.78Pathogenic0.00Affected0.18740.2035-1-3-4.6-42.08
c.919T>A
F307I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307I is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign are FoldX, Rosetta, and Foldetta. Tools that predict it as pathogenic include SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments give AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Benign. Overall, the majority of predictions (10/13) indicate pathogenicity, while only three tools suggest benign. Therefore, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-13.114Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.49Likely Benign0.20.19Likely Benign0.34Likely Benign0.61Ambiguous0.632Likely Pathogenic-5.52Deleterious0.997Probably Damaging0.994Probably Damaging2.06Pathogenic0.01Affected0.25310.3036101.7-34.02
c.919T>C
F307L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include Rosetta and Foldetta, whereas the majority of tools predict it to be pathogenic: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools (FoldX and premPS) give uncertain results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized and the SGM Consensus both indicate a likely pathogenic effect, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign outcome. Overall, the bulk of evidence points to a pathogenic impact, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-10.173Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.54Ambiguous0.10.14Likely Benign0.34Likely Benign0.57Ambiguous0.597Likely Pathogenic-5.52Deleterious0.992Probably Damaging0.987Probably Damaging2.04Pathogenic0.01Affected0.28000.4207201.0-34.02
c.919T>G
F307V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307V is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include Rosetta and premPS, whereas the majority of other in silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) and the consensus score SGM‑Consensus all classify the change as pathogenic or likely pathogenic. High‑accuracy methods give a pathogenic call from AlphaMissense‑Optimized, a likely pathogenic result from the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and an inconclusive result from Foldetta (combining FoldX‑MD and Rosetta). No prediction is missing or inconclusive enough to alter the overall assessment. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-12.262Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.91Ambiguous0.10.10Likely Benign0.51Ambiguous0.36Likely Benign0.605Likely Pathogenic-6.43Deleterious0.997Probably Damaging0.992Probably Damaging2.29Pathogenic0.05Affected0.25230.3393-1-11.4-48.04
c.91C>G
R31G
2D
AIThe SynGAP1 missense variant R31G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign effect for R31G, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.549308Disordered0.437905Uncertain0.3240.8780.250-3.259Likely Benign0.269Likely BenignLikely Benign0.141Likely Benign-1.77Neutral0.686Possibly Damaging0.630Possibly Damaging3.97Benign0.00Affected0.33890.3942-3-24.1-99.14
c.920T>A
F307Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307Y is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently contains no assertion for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-9.870Likely Pathogenic0.889Likely PathogenicAmbiguous0.36Likely Benign0.1-0.21Likely Benign0.08Likely Benign0.11Likely Benign0.596Likely Pathogenic-2.76Deleterious0.997Probably Damaging0.987Probably Damaging1.96Pathogenic0.05Affected0.15700.232573-4.116.00
c.920T>C
F307S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. In silico predictors that provide a definitive call all classify the variant as pathogenic: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic verdict. Predictions that are inconclusive or uncertain include FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-12.282Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.58Ambiguous0.21.22Ambiguous1.40Ambiguous0.99Ambiguous0.766Likely Pathogenic-7.32Deleterious0.999Probably Damaging0.996Probably Damaging1.97Pathogenic0.01Affected0.45760.0758-3-2-3.6-60.10
c.920T>G
F307C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F307C missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). In silico predictors overwhelmingly indicate a deleterious effect: all tools that provide a definitive call—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The only predictions that are inconclusive are FoldX, Rosetta, and Foldetta, which are treated as unavailable. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic status; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. **Based on the consensus of the available predictions, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar status.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-11.484Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.36Ambiguous0.11.44Ambiguous1.40Ambiguous1.05Destabilizing0.754Likely Pathogenic-7.35Deleterious1.000Probably Damaging0.998Probably Damaging1.92Pathogenic0.00Affected0.27290.1628-4-2-0.3-44.04
c.921C>A
F307L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include Rosetta and Foldetta, whereas the majority of tools predict it to be pathogenic: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools (FoldX and premPS) give uncertain results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized and the SGM Consensus both indicate a likely pathogenic effect, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign outcome. Overall, the bulk of evidence points to a pathogenic impact, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-10.173Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.54Ambiguous0.10.14Likely Benign0.34Likely Benign0.57Ambiguous0.529Likely Pathogenic-5.52Deleterious0.992Probably Damaging0.987Probably Damaging2.04Pathogenic0.01Affected0.28000.4207201.0-34.02
c.921C>G
F307L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include Rosetta and Foldetta, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the change as pathogenic. Uncertain results are reported by FoldX and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the consensus of the majority of tools points to a pathogenic effect, and this is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-10.173Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.54Ambiguous0.10.14Likely Benign0.34Likely Benign0.57Ambiguous0.529Likely Pathogenic-5.52Deleterious0.992Probably Damaging0.987Probably Damaging2.04Pathogenic0.01Affected0.28000.4207201.0-34.02
c.922T>A
W308R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-12.264Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.40Destabilizing0.54.27Destabilizing4.84Destabilizing1.88Destabilizing0.868Likely Pathogenic-12.87Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected3.38190.47510.03612-3-3.6-30.03290.4-26.7-0.10.10.00.2XXXPotentially PathogenicThe indole ring of Trp308, located in an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Ile268, Val306, Cys282). The indole group of Trp308 also hydrogen bonds with the backbone atoms of the C2 domain residues forming the anti-parallel β sheet (e.g., Tyr280, Thr294). The guanidinium group of Arg308 is comparably sized to the tryptophan it replaced; however, it is also positively charged.In the variant simulations, the charged side chain remains buried deep in the hydrophobic part of the C2 domain, where it forms new hydrogen bonds with the backbone carbonyl atoms of surrounding residues (e.g., Val306, Ile268). However, the residue swap is likely to disrupt the hydrophobic packing during folding. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.922T>C
W308R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308R is listed in ClinVar (ID 391294.0) as Pathogenic and is not reported in gnomAD. All available in‑silico predictors classify the change as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125Pathogenic 1-12.264Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.40Destabilizing0.54.27Destabilizing4.84Destabilizing1.88Destabilizing0.868Likely Pathogenic-12.87Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected3.38190.47510.03612-3-3.6-30.03290.4-26.7-0.10.10.00.2XXXPotentially PathogenicThe indole ring of Trp308, located in an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Ile268, Val306, Cys282). The indole group of Trp308 also hydrogen bonds with the backbone atoms of the C2 domain residues forming the anti-parallel β sheet (e.g., Tyr280, Thr294). The guanidinium group of Arg308 is comparably sized to the tryptophan it replaced; however, it is also positively charged.In the variant simulations, the charged side chain remains buried deep in the hydrophobic part of the C2 domain, where it forms new hydrogen bonds with the backbone carbonyl atoms of surrounding residues (e.g., Val306, Ile268). However, the residue swap is likely to disrupt the hydrophobic packing during folding. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.922T>G
W308G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308G is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic outcome. No tool predicts a benign effect, so the benign group is empty. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the unanimous predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-16.271Likely Pathogenic0.997Likely PathogenicLikely Pathogenic6.88Destabilizing0.25.07Destabilizing5.98Destabilizing1.97Destabilizing0.860Likely Pathogenic-11.95Deleterious0.999Probably Damaging0.996Probably Damaging0.48Pathogenic0.00Affected0.48840.1644-7-20.5-129.16
c.923G>C
W308S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308S is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic effect. No predictions or stability results are missing or inconclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-15.425Likely Pathogenic0.999Likely PathogenicLikely Pathogenic6.42Destabilizing0.25.31Destabilizing5.87Destabilizing1.93Destabilizing0.861Likely Pathogenic-12.87Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected0.50890.1406Weaken-2-30.1-99.14
c.923G>T
W308L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates “Likely Pathogenic.” Only Rosetta and premPS yield uncertain results, which are treated as unavailable evidence. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No tools predict benign effects. **Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-13.349Likely Pathogenic0.991Likely PathogenicLikely Pathogenic3.53Destabilizing0.51.52Ambiguous2.53Destabilizing0.53Ambiguous0.811Likely Pathogenic-11.95Deleterious0.999Probably Damaging0.996Probably Damaging0.49Pathogenic0.00Affected0.27310.2754-2-24.7-73.05
c.924G>C
W308C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308C is listed in ClinVar as Pathogenic (ClinVar ID 981381.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields “Likely Pathogenic”; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125Pathogenic/Likely path. 2-12.791Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.56Destabilizing0.34.38Destabilizing4.97Destabilizing1.26Destabilizing0.738Likely Pathogenic-11.95Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected3.38190.43900.1621-8-23.4-83.07230.860.5-0.30.1-0.40.4XPotentially PathogenicThe indole ring of Trp308, located in an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Ile268, Val306, Cys282). The indole group of Trp308 also hydrogen bonds with the backbone atoms of the C2 domain residues forming the anti-parallel β sheet (e.g., Tyr280, Thr294). The introduced Cys308 is smaller than the tryptophan it replaced. The thiol group of the Cys308 side chain is well-suited for the inner hydrophobic part of the C2 domain. Although the negative effects are essentially missing from the simulations, the side chain size difference between the residues is likely to disrupt the hydrophobic packing during folding. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.924G>T
W308C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308C is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. All available evidence points to a deleterious effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-12.791Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.56Destabilizing0.34.38Destabilizing4.97Destabilizing1.26Destabilizing0.738Likely Pathogenic-11.95Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected3.38190.43900.1621-8-23.4-83.07230.860.5-0.30.1-0.40.4XPotentially PathogenicThe indole ring of Trp308, located in an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Ile268, Val306, Cys282). The indole group of Trp308 also hydrogen bonds with the backbone atoms of the C2 domain residues forming the anti-parallel β sheet (e.g., Tyr280, Thr294). The introduced Cys308 is smaller than the tryptophan it replaced. The thiol group of the Cys308 side chain is well-suited for the inner hydrophobic part of the C2 domain. Although the negative effects are essentially missing from the simulations, the side chain size difference between the residues is likely to disrupt the hydrophobic packing during folding. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.925G>A
G309S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that classify the variant as benign include REVEL and SIFT, whereas a majority of other in silico predictors (AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SGM‑Consensus, and FoldX) predict it to be pathogenic. Tools with uncertain outcomes (Foldetta, Rosetta, premPS) provide no definitive evidence. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that G309S is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-11.335Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.82Destabilizing0.50.73Ambiguous1.78Ambiguous0.72Ambiguous0.487Likely Benign-5.52Deleterious1.000Probably Damaging1.000Probably Damaging1.73Pathogenic0.07Tolerated0.28280.559110-0.430.03
c.925G>C
G309R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates a likely pathogenic outcome. No tool in the dataset predicts a benign effect. Uncertainty remains for FoldX, Rosetta, Foldetta, and premPS, which are listed as uncertain and do not influence the overall assessment. High‑accuracy evaluations show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-14.375Likely Pathogenic1.000Likely PathogenicLikely Pathogenic1.99Ambiguous0.50.52Ambiguous1.26Ambiguous0.55Ambiguous0.572Likely Pathogenic-7.35Deleterious1.000Probably Damaging1.000Probably Damaging1.70Pathogenic0.04Affected0.09640.5097-3-2-4.199.14
c.925G>T
G309C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a deleterious effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score, all of which classify the change as pathogenic or likely pathogenic. Tools with inconclusive results—Rosetta, Foldetta, and premPS—return uncertain outcomes and do not alter the overall assessment. High‑accuracy methods further support a damaging effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, whereas Foldetta’s stability analysis is inconclusive. Taken together, the evidence strongly favors a pathogenic interpretation, and this conclusion is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-14.331Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.60Destabilizing0.41.09Ambiguous1.85Ambiguous0.67Ambiguous0.656Likely Pathogenic-8.27Deleterious1.000Probably Damaging1.000Probably Damaging1.66Pathogenic0.00Affected0.13780.4574-3-32.946.09
c.926G>A
G309D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are provided by SIFT and Rosetta, whereas the remaining 12 tools (REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus) are pathogenic. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta is inconclusive. Taken together, the majority of evidence supports a pathogenic effect. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-15.264Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.89Destabilizing0.5-0.03Likely Benign1.43Ambiguous0.75Ambiguous0.523Likely Pathogenic-6.43Deleterious1.000Probably Damaging1.000Probably Damaging1.88Pathogenic0.06Tolerated0.18890.26781-1-3.158.04
c.926G>C
G309A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G309A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, SIFT, and Rosetta, whereas pathogenic calls are made by FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Foldetta, premPS, and ESM1b. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenic, while Foldetta remains inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for G309A. This conclusion is not contradicted by ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-7.980In-Between0.986Likely PathogenicLikely Pathogenic2.44Destabilizing0.40.30Likely Benign1.37Ambiguous0.71Ambiguous0.373Likely Benign-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.69Pathogenic0.09Tolerated0.39490.4974102.214.03
c.926G>T
G309V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309V is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while premPS remains uncertain. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports pathogenic. Consequently, the variant is most likely pathogenic, and this prediction is consistent with the absence of a ClinVar entry (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-13.595Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.55Destabilizing0.53.61Destabilizing4.08Destabilizing0.76Ambiguous0.531Likely Pathogenic-8.27Deleterious1.000Probably Damaging1.000Probably Damaging1.67Pathogenic0.00Affected0.12560.3910-1-34.642.08
c.928G>A
E310K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E310K is listed in ClinVar with an uncertain significance (ID 981613) and is not reported in gnomAD. Functional prediction tools uniformly indicate a deleterious effect: SGM‑Consensus, REVEL, FoldX‑MD (uncertain), Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. Consequently, the variant is most likely pathogenic according to the available predictions, which does not contradict the ClinVar uncertain status but suggests a pathogenic interpretation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125Conflicting 5-14.601Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.97Ambiguous1.23.66Destabilizing2.82Destabilizing1.02Destabilizing0.764Likely Pathogenic-3.68Deleterious1.000Probably Damaging0.995Probably Damaging1.19Pathogenic0.01Affected3.38190.24960.845301-0.4-0.94213.458.00.10.00.20.1XPotentially PathogenicThe carboxylate group of Glu310, located in an anti-parallel β sheet strand (res. Thr305-Asn315), is ideally positioned to interact with the side chain hydroxyl and backbone amide groups of Thr295 on a twisted anti-parallel β strand (res. Met289-Arg299). Because the carboxylate group can also interact with the GAP domain residues (e.g., Gln612, Tyr614), Glu310 plays a key role in maintaining the tertiary assembly between the C2 and GAP domains. In the variant simulations, the amino group of the Lys310 side chain hydrogen bonds with the GAP domain residues and forms a salt bridge with Glu613. Although no apparent negative effects are seen due to the residue swap, it is possible that the loss of hydrogen bonding with the hydroxyl group of the Thr295 side chain causes problems during folding, potentially compromising the twisting of the β sheet.
c.928G>C
E310Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E310Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign are Rosetta and Foldetta, whereas the remaining tools—REVEL, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict pathogenicity. FoldX and premPS give uncertain results. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized reports a pathogenic effect; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates Likely Pathogenic; Foldetta, a protein‑folding stability approach combining FoldX‑MD and Rosetta, predicts a benign outcome. Overall, the majority of evidence points to a pathogenic impact, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125-11.093Likely Pathogenic0.981Likely PathogenicLikely Pathogenic1.16Ambiguous0.5-0.38Likely Benign0.39Likely Benign0.85Ambiguous0.688Likely Pathogenic-2.76Deleterious1.000Probably Damaging0.998Probably Damaging1.24Pathogenic0.01Affected0.13340.8341220.0-0.98
c.929A>C
E310A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E310A missense variant is not reported in ClinVar or gnomAD. Prediction tools largely converge on a pathogenic effect: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, while premPS is the sole benign predictor. Uncertain calls come from FoldX, Rosetta, and Foldetta. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus labels it likely pathogenic, and Foldetta remains inconclusive. With the overwhelming majority of evidence pointing to deleterious impact and no ClinVar annotation to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125-13.878Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.65Ambiguous0.61.65Ambiguous1.65Ambiguous0.50Likely Benign0.850Likely Pathogenic-5.52Deleterious0.999Probably Damaging0.995Probably Damaging1.16Pathogenic0.01Affected0.39800.80970-15.3-58.04
c.929A>G
E310G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E310G is listed in ClinVar as Pathogenic (ClinVar ID 2732842.0) and is not reported in gnomAD. Prediction tools that assess the variant’s effect largely agree on a deleterious outcome: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while only premPS predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Consequently, the variant is most likely pathogenic, and this prediction is consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125Pathogenic 1-14.132Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.38Destabilizing0.73.56Destabilizing2.97Destabilizing0.36Likely Benign0.848Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.996Probably Damaging1.12Pathogenic0.00Affected3.38190.27360.6932-203.1-72.06
c.929A>T
E310V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E310V missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are Rosetta and premPS, while the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact. FoldX and Foldetta are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that E310V is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125-15.494Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.08Ambiguous0.90.06Likely Benign0.57Ambiguous0.14Likely Benign0.871Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.998Probably Damaging1.12Pathogenic0.00Affected0.08490.8729-2-27.7-29.98
c.92G>C
R31P
2D
AIThe SynGAP1 missense variant R31P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the majority of computational evidence points to a benign impact for R31P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.549308Disordered0.437905Uncertain0.3240.8780.250-3.185Likely Benign0.300Likely BenignLikely Benign0.209Likely Benign-1.64Neutral0.841Possibly Damaging0.809Possibly Damaging3.96Benign0.00Affected0.22200.50050-22.9-59.07
c.92G>T
R31L
2D
AIThe SynGAP1 missense variant R31L is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in‑silico predictors shows a predominance of benign calls: REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized all predict benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict pathogenic. AlphaMissense‑Default remains uncertain, and no Foldetta stability assessment is available. High‑accuracy tools specifically indicate benign: AlphaMissense‑Optimized is benign, SGM‑Consensus is Likely Benign, and Foldetta data are missing. Overall, the majority of reliable predictions lean toward a benign effect, and this is consistent with the lack of ClinVar evidence; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.549308Disordered0.437905Uncertain0.3240.8780.250-3.147Likely Benign0.360AmbiguousLikely Benign0.149Likely Benign-1.79Neutral0.686Possibly Damaging0.630Possibly Damaging4.01Benign0.00Affected0.22640.5148-3-28.3-43.03
c.930G>C
E310D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E310D is reported in ClinVar (ID 975473.0) as Pathogenic and is not found in gnomAD. Prediction tools that assess the variant’s effect all converge on a deleterious outcome: REVEL, FoldX (uncertain), Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, leaving no tool in the benign category. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also reports Pathogenic. The single uncertain result from FoldX is treated as unavailable. Overall, the variant is most likely pathogenic, and this assessment is consistent with its ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125Likely Pathogenic1-11.218Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.87Ambiguous0.52.39Destabilizing2.13Destabilizing1.04Destabilizing0.666Likely Pathogenic-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.19Pathogenic0.02Affected3.38190.19810.5222320.0-14.03232.627.20.10.00.10.1XPotentially BenignThe carboxylate group of Glu310, located in an anti-parallel β sheet strand (res. Thr305-Asn315), is ideally positioned to interact with the hydroxyl and backbone amide groups of Thr295 on a twisted anti-parallel β strand. Because the carboxylate group can also interact with the GAP domain residues (e.g., Gln612, Tyr614), Glu310 potentially plays a key role in maintaining the tertiary assembly between the C2 and GAP domains. In the variant simulations, the carboxylate group of Asp310 can form the same interactions as glutamate; however, due to its one hydrocarbon shorter length, the connections are less stable or less optimal.
c.930G>T
E310D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E310D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity uniformly favor a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL (Pathogenic), Rosetta (Pathogenic), Foldetta (Pathogenic), premPS (Pathogenic), PROVEAN (Pathogenic), polyPhen‑2 HumDiv (Pathogenic), polyPhen‑2 HumVar (Pathogenic), SIFT (Pathogenic), ESM1b (Pathogenic), FATHMM (Pathogenic), AlphaMissense‑Default (Pathogenic), and AlphaMissense‑Optimized (Pathogenic). No tool predicts a benign outcome; the only inconclusive result is FoldX (Uncertain). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently has no entry for E310D.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.222385Structured0.346136Uncertain0.9140.3370.125-11.218Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.87Ambiguous0.52.39Destabilizing2.13Destabilizing1.04Destabilizing0.666Likely Pathogenic-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.19Pathogenic0.02Affected3.38190.19810.5222320.0-14.03232.627.20.10.00.10.1XPotentially BenignThe carboxylate group of Glu310, located in an anti-parallel β sheet strand (res. Thr305-Asn315), is ideally positioned to interact with the hydroxyl and backbone amide groups of Thr295 on a twisted anti-parallel β strand. Because the carboxylate group can also interact with the GAP domain residues (e.g., Gln612, Tyr614), Glu310 potentially plays a key role in maintaining the tertiary assembly between the C2 and GAP domains. In the variant simulations, the carboxylate group of Asp310 can form the same interactions as glutamate; however, due to its one hydrocarbon shorter length, the connections are less stable or less optimal.
c.931C>A
H311N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H311N missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results are reported for FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the majority of evaluated tools predict pathogenicity, suggesting that H311N is most likely pathogenic. This prediction does not contradict ClinVar status, as no ClinVar classification is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-9.545Likely Pathogenic0.661Likely PathogenicLikely Benign0.82Ambiguous0.11.12Ambiguous0.97Ambiguous0.72Ambiguous0.475Likely Benign-5.35Deleterious0.997Probably Damaging0.992Probably Damaging1.89Pathogenic0.06Tolerated0.15660.238021-0.3-23.04
c.931C>G
H311D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H311D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that assess evolutionary conservation and protein function uniformly indicate a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as pathogenic. The majority‑vote consensus (SGM‑Consensus) also reports it as likely pathogenic. Tools that evaluate structural stability give inconclusive results: FoldX, Rosetta, Foldetta, and premPS are listed as uncertain. High‑accuracy assessments further support a damaging outcome: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (derived from the same set of predictors) reports likely pathogenic, while Foldetta’s combined FoldX‑MD/Rosetta stability analysis remains uncertain. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect, which is consistent with the absence of a benign ClinVar annotation and the lack of population frequency data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-13.513Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.27Ambiguous0.01.83Ambiguous1.55Ambiguous0.89Ambiguous0.633Likely Pathogenic-6.94Deleterious0.997Probably Damaging0.994Probably Damaging1.94Pathogenic0.02Affected0.23010.20081-1-0.3-22.05
c.931C>T
H311Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H311Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Tools with uncertain or inconclusive results—Rosetta, Foldetta, and AlphaMissense‑Default—are treated as unavailable for pathogenicity assessment. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta remains uncertain. Overall, the predictions are split, with five tools favoring benign, five favoring pathogenic, and three inconclusive. Based on the available evidence, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.229226Structured0.354792Uncertain0.9020.3140.125-4.513Likely Benign0.342AmbiguousLikely Benign-0.06Likely Benign0.2-1.58Ambiguous-0.82Ambiguous0.18Likely Benign0.456Likely Benign-3.80Deleterious0.997Probably Damaging0.992Probably Damaging1.86Pathogenic0.02Affected0.09650.4180021.926.03
c.932A>C
H311P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H311P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tool predicts a benign outcome; the remaining predictions are uncertain (FoldX, Foldetta, premPS, AlphaMissense‑Optimized). High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Taken together, the majority of evidence points to a deleterious impact on protein function. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for H311P.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-10.454Likely Pathogenic0.869Likely PathogenicAmbiguous1.57Ambiguous0.62.39Destabilizing1.98Ambiguous0.74Ambiguous0.724Likely Pathogenic-7.76Deleterious0.999Probably Damaging0.998Probably Damaging1.87Pathogenic0.01Affected0.21730.41720-21.6-40.02
c.932A>G
H311R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H311R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, SIFT, and AlphaMissense‑Optimized, whereas a majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic outcome. Tools with uncertain or inconclusive results are Rosetta, Foldetta, and premPS. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized indicates benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates pathogenic, and Foldetta remains uncertain. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-9.825Likely Pathogenic0.719Likely PathogenicLikely Benign0.43Likely Benign0.10.85Ambiguous0.64Ambiguous0.70Ambiguous0.532Likely Pathogenic-5.72Deleterious0.997Probably Damaging0.994Probably Damaging1.94Pathogenic0.14Tolerated0.19310.249020-1.319.05
c.932A>T
H311L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H311L missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include AlphaMissense‑Optimized, Foldetta, premPS, and Rosetta. Tools that predict a pathogenic outcome are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta predicting a benign effect. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-10.119Likely Pathogenic0.575Likely PathogenicLikely Benign-0.53Ambiguous0.0-0.04Likely Benign-0.29Likely Benign0.43Likely Benign0.663Likely Pathogenic-7.99Deleterious0.999Probably Damaging0.996Probably Damaging1.87Pathogenic0.02Affected0.09610.5292-2-37.0-23.98
c.933C>A
H311Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H311Q missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, Rosetta, and Foldetta. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and premPS. The high‑accuracy consensus methods give mixed signals: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, more tools (seven) predict pathogenicity than benign (four), and the SGM Consensus supports a pathogenic classification, while Foldetta offers a contrary benign prediction. The variant is most likely pathogenic based on the aggregate predictions, and this assessment does not contradict the absence of a ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-8.656Likely Pathogenic0.792Likely PathogenicAmbiguous0.15Likely Benign0.10.39Likely Benign0.27Likely Benign0.92Ambiguous0.414Likely Benign-5.95Deleterious0.999Probably Damaging0.996Probably Damaging1.94Pathogenic0.03Affected0.14900.377530-0.3-9.01
c.933C>G
H311Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H311Q missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and Foldetta. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. With seven pathogenic versus four benign predictions, the overall consensus leans toward pathogenicity. This conclusion does not contradict ClinVar status, as no ClinVar classification is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.229226Structured0.354792Uncertain0.9020.3140.125-8.656Likely Pathogenic0.792Likely PathogenicAmbiguous0.15Likely Benign0.10.39Likely Benign0.27Likely Benign0.92Ambiguous0.414Likely Benign-5.95Deleterious0.999Probably Damaging0.996Probably Damaging1.94Pathogenic0.03Affected0.14900.377530-0.3-9.01
c.934T>A
F312I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312I is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity uniformly classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect, so the benign group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-12.000Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.09Destabilizing0.33.10Destabilizing2.60Destabilizing1.72Destabilizing0.872Likely Pathogenic-5.52Deleterious0.997Probably Damaging0.994Probably Damaging1.23Pathogenic0.01Affected0.19970.2842101.7-34.02
c.934T>C
F312L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the SGM‑Consensus score is “Likely Pathogenic.” The only tool with an inconclusive result is FoldX, which is listed as “Uncertain.” No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-9.891Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.16Ambiguous0.32.91Destabilizing2.04Destabilizing1.27Destabilizing0.852Likely Pathogenic-5.52Deleterious0.992Probably Damaging0.987Probably Damaging1.32Pathogenic0.05Affected0.21490.3813201.0-34.02
c.934T>G
F312V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312V is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify the change as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-12.206Likely Pathogenic0.993Likely PathogenicLikely Pathogenic2.13Destabilizing0.13.46Destabilizing2.80Destabilizing1.80Destabilizing0.877Likely Pathogenic-6.43Deleterious0.997Probably Damaging0.992Probably Damaging1.25Pathogenic0.00Affected0.19980.2810-1-11.4-48.04
c.935T>A
F312Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a deleterious effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default, all of which classify the change as pathogenic. No tool in the dataset predicts a benign outcome. High‑accuracy assessments show the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta provide uncertain results. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-7.571In-Between0.949Likely PathogenicAmbiguous1.04Ambiguous0.10.89Ambiguous0.97Ambiguous0.99Ambiguous0.744Likely Pathogenic-2.76Deleterious0.997Probably Damaging0.987Probably Damaging1.21Pathogenic0.02Affected0.14430.272873-4.116.00
c.935T>C
F312S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). All available in‑silico predictors classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts pathogenic. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, with no contradiction to ClinVar status (which is currently unreported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-14.075Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.74Destabilizing0.35.64Destabilizing4.69Destabilizing2.70Destabilizing0.880Likely Pathogenic-7.35Deleterious0.999Probably Damaging0.996Probably Damaging1.17Pathogenic0.00Affected0.35630.1578-3-2-3.6-60.10
c.935T>G
F312C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312C is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic impact. Based on the unanimous pathogenic predictions and the absence of benign calls, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-11.991Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.98Destabilizing0.34.97Destabilizing3.98Destabilizing1.46Destabilizing0.870Likely Pathogenic-7.35Deleterious1.000Probably Damaging0.998Probably Damaging1.16Pathogenic0.00Affected0.22930.2010-4-2-0.3-44.04
c.936C>A
F312L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the SGM‑Consensus score is “Likely Pathogenic.” The only tool with an inconclusive result is FoldX, which is listed as “Uncertain.” No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-9.891Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.16Ambiguous0.32.91Destabilizing2.04Destabilizing1.27Destabilizing0.615Likely Pathogenic-5.52Deleterious0.992Probably Damaging0.987Probably Damaging1.32Pathogenic0.05Affected0.21490.3813201.0-34.02
c.936C>G
F312L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F312L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the SGM‑Consensus score is “Likely Pathogenic.” The only tool with an inconclusive result is FoldX, which is listed as “Uncertain.” No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.225814Structured0.361163Uncertain0.9150.3170.000-9.891Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.16Ambiguous0.32.91Destabilizing2.04Destabilizing1.27Destabilizing0.615Likely Pathogenic-5.52Deleterious0.992Probably Damaging0.987Probably Damaging1.32Pathogenic0.05Affected0.21490.3813201.0-34.02
c.937G>A
E313K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E313K is listed in ClinVar as Benign (ClinVar ID 3695040.0) and is not reported in gnomAD. Prediction tools that report a benign effect are absent; all available predictors that provide a definitive call classify the variant as pathogenic. These include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts Pathogenic, the SGM‑Consensus indicates Likely Pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) is Uncertain. Based on the overwhelming pathogenic predictions, the variant is most likely pathogenic, which contradicts its ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125Likely Benign 1-12.902Likely Pathogenic0.959Likely PathogenicLikely Pathogenic0.64Ambiguous0.61.40Ambiguous1.02Ambiguous0.75Ambiguous0.575Likely Pathogenic-3.31Deleterious1.000Probably Damaging0.995Probably Damaging1.90Pathogenic0.02Affected0.25400.770801-0.4-0.94
c.937G>C
E313Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E313Q is listed in ClinVar with an Uncertain significance status and is not reported in gnomAD. Prediction tools that classify the variant as benign include FoldX, Foldetta, premPS, PROVEAN, and AlphaMissense‑Optimized. Those that predict pathogenicity are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized indicates a benign effect, Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign stability, whereas the SGM‑Consensus remains pathogenic. Overall, the balance of evidence leans toward pathogenicity, and this assessment does not contradict the ClinVar designation of Uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125Uncertain 1-11.420Likely Pathogenic0.629Likely PathogenicLikely Benign0.19Likely Benign0.10.55Ambiguous0.37Likely Benign0.50Likely Benign0.505Likely Pathogenic-2.42Neutral1.000Probably Damaging0.998Probably Damaging1.88Pathogenic0.05Affected0.15230.7396220.0-0.98
c.938A>C
E313A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E313A is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized, whereas the remaining pathogenic‑or‑likely‑pathogenic predictors are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, Foldetta, premPS) returned uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125-14.591Likely Pathogenic0.747Likely PathogenicLikely Benign1.07Ambiguous0.30.97Ambiguous1.02Ambiguous0.62Ambiguous0.680Likely Pathogenic-4.88Deleterious0.999Probably Damaging0.995Probably Damaging1.88Pathogenic0.02Affected0.34160.67430-15.3-58.04
c.938A>G
E313G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E313G is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—all of which classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. Taken together, the overwhelming consensus from both general and high‑accuracy predictors indicates that E313G is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125-14.615Likely Pathogenic0.912Likely PathogenicAmbiguous2.00Destabilizing0.52.42Destabilizing2.21Destabilizing0.79Ambiguous0.750Likely Pathogenic-5.50Deleterious1.000Probably Damaging0.996Probably Damaging1.83Pathogenic0.01Affected0.26380.66800-23.1-72.06
c.938A>T
E313V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E313V missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas a majority of tools (REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the preponderance of evidence points to a pathogenic effect for E313V. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125-13.169Likely Pathogenic0.821Likely PathogenicAmbiguous0.34Likely Benign0.1-0.02Likely Benign0.16Likely Benign0.21Likely Benign0.655Likely Pathogenic-5.73Deleterious1.000Probably Damaging0.998Probably Damaging1.93Pathogenic0.05Affected0.11320.7900-2-27.7-29.98
c.939G>C
E313D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E313D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and SIFT, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicating a likely pathogenic effect, and Foldetta yielding an uncertain stability change. Overall, the balance of evidence points to a pathogenic interpretation; this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125-8.309Likely Pathogenic0.636Likely PathogenicLikely Benign0.87Ambiguous0.00.96Ambiguous0.92Ambiguous0.60Ambiguous0.346Likely Benign-1.66Neutral0.997Probably Damaging0.992Probably Damaging1.88Pathogenic0.14Tolerated0.19700.4640320.0-14.03
c.939G>T
E313D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E313D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and SIFT, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicating a likely pathogenic outcome, and Foldetta yielding an uncertain stability change. Overall, the balance of evidence points to a pathogenic effect for E313D, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.366526Uncertain0.8980.3040.125-8.309Likely Pathogenic0.636Likely PathogenicLikely Benign0.87Ambiguous0.00.96Ambiguous0.92Ambiguous0.60Ambiguous0.346Likely Benign-1.66Neutral0.997Probably Damaging0.992Probably Damaging1.88Pathogenic0.14Tolerated0.19700.4640320.0-14.03
c.940T>A
F314I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a pathogenic effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict deleterious or pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. Tools with uncertain or inconclusive results include Rosetta, Foldetta, and ESM1b. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, while Foldetta’s stability prediction is uncertain. Overall, the majority of evidence points to a pathogenic effect, and this is consistent with the lack of ClinVar annotation (i.e., no benign classification). Therefore, the variant is most likely pathogenic, and there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-7.059In-Between0.992Likely PathogenicLikely Pathogenic2.23Destabilizing0.41.08Ambiguous1.66Ambiguous1.31Destabilizing0.534Likely Pathogenic-4.98Deleterious0.997Probably Damaging0.994Probably Damaging1.26Pathogenic0.01Affected0.20520.2308101.7-34.02
c.940T>C
F314L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta give uncertain results and are treated as unavailable evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that F314L is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-6.004Likely Benign0.998Likely PathogenicLikely Pathogenic0.87Ambiguous0.10.82Ambiguous0.85Ambiguous1.21Destabilizing0.476Likely Benign-4.85Deleterious0.992Probably Damaging0.987Probably Damaging1.30Pathogenic0.05Affected0.22040.3089201.0-34.02
c.940T>G
F314V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314V is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). All available in silico predictors classify the variant as pathogenic: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect, so the benign group is empty. High‑accuracy methods—AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta—each return a pathogenic prediction. No predictions or stability results are missing or inconclusive. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-8.907Likely Pathogenic0.991Likely PathogenicLikely Pathogenic3.31Destabilizing0.42.54Destabilizing2.93Destabilizing1.44Destabilizing0.594Likely Pathogenic-5.90Deleterious0.997Probably Damaging0.992Probably Damaging1.26Pathogenic0.00Affected0.20540.2075-1-11.4-48.04
c.941T>A
F314Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and Rosetta, whereas a majority of tools (SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Predictions that are inconclusive—AlphaMissense‑Optimized, FoldX, and Foldetta—are treated as unavailable. High‑accuracy assessments further support pathogenicity: the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, while Foldetta’s combined stability analysis is uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-13.297Likely Pathogenic0.918Likely PathogenicAmbiguous1.33Ambiguous0.10.29Likely Benign0.81Ambiguous1.28Destabilizing0.374Likely Benign-2.62Deleterious0.997Probably Damaging0.987Probably Damaging1.20Pathogenic0.02Affected0.14270.217373-4.116.00
c.941T>C
F314S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314S (located in the C2 domain) is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as pathogenic: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Thus, the variant is most likely pathogenic based on predictions, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-14.371Likely Pathogenic1.000Likely PathogenicLikely Pathogenic4.51Destabilizing0.43.36Destabilizing3.94Destabilizing2.59Destabilizing0.735Likely Pathogenic-6.95Deleterious0.999Probably Damaging0.996Probably Damaging1.15Pathogenic0.00Affected0.41130.0600-3-2-3.6-60.10
c.941T>G
F314C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. All available evidence points to a damaging effect. Consequently, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-12.458Likely Pathogenic0.996Likely PathogenicLikely Pathogenic3.37Destabilizing0.32.64Destabilizing3.01Destabilizing2.49Destabilizing0.674Likely Pathogenic-6.89Deleterious1.000Probably Damaging0.998Probably Damaging1.13Pathogenic0.00Affected0.24010.1075-4-2-0.3-44.04
c.942T>A
F314L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta give uncertain results and are treated as unavailable evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that F314L is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-6.004Likely Benign0.998Likely PathogenicLikely Pathogenic0.87Ambiguous0.10.82Ambiguous0.85Ambiguous1.21Destabilizing0.336Likely Benign-4.85Deleterious0.992Probably Damaging0.987Probably Damaging1.30Pathogenic0.05Affected0.22040.3089201.0-34.02
c.942T>G
F314L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F314L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta give uncertain results and are treated as unavailable evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that F314L is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.173081Structured0.374049Uncertain0.9000.2710.125-6.004Likely Benign0.998Likely PathogenicLikely Pathogenic0.87Ambiguous0.10.82Ambiguous0.85Ambiguous1.21Destabilizing0.336Likely Benign-4.85Deleterious0.992Probably Damaging0.987Probably Damaging1.30Pathogenic0.05Affected0.22040.3089201.0-34.02
c.943A>C
N315H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N315H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate benign or likely benign. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign stability. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.118441Structured0.379740Uncertain0.8620.2530.125-6.374Likely Benign0.156Likely BenignLikely Benign0.29Likely Benign0.20.22Likely Benign0.26Likely Benign0.28Likely Benign0.258Likely Benign-2.15Neutral1.000Probably Damaging0.999Probably Damaging1.91Pathogenic0.76Tolerated0.16080.7296210.323.04
c.943A>G
N315D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and FATHMM. The remaining tools (FoldX, premPS, AlphaMissense‑Default) are inconclusive. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority; and Foldetta predicts a benign stability change. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.118441Structured0.379740Uncertain0.8620.2530.125-5.667Likely Benign0.536AmbiguousLikely Benign1.27Ambiguous0.6-0.30Likely Benign0.49Likely Benign0.88Ambiguous0.229Likely Benign-2.41Neutral0.999Probably Damaging0.995Probably Damaging2.02Pathogenic0.45Tolerated0.19720.4488210.00.98
c.943A>T
N315Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. The high‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence slightly favors a pathogenic interpretation, with six pathogenic‑predicted tools versus five benign‑predicted tools, and the high‑accuracy consensus leaning pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.379740Uncertain0.8620.2530.125-8.303Likely Pathogenic0.339Likely BenignLikely Benign-1.03Ambiguous0.5-0.85Ambiguous-0.94Ambiguous-0.10Likely Benign0.420Likely Benign-3.81Deleterious1.000Probably Damaging0.999Probably Damaging1.93Pathogenic1.00Tolerated0.06130.6732-2-22.249.07
c.944A>C
N315T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. Two tools, premPS and ESM1b, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of individual predictors (six benign vs. four pathogenic) and the Foldetta result support a benign classification, while the SGM Consensus suggests pathogenicity. Thus, the variant is most likely benign based on the preponderance of evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.118441Structured0.379740Uncertain0.8620.2530.125-7.071In-Between0.211Likely BenignLikely Benign0.31Likely Benign0.1-0.36Likely Benign-0.03Likely Benign0.62Ambiguous0.333Likely Benign-2.91Deleterious0.999Probably Damaging0.995Probably Damaging1.95Pathogenic0.53Tolerated0.14710.8068002.8-13.00
c.944A>G
N315S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact for the variant, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.118441Structured0.379740Uncertain0.8620.2530.125-4.847Likely Benign0.068Likely BenignLikely Benign0.85Ambiguous0.20.78Ambiguous0.82Ambiguous0.68Ambiguous0.250Likely Benign-1.84Neutral0.999Probably Damaging0.992Probably Damaging2.03Pathogenic0.60Tolerated0.40220.7395112.7-27.03
c.944A>T
N315I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant N315I is not reported in ClinVar and is absent from gnomAD. In silico predictors that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, and AlphaMissense‑Optimized. Predictors that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. The high‑accuracy AlphaMissense‑Optimized score is benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; Foldetta, which integrates FoldX‑MD (uncertain) and Rosetta (benign), is considered unavailable. Overall, the balance of evidence leans toward pathogenicity, and this assessment does not conflict with the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.379740Uncertain0.8620.2530.125-9.666Likely Pathogenic0.500AmbiguousLikely Benign-0.72Ambiguous0.4-0.17Likely Benign-0.45Likely Benign0.36Likely Benign0.496Likely Benign-5.19Deleterious1.000Probably Damaging0.999Probably Damaging1.90Pathogenic0.43Tolerated0.07630.7235-2-38.0-0.94
c.945C>A
N315K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315K is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and Foldetta. Tools that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No other high‑accuracy tool provides a conclusive result. Overall, the majority of predictions (seven pathogenic vs. five benign, with two uncertain) indicate that the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.379740Uncertain0.8620.2530.125-10.380Likely Pathogenic0.872Likely PathogenicAmbiguous-0.03Likely Benign0.10.08Likely Benign0.03Likely Benign0.87Ambiguous0.340Likely Benign-3.27Deleterious0.999Probably Damaging0.996Probably Damaging1.98Pathogenic0.54Tolerated0.22680.643610-0.414.07
c.945C>G
N315K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N315K is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and Foldetta. Tools that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of evidence (seven pathogenic vs. five benign, with two uncertain) points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.379740Uncertain0.8620.2530.125-10.380Likely Pathogenic0.872Likely PathogenicAmbiguous-0.03Likely Benign0.10.08Likely Benign0.03Likely Benign0.87Ambiguous0.340Likely Benign-3.27Deleterious0.999Probably Damaging0.996Probably Damaging1.98Pathogenic0.54Tolerated0.22680.643610-0.414.07
c.946A>C
N316H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N316H is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, and AlphaMissense‑Optimized. Tools that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts a benign effect; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (pathogenic), FATHMM (pathogenic), and PROVEAN (pathogenic), indicates a likely pathogenic outcome; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign impact. FoldX and premPS are inconclusive. Overall, the balance of evidence from the majority of prediction tools points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-8.141Likely Pathogenic0.440AmbiguousLikely Benign0.72Ambiguous0.40.07Likely Benign0.40Likely Benign0.62Ambiguous0.306Likely Benign-3.56Deleterious1.000Probably Damaging0.999Probably Damaging1.76Pathogenic0.02Affected0.15550.7702210.323.04
c.946A>G
N316D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316D is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, Rosetta, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain and therefore not considered evidence. Overall, seven of the evaluated tools predict pathogenicity versus four predicting benignity, indicating that the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-11.672Likely Pathogenic0.777Likely PathogenicLikely Benign1.18Ambiguous0.10.46Likely Benign0.82Ambiguous0.69Ambiguous0.293Likely Benign-3.20Deleterious0.999Probably Damaging0.995Probably Damaging1.76Pathogenic0.25Tolerated0.19780.4596210.00.98
c.946A>T
N316Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316Y is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign impact. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-11.226Likely Pathogenic0.767Likely PathogenicLikely Benign0.53Ambiguous0.5-0.09Likely Benign0.22Likely Benign0.50Likely Benign0.454Likely Benign-5.70Deleterious1.000Probably Damaging0.999Probably Damaging1.81Pathogenic0.01Affected0.05740.6971-2-22.249.07
c.947A>C
N316T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. The remaining tools (AlphaMissense‑Default, ESM1b, Foldetta, premPS, Rosetta) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta also yields an uncertain stability change. Overall, the majority of available predictions lean toward pathogenicity, and this assessment does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely pathogenic based on the current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.118441Structured0.385187Uncertain0.8170.2460.125-7.538In-Between0.550AmbiguousLikely Benign2.71Destabilizing0.21.27Ambiguous1.99Ambiguous0.57Ambiguous0.214Likely Benign-3.68Deleterious0.999Probably Damaging0.995Probably Damaging1.79Pathogenic0.08Tolerated0.14820.8474002.8-13.00
c.947A>T
N316I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N316I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and premPS, whereas the majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. No prediction is missing or inconclusive beyond the uncertain AlphaMissense‑Optimized result. Based on the preponderance of pathogenic predictions and the high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-11.164Likely Pathogenic0.899Likely PathogenicAmbiguous2.74Destabilizing0.24.10Destabilizing3.42Destabilizing0.18Likely Benign0.318Likely Benign-6.37Deleterious1.000Probably Damaging0.999Probably Damaging2.00Pathogenic0.03Affected0.07340.7422-2-38.0-0.94
c.948C>A
N316K
2D
AIThe SynGAP1 missense variant N316K is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL and SIFT, whereas the majority of tools predict a pathogenic outcome: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as uncertain. No other high‑confidence predictions are available. Overall, the preponderance of evidence points to a pathogenic effect for N316K, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-10.711Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.52Ambiguous0.70.86Ambiguous0.69Ambiguous0.67Ambiguous0.254Likely Benign-3.87Deleterious0.999Probably Damaging0.996Probably Damaging1.77Pathogenic0.13Tolerated0.22200.659310-0.414.07
c.948C>G
N316K
2D
AISynGAP1 missense variant N316K is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and SIFT, whereas a majority of tools predict pathogenicity: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, yields an uncertain result and is treated as unavailable evidence. Overall, the preponderance of computational predictions indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.118441Structured0.385187Uncertain0.8170.2460.125-10.711Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.52Ambiguous0.70.86Ambiguous0.69Ambiguous0.67Ambiguous0.254Likely Benign-3.87Deleterious0.999Probably Damaging0.996Probably Damaging1.77Pathogenic0.13Tolerated0.22200.659310-0.414.07
c.949C>A
L317M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L317M missense variant is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools show a split: benign calls come from REVEL, FoldX, Foldetta, and PROVEAN, whereas pathogenic calls arise from polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta predicts a benign effect on protein stability. No evidence from ClinVar contradicts these findings. Overall, the preponderance of pathogenic predictions and the SGM‑Consensus result suggest that the variant is most likely pathogenic, though the benign signal from Foldetta and other tools indicates uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-9.558Likely Pathogenic0.788Likely PathogenicAmbiguous0.14Likely Benign0.10.84Ambiguous0.49Likely Benign0.94Ambiguous0.250Likely Benign-1.84Neutral1.000Probably Damaging0.999Probably Damaging1.71Pathogenic0.04Affected0.09370.312242-1.918.03
c.949C>G
L317V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L317V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely disagree: benign calls come from REVEL and AlphaMissense‑Optimized, while pathogenic calls are made by FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized predicting Benign, SGM‑Consensus predicting Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yielding an Uncertain result. Overall, the majority of evidence points toward pathogenicity, with only two tools indicating benign. Because ClinVar contains no entry, there is no conflict with existing clinical interpretation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-8.406Likely Pathogenic0.403AmbiguousLikely Benign2.51Destabilizing0.10.97Ambiguous1.74Ambiguous1.12Destabilizing0.298Likely Benign-2.76Deleterious0.999Probably Damaging0.994Probably Damaging1.74Pathogenic0.03Affected0.15180.2950210.4-14.03
c.94A>C
T32P
2D
AIThe SynGAP1 missense variant T32P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. In contrast, two tools—polyPhen‑2 HumDiv and SIFT—classify the change as pathogenic. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; no Foldetta stability data are available. Overall, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.437154Uncertain0.3490.8790.375-2.958Likely Benign0.055Likely BenignLikely Benign0.102Likely Benign-0.94Neutral0.604Possibly Damaging0.185Benign4.14Benign0.00Affected0.23270.58180-1-0.9-3.99
c.94A>G
T32A
2D
AIThe SynGAP1 missense variant T32A is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic prediction comes from SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, has no available result for this variant. Overall, the consensus of the majority of tools and the high‑accuracy predictions point to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.437154Uncertain0.3490.8790.375-3.330Likely Benign0.072Likely BenignLikely Benign0.047Likely Benign-0.63Neutral0.043Benign0.016Benign4.21Benign0.00Affected0.41740.4742102.5-30.03
c.94A>T
T32S
2D
AIThe SynGAP1 missense variant T32S is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic prediction comes from SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, has no available result for this variant. Overall, the consensus of the majority of tools and the high‑accuracy predictions point to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.437154Uncertain0.3490.8790.375-2.618Likely Benign0.072Likely BenignLikely Benign0.062Likely Benign-0.39Neutral0.171Benign0.050Benign4.18Benign0.00Affected0.36030.517411-0.1-14.03
c.950T>A
L317Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on these predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-13.424Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.87Destabilizing0.22.47Destabilizing2.67Destabilizing1.61Destabilizing0.607Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.00Affected0.12520.1251-2-2-7.314.97
c.950T>C
L317P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tools predict a benign effect, so the benign group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-14.778Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.61Destabilizing1.44.29Destabilizing3.95Destabilizing1.26Destabilizing0.654Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.82Pathogenic0.00Affected0.34050.1153-3-3-5.4-16.04
c.950T>G
L317R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-14.185Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.33Destabilizing0.22.01Destabilizing2.67Destabilizing1.63Destabilizing0.569Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.00Affected0.15010.0893-3-2-8.343.03
c.952C>A
P318T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P318T is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly favor a deleterious effect: REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict pathogenic or likely pathogenic. No tool in the dataset predicts a benign outcome; the only inconclusive results come from Rosetta, Foldetta, and premPS, which are treated as unavailable evidence. High‑accuracy assessments confirm this trend: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta is uncertain. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000-10.759Likely Pathogenic0.962Likely PathogenicLikely Pathogenic2.03Destabilizing0.21.54Ambiguous1.79Ambiguous0.84Ambiguous0.680Likely Pathogenic-7.09Deleterious1.000Probably Damaging0.999Probably Damaging1.84Pathogenic0.01Affected0.15830.60440-10.93.99
c.952C>G
P318A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P318A missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tool predicts a benign outcome. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while AlphaMissense‑Optimized remains uncertain and Foldetta is also uncertain. Taken together, the overwhelming majority of evidence points to a pathogenic effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000-9.642Likely Pathogenic0.872Likely PathogenicAmbiguous1.90Ambiguous0.21.69Ambiguous1.80Ambiguous0.94Ambiguous0.546Likely Pathogenic-7.12Deleterious1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.04Affected0.37600.55851-13.4-26.04
c.953C>A
P318Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P318Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity. Only FoldX, Rosetta, and Foldetta provide uncertain results and are therefore not considered evidence for benign impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Consequently, the variant is most likely pathogenic based on the consensus of predictive algorithms, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000-11.403Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.64Ambiguous0.21.29Ambiguous1.47Ambiguous1.18Destabilizing0.638Likely Pathogenic-7.05Deleterious1.000Probably Damaging1.000Probably Damaging1.83Pathogenic0.01Affected0.14670.47310-1-1.931.01
c.953C>G
P318R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 P318R is not reported in ClinVar and is absent from gnomAD. In silico predictors that classify the variant as benign: none. Those that predict pathogenicity include SGM‑Consensus (Likely Pathogenic), REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Predictions from FoldX, Rosetta, and Foldetta are uncertain. High‑accuracy tools give a consistent pathogenic signal: AlphaMissense‑Optimized reports pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates likely pathogenic; Foldetta remains inconclusive. Overall, the consensus of the majority of predictors supports a pathogenic effect. This conclusion is not contradicted by ClinVar status, which is currently unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.111485Structured0.400936Uncertain0.8580.2340.000-14.132Likely Pathogenic0.987Likely PathogenicLikely Pathogenic1.20Ambiguous0.10.70Ambiguous0.95Ambiguous1.01Destabilizing0.643Likely Pathogenic-8.01Deleterious1.000Probably Damaging1.000Probably Damaging1.84Pathogenic0.01Affected0.13080.33100-2-2.959.07
c.955G>A
A319T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A319T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen2_HumVar. Those that predict a pathogenic effect are polyPhen2_HumDiv and FATHMM. The remaining tools—FoldX, Rosetta, Foldetta, and ESM1b—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of reliable predictors classify the variant as benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.179055Structured0.410405Uncertain0.8790.2540.125-7.841In-Between0.098Likely BenignLikely Benign0.55Ambiguous0.30.70Ambiguous0.63Ambiguous0.30Likely Benign0.116Likely Benign-1.35Neutral0.775Possibly Damaging0.306Benign1.92Pathogenic0.09Tolerated0.12740.608310-2.530.03
c.955G>T
A319S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A319S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as benign. No prediction or stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.179055Structured0.410405Uncertain0.8790.2540.125-7.109In-Between0.093Likely BenignLikely Benign0.16Likely Benign0.20.02Likely Benign0.09Likely Benign0.13Likely Benign0.165Likely Benign-0.58Neutral0.978Probably Damaging0.754Possibly Damaging2.02Pathogenic0.12Tolerated0.25370.470311-2.616.00
c.956C>A
A319D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A319D missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized; pathogenic predictions from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a likely pathogenic verdict (3/4 pathogenic votes). High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, whereas the SGM‑Consensus remains pathogenic. Foldetta, which integrates FoldX‑MD (benign) and Rosetta (uncertain), is considered unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.410405Uncertain0.8790.2540.125-11.144Likely Pathogenic0.752Likely PathogenicLikely Benign-0.02Likely Benign0.2-0.84Ambiguous-0.43Likely Benign0.30Likely Benign0.373Likely Benign-2.38Neutral0.998Probably Damaging0.966Probably Damaging2.01Pathogenic0.20Tolerated0.15040.13600-2-5.344.01
c.956C>G
A319G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A319G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict pathogenicity, while Rosetta remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports benign. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.179055Structured0.410405Uncertain0.8790.2540.125-6.505Likely Benign0.148Likely BenignLikely Benign0.11Likely Benign0.40.56Ambiguous0.34Likely Benign0.39Likely Benign0.219Likely Benign-1.83Neutral0.994Probably Damaging0.900Possibly Damaging1.89Pathogenic0.09Tolerated0.23450.453210-2.2-14.03
c.956C>T
A319V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A319V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. FoldX, Rosetta, and Foldetta give uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is also inconclusive. Overall, the majority of evidence points to a benign effect, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.179055Structured0.410405Uncertain0.8790.2540.125-8.179Likely Pathogenic0.141Likely BenignLikely Benign0.58Ambiguous0.40.63Ambiguous0.61Ambiguous0.23Likely Benign0.329Likely Benign-2.32Neutral0.989Probably Damaging0.824Possibly Damaging1.88Pathogenic0.10Tolerated0.10940.6390002.428.05
c.958G>A
V320I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V320I is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while Rosetta remains inconclusive. High‑accuracy assessments corroborate the benign trend: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. Overall, the preponderance of evidence points to a benign effect for V320I, and this conclusion does not conflict with the current ClinVar designation of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.185198Structured0.419626Uncertain0.9050.2660.125Uncertain 1-5.220Likely Benign0.111Likely BenignLikely Benign-0.27Likely Benign0.20.66Ambiguous0.20Likely Benign0.01Likely Benign0.027Likely Benign-0.21Neutral0.198Benign0.114Benign1.77Pathogenic0.45Tolerated3.38230.05140.3207340.314.03
c.958G>T
V320F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant V320F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on benign impact include REVEL, premPS, and SIFT, whereas tools that agree on pathogenic impact include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as inconclusive, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as inconclusive. Because the majority of available predictions and the SGM‑Consensus favor pathogenicity, the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for V320F.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.419626Uncertain0.9050.2660.125-9.958Likely Pathogenic0.877Likely PathogenicAmbiguous1.49Ambiguous1.41.55Ambiguous1.52Ambiguous0.44Likely Benign0.237Likely Benign-3.26Deleterious0.994Probably Damaging0.944Probably Damaging1.79Pathogenic0.06Tolerated0.04730.3064-1-1-1.448.04
c.959T>A
V320D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V320D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL and SIFT; pathogenic predictions from premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Stability‑based methods FoldX and Rosetta returned uncertain results, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also yielded an uncertain prediction. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect, which is consistent with the lack of ClinVar annotation and gnomAD absence. Thus, the variant is most likely pathogenic, and this prediction does not contradict ClinVar status because ClinVar has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.419626Uncertain0.9050.2660.125-11.269Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.99Ambiguous1.01.67Ambiguous1.83Ambiguous1.50Destabilizing0.405Likely Benign-5.58Deleterious0.999Probably Damaging0.972Probably Damaging1.93Pathogenic0.07Tolerated0.11010.0482-2-3-7.715.96
c.959T>C
V320A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V320A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM. Four tools (AlphaMissense‑Default, FoldX, Rosetta, Foldetta) give uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, more tools (five) predict pathogenicity than benign (four), and the high‑accuracy consensus leans toward pathogenic. Thus, the variant is most likely pathogenic, with no contradiction to ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.185198Structured0.419626Uncertain0.9050.2660.125-5.488Likely Benign0.545AmbiguousLikely Benign1.26Ambiguous0.71.48Ambiguous1.37Ambiguous1.27Destabilizing0.179Likely Benign-3.05Deleterious0.948Possibly Damaging0.761Possibly Damaging1.84Pathogenic0.35Tolerated0.24050.190300-2.4-28.05
c.959T>G
V320G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V320G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools cluster into two agreement groups: the single benign prediction comes from REVEL, while the pathogenic group includes FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is uncertain; the SGM Consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—returns pathogenic; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts pathogenic. Overall, the preponderance of evidence indicates that V320G is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.185198Structured0.419626Uncertain0.9050.2660.125-9.043Likely Pathogenic0.816Likely PathogenicAmbiguous2.15Destabilizing1.11.87Ambiguous2.01Destabilizing1.48Destabilizing0.438Likely Benign-5.74Deleterious0.958Probably Damaging0.999Probably Damaging1.89Pathogenic0.02Affected0.16880.1949-1-3-4.6-42.08
c.95C>G
T32S
2D
AIThe SynGAP1 missense variant T32S is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic prediction comes from SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, has no available result for this variant. Overall, the consensus of the majority of tools and the high‑accuracy predictions point to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.437154Uncertain0.3490.8790.375-2.618Likely Benign0.072Likely BenignLikely Benign0.024Likely Benign-0.39Neutral0.171Benign0.050Benign4.18Benign0.00Affected0.36030.517411-0.1-14.03
c.961C>A
R321S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R321S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Two tools—FoldX and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions lean toward a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on the available computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.175930Structured0.423273Uncertain0.9310.2970.125-10.146Likely Pathogenic0.497AmbiguousLikely Benign0.66Ambiguous0.1-0.30Likely Benign0.18Likely Benign0.24Likely Benign0.379Likely Benign-2.27Neutral0.999Probably Damaging0.997Probably Damaging2.00Pathogenic0.10Tolerated0.29580.27850-13.7-69.11
c.961C>G
R321G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R321G is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, Rosetta, AlphaMissense‑Default, AlphaMissense‑Optimized, and premPS. Tools that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of conventional predictors lean toward pathogenicity, while the high‑accuracy subset is mixed, with one benign, one pathogenic, and one uncertain result. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant has not yet been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.175930Structured0.423273Uncertain0.9310.2970.125-10.554Likely Pathogenic0.293Likely BenignLikely Benign0.90Ambiguous0.10.28Likely Benign0.59Ambiguous0.49Likely Benign0.430Likely Benign-3.70Deleterious0.999Probably Damaging0.997Probably Damaging1.92Pathogenic0.04Affected0.32240.2898-3-24.1-99.14
c.962G>C
R321P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R321P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. FoldX and Rosetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools (8/12) predict pathogenicity, whereas 4/12 predict benign, with two high‑accuracy tools supporting benign and one supporting pathogenic. Thus, the variant is most likely pathogenic based on the preponderance of evidence, and this assessment does not contradict ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.175930Structured0.423273Uncertain0.9310.2970.125-11.576Likely Pathogenic0.740Likely PathogenicLikely Benign1.22Ambiguous0.3-0.77Ambiguous0.23Likely Benign0.41Likely Benign0.488Likely Benign-3.59Deleterious1.000Probably Damaging0.999Probably Damaging1.92Pathogenic0.03Affected0.21860.36610-22.9-59.07
c.962G>T
R321L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R321L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include SIFT, polyPhen‑2 (HumDiv and HumVar), PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign; FoldX and Rosetta individually are inconclusive. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.175930Structured0.423273Uncertain0.9310.2970.125-11.709Likely Pathogenic0.551AmbiguousLikely Benign0.54Ambiguous0.0-0.58Ambiguous-0.02Likely Benign0.18Likely Benign0.451Likely Benign-4.06Deleterious0.999Probably Damaging0.997Probably Damaging1.93Pathogenic0.03Affected0.17450.4048-3-28.3-43.03
c.964G>A
A322T
2D
AIThe SynGAP1 missense variant A322T is not reported in ClinVar and is absent from gnomAD. Consensus from most in silico predictors classifies the change as benign: SGM‑Consensus (Likely Benign), REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a neutral effect. Only FATHMM indicates a pathogenic signal, while FoldX and premPS are inconclusive. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign impact on protein stability. Overall, the majority of evidence supports a benign effect for A322T, and this is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.175930Structured0.425745Uncertain0.9380.3340.000-2.252Likely Benign0.064Likely BenignLikely Benign0.58Ambiguous0.90.22Likely Benign0.40Likely Benign-0.52Ambiguous0.112Likely Benign0.20Neutral0.010Benign0.005Benign1.95Pathogenic0.73Tolerated0.13670.643210-2.530.03
c.964G>C
A322P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A322P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, premPS, PROVEAN, polyPhen‑2 HumVar, and SIFT, while pathogenic calls are made by SGM‑Consensus, Rosetta, Foldetta, polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: FoldX and AlphaMissense‑Optimized. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. Overall, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar, which has no entry for this variant. Thus, the variant is most likely pathogenic, with no ClinVar evidence to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.175930Structured0.425745Uncertain0.9380.3340.000-10.558Likely Pathogenic0.878Likely PathogenicAmbiguous1.26Ambiguous1.35.43Destabilizing3.35Destabilizing0.40Likely Benign0.343Likely Benign-1.72Neutral0.784Possibly Damaging0.390Benign1.90Pathogenic0.18Tolerated0.20640.54001-1-3.426.04
c.964G>T
A322S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A322S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. Only FATHMM predicts a pathogenic outcome. Grouping by consensus, the benign‑predicting tools outnumber the single pathogenic prediction. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also indicates a benign effect. No prediction or stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.175930Structured0.425745Uncertain0.9380.3340.000-1.424Likely Benign0.058Likely BenignLikely Benign0.41Likely Benign0.20.38Likely Benign0.40Likely Benign-0.44Likely Benign0.127Likely Benign1.09Neutral0.010Benign0.010Benign2.00Pathogenic0.67Tolerated0.26960.525311-2.616.00
c.965C>A
A322D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A322D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The remaining tools—FoldX, Rosetta, ESM1b, and AlphaMissense‑Default—return uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta indicates no significant stability change (uncertain). Overall, the preponderance of evidence (seven benign predictions versus one pathogenic) suggests the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.175930Structured0.425745Uncertain0.9380.3340.000-7.184In-Between0.411AmbiguousLikely Benign0.65Ambiguous0.11.35Ambiguous1.00Ambiguous0.34Likely Benign0.246Likely Benign-0.95Neutral0.270Benign0.136Benign1.96Pathogenic0.32Tolerated0.16460.16600-2-5.344.01
c.965C>G
A322G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A322G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score. Only FATHMM predicts a pathogenic outcome. Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain or inconclusive and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Based on the preponderance of benign predictions and the lack of contradictory evidence, the variant is most likely benign; this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.175930Structured0.425745Uncertain0.9380.3340.000-5.230Likely Benign0.121Likely BenignLikely Benign0.84Ambiguous0.11.43Ambiguous1.14Ambiguous0.64Ambiguous0.054Likely Benign-1.07Neutral0.139Benign0.088Benign1.94Pathogenic0.19Tolerated0.25130.468310-2.2-14.03
c.965C>T
A322V
2D
AIThe SynGAP1 missense variant A322V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. No predictions or stability results are missing or inconclusive. Based on the overwhelming consensus of the available tools, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.175930Structured0.425745Uncertain0.9380.3340.000-4.905Likely Benign0.121Likely BenignLikely Benign0.02Likely Benign1.0-0.42Likely Benign-0.20Likely Benign0.19Likely Benign0.052Likely Benign-1.63Neutral0.270Benign0.136Benign1.96Pathogenic0.22Tolerated0.12790.6126002.428.05
c.967C>A
L323M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L323M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The remaining tools—Foldetta, premPS, AlphaMissense‑Default, ESM1b, and Rosetta—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is also inconclusive. Taken together, the evidence leans toward a benign impact for the variant, and this assessment does not contradict any ClinVar annotation, as none exists for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.268042Structured0.428564Uncertain0.9560.3690.000-7.065In-Between0.427AmbiguousLikely Benign0.11Likely Benign0.11.82Ambiguous0.97Ambiguous0.93Ambiguous0.270Likely Benign-1.02Neutral0.997Probably Damaging0.939Probably Damaging0.64Pathogenic0.03Affected0.06370.301042-1.918.03
c.967C>G
L323V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L323V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, premPS, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and pathogenic predictions (FoldX, Rosetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM). The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Benign. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority of the four high‑accuracy tools) also indicates Likely Benign; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts pathogenic. Overall, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.428564Uncertain0.9560.3690.000-3.483Likely Benign0.107Likely BenignLikely Benign2.18Destabilizing0.32.22Destabilizing2.20Destabilizing0.17Likely Benign0.227Likely Benign0.19Neutral0.898Possibly Damaging0.472Possibly Damaging0.80Pathogenic0.80Tolerated0.12770.2656210.4-14.03
c.968T>A
L323Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as pathogenic. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—return pathogenic or likely pathogenic calls. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000-14.487Likely Pathogenic0.996Likely PathogenicLikely Pathogenic3.19Destabilizing0.23.28Destabilizing3.24Destabilizing1.85Destabilizing0.728Likely Pathogenic-4.54Deleterious0.999Probably Damaging0.977Probably Damaging0.59Pathogenic0.00Affected0.09150.0758-2-2-7.314.97
c.968T>C
L323P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000Uncertain 1-12.507Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.39Destabilizing0.68.46Destabilizing5.93Destabilizing2.20Destabilizing0.762Likely Pathogenic-4.80Deleterious0.999Probably Damaging0.977Probably Damaging0.59Pathogenic0.01Affected4.293980.36780.1221-3-3-5.4-16.04201.968.20.00.10.60.3XPotentially PathogenicThe iso-butyl side chain of Leu323, located at the beginning of an anti-parallel β sheet strand (res. Ala322-Asp330), packs against multiple hydrophobic leucine residues (e.g., Leu264, Leu266, Leu284, Leu286). In contrast, in the variant simulations, the less bulky cyclic five-membered pyrrolidine ring of Pro323 cannot fill the hydrophobic space as effectively as the branched hydrocarbon side chain of leucine. Notably, the backbone amide group of Leu323 forms a hydrogen bond with the backbone carbonyl group of Cys285. Pro323 cannot form this bond due to the absence of the backbone amide group, resulting in partial unfolding of the anti-parallel β sheet end in the variant simulations.
c.968T>G
L323R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323R is listed in ClinVar (ID 978601.0) as Pathogenic and is not reported in gnomAD. All available in‑silico predictors classify the change as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool reports a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Consequently, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000Likely Pathogenic 1-14.568Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.75Destabilizing0.44.47Destabilizing4.11Destabilizing2.15Destabilizing0.692Likely Pathogenic-4.70Deleterious0.999Probably Damaging0.969Probably Damaging0.59Pathogenic0.01Affected3.39220.10660.0600-3-2-8.343.03261.8-61.6-0.40.20.80.2XXXPotentially PathogenicThe iso-butyl side chain of Leu323, located at the beginning of an anti-parallel β sheet strand (res. Ala322-Asp330), packs against multiple hydrophobic leucine residues (e.g., Leu264, Leu266, Leu284, Leu286). In contrast, in the variant simulations, the positively charged guanidinium group of the Arg323 side chain is unsuitable for the hydrophobic niche. Consequently, the side chain either rotates away from the center of the C2 domain or, if it remains within the C2 domain core, it reorients nearby residues to form hydrogen bonds. Regardless, the residue swap extensively disrupts the C2 domain structure.
c.970C>G
R324G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R324G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default; the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. With the majority of evidence pointing to deleterious impact and two of the three high‑accuracy methods supporting pathogenicity, the variant is most likely pathogenic. This conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.257454Structured0.426893Uncertain0.9540.3970.000-12.266Likely Pathogenic0.708Likely PathogenicLikely Benign2.99Destabilizing0.13.18Destabilizing3.09Destabilizing1.27Destabilizing0.496Likely Benign-2.64Deleterious0.999Probably Damaging0.997Probably Damaging1.84Pathogenic0.39Tolerated0.35460.4135-3-24.1-99.14
c.971G>C
R324P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R324P is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, PROVEAN, and SIFT, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic” because three of the four contributing tools predict pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenic. Based on the preponderance of pathogenic predictions—including the high‑accuracy tools—the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.257454Structured0.426893Uncertain0.9540.3970.000-14.533Likely Pathogenic0.993Likely PathogenicLikely Pathogenic4.61Destabilizing0.52.19Destabilizing3.40Destabilizing1.03Destabilizing0.486Likely Benign-2.15Neutral1.000Probably Damaging0.999Probably Damaging1.83Pathogenic0.29Tolerated0.22910.55560-22.9-59.07
c.973C>A
L325M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and premPS. Two tools give uncertain results: Foldetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. No prediction or folding stability result is missing or inconclusive. Overall, the majority of tools (six pathogenic vs five benign) lean toward pathogenicity, but the high‑accuracy methods and several benign predictions introduce uncertainty. Thus, the variant is most likely pathogenic based on the collective evidence, and this assessment is not contradicted by any ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.424577Uncertain0.9550.4360.000-6.725Likely Benign0.445AmbiguousLikely Benign0.22Likely Benign0.02.04Destabilizing1.13Ambiguous1.05Destabilizing0.306Likely Benign-0.86Neutral0.997Probably Damaging0.939Probably Damaging1.36Pathogenic0.01Affected0.09340.394242-1.918.03
c.973C>G
L325V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L325V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Rosetta and Foldetta give uncertain results. The high‑accuracy consensus from AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.352862Structured0.424577Uncertain0.9550.4360.000-3.104Likely Benign0.162Likely BenignLikely Benign2.26Destabilizing0.11.27Ambiguous1.77Ambiguous-0.39Likely Benign0.183Likely Benign0.16Neutral0.898Possibly Damaging0.472Possibly Damaging1.68Pathogenic1.00Tolerated0.15710.3957210.4-14.03
c.974T>A
L325Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as pathogenic. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—return pathogenic or likely pathogenic calls. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-17.005Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.23Destabilizing0.02.68Destabilizing2.96Destabilizing2.02Destabilizing0.547Likely Pathogenic-3.97Deleterious0.999Probably Damaging0.977Probably Damaging1.33Pathogenic0.00Affected0.12350.1405-2-2-7.314.97
c.974T>C
L325P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325P is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic effect. No predictions or stability results are missing or inconclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-16.130Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.49Destabilizing0.37.27Destabilizing6.38Destabilizing1.89Destabilizing0.607Likely Pathogenic-4.37Deleterious0.999Probably Damaging0.977Probably Damaging1.33Pathogenic0.00Affected0.33930.1903-3-3-5.4-16.04
c.974T>G
L325R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. No predictions or stability results are missing or inconclusive. **Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status (no ClinVar entry).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-16.612Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.34Destabilizing0.34.11Destabilizing4.23Destabilizing1.94Destabilizing0.551Likely Pathogenic-4.39Deleterious0.999Probably Damaging0.969Probably Damaging1.33Pathogenic0.00Affected0.14050.1047-3-2-8.343.03
c.976C>A
H326N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326N has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and SIFT, whereas a majority (seven) predict a pathogenic outcome: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the balance of evidence points to a pathogenic impact for H326N, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.914Likely Pathogenic0.925Likely PathogenicAmbiguous0.81Ambiguous0.21.48Ambiguous1.15Ambiguous0.97Ambiguous0.409Likely Benign-5.63Deleterious0.997Probably Damaging0.992Probably Damaging1.95Pathogenic0.11Tolerated0.19290.255221-0.3-23.04
c.976C>G
H326D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326D missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only SIFT, which scores the variant as benign. All other evaluated algorithms—REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic outcome. Tools with inconclusive results are FoldX, Foldetta, and premPS, which are listed as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, reports an uncertain result. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-13.000Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.87Ambiguous0.62.00Destabilizing1.44Ambiguous0.96Ambiguous0.561Likely Pathogenic-7.67Deleterious0.997Probably Damaging0.994Probably Damaging2.04Pathogenic0.10Tolerated0.26120.16111-1-0.3-22.05
c.976C>T
H326Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas a majority of tools (REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of evidence points to a pathogenic effect for H326Y, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-10.896Likely Pathogenic0.855Likely PathogenicAmbiguous0.03Likely Benign0.40.25Likely Benign0.14Likely Benign0.07Likely Benign0.562Likely Pathogenic-5.32Deleterious0.997Probably Damaging0.992Probably Damaging1.92Pathogenic0.02Affected0.07960.4323021.926.03
c.977A>C
H326P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; pathogenic predictions are reported by REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). The only inconclusive result is premPS, which is listed as Uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Pathogenic. Based on the consensus of these predictions, the variant is most likely pathogenic, and this conclusion is consistent with the absence of ClinVar evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-18.452Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.67Destabilizing0.32.59Destabilizing2.63Destabilizing0.88Ambiguous0.711Likely Pathogenic-8.73Deleterious0.999Probably Damaging0.998Probably Damaging1.92Pathogenic0.03Affected0.23830.44920-21.6-40.02
c.977A>G
H326R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326R missense variant is not listed in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include SIFT and Foldetta, whereas the remaining tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports it as likely pathogenic; Foldetta, a protein‑folding stability approach that integrates FoldX‑MD and Rosetta outputs, predicts a benign effect. Because the majority of evidence points to a deleterious change, the variant is most likely pathogenic, and this assessment is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-12.369Likely Pathogenic0.980Likely PathogenicLikely Pathogenic-0.65Ambiguous0.11.40Ambiguous0.38Likely Benign0.83Ambiguous0.601Likely Pathogenic-6.89Deleterious0.997Probably Damaging0.994Probably Damaging1.97Pathogenic0.10Tolerated0.18320.241320-1.319.05
c.977A>T
H326L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326L missense variant is not reported in ClinVar (status: None) and has no entry in gnomAD. Prediction tools that agree on a benign effect include SIFT, premPS, Rosetta, and Foldetta. Tools that agree on a pathogenic effect include REVEL, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy methods give mixed results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta) predicts benign. No evidence is available from FoldX or AlphaMissense‑Optimized to support either outcome. Overall, the majority of predictions (nine pathogenic vs. four benign) indicate that H326L is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-10.421Likely Pathogenic0.888Likely PathogenicAmbiguous-0.85Ambiguous0.20.36Likely Benign-0.25Likely Benign0.44Likely Benign0.627Likely Pathogenic-9.64Deleterious0.999Probably Damaging0.996Probably Damaging1.95Pathogenic0.08Tolerated0.09920.5799-2-37.0-23.98
c.978T>A
H326Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and SIFT, whereas a majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools, Foldetta (combining FoldX‑MD and Rosetta) and Rosetta alone, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for H326Q. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.688Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.46Likely Benign0.11.67Ambiguous1.07Ambiguous1.00Destabilizing0.444Likely Benign-6.89Deleterious0.999Probably Damaging0.996Probably Damaging2.07Pathogenic0.10Tolerated0.14850.350030-0.3-9.01
c.978T>G
H326Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and SIFT, whereas a majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools, Foldetta (combining FoldX‑MD and Rosetta) and Rosetta alone, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus also indicates likely pathogenic, while Foldetta remains uncertain. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect for H326Q. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.688Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.46Likely Benign0.11.67Ambiguous1.07Ambiguous1.00Destabilizing0.444Likely Benign-6.89Deleterious0.999Probably Damaging0.996Probably Damaging2.07Pathogenic0.10Tolerated0.14850.350030-0.3-9.01
c.979C>A
L327M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L327M missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, AlphaMissense‑Optimized, and Foldetta, whereas those that predict a pathogenic outcome are SGM‑Consensus, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta predicting a benign effect. Overall, the majority of tools indicate a pathogenic effect, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-10.320Likely Pathogenic0.727Likely PathogenicLikely Benign0.20Likely Benign0.00.72Ambiguous0.46Likely Benign1.07Destabilizing0.320Likely Benign-1.61Neutral1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.01Affected0.08060.380742-1.918.03
c.97C>A
Q33K
2D
AIThe SynGAP1 missense variant Q33K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.436712Uncertain0.3420.8600.375-0.317Likely Benign0.217Likely BenignLikely Benign0.026Likely Benign-0.53Neutral0.019Benign0.021Benign4.24Benign0.00Affected0.23660.451411-0.40.04
c.97C>G
Q33E
2D
AIThe SynGAP1 missense variant Q33E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign status: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.436712Uncertain0.3420.8600.3750.191Likely Benign0.110Likely BenignLikely Benign0.024Likely Benign-0.13Neutral0.017Benign0.014Benign4.25Benign0.00Affected0.17730.3326220.00.98
c.980T>A
L327Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic or likely pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. With all available evidence pointing to a harmful impact and no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-14.243Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.03Destabilizing0.12.17Destabilizing2.60Destabilizing2.11Destabilizing0.605Likely Pathogenic-5.26Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.00Affected0.11310.1042-2-2-7.314.97
c.980T>C
L327P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327P (ClinVar ID 660421) is classified as Pathogenic in ClinVar and is not reported in gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, leaving no tools in the benign category. High‑accuracy assessments further support this: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is Pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000Pathogenic/Likely path. 4-16.602Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.38Destabilizing0.14.00Destabilizing4.69Destabilizing2.62Destabilizing0.658Likely Pathogenic-5.97Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.01Affected3.38230.39210.1703-3-3-5.4-16.04221.769.40.10.00.60.1XPotentially PathogenicThe backbone amide group of Leu327, located in the middle of an anti-parallel β sheet strand (res. Ala322-Asp330), forms a hydrogen bond with the carbonyl group of Gly344 on a neighboring β strand (res. Lys336-Pro349) in the WT simulations. In contrast, in the variant simulations, the introduction of Pro327 destabilizes the hydrogen bonding between the two anti-parallel β strands because proline lacks the backbone amide group altogether. Additionally, in the WT simulations, the iso-butyl side chain of Leu327 packs against multiple hydrophobic residues (e.g., Leu274, V400, Val343), whereas the less bulky cyclic five-membered pyrrolidine ring of Pro327 cannot fill the same space as effectively. Thus, although no large-scale unfolding is observed during the variant simulations, the residue swap is likely to cause severe problems for the correct C2 domain folding, which could also affect the SynGAP-membrane association.10.1016/j.ajhg.2020.11.011
c.980T>G
L327R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a destabilizing, pathogenic effect. All available predictions are concordant and indicate a likely pathogenic impact. Thus, based on the current computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-13.403Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.46Destabilizing0.34.75Destabilizing4.61Destabilizing1.95Destabilizing0.619Likely Pathogenic-5.28Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.00Affected0.12810.1085-3-2-8.343.03
c.982T>A
Y328N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-13.778Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.72Destabilizing0.13.88Destabilizing3.30Destabilizing2.06Destabilizing0.548Likely Pathogenic-8.07Deleterious1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.01Affected0.23740.0703-2-2-2.2-49.07
c.982T>C
Y328H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-10.885Likely Pathogenic0.983Likely PathogenicLikely Pathogenic2.08Destabilizing0.02.43Destabilizing2.26Destabilizing1.35Destabilizing0.516Likely Pathogenic-4.53Deleterious1.000Probably Damaging0.999Probably Damaging1.54Pathogenic0.02Affected0.25720.070302-1.9-26.03
c.982T>G
Y328D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328D is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, every tool examined (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) classifies the substitution as pathogenic; no tool predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-13.701Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.32Destabilizing0.24.97Destabilizing4.65Destabilizing1.87Destabilizing0.680Likely Pathogenic-8.93Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.01Affected0.42330.0703-4-3-2.2-48.09
c.983A>C
Y328S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328S is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic impact on protein stability. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-12.358Likely Pathogenic0.984Likely PathogenicLikely Pathogenic3.13Destabilizing0.14.55Destabilizing3.84Destabilizing1.80Destabilizing0.586Likely Pathogenic-8.01Deleterious1.000Probably Damaging0.998Probably Damaging1.54Pathogenic0.01Affected0.49240.2449-3-20.5-76.10
c.983A>G
Y328C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the substitution as pathogenic. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely pathogenic verdict, and Foldetta (integrating FoldX‑MD and Rosetta outputs) also reports a pathogenic outcome. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.411940Structured0.392519Uncertain0.9160.4970.000-12.385Likely Pathogenic0.975Likely PathogenicLikely Pathogenic2.52Destabilizing0.13.74Destabilizing3.13Destabilizing1.40Destabilizing0.523Likely Pathogenic-8.01Deleterious1.000Probably Damaging0.999Probably Damaging1.55Pathogenic0.01Affected0.31540.28820-23.8-60.04
c.983A>T
Y328F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y328F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.411940Structured0.392519Uncertain0.9160.4970.000-6.770Likely Benign0.444AmbiguousLikely Benign0.34Likely Benign0.10.43Likely Benign0.39Likely Benign0.37Likely Benign0.330Likely Benign-3.21Deleterious0.999Probably Damaging0.992Probably Damaging1.67Pathogenic0.16Tolerated0.24090.3643734.1-16.00
c.985C>A
R329S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R329S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Stability‑based methods (FoldX, Rosetta, Foldetta, premPS) yield uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as Uncertain. Overall, the majority of available predictions support a pathogenic impact. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250-10.731Likely Pathogenic0.984Likely PathogenicLikely Pathogenic1.80Ambiguous0.30.78Ambiguous1.29Ambiguous0.78Ambiguous0.192Likely Benign-3.36Deleterious0.653Possibly Damaging0.226Benign4.07Benign0.04Affected0.28860.36250-13.7-69.11
c.985C>G
R329G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 R329G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, while pathogenic calls are made by FoldX, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments give an overall pathogenic signal: AlphaMissense‑Optimized is inconclusive, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta is inconclusive. Taken together, the majority of evidence points to a pathogenic effect, and this conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250-12.426Likely Pathogenic0.927Likely PathogenicAmbiguous2.21Destabilizing0.31.58Ambiguous1.90Ambiguous0.92Ambiguous0.204Likely Benign-4.78Deleterious0.653Possibly Damaging0.293Benign4.03Benign0.04Affected0.31470.3037-3-24.1-99.14
c.986G>C
R329P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R329P is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of algorithms predict a pathogenic outcome: FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score is “Likely Pathogenic,” and premPS is uncertain. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenicity. Overall, the evidence overwhelmingly points to a pathogenic effect for R329P, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250-14.528Likely Pathogenic0.965Likely PathogenicLikely Pathogenic3.06Destabilizing0.24.99Destabilizing4.03Destabilizing0.73Ambiguous0.350Likely Benign-4.28Deleterious0.902Possibly Damaging0.544Possibly Damaging4.00Benign0.01Affected0.22150.40990-22.9-59.07
c.986G>T
R329L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R329L has no ClinVar entry and is not reported in gnomAD. Consensus from standard prediction tools shows a split: benign calls come from REVEL, FoldX, FATHMM, and polyPhen‑2 HumVar, while pathogenic calls arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. Predictions marked uncertain (Rosetta, premPS, AlphaMissense‑Optimized) are treated as unavailable. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the majority of tools lean toward pathogenicity, but the folding‑stability evidence suggests a benign effect. Given the lack of ClinVar annotation, there is no contradiction. The variant is most likely pathogenic based on the preponderance of pathogenic predictions, though the benign folding‑stability result introduces uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.384043Structured0.376086Uncertain0.8870.4790.250-10.186Likely Pathogenic0.907Likely PathogenicAmbiguous-0.09Likely Benign0.40.53Ambiguous0.22Likely Benign0.54Ambiguous0.219Likely Benign-4.81Deleterious0.653Possibly Damaging0.361Benign4.02Benign0.01Affected0.18270.4121-3-28.3-43.03
c.988G>A
D330N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330N missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious interpretation: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic,” while AlphaMissense‑Optimized and Foldetta yield uncertain results and are treated as unavailable. No folding‑stability methods (FoldX, Rosetta, premPS) provide decisive evidence. Overall, the preponderance of pathogenic predictions strongly suggests that D330N is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-12.993Likely Pathogenic0.909Likely PathogenicAmbiguous1.61Ambiguous0.20.59Ambiguous1.10Ambiguous0.59Ambiguous0.350Likely Benign-3.46Deleterious0.980Probably Damaging0.721Possibly Damaging1.01Pathogenic0.02Affected0.12520.4263210.0-0.98
c.988G>C
D330H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330H missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into three groups: benign predictions are limited to REVEL; pathogenic predictions include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, FoldX, and the SGM‑Consensus (Likely Pathogenic). Uncertain or inconclusive results come from Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus also indicates likely pathogenic, while Foldetta’s stability analysis is inconclusive. Taken together, the overwhelming majority of evidence points to a pathogenic impact for D330H. This conclusion is not contradicted by any ClinVar annotation, as the variant is currently unreported in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-13.926Likely Pathogenic0.980Likely PathogenicLikely Pathogenic2.29Destabilizing0.61.32Ambiguous1.81Ambiguous0.61Ambiguous0.425Likely Benign-4.67Deleterious0.998Probably Damaging0.961Probably Damaging0.96Pathogenic0.01Affected0.16080.48431-10.322.05
c.988G>T
D330Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D330Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and premPS, whereas the remaining tools—including SGM‑Consensus, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; FoldX is uncertain and therefore not counted. High‑accuracy methods all support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta is pathogenic. Taken together, the overwhelming majority of evidence indicates that D330Y is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-14.200Likely Pathogenic0.956Likely PathogenicLikely Pathogenic1.98Ambiguous0.62.90Destabilizing2.44Destabilizing0.35Likely Benign0.472Likely Benign-6.47Deleterious0.998Probably Damaging0.948Probably Damaging0.89Pathogenic0.00Affected0.05390.4689-4-32.248.09
c.989A>C
D330A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL and SIFT, while a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Tools with uncertain or inconclusive results—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—do not provide definitive evidence. High‑accuracy methods give the following: SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; AlphaMissense‑Optimized is uncertain; Foldetta is also uncertain. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect for D330A. This conclusion is not contradicted by ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-14.051Likely Pathogenic0.929Likely PathogenicAmbiguous1.75Ambiguous0.31.06Ambiguous1.41Ambiguous0.60Ambiguous0.399Likely Benign-5.49Deleterious0.961Probably Damaging0.655Possibly Damaging0.93Pathogenic0.11Tolerated0.40870.44760-25.3-44.01
c.989A>G
D330G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D330G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, whereas the majority of algorithms predict a pathogenic impact: FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two predictors (AlphaMissense‑Optimized and premPS) give uncertain results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, classifies the variant as pathogenic. Overall, the preponderance of evidence indicates that D330G is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-13.064Likely Pathogenic0.950Likely PathogenicAmbiguous2.69Destabilizing0.22.17Destabilizing2.43Destabilizing0.63Ambiguous0.373Likely Benign-5.03Deleterious0.980Probably Damaging0.782Possibly Damaging0.94Pathogenic0.01Affected0.39350.50151-13.1-58.04
c.989A>T
D330V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D330V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and premPS, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, and AlphaMissense‑Default. Uncertain predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are treated as unavailable. High‑accuracy assessments show that the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. AlphaMissense‑Optimized and Foldetta provide inconclusive results and are therefore not considered evidence. Overall, the preponderance of evidence points to a pathogenic effect for D330V, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-13.176Likely Pathogenic0.950Likely PathogenicAmbiguous2.06Destabilizing0.50.57Ambiguous1.32Ambiguous0.45Likely Benign0.428Likely Benign-6.40Deleterious0.994Probably Damaging0.892Possibly Damaging0.89Pathogenic0.01Affected0.08620.4633-2-37.7-15.96
c.98A>C
Q33P
2D
AIThe SynGAP1 missense variant Q33P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta results are not available for this variant. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.436712Uncertain0.3420.8600.3750.546Likely Benign0.049Likely BenignLikely Benign0.098Likely Benign-0.75Neutral0.000Benign0.000Benign4.21Benign0.00Affected0.24450.56230-11.9-31.01
c.98A>G
Q33R
2D
AIThe SynGAP1 missense variant Q33R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Benign, and AlphaMissense‑Optimized also reports a benign prediction. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect. The predictions do not contradict ClinVar status, as ClinVar contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.436712Uncertain0.3420.8600.3750.561Likely Benign0.171Likely BenignLikely Benign0.035Likely Benign-0.82Neutral0.084Benign0.046Benign4.20Benign0.00Affected0.19360.277311-1.028.06
c.98A>T
Q33L
2D
AIThe SynGAP1 missense variant Q33L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.436712Uncertain0.3420.8600.3750.253Likely Benign0.174Likely BenignLikely Benign0.075Likely Benign-1.24Neutral0.084Benign0.033Benign4.18Benign0.00Affected0.11270.6214-2-27.3-14.97
c.990C>A
D330E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are Rosetta and FATHMM. The remaining tools—FoldX, AlphaMissense‑Default, and Foldetta—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.380708Structured0.360008Uncertain0.8050.4880.250-3.427Likely Benign0.407AmbiguousLikely Benign0.98Ambiguous0.22.31Destabilizing1.65Ambiguous0.39Likely Benign0.073Likely Benign-1.38Neutral0.122Benign0.030Benign0.97Pathogenic0.67Tolerated0.14640.4416320.014.03
c.990C>G
D330E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are Rosetta and FATHMM. The remaining tools—FoldX, AlphaMissense‑Default, and Foldetta—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.380708Structured0.360008Uncertain0.8050.4880.250-3.427Likely Benign0.407AmbiguousLikely Benign0.98Ambiguous0.22.31Destabilizing1.65Ambiguous0.39Likely Benign0.075Likely Benign-1.38Neutral0.122Benign0.030Benign0.97Pathogenic0.67Tolerated0.14640.4416320.014.03
c.991T>A
S331T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S331T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX and premPS are inconclusive (Uncertain). High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Taken together, the majority of evidence indicates that S331T is most likely benign, and this conclusion does not contradict the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.433034Structured0.346458Uncertain0.6580.4750.250-2.474Likely Benign0.071Likely BenignLikely Benign0.60Ambiguous0.2-0.10Likely Benign0.25Likely Benign-0.72Ambiguous0.095Likely Benign1.13Neutral0.003Benign0.002Benign1.86Pathogenic0.98Tolerated0.15050.4552110.114.03
c.991T>C
S331P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S331P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, ESM1b, polyPhen‑2 HumVar, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are Rosetta, polyPhen‑2 HumDiv, and FATHMM. Two tools give inconclusive results: AlphaMissense‑Default and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and gnomAD presence, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.433034Structured0.346458Uncertain0.6580.4750.250-5.104Likely Benign0.409AmbiguousLikely Benign0.33Likely Benign0.22.35Destabilizing1.34Ambiguous0.44Likely Benign0.186Likely Benign-1.81Neutral0.784Possibly Damaging0.390Benign1.83Pathogenic0.26Tolerated0.23060.40861-1-0.810.04
c.991T>G
S331A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S331A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only FATHMM predicts pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a benign majority vote (3 benign vs. 1 pathogenic). High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote) is benign; and Foldetta, combining FoldX‑MD and Rosetta outputs, is benign. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.433034Structured0.346458Uncertain0.6580.4750.250-2.199Likely Benign0.101Likely BenignLikely Benign0.22Likely Benign0.1-0.08Likely Benign0.07Likely Benign-0.15Likely Benign0.071Likely Benign-0.44Neutral0.139Benign0.060Benign1.89Pathogenic0.67Tolerated0.53140.3008Weaken112.6-16.00
c.992C>T
S331L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S331L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign or likely benign. Only FATHMM predicts pathogenicity, while FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the consensus of the majority of tools supports a benign classification, and this is consistent with the lack of ClinVar evidence; there is no contradiction with ClinVar status. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.433034Structured0.346458Uncertain0.6580.4750.250-6.570Likely Benign0.219Likely BenignLikely Benign0.54Ambiguous0.01.06Ambiguous0.80Ambiguous0.07Likely Benign0.090Likely Benign-1.72Neutral0.270Benign0.136Benign1.87Pathogenic0.58Tolerated0.09530.4124-3-24.626.08
c.994G>A
D332N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D332N is not reported in ClinVar and is absent from gnomAD. Benign predictions come from REVEL, Rosetta, premPS, and SIFT, while pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default; SGM‑Consensus indicates a likely pathogenic outcome. FoldX and Foldetta give uncertain results. High‑accuracy tools show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as uncertain. Overall, the majority of conventional predictors lean toward pathogenicity, but the high‑accuracy AlphaMissense‑Optimized result is benign and Foldetta is inconclusive. Thus, the variant is most likely pathogenic based on the collective evidence, and this assessment does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-10.931Likely Pathogenic0.771Likely PathogenicLikely Benign1.20Ambiguous0.1-0.16Likely Benign0.52Ambiguous0.49Likely Benign0.396Likely Benign-4.14Deleterious0.999Probably Damaging0.997Probably Damaging1.32Pathogenic0.11Tolerated0.07850.3963210.0-0.98
c.994G>C
D332H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D332H has no ClinVar entry and is absent from gnomAD. Functional prediction tools that agree on a benign effect are Rosetta and premPS, whereas the majority of predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—classify the change as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Taken together, the preponderance of evidence indicates that D332H is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-13.255Likely Pathogenic0.973Likely PathogenicLikely Pathogenic1.50Ambiguous0.4-0.28Likely Benign0.61Ambiguous0.22Likely Benign0.505Likely Pathogenic-5.63Deleterious1.000Probably Damaging0.999Probably Damaging1.23Pathogenic0.01Affected0.10050.45421-10.322.05
c.994G>T
D332Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D332Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and premPS, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus confirms a likely pathogenic status, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yields an uncertain result. Overall, the majority of evidence points to a pathogenic impact for D332Y, and this conclusion does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-14.210Likely Pathogenic0.966Likely PathogenicLikely Pathogenic1.15Ambiguous0.6-0.07Likely Benign0.54Ambiguous0.41Likely Benign0.485Likely Benign-7.33Deleterious1.000Probably Damaging0.999Probably Damaging1.20Pathogenic0.00Affected0.03720.4018-4-32.248.09
c.995A>C
D332A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and Rosetta, while the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain or inconclusive results come from FoldX, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-12.290Likely Pathogenic0.876Likely PathogenicAmbiguous1.19Ambiguous0.20.32Likely Benign0.76Ambiguous0.54Ambiguous0.458Likely Benign-6.45Deleterious1.000Probably Damaging0.998Probably Damaging1.24Pathogenic0.02Affected0.29980.41760-25.3-44.01
c.995A>G
D332G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332G missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. Predictions that are inconclusive or uncertain are given by FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for D332G, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-10.844Likely Pathogenic0.860Likely PathogenicAmbiguous1.78Ambiguous0.30.69Ambiguous1.24Ambiguous0.63Ambiguous0.539Likely Pathogenic-5.98Deleterious0.999Probably Damaging0.997Probably Damaging1.31Pathogenic0.07Tolerated0.30520.47651-13.1-58.04
c.995A>T
D332V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, and premPS, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain results come from FoldX, Rosetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the balance of evidence favors a pathogenic classification; this conclusion does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-13.710Likely Pathogenic0.933Likely PathogenicAmbiguous1.39Ambiguous0.1-0.52Ambiguous0.44Likely Benign0.50Likely Benign0.484Likely Benign-7.27Deleterious1.000Probably Damaging0.999Probably Damaging1.21Pathogenic0.03Affected0.05730.4132-2-37.7-15.96
c.996C>A
D332E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332E missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split. Overall, the majority of evidence points to a benign effect. This conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.339168Structured0.336528Uncertain0.5370.4450.375-4.915Likely Benign0.320Likely BenignLikely Benign0.50Ambiguous0.20.04Likely Benign0.27Likely Benign0.35Likely Benign0.191Likely Benign-2.66Deleterious0.997Probably Damaging0.994Probably Damaging1.29Pathogenic0.24Tolerated0.09700.3915320.014.03
c.996C>G
D332E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign classification. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.339168Structured0.336528Uncertain0.5370.4450.375-4.915Likely Benign0.320Likely BenignLikely Benign0.50Ambiguous0.20.04Likely Benign0.27Likely Benign0.35Likely Benign0.188Likely Benign-2.66Deleterious0.997Probably Damaging0.994Probably Damaging1.29Pathogenic0.24Tolerated0.09700.3915320.014.03
c.997A>C
K333Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K333Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and SIFT, while those that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Tools with inconclusive results are AlphaMissense‑Optimized, Foldetta, premPS, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign (combining FoldX‑MD and Rosetta outputs). Overall, the majority of evidence points toward a pathogenic classification, which does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-11.647Likely Pathogenic0.866Likely PathogenicAmbiguous0.00Likely Benign0.10.51Ambiguous0.26Likely Benign0.76Ambiguous0.444Likely Benign-3.11Deleterious1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.08Tolerated0.40150.1219110.4-0.04
c.997A>G
K333E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K333E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and SIFT. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a pathogenic impact for K333E. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-14.059Likely Pathogenic0.991Likely PathogenicLikely Pathogenic-0.06Likely Benign0.20.30Likely Benign0.12Likely Benign0.89Ambiguous0.488Likely Benign-3.21Deleterious0.999Probably Damaging0.995Probably Damaging1.91Pathogenic0.09Tolerated0.34290.1039010.40.94
c.998A>C
K333T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K333T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include Rosetta, Foldetta, premPS, and SIFT, whereas a larger set—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score—predict a pathogenic impact. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) reports a benign effect. Overall, the majority of evidence points to a pathogenic effect for K333T, and this conclusion does not conflict with any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-11.358Likely Pathogenic0.949Likely PathogenicAmbiguous0.51Ambiguous0.0-0.15Likely Benign0.18Likely Benign0.46Likely Benign0.506Likely Pathogenic-4.82Deleterious1.000Probably Damaging0.998Probably Damaging1.96Pathogenic0.08Tolerated0.18390.33540-13.2-27.07
c.998A>G
K333R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K333R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Consensus predictions from multiple in‑silico tools cluster into two groups: benign (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus “Likely Benign”) and pathogenic (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign stability. No prediction or folding result is missing or inconclusive. Overall, the majority of evidence points to a benign effect for K333R, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.311707Structured0.330781Uncertain0.5370.4470.500-4.897Likely Benign0.120Likely BenignLikely Benign-0.23Likely Benign0.00.15Likely Benign-0.04Likely Benign0.33Likely Benign0.232Likely Benign-2.02Neutral0.999Probably Damaging0.995Probably Damaging2.01Pathogenic0.14Tolerated0.42940.113432-0.628.01
c.998A>T
K333I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K333I missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX and premPS, whereas the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; Rosetta and Foldetta give uncertain results. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-14.517Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.30Likely Benign0.00.95Ambiguous0.63Ambiguous0.43Likely Benign0.544Likely Pathogenic-6.49Deleterious1.000Probably Damaging0.999Probably Damaging1.89Pathogenic0.03Affected0.09310.3521-2-38.4-15.01
c.999A>C
K333N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K333N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign predictions come from REVEL, FoldX, Rosetta, and SIFT, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The high‑accuracy subset yields contrasting results: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus also indicates Likely Pathogenic, while Foldetta (combining FoldX‑MD and Rosetta stability outputs) predicts benign. premPS is inconclusive. Overall, the majority of tools lean toward pathogenicity, and the high‑accuracy predictions are not uniformly supportive of benign status. Therefore, K333N is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-11.821Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.30Likely Benign0.10.42Likely Benign0.36Likely Benign0.55Ambiguous0.359Likely Benign-4.03Deleterious1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.13Tolerated0.32670.1315100.4-14.07
c.999A>T
K333N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K333N has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and SIFT, whereas a larger group predicts pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The high‑accuracy methods give mixed results: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, whereas Foldetta (combining FoldX‑MD and Rosetta outputs) reports a benign stability change. premPS is inconclusive and is treated as unavailable. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-11.821Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.30Likely Benign0.10.42Likely Benign0.36Likely Benign0.55Ambiguous0.366Likely Benign-4.03Deleterious1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.13Tolerated0.32670.1315100.4-14.07
c.99A>C
Q33H
2D
AIThe SynGAP1 missense variant Q33H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign impact for the variant, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.436712Uncertain0.3420.8600.375-0.450Likely Benign0.133Likely BenignLikely Benign0.054Likely Benign-0.95Neutral0.704Possibly Damaging0.198Benign4.16Benign0.00Affected0.18560.4509300.39.01
c.99A>T
Q33H
2D
AIThe SynGAP1 missense variant Q33H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign impact for the variant, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.707965Disordered0.436712Uncertain0.3420.8600.375-0.450Likely Benign0.133Likely BenignLikely Benign0.054Likely Benign-0.95Neutral0.704Possibly Damaging0.198Benign4.16Benign0.00Affected0.18560.4509300.39.01
c.9G>C
R3S
2D
AIThe SynGAP1 missense variant R3S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta results are not available for this variant. Overall, the majority of evidence points to a benign effect. The prediction is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.538167Disordered0.550331Binding0.3580.9200.875-2.296Likely Benign0.310Likely BenignLikely Benign0.111Likely Benign-0.53Neutral0.115Benign0.013Benign4.02Benign0.00Affected4.3210.31480.4732-103.7-69.11
c.1003C>T
R335C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R335C is listed in ClinVar with an uncertain significance (ClinVar ID 2835865.0) and is present in gnomAD (ID 6‑33437908‑C‑T). Functional prediction tools cluster into two groups: benign predictions come from REVEL and premPS, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive are AlphaMissense‑Optimized, FoldX, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from the unanimous pathogenic vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect. This conclusion aligns with the ClinVar designation of uncertain significance, which does not contradict the prediction that the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.331028Uncertain0.4830.4280.500Uncertain 16-33437908-C-T16.20e-7-14.354Likely Pathogenic0.938Likely PathogenicAmbiguous0.53Ambiguous0.10.85Ambiguous0.69Ambiguous0.46Likely Benign0.277Likely Benign-5.69Deleterious1.000Probably Damaging0.998Probably Damaging1.67Pathogenic0.01Affected3.38220.28820.3290-3-47.0-53.05
c.1007A>G
K336R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K336R is not reported in ClinVar (ClinVar status: not listed) but is present in the gnomAD database (gnomAD ID: 6‑33437912‑A‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tool predicting a pathogenic outcome is FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, the SGM‑Consensus is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. No predictions or folding‑stability results are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.318242Structured0.338219Uncertain0.3960.4280.5006-33437912-A-G16.20e-7-5.897Likely Benign0.089Likely BenignLikely Benign0.00Likely Benign0.0-0.15Likely Benign-0.08Likely Benign0.52Ambiguous0.038Likely Benign-2.01Neutral0.002Benign0.005Benign1.69Pathogenic0.12Tolerated3.38220.48990.124023-0.628.01
c.1018G>T
A340S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A340S is reported in gnomAD (variant ID 6‑33437923‑G‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while only FATHMM predicts pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a benign majority (3 benign vs. 1 pathogenic). High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign; the SGM‑Consensus is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.390993Structured0.410781Uncertain0.5580.4850.2506-33437923-G-T16.20e-7-0.705Likely Benign0.083Likely BenignLikely Benign0.15Likely Benign0.00.27Likely Benign0.21Likely Benign-0.46Likely Benign0.083Likely Benign1.62Neutral0.007Benign0.008Benign1.93Pathogenic0.51Tolerated3.42130.28520.630911-2.616.00
c.1024T>C
Y342H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342H is reported in gnomAD (ID 6‑33437929‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. Five tools predict pathogenicity versus three predicting benign, with the remaining five (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yielding uncertain or inconclusive results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the preponderance of evidence indicates that Y342H is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.2506-33437929-T-C16.20e-7-6.459Likely Benign0.944Likely PathogenicAmbiguous1.63Ambiguous0.11.33Ambiguous1.48Ambiguous0.73Ambiguous0.453Likely Benign-3.61Deleterious1.000Probably Damaging0.999Probably Damaging1.72Pathogenic0.06Tolerated3.37250.24910.086220-1.9-26.03
c.1027G>A
V343I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343I is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33437932‑G‑A). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to “Likely Benign” (3 benign vs. 1 pathogenic). High‑accuracy assessments are consistent: AlphaMissense‑Optimized is benign; the SGM‑Consensus is likely benign; and Foldetta, combining FoldX‑MD and Rosetta outputs, is benign. Overall, the collective evidence strongly supports a benign classification, and this does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.291804Structured0.383911Uncertain0.8820.4970.250Uncertain 26-33437932-G-A16.20e-7-6.020Likely Benign0.117Likely BenignLikely Benign-0.27Likely Benign0.0-0.04Likely Benign-0.16Likely Benign-0.39Likely Benign0.020Likely Benign-0.14Neutral0.159Benign0.084Benign1.98Pathogenic0.27Tolerated3.37250.10950.4536430.314.03240.2-26.9-0.20.2-0.20.2XPotentially BenignThe iso-propyl side chain of Val343, located in an anti-parallel β sheet strand (res. Gly341-Pro349), is packing against multiple hydrophobic residues of the C2 domain (e.g., Leu327, Leu274, Val365). In the variant simulations, the sec-butyl side chain of Ile343 is basically able to form the same interactions as valine due to its similar hydrophobic profile. The residue swap also does not seem to cause negative effects on the protein structure based on the simulations.
c.1037T>C
V346A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V346A is reported in gnomAD (6‑33437942‑T‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect are limited to REVEL, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) uniformly predict a pathogenic impact; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.350921Uncertain0.9490.4610.0006-33437942-T-C16.20e-7-8.556Likely Pathogenic0.856Likely PathogenicAmbiguous2.72Destabilizing0.22.73Destabilizing2.73Destabilizing1.92Destabilizing0.477Likely Benign-3.68Deleterious0.994Probably Damaging0.970Probably Damaging1.70Pathogenic0.01Affected3.37250.33410.296700-2.4-28.05
c.1061C>T
A354V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A354V is not reported in ClinVar and is present in the gnomAD database (variant ID 6‑33437966‑C‑T). Functional prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM. The high‑accuracy consensus methods support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign outcome. Predictions from FoldX and Rosetta are inconclusive and are treated as unavailable. Overall, the majority of evidence indicates that A354V is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.381329Uncertain0.8820.3350.1256-33437966-C-T16.26e-7-6.223Likely Benign0.122Likely BenignLikely Benign0.65Ambiguous0.1-1.02Ambiguous-0.19Likely Benign0.18Likely Benign0.027Likely Benign-1.11Neutral0.146Benign0.038Benign1.81Pathogenic0.05Affected3.38240.14290.6388002.428.05
c.1069C>T
H357Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H357Y is reported in gnomAD (variant ID 6‑33437974‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while only polyPhen‑2 HumDiv indicates pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as likely benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.203355Structured0.399052Uncertain0.8610.4130.2506-33437974-C-T16.21e-7-5.888Likely Benign0.168Likely BenignLikely Benign-0.33Likely Benign0.20.08Likely Benign-0.13Likely Benign-0.07Likely Benign0.140Likely Benign-1.71Neutral0.936Possibly Damaging0.388Benign4.19Benign0.14Tolerated3.39220.10100.4658201.926.03
c.1076C>T
T359I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T359I is reported in gnomAD (variant ID 6‑33437981‑C‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. Uncertain results are reported for FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign effect. There is no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.2506-33437981-C-T16.22e-7-2.594Likely Benign0.181Likely BenignLikely Benign-0.66Ambiguous0.1-0.64Ambiguous-0.65Ambiguous-0.63Ambiguous0.085Likely Benign0.77Neutral0.070Benign0.006Benign1.80Pathogenic0.23Tolerated3.38240.11230.5921-105.212.05
c.1088A>G
Y363C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y363C is not reported in ClinVar (ClinVar ID: None) but is present in gnomAD (ID 6‑33437993‑A‑G). Prediction tools cluster into two groups: benign predictions come from REVEL and AlphaMissense‑Optimized, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—indicate pathogenicity. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. With the majority of evidence pointing to deleterious effects and no ClinVar annotation to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.435392Uncertain0.9540.5860.1256-33437993-A-G17.13e-7-9.059Likely Pathogenic0.721Likely PathogenicLikely Benign2.21Destabilizing0.13.96Destabilizing3.09Destabilizing2.05Destabilizing0.414Likely Benign-8.07Deleterious1.000Probably Damaging0.996Probably Damaging1.54Pathogenic0.00Affected3.39240.37590.3463-203.8-60.04
c.1090C>T
P364S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P364S resides in the C2 domain. It is not reported in ClinVar and is present in gnomAD (ID 6‑33437995‑C‑T). Prediction tools that classify the variant as benign include REVEL, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM; the SGM‑Consensus score is also labeled Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. No prediction or stability result is missing or inconclusive beyond the Uncertain labels. Based on the majority of evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.390993Structured0.439474Uncertain0.9420.5900.2506-33437995-C-T16.20e-7-8.318Likely Pathogenic0.214Likely BenignLikely Benign1.34Ambiguous0.30.68Ambiguous1.01Ambiguous0.83Ambiguous0.307Likely Benign-5.98Deleterious1.000Probably Damaging0.996Probably Damaging1.62Pathogenic0.05Affected3.39200.33900.5512-110.8-10.04
c.1097C>T
T366I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T366I is reported in gnomAD (6‑33438002‑C‑T) and has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. No other tools provide conclusive evidence for pathogenicity. **Based on the aggregate predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none available).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.414856Structured0.441902Uncertain0.8970.6420.2506-33438002-C-T16.20e-7-4.921Likely Benign0.279Likely BenignLikely Benign-0.62Ambiguous0.1-0.31Likely Benign-0.47Likely Benign-0.14Likely Benign0.058Likely Benign-1.22Neutral0.002Benign0.001Benign1.77Pathogenic0.26Tolerated3.38230.10620.6215-105.212.05
c.1103C>T
P368L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P368L is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438008‑C‑T). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Predictions that are uncertain or inconclusive are FoldX, Rosetta, premPS, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments give AlphaMissense‑Optimized a benign score, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is uncertain. Based on the overall distribution of predictions, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.363090Structured0.439989Uncertain0.5800.6770.2506-33438008-C-T16.33e-7-6.520Likely Benign0.444AmbiguousLikely Benign1.52Ambiguous0.71.15Ambiguous1.34Ambiguous0.52Ambiguous0.248Likely Benign-6.61Deleterious0.991Probably Damaging0.831Possibly Damaging1.77Pathogenic0.00Affected3.42190.23360.7125-3-35.416.04
c.110C>A
S37Y
2D
AIThe SynGAP1 missense variant S37Y is listed in gnomAD (ID 6‑33423519‑C‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default is uncertain, and Foldetta (FoldX‑MD/Rosetta stability assessment) has no available result. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta data is missing. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the absence of a ClinVar pathogenic classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.642678Disordered0.433492Uncertain0.3170.8060.5006-33423519-C-A16.20e-7-4.447Likely Benign0.370AmbiguousLikely Benign0.132Likely Benign-1.61Neutral0.880Possibly Damaging0.888Possibly Damaging3.90Benign0.00Affected4.3210.12470.5256-2-3-0.576.10
c.1113T>G
S371R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S371R is reported in gnomAD (variant ID 6‑33438018‑T‑G) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only AlphaMissense‑Default predicts a pathogenic outcome. The SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves as “Likely Benign” (3 benign vs. 1 pathogenic). High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM‑Consensus is benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. No prediction or stability result is missing or inconclusive. Overall, the evidence strongly favors a benign classification, and this is consistent with the absence of a ClinVar pathogenic report.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.444081Structured0.432086Uncertain0.2940.7460.3756-33438018-T-G11.18e-6-6.415Likely Benign0.762Likely PathogenicLikely Benign0.51Ambiguous1.2-0.25Likely Benign0.13Likely Benign0.57Ambiguous0.340Likely Benign-1.17Neutral0.396Benign0.099Benign5.35Benign0.26Tolerated3.52180.13620.4131-10-3.769.11
c.1117G>A
G373R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G373R is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438022‑G‑A). Prediction tools that classify the variant as benign include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Optimized, and premPS. Those that predict pathogenicity are REVEL, FoldX, Foldetta, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as pathogenic. No prediction or folding result is missing or inconclusive. Overall, the majority of tools (six versus five) and the consensus of high‑accuracy methods lean toward a benign effect. This conclusion does not contradict ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.529623Disordered0.429267Uncertain0.2950.7990.6256-33438022-G-A16.28e-7-7.878In-Between0.653Likely PathogenicLikely Benign4.28Destabilizing3.50.14Likely Benign2.21Destabilizing0.21Likely Benign0.510Likely Pathogenic-0.64Neutral0.001Benign0.000Benign3.90Benign0.01Affected3.53160.10890.4524-2-3-4.199.14
c.1120T>C
S374P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S374P is reported in gnomAD (6‑33438025‑T‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and Rosetta; FoldX and Foldetta are inconclusive. The high‑accuracy consensus (SGM‑Consensus) is “Likely Benign,” derived from the unanimous benign calls of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN. AlphaMissense‑Optimized also predicts benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact. There is no ClinVar status to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.642678Disordered0.428948Uncertain0.3330.8120.6256-33438025-T-C17.85e-7-4.849Likely Benign0.125Likely BenignLikely Benign0.66Ambiguous0.62.22Destabilizing1.44Ambiguous0.34Likely Benign0.388Likely Benign-0.89Neutral0.396Benign0.099Benign5.30Benign0.02Affected4.32130.30120.6813-11-0.810.04
c.1126G>A
G376S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G376S is reported in gnomAD (ID 6‑33438031‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Pathogenic predictions arise from FoldX, polyPhen‑2 (HumDiv and HumVar), and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates benign, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, is uncertain. Overall, the majority of evidence points to a benign effect; this conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.680603Disordered0.428979Uncertain0.3260.8690.6256-33438031-G-A16.21e-7-4.913Likely Benign0.087Likely BenignLikely Benign2.30Destabilizing0.5-0.45Likely Benign0.93Ambiguous0.32Likely Benign0.471Likely Benign-0.73Neutral1.000Probably Damaging0.998Probably Damaging1.33Pathogenic0.22Tolerated4.32120.28310.480101-0.430.03
c.1129A>C
M377L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M377L is catalogued in gnomAD (ID 6‑33438034‑A‑C) but has no entry in ClinVar. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report benign. Only Rosetta yields an uncertain result, which is treated as unavailable. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, reports benign. No tool predicts pathogenicity. Consequently, the variant is most likely benign, and this conclusion is not contradicted by ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.675549Disordered0.431183Uncertain0.3240.8840.6256-33438034-A-C11.95e-6-2.394Likely Benign0.082Likely BenignLikely Benign0.13Likely Benign0.10.69Ambiguous0.41Likely Benign0.16Likely Benign0.175Likely Benign-0.32Neutral0.000Benign0.001Benign5.46Benign0.58Tolerated4.32120.25160.4885241.9-18.03
c.1131G>A
M377I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M377I (ClinVar ID 3803473.0, status = Uncertain) is present in gnomAD (ID = 6‑33438036‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” while Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Overall, the computational evidence strongly favors a benign classification, which does not contradict the ClinVar status of Uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.675549Disordered0.431183Uncertain0.3240.8840.625Uncertain 16-33438036-G-A16.23e-7-2.895Likely Benign0.212Likely BenignLikely Benign0.76Ambiguous0.30.54Ambiguous0.65Ambiguous0.24Likely Benign0.227Likely Benign-0.41Neutral0.000Benign0.001Benign5.46Benign0.26Tolerated4.32120.22400.4133122.6-18.03
c.1133G>A
G378D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G378D is not reported in ClinVar (ClinVar ID: None) but is present in gnomAD (ID 6‑33438038‑G‑A). Prediction tools that classify the variant as benign include premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized. Tools that predict pathogenicity are REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. ESM1b is uncertain, and no other high‑accuracy predictions are available. Overall, the majority of evidence supports a pathogenic effect, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.767246Disordered0.432858Uncertain0.3410.9150.6256-33438038-G-A16.97e-7-7.767In-Between0.576Likely PathogenicLikely Benign11.41Destabilizing5.011.84Destabilizing11.63Destabilizing0.50Likely Benign0.619Likely Pathogenic-0.63Neutral1.000Probably Damaging0.992Probably Damaging1.32Pathogenic0.08Tolerated4.32120.21300.2035-11-3.158.04
c.1133G>T
G378V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G378V is catalogued in gnomAD (ID 6‑33438038‑G‑T) but has no ClinVar submission. Functional prediction tools split in their assessment: benign calls come from premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, while pathogenic calls arise from REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign status. High‑accuracy analyses further support a benign interpretation: AlphaMissense‑Optimized predicts benign, SGM‑Consensus is likely benign, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts pathogenic. Overall, the balance of evidence, especially from the high‑accuracy tools, points to a benign effect for G378V, and this conclusion does not conflict with ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.767246Disordered0.432858Uncertain0.3410.9150.6256-33438038-G-T16.97e-7-6.837Likely Benign0.168Likely BenignLikely Benign12.88Destabilizing5.021.64Destabilizing17.26Destabilizing0.04Likely Benign0.606Likely Pathogenic-0.98Neutral1.000Probably Damaging0.994Probably Damaging1.32Pathogenic0.04Affected4.32120.16860.3708-3-14.642.08
c.1141G>T
G381W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G381W is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438046‑G‑T). Prediction tools that agree on a benign effect include premPS, PROVEAN, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments give AlphaMissense‑Optimized a benign call, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) a pathogenic call, and Foldetta (combining FoldX‑MD and Rosetta outputs) a pathogenic call. No prediction or folding result is missing or inconclusive. Overall, the majority of tools and the high‑accuracy methods indicate a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.724957Disordered0.431692Uncertain0.3010.9510.7506-33438046-G-T16.24e-7-10.173Likely Pathogenic0.438AmbiguousLikely Benign8.81Destabilizing2.03.17Destabilizing5.99Destabilizing0.02Likely Benign0.576Likely Pathogenic-1.04Neutral0.996Probably Damaging0.920Probably Damaging1.31Pathogenic0.01Affected4.3290.09930.4000-2-7-0.5129.16
c.1142G>C
G381A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G381A is reported in gnomAD (variant ID 6-33438047‑G‑C) but has no ClinVar entry. Functional prediction tools fall into two groups: benign predictions come from premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen‑2 HumVar; pathogenic predictions come from REVEL, FoldX, Rosetta, polyPhen‑2 HumDiv, FATHMM, and the SGM‑Consensus score. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, while Foldetta (combining FoldX‑MD and Rosetta stability outputs) indicates a pathogenic effect. No prediction or stability result is missing or inconclusive. Overall, the majority of tools suggest a benign effect, and the high‑accuracy consensus leans toward benign, though Foldetta’s pathogenic signal introduces uncertainty. The variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.724957Disordered0.431692Uncertain0.3010.9510.7506-33438047-G-C16.23e-7-6.266Likely Benign0.103Likely BenignLikely Benign3.97Destabilizing0.72.05Destabilizing3.01Destabilizing0.06Likely Benign0.507Likely Pathogenic-0.63Neutral0.718Possibly Damaging0.332Benign1.33Pathogenic0.52Tolerated4.3290.38090.4770012.214.03
c.1147G>T
G383W
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G383W is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33438052‑G‑T). Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as benign, and Foldetta as pathogenic. Because the majority of conventional predictors favor pathogenicity while the high‑accuracy subset is split, the overall evidence leans toward a pathogenic interpretation. This conclusion does not conflict with the ClinVar uncertain status, which reflects the current lack of definitive clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.728858Disordered0.429104Uncertain0.2960.9490.750Uncertain 16-33438052-G-T16.22e-7-10.161Likely Pathogenic0.439AmbiguousLikely Benign5.81Destabilizing3.64.44Destabilizing5.13Destabilizing0.08Likely Benign0.469Likely Benign-1.01Neutral0.959Probably Damaging0.704Possibly Damaging4.09Benign0.00Affected4.3270.09720.3785-2-7-0.5129.16
c.1150G>A
G384S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G384S (gnomAD ID 6-33438055‑G‑A) is listed in ClinVar with an uncertain significance. Functional prediction tools cluster into two groups: benign predictions from REVEL, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote) is likely benign, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No evidence from FoldX or Rosetta alone is available. Overall, the preponderance of evidence points to a benign effect, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.728858Disordered0.427831Uncertain0.3230.9340.750Uncertain 16-33438055-G-A16.22e-7-5.243Likely Benign0.090Likely BenignLikely Benign1.92Ambiguous0.21.66Ambiguous1.79Ambiguous0.19Likely Benign0.315Likely Benign-0.67Neutral0.980Probably Damaging0.968Probably Damaging1.33Pathogenic0.04Affected4.3220.29050.492410-0.430.03202.4-49.80.51.0-0.20.0UncertainGly384 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and so they are rich in glycines, prolines, and, to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Ser384 is potentially tolerated in the Ω loop, although the hydroxyl group of Ser384 forms various hydrogen bonds with several other loop residues in the variant simulations. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1159G>T
G387C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G387C is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438064‑G‑T). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, SIFT, and FATHMM; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of high‑confidence tools lean toward a benign interpretation, and this does not contradict the ClinVar status, which has no pathogenic classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.642678Disordered0.422910Uncertain0.2930.8610.7506-33438064-G-T16.21e-7-7.609In-Between0.146Likely BenignLikely Benign2.88Destabilizing0.62.34Destabilizing2.61Destabilizing-0.03Likely Benign0.430Likely Benign-0.58Neutral0.859Possibly Damaging0.346Benign1.32Pathogenic0.01Affected4.3230.15890.4240-3-32.946.09
c.1162G>A
G388S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G388S is catalogued in gnomAD (ID 6‑33438067‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that converge on a pathogenic interpretation are FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The high‑accuracy AlphaMissense‑Optimized score is benign, while the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. In contrast, the protein‑folding stability predictor Foldetta, which integrates FoldX‑MD and Rosetta outputs, indicates a pathogenic effect. No prediction is available from Rosetta alone, and the SGM‑Consensus result aligns with the benign consensus. Overall, the majority of evidence points to a benign impact, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.736850Disordered0.420316Uncertain0.3190.8270.7506-33438067-G-A16.21e-7-5.036Likely Benign0.089Likely BenignLikely Benign3.42Destabilizing3.51.69Ambiguous2.56Destabilizing0.18Likely Benign0.446Likely Benign-0.52Neutral0.980Probably Damaging0.968Probably Damaging1.33Pathogenic0.05Affected4.3230.29010.498501-0.430.03
c.1180A>G
K394E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K394E is not listed in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438085‑A‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Those that predict a pathogenic effect are premPS, PROVEAN, SIFT, and AlphaMissense‑Default. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. No prediction or folding‑stability result is available that decisively supports either outcome. Overall, the majority of tools (six benign vs four pathogenic) lean toward a benign interpretation, and this assessment does not contradict the absence of a ClinVar classification. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.505461Disordered0.399336Uncertain0.3870.6340.6256-33438085-A-G16.20e-7-6.903Likely Benign0.896Likely PathogenicAmbiguous0.07Likely Benign0.13.71Destabilizing1.89Ambiguous1.20Destabilizing0.446Likely Benign-2.54Deleterious0.063Benign0.038Benign4.61Benign0.04Affected3.44140.45560.1916100.40.94
c.1190G>T
C397F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397F is reported in gnomAD (6-33438095-G-T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, Rosetta, and the protein‑folding stability method Foldetta. FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as benign, while Foldetta indicates a pathogenic effect. Because the majority of tools (nine benign vs. four pathogenic) lean toward a benign outcome and the high‑accuracy consensus is split, the variant is most likely benign. This assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.429200Structured0.395774Uncertain0.7780.5510.2506-33438095-G-T16.20e-7-6.571Likely Benign0.194Likely BenignLikely Benign1.31Ambiguous1.73.61Destabilizing2.46Destabilizing0.12Likely Benign0.493Likely Benign-1.95Neutral0.952Possibly Damaging0.497Possibly Damaging4.65Benign0.07Tolerated3.41150.14260.5231-2-40.344.04
c.1202G>T
R401L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R401L is not reported in ClinVar and is present in gnomAD (ID 6‑33438107‑G‑T). Prediction tools that classify the variant as benign include Rosetta, FATHMM, and premPS, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) indicate a pathogenic effect. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No evidence from FoldX alone is available. Based on the preponderance of pathogenic predictions and the corroborating high‑accuracy tools, R401L is most likely pathogenic; this assessment does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.314870Structured0.424277Uncertain0.9610.4190.0006-33438107-G-T16.20e-7-12.280Likely Pathogenic0.972Likely PathogenicLikely Pathogenic-1.52Ambiguous0.1-0.23Likely Benign-0.88Ambiguous0.22Likely Benign0.858Likely Pathogenic-6.42Deleterious0.997Probably Damaging0.987Probably Damaging5.44Benign0.02Affected3.38270.19720.4263-2-38.3-43.03
c.1211C>T
A404V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A404V missense variant is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438116‑C‑T). Prediction tools that agree on a benign effect include REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN and ESM1b. Four tools (FoldX, Rosetta, AlphaMissense‑Default, Foldetta) give uncertain or inconclusive results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta remains uncertain. Overall, the majority of predictions lean toward a benign impact, though a key consensus method suggests pathogenicity, leaving the variant’s effect unresolved. **The variant is most likely benign based on the prevailing predictions, and this assessment does not contradict ClinVar status, as no ClinVar classification exists.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.232838Structured0.415505Uncertain0.9650.3550.0006-33438116-C-T16.20e-7-8.219Likely Pathogenic0.343AmbiguousLikely Benign0.56Ambiguous0.3-1.55Ambiguous-0.50Ambiguous-0.05Likely Benign0.118Likely Benign-2.96Deleterious0.345Benign0.018Benign4.20Benign0.47Tolerated3.38280.12880.6842002.428.05
c.1223C>T
T408I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T408I missense variant is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438128‑C‑T). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. Tools with uncertain or mixed outputs are AlphaMissense‑Default and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points toward a benign effect, and this conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.161087Structured0.370935Uncertain0.9070.2390.0006-33438128-C-T16.19e-7-10.023Likely Pathogenic0.542AmbiguousLikely Benign-0.16Likely Benign0.1-0.67Ambiguous-0.42Likely Benign0.38Likely Benign0.131Likely Benign-4.53Deleterious0.976Probably Damaging0.607Possibly Damaging4.08Benign0.05Affected3.38280.09050.6700-105.212.05
c.124C>T
P42S
2D
AIThe SynGAP1 missense variant P42S is listed in gnomAD (ID 6‑33423533‑C‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions are reported by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign effect for P42S, and this conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431487Uncertain0.4200.7710.3756-33423533-C-T16.20e-7-3.472Likely Benign0.109Likely BenignLikely Benign0.048Likely Benign-1.12Neutral0.909Possibly Damaging0.901Possibly Damaging4.24Benign0.00Affected4.3210.34620.4470-110.8-10.04
c.1261G>A
A421T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A421T is not reported in ClinVar and is present in gnomAD (ID 6‑33438166‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is “Likely Pathogenic.” Uncertain results from FoldX and premPS are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of consensus predictions lean toward a benign impact, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.0006-33438166-G-A16.19e-7-9.217Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.75Ambiguous0.20.18Likely Benign0.47Likely Benign0.99Ambiguous0.179Likely Benign-3.12Deleterious0.353Benign0.136Benign3.43Benign0.09Tolerated3.37290.13460.443901-2.530.03
c.127G>A
G43S
2D
AIThe SynGAP1 missense variant G43S is listed in ClinVar with an “Uncertain” status and is present in gnomAD (6‑33423536‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only SIFT predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (derived from the same four high‑accuracy tools) also as benign; Foldetta results are unavailable. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431462Uncertain0.3960.7620.375Uncertain 26-33423536-G-A16.20e-7-3.301Likely Benign0.078Likely BenignLikely Benign0.057Likely Benign-0.30Neutral0.162Benign0.096Benign4.29Benign0.00Affected4.3210.25590.406410-0.430.03
c.1282T>C
Y428H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y428H is not reported in ClinVar but is present in gnomAD (ID 6‑33438187‑T‑C). Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM Consensus score (Likely Pathogenic) all suggest a deleterious impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Consequently, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.0006-33438187-T-C16.19e-7-8.566Likely Pathogenic0.961Likely PathogenicLikely Pathogenic3.18Destabilizing0.12.20Destabilizing2.69Destabilizing1.80Destabilizing0.458Likely Benign-4.77Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.04Affected3.38250.26850.071120-1.9-26.03
c.1289T>C
M430T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430T is reported in gnomAD (6‑33438194‑T‑C) and has no ClinVar entry. Consensus from multiple in‑silico predictors indicates a benign effect: REVEL, FoldX (uncertain), Rosetta, Foldetta (uncertain), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify it as benign or likely benign. No tool predicts pathogenicity. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is benign, the SGM Consensus is likely benign, and Foldetta is uncertain. Overall, the computational evidence strongly supports a benign classification, and this is consistent with the absence of a ClinVar pathogenic report. Thus, the variant is most likely benign, and this is not contradictory to ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.0006-33438194-T-C16.19e-7-3.430Likely Benign0.107Likely BenignLikely Benign1.89Ambiguous0.10.01Likely Benign0.95Ambiguous0.43Likely Benign0.103Likely Benign-1.48Neutral0.016Benign0.010Benign3.48Benign0.40Tolerated3.37290.20020.3184-1-1-2.6-30.09
c.1290G>A
M430I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430I is catalogued in gnomAD (6‑33438195‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from FoldX, premPS, and AlphaMissense‑Default. High‑accuracy assessments reinforce the benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.0006-33438195-G-A16.19e-7-4.655Likely Benign0.420AmbiguousLikely Benign1.22Ambiguous0.1-0.29Likely Benign0.47Likely Benign0.65Ambiguous0.068Likely Benign-1.62Neutral0.134Benign0.025Benign3.54Benign0.40Tolerated3.37290.15240.4116122.6-18.03
c.1300G>A
V434I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V434I (ClinVar ID 212346.0, status Uncertain) is present in gnomAD (ID 6‑33438205‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No predictions or stability results are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, which does not contradict the ClinVar status of Uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.158265Structured0.342846Uncertain0.9540.3060.000Uncertain 16-33438205-G-A16.19e-7-6.999Likely Benign0.129Likely BenignLikely Benign-0.04Likely Benign0.00.22Likely Benign0.09Likely Benign0.31Likely Benign0.192Likely Benign-0.82Neutral0.947Possibly Damaging0.851Possibly Damaging3.53Benign0.18Tolerated3.37290.06750.3415430.314.03246.7-27.70.00.00.10.0XPotentially BenignThe iso-propyl side chain of Val434, located at the end of an α helix (res. Met414-Glu436), packs against hydrophobic residues in an interhelix space (e.g., Met430, Ala707, Leu711). In the variant simulations, the sec-butyl group of Ile434 is able to form the same hydrophobic interactions. Accordingly, the residue swap does not negatively affect the protein structure based on the simulations.
c.1315C>A
L439M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L439M is reported in gnomAD (variant ID 6‑33438220‑C‑A) but has no ClinVar entry. Functional prediction tools that agree on benign impact include REVEL, FoldX, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from premPS, polyPhen‑2 (HumDiv and HumVar) and SIFT. Uncertain results are reported by Rosetta, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta as inconclusive. Overall, the majority of evidence points to a benign effect; there is no ClinVar classification to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.222385Structured0.281542Uncertain0.9420.2650.0006-33438220-C-A16.20e-7-5.840Likely Benign0.363AmbiguousLikely Benign-0.33Likely Benign0.11.34Ambiguous0.51Ambiguous1.01Destabilizing0.187Likely Benign-1.43Neutral1.000Probably Damaging0.999Probably Damaging3.24Benign0.02Affected3.38250.07200.275324-1.918.03
c.1325A>G
K442R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K442R is catalogued in gnomAD (ID 6‑33438230‑A‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tools predicting a pathogenic outcome are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) classifies the variant as benign. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.170161Structured0.255766Uncertain0.9120.2250.0006-33438230-A-G16.20e-7-5.761Likely Benign0.093Likely BenignLikely Benign0.13Likely Benign0.10.29Likely Benign0.21Likely Benign0.51Ambiguous0.098Likely Benign-1.42Neutral0.972Probably Damaging0.875Possibly Damaging3.46Benign0.35Tolerated3.37290.38850.077823-0.628.01
c.1333G>C
E445Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E445Q is reported in gnomAD (ID 6‑33438238‑G‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions (REVEL, FoldX, Rosetta, SIFT, FATHMM) and pathogenic predictions (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, ESM1b). Two tools remain inconclusive (premPS, AlphaMissense‑Optimized). High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic effect; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign impact. Overall, the balance of evidence tilts toward pathogenicity, with the high‑accuracy consensus supporting this view, and there is no conflict with ClinVar status because the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.270205Uncertain0.9470.2280.0006-33438238-G-C16.19e-7-12.430Likely Pathogenic0.790Likely PathogenicAmbiguous-0.03Likely Benign0.00.20Likely Benign0.09Likely Benign0.70Ambiguous0.240Likely Benign-2.86Deleterious0.987Probably Damaging0.946Probably Damaging3.40Benign0.12Tolerated3.38310.07870.5018220.0-0.98
c.1336G>A
E446K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E446K is not reported in ClinVar (ClinVar status: not present) and is found in gnomAD (ID 6‑33438241‑G‑A). Prediction tools that agree on a benign effect include only FATHMM. Tools that agree on a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote). Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy methods give the following: AlphaMissense‑Optimized is uncertain; SGM‑Consensus indicates likely pathogenic; Foldetta is uncertain. Overall, the majority of evidence points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.0006-33438241-G-A16.19e-7-14.140Likely Pathogenic0.953Likely PathogenicAmbiguous0.80Ambiguous0.41.57Ambiguous1.19Ambiguous0.81Ambiguous0.518Likely Pathogenic-3.75Deleterious0.994Probably Damaging0.975Probably Damaging3.36Benign0.01Affected3.38310.21410.651110-0.4-0.94
c.1346G>A
S449N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S449N is not reported in ClinVar (ClinVar status: not listed) but is present in the gnomAD database (gnomAD ID: 6‑33438251‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from premPS (uncertain) and ESM1b (uncertain). High‑accuracy assessments reinforce the benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.254060Structured0.301437Uncertain0.9580.2510.0006-33438251-G-A16.19e-7-7.692In-Between0.210Likely BenignLikely Benign0.38Likely Benign0.1-0.03Likely Benign0.18Likely Benign0.81Ambiguous0.070Likely Benign-2.31Neutral0.372Benign0.026Benign3.37Benign0.18Tolerated3.37320.10850.376711-2.727.03
c.1349C>T
A450V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A450V is not reported in ClinVar and is present in gnomAD (ID 6‑33438254‑C‑T). Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments give mixed results: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of tools lean toward a benign effect, and there is no ClinVar entry to contradict this assessment. Thus, the variant is most likely benign based on current predictions, with a single high‑accuracy tool suggesting pathogenicity but not overturning the overall benign consensus.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.0006-33438254-C-T16.20e-7-11.489Likely Pathogenic0.578Likely PathogenicLikely Benign0.04Likely Benign0.20.27Likely Benign0.16Likely Benign0.46Likely Benign0.306Likely Benign-3.69Deleterious0.998Probably Damaging0.955Probably Damaging3.55Benign0.04Affected3.37320.07920.5638002.428.05
c.137C>G
P46R
2D
AIThe SynGAP1 missense variant P46R is catalogued in gnomAD (ID 6‑33423546‑C‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar) and SIFT. AlphaMissense‑Default is uncertain, and Foldetta (FoldX‑MD/Rosetta stability assessment) has no available result. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta data is missing. Overall, the majority of evidence points to a benign effect. There is no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.390993Structured0.433588Uncertain0.5490.7410.3756-33423546-C-G16.20e-7-0.520Likely Benign0.385AmbiguousLikely Benign0.155Likely Benign0.39Neutral0.972Probably Damaging0.954Probably Damaging4.39Benign0.00Affected4.3210.16690.4543-20-2.959.07
c.1385A>G
K462R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462R is catalogued in gnomAD (ID 6‑33438290‑A‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Three tools (Rosetta, Foldetta, premPS) yield uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta is uncertain, so neither provides decisive evidence. Overall, the majority of reliable predictors lean toward a benign effect. This consensus does not contradict ClinVar status, which is currently absent. Thus, based on available predictions, K462R is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.297737Uncertain0.9210.1590.1256-33438290-A-G16.20e-7-9.980Likely Pathogenic0.184Likely BenignLikely Benign0.13Likely Benign0.10.90Ambiguous0.52Ambiguous0.84Ambiguous0.246Likely Benign-2.75Deleterious0.983Probably Damaging0.962Probably Damaging3.43Benign0.09Tolerated3.37340.49950.120123-0.628.01
c.1386G>T
K462N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462N is reported in gnomAD (ID 6‑33438291‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Stability‑based methods (FoldX, Rosetta, premPS) and Foldetta are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, while Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for K462N. This conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.1256-33438291-G-T16.20e-7-12.823Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.69Ambiguous0.11.67Ambiguous1.18Ambiguous0.90Ambiguous0.303Likely Benign-4.83Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.07Tolerated3.37340.39670.1242010.4-14.07
c.139C>T
R47W
2D
AIThe SynGAP1 missense variant R47W is listed in ClinVar as a variant of uncertain significance and is present in the gnomAD database (ID 6‑33423548‑C‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized, whereas those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic versus two benign votes), and Foldetta results are unavailable. Overall, the majority of conventional tools suggest a pathogenic impact, but the single high‑accuracy benign prediction and the inconclusive consensus temper this view. Consequently, the variant is most likely pathogenic based on the preponderance of evidence, and this assessment does not contradict the ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.318242Structured0.436559Uncertain0.5200.7190.125Uncertain 16-33423548-C-T16.20e-7-9.201Likely Pathogenic0.752Likely PathogenicLikely Benign0.201Likely Benign-2.17Neutral0.994Probably Damaging0.919Probably Damaging4.00Benign0.00Affected4.3210.11010.4158-323.630.03
c.1403T>C
M468T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468T is listed in ClinVar with an “Uncertain” status and is present in the gnomAD database. Prediction tools that are available all converge on a pathogenic interpretation: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool reports a benign outcome. High‑accuracy assessments are consistent: AlphaMissense‑Optimized is “Uncertain,” SGM Consensus is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. **Based on the aggregate predictions, the variant is most likely pathogenic, which does not contradict the ClinVar “Uncertain” classification.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000Uncertain 26-33438435-T-C16.20e-7-12.399Likely Pathogenic0.862Likely PathogenicAmbiguous3.47Destabilizing0.13.10Destabilizing3.29Destabilizing1.84Destabilizing0.801Likely Pathogenic-3.85Deleterious0.994Probably Damaging0.985Probably Damaging-1.31Pathogenic0.01Affected3.37310.20940.1950-1-1-2.6-30.09214.647.10.00.00.10.0XPotentially PathogenicThe thioether group of Met468, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues (e.g., Phe464, Leu465, Leu489) in an inter-helix space formed by two other α helices (res. Ala461–Phe476, res. Thr488–Gly502). In the variant simulations, the hydrophilic side chain of Thr468 does not pack favorably in the hydrophobic niche, and the methionine-aromatic stacking is lost. Although the hydroxyl group of Thr468 forms an H-bond with the backbone carbonyl group of Phe464, the integrity of the α helix is not affected in the simulations. No large-scale structural changes are observed during the variant simulations; however, due to the importance of hydrophobic packing, the effects could be more pronounced during protein folding.
c.1404G>A
M468I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M468I is listed in ClinVar with an uncertain significance (ClinVar ID 3657719.0) and is present in gnomAD (6‑33438436‑G‑A). Functional prediction tools cluster into two groups: benign predictions come from premPS, PROVEAN, and SIFT, while pathogenic predictions arise from REVEL, FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools report uncertainty: AlphaMissense‑Optimized and Rosetta. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, SGM Consensus is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Overall, the preponderance of evidence indicates a pathogenic impact for M468I, which does not contradict the ClinVar uncertain status but suggests a likely pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000Uncertain 16-33438436-G-A16.20e-7-8.583Likely Pathogenic0.907Likely PathogenicAmbiguous2.53Destabilizing0.21.89Ambiguous2.21Destabilizing0.37Likely Benign0.508Likely Pathogenic-1.06Neutral0.748Possibly Damaging0.886Possibly Damaging-1.10Pathogenic0.07Tolerated3.37310.13690.3354122.6-18.03
c.1408A>C
M470L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M470L is listed in ClinVar as benign (ClinVar ID 536996.0) and is present in gnomAD (variant ID 6‑33438440‑A‑C). Functional prediction tools cluster into two groups: benign predictions come from SIFT and AlphaMissense‑Optimized, while pathogenic predictions are made by REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No definitive folding‑stability change is reported by FoldX or Rosetta individually. Overall, the majority of predictive algorithms favor a pathogenic effect, directly contradicting the benign classification in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000Likely Benign 16-33438440-A-C16.20e-7-8.993Likely Pathogenic0.406AmbiguousLikely Benign0.73Ambiguous0.10.84Ambiguous0.79Ambiguous1.04Destabilizing0.678Likely Pathogenic-2.72Deleterious0.484Possibly Damaging0.654Possibly Damaging-1.22Pathogenic0.16Tolerated3.37340.11920.4071421.9-18.03225.317.90.00.0-0.80.5XPotentially BenignThe thioether group of Met470, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues in the inter-helix space (e.g., Val473, Leu558) formed by two other α helices (res. Ser604–Arg581, res. Pro562–Arg579). In the WT simulations, Met470 also packs against the positively charged guanidinium groups of Arg575, Arg429, and Arg579, which form salt bridges with the negatively charged carboxylate groups of the Asp474 and Asp467 side chains at the protein surface. In the variant simulations, the iso-butyl side chain of Leu470 packs similarly with the hydrophobic residues as methionine, resulting in no negative effects on the protein structure during the simulation.
c.1412C>G
S471C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S471C is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33438444‑C‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of predictions (10 benign vs. 3 pathogenic) indicate that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no reported pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.305330Structured0.355411Uncertain0.8880.2610.0006-33438444-C-G16.20e-7-3.454Likely Benign0.093Likely BenignLikely Benign0.36Likely Benign0.0-0.05Likely Benign0.16Likely Benign0.07Likely Benign0.273Likely Benign-2.90Deleterious0.000Benign0.001Benign-1.32Pathogenic0.01Affected3.37340.10480.4913-103.316.06
c.1417G>A
V473I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V473I is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33438449‑G‑A). Functional prediction tools that agree on benign impact include REVEL, FoldX, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Pathogenic predictions are provided by both polyPhen‑2 HumDiv and HumVar. Predictions that are inconclusive are AlphaMissense‑Default, ESM1b, Foldetta, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is unavailable due to no majority, and Foldetta is uncertain. Overall, the balance of evidence favors a benign effect for V473I, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.191378Structured0.362529Uncertain0.8840.2390.000Uncertain 16-33438449-G-A16.20e-7-7.481In-Between0.418AmbiguousLikely Benign-0.12Likely Benign0.01.20Ambiguous0.54Ambiguous-0.06Likely Benign0.203Likely Benign-0.91Neutral0.929Possibly Damaging0.917Probably Damaging3.74Benign0.18Tolerated3.37340.05680.3335340.314.03
c.1421A>G
D474G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D474G is not reported in ClinVar and is present in gnomAD (ID 6‑33438453‑A‑G). Functional prediction tools show a split: benign calls come from FoldX, Foldetta, premPS, and SIFT, while pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; Rosetta remains uncertain. High‑accuracy assessments give a pathogenic verdict from AlphaMissense‑Optimized and a pathogenic consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). In contrast, Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts benign stability. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.373433Uncertain0.8640.2550.0006-33438453-A-G16.20e-7-11.215Likely Pathogenic0.959Likely PathogenicLikely Pathogenic-0.38Likely Benign0.00.82Ambiguous0.22Likely Benign0.44Likely Benign0.823Likely Pathogenic-6.13Deleterious1.000Probably Damaging0.999Probably Damaging-1.28Pathogenic0.07Tolerated3.37340.32450.4933-113.1-58.04
c.1423C>T
R475W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R475W is listed in ClinVar with an “Uncertain” status and is present in gnomAD (variant ID 6‑33438455‑C‑T). Prediction tools that agree on a benign effect include only Foldetta, whereas the remaining tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) uniformly predict a pathogenic impact; FoldX, Rosetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a pathogenic effect, which does not contradict the ClinVar “Uncertain” classification but suggests that the variant is more likely pathogenic rather than benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.382696Uncertain0.8520.2610.000Uncertain 16-33438455-C-T16.20e-7-13.235Likely Pathogenic0.962Likely PathogenicLikely Pathogenic1.44Ambiguous0.4-0.92Ambiguous0.26Likely Benign0.56Ambiguous0.725Likely Pathogenic-7.56Deleterious1.000Probably Damaging0.995Probably Damaging-1.45Pathogenic0.00Affected3.39280.12310.27852-33.630.03266.939.60.00.00.00.1XXXPotentially PathogenicIn the WT simulations, the guanidinium group of Arg475, located near the end of an α-helix (res. Ala461-Phe476), stacks with the phenyl ring of Phe476 and forms a salt bridge with Glu472. Additionally, Arg475 occasionally forms another salt bridge with the carboxylate group of Glu486 on the α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. Therefore, Arg475 potentially plays a key role in positioning the loop by interacting with Glu486, which is necessary for the positioning of the “arginine finger” (Arg485) and, ultimately, for RasGTPase activation.In the variant simulations, Trp475 moves and stacks with Arg479 on the proceeding α-α loop, disrupting the terminal end of the α-helix. Lastly, the potential effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1429A>G
M477V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477V is listed in ClinVar with no submitted interpretation and is present in the gnomAD database (variant ID 6‑33438461‑A‑G). Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen2_HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. Only two tools predict a pathogenic outcome: polyPhen2_HumDiv and FATHMM. Predictions from FoldX and Foldetta are uncertain. High‑accuracy methods reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, while Foldetta remains inconclusive. Taken together, the majority of evidence supports a benign classification for M477V, and this assessment does not contradict the ClinVar status, which currently has no pathogenic claim.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.268042Structured0.408680Uncertain0.7610.2500.0006-33438461-A-G16.20e-7-3.995Likely Benign0.127Likely BenignLikely Benign1.64Ambiguous0.30.42Likely Benign1.03Ambiguous0.24Likely Benign0.209Likely Benign-1.04Neutral0.716Possibly Damaging0.204Benign-1.19Pathogenic0.22Tolerated3.37340.30930.3445122.3-32.0610.1016/j.ajhg.2020.11.011
c.1432G>C
E478Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478Q is listed in gnomAD (ID 6‑33438464‑G‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑vs‑2 split. Overall, the majority of evidence (nine benign vs three pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.414660Uncertain0.7870.2490.0006-33438464-G-C16.20e-7-9.881Likely Pathogenic0.603Likely PathogenicLikely Benign-0.04Likely Benign0.00.31Likely Benign0.14Likely Benign0.07Likely Benign0.222Likely Benign-2.49Neutral0.623Possibly Damaging0.199Benign3.40Benign0.14Tolerated3.37340.10270.5867220.0-0.98
c.1435C>G
R479G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R479G is reported in gnomAD (ID 6-33438467-C-G) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, Rosetta, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta, which assess protein‑folding stability, returned uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as pathogenic, and Foldetta as inconclusive. Overall, the majority of computational evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation. Therefore, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.0006-33438467-C-G16.20e-7-8.600Likely Pathogenic0.624Likely PathogenicLikely Benign0.97Ambiguous0.02.51Destabilizing1.74Ambiguous0.71Ambiguous0.228Likely Benign-2.82Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.42Tolerated3.39320.29110.2707-2-34.1-99.14
c.1438G>A
E480K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E480K is catalogued in gnomAD (ID 6‑33438470‑G‑A) but has no entry in ClinVar. Functional prediction tools cluster into two groups: benign predictions come from FoldX and SIFT, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results are reported by Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is labeled Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that E480K is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.426867Uncertain0.7980.2500.0006-33438470-G-A16.20e-7-14.059Likely Pathogenic0.961Likely PathogenicLikely Pathogenic0.40Likely Benign0.11.08Ambiguous0.74Ambiguous0.83Ambiguous0.768Likely Pathogenic-3.45Deleterious0.996Probably Damaging0.987Probably Damaging-1.26Pathogenic0.11Tolerated3.37340.18280.681310-0.4-0.94
c.1449A>G
I483M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I483M missense variant is not reported in ClinVar (ClinVar status: not present) but is catalogued in gnomAD (gnomAD ID: 6‑33438481‑A‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as pathogenic, and Foldetta as benign. No conclusive folding‑stability result is available from Rosetta. Overall, the majority of high‑accuracy tools (two benign, one pathogenic) lean toward a benign interpretation, and this assessment is not contradicted by any ClinVar annotation. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.0006-33438481-A-G16.20e-7-8.839Likely Pathogenic0.777Likely PathogenicLikely Benign0.02Likely Benign0.00.73Ambiguous0.38Likely Benign1.06Destabilizing0.261Likely Benign-2.78Deleterious1.000Probably Damaging1.000Probably Damaging3.26Benign0.05Affected3.37320.06070.195912-2.618.03
c.1453C>G
R485G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R485G is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID: 6‑33438485‑C‑G). Prediction tools that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; no tools predict a benign outcome. Uncertain or inconclusive predictions come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Uncertain. Overall, the evidence strongly favors a pathogenic classification, and this conclusion does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.377409Uncertain0.8050.2460.1256-33438485-C-G16.20e-7-15.777Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.84Ambiguous0.11.60Ambiguous1.22Ambiguous0.98Ambiguous0.631Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging1.92Pathogenic0.00Affected3.37350.31400.2678-2-34.1-99.14
c.1465C>T
L489F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L489F is listed in ClinVar with an uncertain significance (ClinVar ID 522018.0) and is present in the gnomAD database (gnomAD ID 6‑33438497‑C‑T). In silico prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report a pathogenic outcome, while no tool predicts a benign effect. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No prediction or folding‑stability result is missing or ambiguous. **Thus, the variant is most likely pathogenic based on the collective predictions, and this does not contradict the ClinVar uncertain status.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.326126Uncertain0.9490.2340.125Uncertain 26-33438497-C-T16.20e-7-12.066Likely Pathogenic0.965Likely PathogenicLikely Pathogenic1.72Ambiguous0.51.14Ambiguous1.43Ambiguous0.56Ambiguous0.724Likely Pathogenic-3.76Deleterious1.000Probably Damaging0.997Probably Damaging-1.51Pathogenic0.01Affected3.37350.07910.372920-1.034.02246.4-17.80.00.00.60.1XPotentially BenignThe iso-butyl side chain of Leu489, located in the α-helix (res. Leu489-Glu519) within an inter-helix space of four helices (res. Ala461-Phe476, res. Val441-Ser457, and res. Met414-Glu436), packs with hydrophobic residues (e.g., Cys432, Ala448, Lys444, Ala493, Val447, Met468) in the inter-helix space. In the variant simulations, the phenyl ring of the Phe489 side chain can also pack favorably in the hydrophobic region. However, due to the size difference, the aromatic side chain of Phe489 tends to reposition to escape the tight region to accommodate the larger side chain, stacking with Lys444. Although no apparent negative changes are observed during the variant simulation, the size difference between the swapped residues could affect the protein folding process.
c.1468G>A
A490T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A490T is listed in gnomAD (variant ID 6‑33438500‑G‑A) but has no ClinVar entry. Prediction tools that agree on a pathogenic effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Tools that are inconclusive or uncertain are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. No tool predicts a benign outcome. High‑accuracy assessments show that the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while AlphaMissense‑Optimized remains uncertain and Foldetta is also uncertain. Based on the preponderance of pathogenic predictions and the lack of any benign calls, the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.322979Uncertain0.9380.2100.1256-33438500-G-A16.20e-7-10.266Likely Pathogenic0.892Likely PathogenicAmbiguous0.80Ambiguous0.21.70Ambiguous1.25Ambiguous1.00Destabilizing0.821Likely Pathogenic-3.87Deleterious0.998Probably Damaging0.993Probably Damaging-1.34Pathogenic0.03Affected3.37350.10650.449501-2.530.03
c.1471A>G
T491A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T491A is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (gnomAD ID: 6‑33438503‑A‑G). Prediction tools that agree on a benign effect include FoldX, Rosetta, and Foldetta. Tools that predict a pathogenic effect include SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions (10 pathogenic vs. 3 benign) indicate a likely pathogenic impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.064632Structured0.325158Uncertain0.9290.1880.1256-33438503-A-G16.20e-7-11.033Likely Pathogenic0.934Likely PathogenicAmbiguous0.10Likely Benign0.3-0.27Likely Benign-0.09Likely Benign1.06Destabilizing0.851Likely Pathogenic-4.82Deleterious0.998Probably Damaging0.989Probably Damaging-1.47Pathogenic0.01Affected3.37350.39030.2874012.5-30.03
c.1484A>G
E495G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E495G missense variant is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33438516‑A‑G). Among the available in‑silico predictors, the following tools uniformly indicate a pathogenic effect: REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (which itself is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). No tool in the dataset predicts a benign outcome; predictions that are uncertain (FoldX, Foldetta, premPS, AlphaMissense‑Optimized) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM‑Consensus as “Likely Pathogenic,” and Foldetta as “Uncertain.” Overall, the preponderance of pathogenic predictions strongly suggests that the variant is most likely pathogenic, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.364496Uncertain0.9330.1610.000Uncertain 16-33438516-A-G16.20e-7-9.400Likely Pathogenic0.923Likely PathogenicAmbiguous1.21Ambiguous0.02.06Destabilizing1.64Ambiguous0.78Ambiguous0.867Likely Pathogenic-6.70Deleterious1.000Probably Damaging0.999Probably Damaging-1.46Pathogenic0.02Affected3.37350.21770.4784-203.1-72.06
c.1497A>C
R499S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R499S is catalogued in gnomAD (ID 6‑33438529‑A‑C) but has no ClinVar entry. Functional prediction tools largely converge on a deleterious effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate pathogenicity. No tool reports a benign outcome. High‑accuracy assessments are mixed: AlphaMissense‑Optimized and Foldetta are uncertain, whereas the SGM‑Consensus remains likely pathogenic. Protein‑stability predictions are inconclusive (FoldX uncertain, Rosetta pathogenic, Foldetta uncertain). Taken together, the overwhelming majority of evidence supports a pathogenic classification for R499S. This conclusion is consistent with the absence of a ClinVar status, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.071867Structured0.386723Uncertain0.8990.1460.0006-33438529-A-C16.20e-7-9.559Likely Pathogenic0.935Likely PathogenicAmbiguous1.03Ambiguous0.02.19Destabilizing1.61Ambiguous1.40Destabilizing0.632Likely Pathogenic-2.69Deleterious0.958Probably Damaging0.702Possibly Damaging-1.43Pathogenic0.01Affected3.37350.24430.1649-103.7-69.11
c.1520A>G
K507R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K507R is not listed in ClinVar (ClinVar status: not reported) but is present in gnomAD (gnomAD ID 6-33438552-A-G). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The high‑accuracy AlphaMissense‑Optimized score is benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. No prediction or folding stability result is missing or inconclusive. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which has no pathogenic annotation for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.019401Structured0.262601Uncertain0.8850.2220.0006-33438552-A-G16.20e-7-7.363In-Between0.085Likely BenignLikely Benign-0.08Likely Benign0.10.38Likely Benign0.15Likely Benign0.36Likely Benign0.503Likely Pathogenic-0.68Neutral0.992Probably Damaging0.980Probably Damaging-1.48Pathogenic0.27Tolerated3.37350.31550.057923-0.628.01
c.1524T>A
D508E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D508E is reported in gnomAD (ID 6‑33438556‑T‑A) and has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the protein‑stability method Foldetta. Only PROVEAN predicts a pathogenic outcome, while Rosetta and premPS are inconclusive. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign. Overall, the majority of evidence points to a benign effect, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.019401Structured0.255890Uncertain0.8900.2280.0006-33438556-T-A16.20e-7-5.959Likely Benign0.242Likely BenignLikely Benign-0.39Likely Benign0.10.99Ambiguous0.30Likely Benign0.59Ambiguous0.118Likely Benign-3.16Deleterious0.005Benign0.006Benign3.43Benign0.20Tolerated3.37350.17660.4304230.014.03
c.1543C>T
R515C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R515C is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (6‑33438786‑C‑T). Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized. All other evaluated algorithms—SGM Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—predict a pathogenic impact. The remaining tools (FoldX, Rosetta, Foldetta, premPS) give uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as likely pathogenic, and Foldetta as uncertain. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.055536Structured0.191256Uncertain0.9240.2750.0006-33438786-C-T16.20e-7-10.973Likely Pathogenic0.628Likely PathogenicLikely Benign1.00Ambiguous0.01.13Ambiguous1.07Ambiguous0.72Ambiguous0.691Likely Pathogenic-5.49Deleterious1.000Probably Damaging1.000Probably Damaging-1.36Pathogenic0.01Affected3.37350.30550.1546-3-47.0-53.05
c.1555G>A
E519K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E519K missense variant is listed in gnomAD (ID 6‑33438798‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and FATHMM, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E519K, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.078022Structured0.104514Uncertain0.8990.3280.0006-33438798-G-A16.20e-7-13.532Likely Pathogenic0.970Likely PathogenicLikely Pathogenic-0.55Ambiguous0.0-0.60Ambiguous-0.58Ambiguous0.06Likely Benign0.328Likely Benign-3.48Deleterious0.996Probably Damaging0.987Probably Damaging3.28Benign0.03Affected3.37350.25450.337910-0.4-0.94
c.155C>T
S52L
2D
AISynGAP1 missense variant S52L is listed in ClinVar with an uncertain significance and is present in the gnomAD database (ID 6‑33423564‑C‑T). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default; ESM1b remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also favors benign. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the collective evidence points to a likely benign effect, which does not contradict the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.291804Structured0.457753Uncertain0.4990.6770.000Uncertain 16-33423564-C-T16.20e-7-7.199In-Between0.688Likely PathogenicLikely Benign0.087Likely Benign-1.41Neutral0.829Possibly Damaging0.706Possibly Damaging4.10Benign0.00Affected4.3210.09910.6100-3-24.626.08
c.1570T>A
C524S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C524S is listed in gnomAD (variant ID 6‑33438813‑T‑A) but has no ClinVar entry. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report a pathogenic outcome, while FoldX, Rosetta, and Foldetta are uncertain and therefore not counted as evidence. Grouping by agreement yields a benign‑prediction set that is empty and a pathogenic‑prediction set that contains the eleven tools above. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; Foldetta remains uncertain. Consequently, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.024729Uncertain0.9160.3850.1256-33438813-T-A16.20e-7-11.174Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.80Ambiguous0.11.55Ambiguous1.18Ambiguous1.58Destabilizing0.915Likely Pathogenic-9.94Deleterious1.000Probably Damaging1.000Probably Damaging-1.38Pathogenic0.00Affected3.37350.53620.1848Weaken-10-3.3-16.06
c.1573G>A
E525K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E525K is reported in gnomAD (ID 6‑33438816‑G‑A) but has no ClinVar entry. Functional prediction tools show a split assessment: benign predictions come from FoldX, Rosetta, Foldetta, and FATHMM, whereas pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). The high‑accuracy AlphaMissense‑Optimized tool classifies the variant as pathogenic, the SGM‑Consensus also indicates likely pathogenic, while the Foldetta stability analysis predicts a benign effect. No prediction or stability result is missing or inconclusive. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.023618Uncertain0.9370.3820.1256-33438816-G-A16.20e-7-15.628Likely Pathogenic0.995Likely PathogenicLikely Pathogenic-0.13Likely Benign0.50.34Likely Benign0.11Likely Benign0.96Ambiguous0.629Likely Pathogenic-3.98Deleterious0.999Probably Damaging0.988Probably Damaging2.71Benign0.00Affected3.37350.23490.429310-0.4-0.94
c.1585A>C
I529L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529L is listed in gnomAD (variant ID 6‑33438828‑A‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is benign. No prediction or folding result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.0006-33438828-A-C16.20e-70.920Likely Benign0.066Likely BenignLikely Benign-0.13Likely Benign0.0-0.11Likely Benign-0.12Likely Benign-0.21Likely Benign0.309Likely Benign0.00Neutral0.001Benign0.022Benign-1.24Pathogenic0.48Tolerated3.37350.08190.378922-0.70.00
c.1585A>G
I529V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529V is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID 6‑33438828‑A‑G). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, the SGM Consensus is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. Based on the collective predictions, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.0006-33438828-A-G16.20e-7-2.342Likely Benign0.068Likely BenignLikely Benign0.18Likely Benign0.00.03Likely Benign0.11Likely Benign0.36Likely Benign0.230Likely Benign-0.21Neutral0.019Benign0.014Benign-1.24Pathogenic1.00Tolerated3.37350.10430.352634-0.3-14.03
c.1589A>G
K530R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K530R is catalogued in gnomAD (6‑33438832‑A‑G) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is benign. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.308712Structured0.018455Uncertain0.8910.4090.0006-33438832-A-G16.19e-7-3.836Likely Benign0.081Likely BenignLikely Benign-0.02Likely Benign0.10.18Likely Benign0.08Likely Benign0.33Likely Benign0.234Likely Benign-1.39Neutral0.000Benign0.002Benign-1.54Pathogenic0.08Tolerated3.37350.32970.071623-0.628.01
c.1609G>T
A537S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A537S is reported in gnomAD (6-33438852-G-T) and has no ClinVar entry. Consensus from multiple in silico predictors indicates a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all score benign, while polyPhen‑2 (HumDiv and HumVar) and FATHMM predict pathogenicity. When predictions are grouped, the majority of tools (ten) support benign, whereas three tools support pathogenic. High‑accuracy assessments further reinforce the benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Consequently, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.116183Structured0.037313Uncertain0.9280.3620.0006-33438852-G-T16.20e-7-3.602Likely Benign0.095Likely BenignLikely Benign0.28Likely Benign0.00.46Likely Benign0.37Likely Benign0.28Likely Benign0.206Likely Benign-0.66Neutral0.528Possibly Damaging0.592Possibly Damaging-1.25Pathogenic0.60Tolerated3.37350.27290.443111-2.616.00
c.1619A>G
Q540R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q540R has no ClinVar entry and is present in gnomAD (ID 6‑33438862‑A‑G). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Two tools report uncertainty: premPS and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. Overall, the majority of evidence points to a benign impact, with only a minority of tools indicating pathogenicity. This conclusion does not contradict ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.085092Structured0.029522Uncertain0.9580.3710.0006-33438862-A-G16.19e-7-13.312Likely Pathogenic0.540AmbiguousLikely Benign-0.06Likely Benign0.0-0.07Likely Benign-0.07Likely Benign0.88Ambiguous0.795Likely Pathogenic-3.98Deleterious0.991Probably Damaging0.985Probably Damaging-1.28Pathogenic0.08Tolerated3.37350.13280.188611-1.028.06
c.1631G>A
R544Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R544Q is listed in ClinVar with an “Uncertain” status and is present in gnomAD (variant ID 6‑33438874‑G‑A). Prediction tools that classify the change as benign include FoldX, PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are REVEL, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Foldetta and Rosetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence points toward a pathogenic effect, which is not contradictory to the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.038858Structured0.016004Uncertain0.9670.3330.000Uncertain 16-33438874-G-A16.20e-7-10.281Likely Pathogenic0.596Likely PathogenicLikely Benign0.19Likely Benign0.20.87Ambiguous0.53Ambiguous1.40Destabilizing0.542Likely Pathogenic-2.41Neutral1.000Probably Damaging0.997Probably Damaging-1.40Pathogenic0.09Tolerated3.37350.21030.1959111.0-28.06
c.1636T>A
C546S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C546S is reported in gnomAD (ID 6‑33438879‑T‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from FoldX and SIFT; pathogenic predictions from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools give uncertain results: Rosetta and Foldetta. High‑accuracy assessments reinforce a pathogenic signal: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels the variant as Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains inconclusive. Overall, the preponderance of evidence, including the high‑accuracy tools, indicates that C546S is most likely pathogenic, and this assessment does not conflict with any ClinVar classification because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.027463Structured0.009041Uncertain0.9600.2880.0006-33438879-T-A16.20e-7-8.079Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.44Likely Benign0.11.39Ambiguous0.92Ambiguous1.65Destabilizing0.836Likely Pathogenic-8.04Deleterious1.000Probably Damaging1.000Probably Damaging-1.21Pathogenic0.17Tolerated3.37350.43430.1950-10-3.3-16.06
c.1636T>G
C546G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant C546G is not reported in ClinVar and is present in gnomAD (ID 6‑33438879‑T‑G). Prediction tools that indicate a benign effect include only SIFT, whereas the remaining tools—REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus—predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta is inconclusive and therefore not considered evidence. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.027463Structured0.009041Uncertain0.9600.2880.0006-33438879-T-G16.20e-7-14.026Likely Pathogenic0.977Likely PathogenicLikely Pathogenic1.55Ambiguous0.02.43Destabilizing1.99Ambiguous1.53Destabilizing0.877Likely Pathogenic-9.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.26Pathogenic0.06Tolerated3.37350.31350.2513-3-3-2.9-46.09
c.1646T>C
L549S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L549S is catalogued in gnomAD (ID 6‑33438889‑T‑C) but has no ClinVar entry. Functional prediction tools largely converge on a deleterious effect: SIFT reports a benign change, whereas the remaining 10 evaluated algorithms (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict pathogenicity. The high‑accuracy predictors reinforce this trend: AlphaMissense‑Optimized returns a pathogenic score, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. No evidence from FoldX or Rosetta alone is available. Consequently, the variant is most likely pathogenic, and this assessment does not conflict with ClinVar, which contains no classification for this allele.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.007921Uncertain0.9550.2810.0006-33438889-T-C16.20e-7-13.018Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.76Ambiguous0.41.03Ambiguous1.40Ambiguous1.01Destabilizing0.801Likely Pathogenic-4.85Deleterious1.000Probably Damaging1.000Probably Damaging-1.14Pathogenic0.34Tolerated3.37350.29650.0305-2-3-4.6-26.08
c.1649C>T
A550V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A550V variant has no ClinVar entry and is catalogued in gnomAD (ID 6‑33438892‑C‑T). Prediction tools that agree on a benign effect include Foldetta, premPS, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain results come from FoldX and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as pathogenic, and Foldetta as benign. Overall, the majority of tools (seven versus four) favor a pathogenic interpretation, and this does not contradict any ClinVar classification because none is available. Thus, based on the current predictions, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018106Structured0.007241Uncertain0.9540.2650.0006-33438892-C-T16.20e-7-10.461Likely Pathogenic0.441AmbiguousLikely Benign0.77Ambiguous0.2-0.05Likely Benign0.36Likely Benign0.48Likely Benign0.540Likely Pathogenic-2.93Deleterious0.984Probably Damaging0.494Possibly Damaging-1.05Pathogenic0.39Tolerated3.37330.08740.4370002.428.05
c.164A>C
Q55P
2D
AIThe SynGAP1 missense variant Q55P is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33423573‑A‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, whereas those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two pathogenic vs two benign), and Foldetta results are unavailable. Overall, more tools predict pathogenicity than benignity, and no ClinVar entry contradicts this assessment. Therefore, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.332115Structured0.470108Uncertain0.4610.6570.0006-33423573-A-C16.20e-7-13.163Likely Pathogenic0.897Likely PathogenicAmbiguous0.260Likely Benign-2.06Neutral0.462Possibly Damaging0.480Possibly Damaging3.83Benign0.00Affected4.3210.25570.5508-101.9-31.01
c.1652T>A
L551Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L551Q is not reported in ClinVar and is present in gnomAD (allele ID 6‑33438895‑T‑A). In silico prediction tools uniformly indicate a deleterious effect: benign‑predicting tools: none; pathogenic‑predicting tools: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No predictions are inconclusive or missing. **Thus, the variant is most likely pathogenic based on the available predictions, and this conclusion does not contradict the ClinVar status (no entry).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.009977Structured0.006653Uncertain0.9600.2540.0006-33438895-T-A16.20e-7-13.632Likely Pathogenic0.990Likely PathogenicLikely Pathogenic2.48Destabilizing0.12.19Destabilizing2.34Destabilizing2.37Destabilizing0.936Likely Pathogenic-3.68Deleterious1.000Probably Damaging1.000Probably Damaging-1.60Pathogenic0.01Affected3.37350.09830.0688-2-2-7.314.97
c.1659G>C
K553N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K553N is not reported in ClinVar and is present in gnomAD (6-33438902-G-C). Functional prediction tools largely agree on a deleterious effect: SIFT is the sole benign predictor, whereas REVEL, SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. FoldX, Rosetta, and Foldetta return uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta remains uncertain. Overall, the consensus of the majority of tools indicates that K553N is most likely pathogenic, and this conclusion is consistent with the absence of a ClinVar entry (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.012270Structured0.006539Uncertain0.9490.2460.0006-33438902-G-C16.20e-7-13.664Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.63Ambiguous0.00.62Ambiguous0.63Ambiguous1.11Destabilizing0.566Likely Pathogenic-4.77Deleterious1.000Probably Damaging1.000Probably Damaging-1.24Pathogenic0.11Tolerated3.37350.27580.0926010.4-14.07
c.1660G>A
V554M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V554M is not reported in ClinVar but is present in gnomAD (ID 6‑33438903‑G‑A). Functional prediction tools show a split opinion: benign calls come from REVEL, Rosetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls arise from polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default; FoldX, Foldetta, and premPS are inconclusive. High‑accuracy assessment focuses on AlphaMissense‑Optimized, the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta. AlphaMissense‑Optimized predicts benign, the SGM Consensus is a tie and thus unavailable, and Foldetta is uncertain, so it is treated as unavailable. Overall, the available evidence leans toward a benign effect, and this does not contradict ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.020522Structured0.007349Uncertain0.9550.2260.0006-33438903-G-A16.20e-7-8.118Likely Pathogenic0.671Likely PathogenicLikely Benign-1.11Ambiguous0.0-0.20Likely Benign-0.66Ambiguous0.73Ambiguous0.217Likely Benign-2.26Neutral0.994Probably Damaging0.867Possibly Damaging3.22Benign0.00Affected3.37350.07430.281012-2.332.06
c.1678G>T
V560L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V560L variant has no ClinVar entry (ClinVar status: None) but is catalogued in gnomAD (ID 6‑33440730‑G‑T). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are polyPhen‑2 HumDiv, ESM1b, and FATHMM (polyPhen‑2 HumVar is benign, AlphaMissense‑Default is uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) leaning pathogenic (2 pathogenic vs 1 benign), and Foldetta indicating a benign stability change. Overall, the majority of conventional tools favor a benign classification, yet the high‑accuracy consensus and Foldetta suggest a pathogenic signal. Based on the most reliable predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.021381Structured0.013872Uncertain0.8530.2040.0006-33440730-G-T16.34e-7-10.191Likely Pathogenic0.533AmbiguousLikely Benign-0.44Likely Benign0.00.48Likely Benign0.02Likely Benign0.45Likely Benign0.489Likely Benign-2.45Neutral0.508Possibly Damaging0.209Benign-1.24Pathogenic0.40Tolerated3.37350.14300.416212-0.414.03
c.1681T>A
F561I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F561I is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (variant ID 6‑33440733‑T‑A). Prediction tools that agree on a benign effect include only SIFT. All other evaluated predictors—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.024826Structured0.018013Uncertain0.9030.1960.0006-33440733-T-A16.32e-7-11.708Likely Pathogenic0.990Likely PathogenicLikely Pathogenic3.82Destabilizing0.12.13Destabilizing2.98Destabilizing1.46Destabilizing0.710Likely Pathogenic-5.97Deleterious0.999Probably Damaging0.997Probably Damaging-1.06Pathogenic0.09Tolerated3.37350.18250.1925011.7-34.02
c.1709C>T
A570V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A570V missense variant is catalogued in gnomAD (ID 6‑33440761‑C‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from premPS and SIFT, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Four tools report uncertainty: FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.054494Uncertain0.9320.2630.0006-33440761-C-T16.22e-7-13.083Likely Pathogenic0.882Likely PathogenicAmbiguous0.88Ambiguous0.31.63Ambiguous1.26Ambiguous0.46Likely Benign0.669Likely Pathogenic-3.75Deleterious0.999Probably Damaging0.988Probably Damaging-1.30Pathogenic0.06Tolerated3.37350.10500.3173002.428.05
c.1712C>T
S571L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S571L is listed in ClinVar with an uncertain significance (ClinVar ID 3897075) and is present in gnomAD (ID 6‑33440764‑C‑T). Prediction tools that indicate a benign effect include premPS and AlphaMissense‑Optimized, whereas the remaining tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) all predict a pathogenic outcome. The high‑accuracy AlphaMissense‑Optimized score is benign, whereas the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—supports pathogenicity. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for S571L, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.069024Structured0.045569Uncertain0.9280.2700.000Uncertain 26-33440764-C-T16.23e-7-11.651Likely Pathogenic0.660Likely PathogenicLikely Benign-1.53Ambiguous0.1-1.05Ambiguous-1.29Ambiguous0.27Likely Benign0.841Likely Pathogenic-5.61Deleterious1.000Probably Damaging0.996Probably Damaging-1.25Pathogenic0.04Affected3.37350.09590.3918-2-34.626.08
c.1730C>G
A577G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A577G is listed in ClinVar as Benign (ClinVar ID 1010280.0) and is present in gnomAD (ID 6‑33440782‑C‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions that are inconclusive (FoldX, Rosetta, Foldetta, premPS) are treated as unavailable. High‑accuracy methods give a benign verdict: AlphaMissense‑Optimized is benign, the SGM‑Consensus is Likely Benign, and Foldetta is uncertain. Overall, the majority of reliable predictions support a benign impact, which is consistent with the ClinVar status and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.113710Structured0.019074Uncertain0.9130.2390.000Benign/Likely benign 26-33440782-C-G16.20e-7-5.717Likely Benign0.268Likely BenignLikely Benign0.83Ambiguous0.01.02Ambiguous0.93Ambiguous0.86Ambiguous0.443Likely Benign-1.84Neutral0.997Probably Damaging0.990Probably Damaging-1.31Pathogenic0.31Tolerated3.37340.21200.378010-2.2-14.03158.723.60.00.00.00.0XPotentially BenignAla577 is located near the end and outer surface of an α-helix (res. Arg563-Glu578), where its methyl group does not form any particular interactions in the WT simulations. The introduced residue, glycine, is known as an “α-helix breaker.” However, the residue swap caused only minor helix shortening in one of the replica simulations for the variant system. Regardless, the residue swap seems to be well tolerated based on the variant simulations.
c.1735C>G
R579G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R579G is reported in gnomAD (ID 6‑33440787‑C‑G) and has no ClinVar entry. Prediction tools that assess pathogenicity uniformly favor a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all predict pathogenic. No tool in the dataset reports a benign outcome; the only uncertain calls are from FoldX, AlphaMissense‑Optimized, and Foldetta. High‑accuracy assessments further support pathogenicity: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic, while AlphaMissense‑Optimized and Foldetta remain uncertain. Consequently, the collective evidence indicates that R579G is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.053060Structured0.022872Uncertain0.8770.2440.0006-33440787-C-G16.20e-7-14.298Likely Pathogenic0.948Likely PathogenicAmbiguous1.43Ambiguous0.02.36Destabilizing1.90Ambiguous1.32Destabilizing0.680Likely Pathogenic-5.96Deleterious1.000Probably Damaging1.000Probably Damaging-1.40Pathogenic0.01Affected3.37340.30780.2554-2-34.1-99.14
c.1738G>A
G580S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G580S is listed in ClinVar with an “Uncertain” status (ClinVar ID 1487029.0) and is present in the gnomAD database (gnomAD ID 6‑33440790‑G‑A). Among the available in‑silico predictors, the majority (REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) indicate a pathogenic effect, whereas only SIFT predicts a benign outcome. Predictions that are inconclusive or uncertain include Rosetta, Foldetta, premPS, AlphaMissense‑Optimized, and the SGM‑Consensus (which is derived from the pathogenic majority of the four contributing tools). High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain (combining a pathogenic FoldX result with an uncertain Rosetta result). Overall, the preponderance of evidence points to a pathogenic effect, which is in contrast to the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.025952Uncertain0.8530.2360.000Uncertain 16-33440790-G-A16.20e-7-10.788Likely Pathogenic0.861Likely PathogenicAmbiguous2.84Destabilizing0.20.59Ambiguous1.72Ambiguous0.87Ambiguous0.644Likely Pathogenic-5.73Deleterious1.000Probably Damaging0.999Probably Damaging-1.23Pathogenic0.07Tolerated3.37340.25090.308510-0.430.03233.9-49.30.80.00.60.1XPotentially BenignGly580 is located on the outer surface in a short α-α loop turn connecting two α-helices (res. Arg563-Glu578, res. Glu582-Phe608) in the WT simulations. In the variant simulations, the side chain of Ser580 faces outward, and its hydroxyl group does not make any new or additional interactions compared to Gly580 in the WT simulations that could affect the protein structure.
c.173T>C
M58T
2D
AIThe SynGAP1 missense variant M58T is listed in gnomAD (ID 6‑33423582‑T‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.188120Structured0.484415Uncertain0.5150.6650.0006-33423582-T-C16.20e-7-4.308Likely Benign0.980Likely PathogenicLikely Pathogenic0.159Likely Benign-1.58Neutral0.018Benign0.184Benign4.09Benign0.00Affected4.3210.19990.2357-1-1-2.6-30.09
c.1742G>C
R581P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R581P is not reported in ClinVar and is present in gnomAD (variant ID 6‑33440794‑G‑C). Functional prediction tools that agree on a benign effect include premPS and SIFT, whereas the majority of tools predict a pathogenic impact: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. No predictions are inconclusive or missing. Overall, the evidence strongly favors a pathogenic classification for R581P, and this is consistent with the absence of a ClinVar entry (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.029544Uncertain0.8290.2360.0006-33440794-G-C16.20e-7-13.309Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.13Destabilizing0.13.80Destabilizing3.97Destabilizing0.44Likely Benign0.562Likely Pathogenic-5.68Deleterious1.000Probably Damaging1.000Probably Damaging-1.01Pathogenic0.07Tolerated3.37340.21920.3639-202.9-59.07
c.174G>A
M58I
2D
AIThe SynGAP1 missense variant M58I is not reported in ClinVar (ClinVar ID = None) but is present in gnomAD (ID = 6‑33423583‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains likely benign; Foldetta results are unavailable. Overall, the majority of predictions lean toward a benign impact, and this is not contradicted by ClinVar status. Thus, based on the available evidence, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.188120Structured0.484415Uncertain0.5150.6650.0006-33423583-G-A16.20e-7-2.153Likely Benign0.971Likely PathogenicLikely Pathogenic0.078Likely Benign-0.55Neutral0.006Benign0.091Benign4.21Benign0.00Affected4.3210.13970.3848122.6-18.03
c.1750A>G
I584V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I584V is catalogued in gnomAD (ID 6‑33440802‑A‑G) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, and FATHMM. Two tools (FoldX and ESM1b) returned uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign (2 benign vs. 1 pathogenic vote), and Foldetta predicts benign stability. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar classification is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.059222Structured0.046673Uncertain0.8460.2440.0006-33440802-A-G16.20e-7-7.562In-Between0.234Likely BenignLikely Benign0.67Ambiguous0.10.29Likely Benign0.48Likely Benign1.16Destabilizing0.405Likely Benign-0.95Neutral0.642Possibly Damaging0.349Benign-1.18Pathogenic0.18Tolerated3.37340.10070.265934-0.3-14.03
c.1752C>G
I584M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 I584M is listed in ClinVar (ID 1301269) with an uncertain significance designation and is present in gnomAD (variant ID 6‑33440804‑C‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of individual predictors lean toward a benign outcome, with two high‑accuracy tools supporting benign and one supporting pathogenic. Thus, the variant is most likely benign, which is consistent with its ClinVar uncertain status and does not contradict that classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.059222Structured0.046673Uncertain0.8460.2440.000Uncertain 36-33440804-C-G16.20e-7-10.119Likely Pathogenic0.419AmbiguousLikely Benign0.11Likely Benign0.10.46Likely Benign0.29Likely Benign1.16Destabilizing0.478Likely Benign-2.62Deleterious0.983Probably Damaging0.925Probably Damaging-1.25Pathogenic0.12Tolerated3.37340.07770.212721-2.618.03247.5-20.3-0.10.3-0.10.1XPotentially BenignA hydrophobic residue, Ile584, located in an α helix (res. Glu582-Met603), is swapped for another hydrophobic residue, Met584. The sec-butyl hydrocarbon side chain of Ile584 packs hydrophobically with residues in an inter-helix hydrophobic space (e.g., Leu588, Met477, Val473, and Ile483).In the variant simulations, the thioether hydrophobic side chain of Met584 maintains similar interactions as Ile584 in the WT, as it is roughly the same size and fits well within the hydrophobic space. Thus, the residue swap does not appear to cause any negative effects on the protein structure.
c.1759A>T
R587W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R587W is not reported in ClinVar and is present in gnomAD (ID 6‑33440811‑A‑T). Functional prediction tools show a split assessment: benign predictions come from FoldX, Rosetta, and Foldetta, whereas pathogenic predictions are reported by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: premPS and AlphaMissense‑Optimized. High‑accuracy consensus methods further clarify the picture: the SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic effect, whereas Foldetta, a protein‑folding stability predictor combining FoldX‑MD and Rosetta outputs, classifies the variant as benign. AlphaMissense‑Optimized remains inconclusive. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not conflict with the ClinVar status, which currently lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.054297Structured0.077330Uncertain0.8620.2160.0006-33440811-A-T16.20e-7-15.383Likely Pathogenic0.879Likely PathogenicAmbiguous-0.01Likely Benign0.1-0.44Likely Benign-0.23Likely Benign0.76Ambiguous0.692Likely Pathogenic-7.17Deleterious1.000Probably Damaging0.985Probably Damaging-1.33Pathogenic0.01Affected3.37350.13260.3992-323.630.03
c.1790T>G
F597C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F597C is reported in gnomAD (variant ID 6-33440842‑T‑G) but has no ClinVar entry. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.010926Structured0.142961Uncertain0.9440.1510.0006-33440842-T-G16.19e-7-12.099Likely Pathogenic0.988Likely PathogenicLikely Pathogenic3.77Destabilizing0.24.17Destabilizing3.97Destabilizing1.97Destabilizing0.953Likely Pathogenic-7.96Deleterious1.000Probably Damaging1.000Probably Damaging-2.19Pathogenic0.00Affected3.37350.26180.0783-2-4-0.3-44.04
c.1802C>G
A601G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A601G missense variant is listed in gnomAD (ID 6‑33440854‑C‑G) but has no ClinVar entry. Prediction tools that agree on a benign effect are FATHMM and AlphaMissense‑Optimized; those that agree on a pathogenic effect are REVEL, FoldX, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The high‑accuracy consensus methods give a pathogenic verdict: the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also pathogenic. AlphaMissense‑Default and premPS are uncertain, and no evidence is available from other folding‑stability tools. Overall, the preponderance of evidence points to a pathogenic impact for A601G, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.008895Structured0.174517Uncertain0.9550.1560.0006-33440854-C-G16.19e-7-11.772Likely Pathogenic0.543AmbiguousLikely Benign2.03Destabilizing0.02.31Destabilizing2.17Destabilizing0.94Ambiguous0.511Likely Pathogenic-3.98Deleterious1.000Probably Damaging0.997Probably Damaging2.55Benign0.01Affected3.37350.23370.437001-2.2-14.03
c.1819C>T
L607F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L607F is catalogued in gnomAD (6‑33440871‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all report pathogenic or likely pathogenic. Only FoldX predicts a benign outcome, while Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized are uncertain. High‑accuracy assessments show the SGM‑Consensus as likely pathogenic, AlphaMissense‑Optimized as uncertain, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for L607F, and this conclusion is not contradicted by ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.194229Uncertain0.8690.2500.0006-33440871-C-T16.19e-7-13.654Likely Pathogenic0.948Likely PathogenicAmbiguous0.23Likely Benign0.11.20Ambiguous0.72Ambiguous0.61Ambiguous0.758Likely Pathogenic-3.98Deleterious0.998Probably Damaging0.997Probably Damaging-1.54Pathogenic0.01Affected3.37350.08720.281602-1.034.02
c.1828C>A
L610I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610I is listed in gnomAD (ID 6‑33440880‑C‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions arise from REVEL, polyPhen‑2 (HumDiv and HumVar) and FATHMM. Four tools are uncertain (FoldX, Foldetta, premPS, AlphaMissense‑Default). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores benign, the SGM consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, whereas Foldetta’s stability estimate is unavailable. Overall, the balance of evidence points to a benign effect for L610I, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.271506Structured0.209504Uncertain0.8880.2530.0006-33440880-C-A16.19e-7-6.362Likely Benign0.389AmbiguousLikely Benign1.50Ambiguous0.20.18Likely Benign0.84Ambiguous0.76Ambiguous0.544Likely Pathogenic-1.86Neutral0.992Probably Damaging0.997Probably Damaging-1.34Pathogenic0.15Tolerated3.37350.09990.3219220.70.00
c.1832T>C
M611T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M611T is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33440884‑T‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. Four tools (FoldX, Rosetta, Foldetta, premPS) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact, and this does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.236433Structured0.210791Uncertain0.8700.2530.000Uncertain 16-33440884-T-C16.19e-7-5.696Likely Benign0.101Likely BenignLikely Benign1.98Ambiguous0.20.94Ambiguous1.46Ambiguous0.87Ambiguous0.240Likely Benign-2.40Neutral0.034Benign0.038Benign-1.19Pathogenic0.29Tolerated3.37350.16350.1415-1-1-2.6-30.09
c.1833G>A
M611I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M611I is reported in gnomAD (ID 6‑33440885‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized; pathogenic predictions arise from SGM‑Consensus, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments further clarify the variant’s likely effect: AlphaMissense‑Optimized classifies it as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates pathogenicity, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain stability change. No folding‑stability method provides definitive evidence. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not conflict with ClinVar status, which lacks an entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.236433Structured0.210791Uncertain0.8700.2530.0006-33440885-G-A16.19e-7-8.552Likely Pathogenic0.736Likely PathogenicLikely Benign1.45Ambiguous0.41.36Ambiguous1.41Ambiguous0.72Ambiguous0.292Likely Benign-2.10Neutral0.250Benign0.091Benign-1.14Pathogenic0.38Tolerated3.37350.10090.2302122.6-18.03
c.1841A>C
Y614S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y614S is not reported in ClinVar and is present in gnomAD (ID 6‑33440893‑A‑C). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas the majority of algorithms—AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), premPS, Rosetta, Foldetta, and the SGM Consensus—indicate pathogenicity; FoldX remains uncertain. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic classification, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.0006-33440893-A-C16.20e-7-12.709Likely Pathogenic0.990Likely PathogenicLikely Pathogenic1.74Ambiguous0.43.25Destabilizing2.50Destabilizing2.05Destabilizing0.482Likely Benign-8.83Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.09Tolerated3.37350.41550.1220-2-30.5-76.10
c.1848T>A
D616E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D616E missense variant is catalogued in gnomAD (ID 6‑33440900‑T‑A) but has no ClinVar submission. Functional prediction tools show a split assessment: benign calls come from REVEL, both polyPhen‑2 HumDiv and HumVar, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls arise from PROVEAN, SIFT, and AlphaMissense‑Default. The remaining predictors (FoldX, Rosetta, Foldetta, premPS, ESM1b) are inconclusive. A high‑accuracy consensus (SGM) that aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN yields a pathogenic verdict. AlphaMissense‑Optimized remains benign, and Foldetta, which evaluates protein‑folding stability, is uncertain. Overall, the majority of evidence leans toward pathogenicity, and this conclusion does not conflict with ClinVar because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.166689Uncertain0.8670.2520.0006-33440900-T-A16.20e-7-7.250In-Between0.695Likely PathogenicLikely Benign0.96Ambiguous0.11.52Ambiguous1.24Ambiguous0.58Ambiguous0.092Likely Benign-2.85Deleterious0.421Benign0.232Benign3.32Benign0.03Affected3.37350.12250.4128230.014.03
c.1849G>A
E617K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E617K is not reported in ClinVar but is present in gnomAD (6‑33440901‑G‑A). Functional prediction tools cluster into two groups: benign predictions come from FoldX, premPS, and SIFT, while pathogenic predictions arise from SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. A third set of methods (Foldetta, AlphaMissense‑Optimized, Rosetta) yield uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect for E617K, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.155123Uncertain0.8770.2400.0006-33440901-G-A16.20e-7-10.702Likely Pathogenic0.910Likely PathogenicAmbiguous0.37Likely Benign0.11.19Ambiguous0.78Ambiguous0.17Likely Benign0.534Likely Pathogenic-3.32Deleterious0.997Probably Damaging0.987Probably Damaging-1.34Pathogenic0.48Tolerated3.37350.19810.628210-0.4-0.94
c.184G>A
D62N
2D
AIThe SynGAP1 missense variant D62N is reported in gnomAD (variant ID 6‑33423593‑G‑A) but has no ClinVar entry. In silico prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign status. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the consensus of the majority of tools indicates that D62N is most likely benign, and this assessment does not contradict any ClinVar classification because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.425610Structured0.476010Uncertain0.5750.7200.1256-33423593-G-A16.20e-7-4.607Likely Benign0.207Likely BenignLikely Benign0.075Likely Benign-1.08Neutral0.028Benign0.032Benign4.11Benign0.00Affected4.3210.16700.6154120.0-0.98
c.1861C>G
R621G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R621G is reported in gnomAD (ID 6‑33440913‑C‑G) but has no ClinVar entry. In silico predictors largely agree on a deleterious effect: pathogenic calls come from REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The only benign prediction is from FATHMM; FoldX and Foldetta give uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.222385Structured0.084420Uncertain0.9450.2160.0006-33440913-C-G16.20e-7-16.611Likely Pathogenic0.993Likely PathogenicLikely Pathogenic1.18Ambiguous0.32.07Destabilizing1.63Ambiguous1.17Destabilizing0.558Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.84Benign0.01Affected3.37350.31090.2651-2-34.1-99.14
c.1883A>G
K628R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K628R is reported in gnomAD (variant ID 6‑33440935‑A‑G) but has no ClinVar entry. Functional prediction tools show a split assessment: benign calls come from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Two tools remain inconclusive (premPS and AlphaMissense‑Default). The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a likely pathogenic verdict, while the high‑accuracy AlphaMissense‑Optimized predicts benign. Foldetta, a protein‑folding stability method that combines FoldX‑MD and Rosetta outputs, also predicts benign. Overall, the majority of evidence leans toward pathogenicity, and this conclusion does not conflict with ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.035486Uncertain0.9570.2290.0006-33440935-A-G16.20e-7-11.324Likely Pathogenic0.476AmbiguousLikely Benign0.22Likely Benign0.1-0.11Likely Benign0.06Likely Benign0.94Ambiguous0.592Likely Pathogenic-2.99Deleterious0.996Probably Damaging0.990Probably Damaging2.49Pathogenic0.00Affected3.37340.38730.087323-0.628.01
c.1884G>T
K628N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K628N is catalogued in gnomAD (6‑33440936‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: a single benign prediction from REVEL, and a consensus of nine pathogenic predictions from premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also labels the variant as Likely Pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus confirms a likely pathogenic status, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result and therefore does not alter the overall interpretation. Consequently, the variant is most likely pathogenic according to the available computational evidence, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.035486Uncertain0.9570.2290.0006-33440936-G-T16.20e-7-12.284Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.78Ambiguous0.10.59Ambiguous0.69Ambiguous1.11Destabilizing0.403Likely Benign-4.98Deleterious1.000Probably Damaging1.000Probably Damaging2.37Pathogenic0.00Affected3.37340.27400.1254010.4-14.07
c.1890C>G
I630M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I630M is listed in gnomAD (ID 6‑33440942‑C‑G) but has no ClinVar entry. Functional prediction tools show a split: benign calls come from Rosetta, Foldetta, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic calls come from REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. FoldX is uncertain, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive. High‑accuracy assessments give AlphaMissense‑Optimized benign, Foldetta benign, and an inconclusive SGM Consensus. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.040537Structured0.036106Uncertain0.9660.2360.0006-33440942-C-G16.20e-7-10.586Likely Pathogenic0.259Likely BenignLikely Benign-0.55Ambiguous0.10.32Likely Benign-0.12Likely Benign1.06Destabilizing0.508Likely Pathogenic-1.90Neutral0.833Possibly Damaging0.700Possibly Damaging-1.38Pathogenic0.02Affected3.37340.06180.175912-2.618.03
c.1897C>G
L633V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L633V is not reported in ClinVar and is present in the gnomAD database (ID 6‑33440949‑C‑G). Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, SGM‑Consensus, and Foldetta; the Rosetta score is uncertain and therefore not considered. High‑accuracy methods give a pathogenic consensus: AlphaMissense‑Optimized predicts benign, but the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta both predict pathogenic. Overall, the majority of evidence supports a pathogenic impact for L633V, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.045407Uncertain0.9520.2520.0006-33440949-C-G16.20e-7-9.992Likely Pathogenic0.760Likely PathogenicLikely Benign2.32Destabilizing0.21.71Ambiguous2.02Destabilizing1.32Destabilizing0.327Likely Benign-2.99Deleterious0.996Probably Damaging0.992Probably Damaging2.86Benign0.03Affected3.37340.15170.2766120.4-14.03
c.1918A>T
T640S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T640S is listed in ClinVar as Benign (ClinVar ID 2980241.0) and is present in the gnomAD database (gnomAD ID 6‑33441177‑A‑T). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive result is from FoldX, which is treated as unavailable. High‑accuracy assessments confirm benignity: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is benign. Overall, the variant is most likely benign, and this conclusion is consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.066181Structured0.137043Uncertain0.8930.2840.000Benign 16-33441177-A-T16.20e-7-2.371Likely Benign0.062Likely BenignLikely Benign-0.78Ambiguous0.10.43Likely Benign-0.18Likely Benign-0.30Likely Benign0.088Likely Benign0.92Neutral0.000Benign0.001Benign3.60Benign0.33Tolerated3.37300.34060.348411-0.1-14.03
c.191T>C
I64T
2D
AIThe SynGAP1 missense variant I64T is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33425799‑T‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Those that predict a pathogenic effect are SIFT and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Benign, and the Foldetta protein‑folding stability analysis is unavailable. Based on the collective predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.422041Structured0.475481Uncertain0.4780.7470.1256-33425799-T-C16.20e-7-3.183Likely Benign0.943Likely PathogenicAmbiguous0.075Likely Benign-0.51Neutral0.092Benign0.007Benign4.08Benign0.00Affected4.3210.09780.0851-10-5.2-12.05
c.1940G>A
G647D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G647D is reported in ClinVar as having no entry and is present in gnomAD (6‑33441199‑G‑A). Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized all predict benign. Only AlphaMissense‑Default predicts pathogenic, while FoldX, Foldetta, premPS, and ESM1b are uncertain. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields benign; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Overall, the consensus of most tools and the high‑accuracy predictions indicate that G647D is most likely benign, and this is consistent with the absence of a pathogenic ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.048328Structured0.325524Uncertain0.9360.3560.0006-33441199-G-A16.20e-7-7.643In-Between0.582Likely PathogenicLikely Benign0.68Ambiguous0.10.33Likely Benign0.51Ambiguous0.56Ambiguous0.098Likely Benign-1.63Neutral0.282Benign0.128Benign3.45Benign0.24Tolerated3.37300.16300.1372-11-3.158.04
c.194A>G
H65R
2D
AIThe SynGAP1 missense variant H65R is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33425802‑A‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM‑Consensus remains benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.411940Structured0.476188Uncertain0.4580.7580.125Uncertain 16-33425802-A-G16.20e-7-1.980Likely Benign0.967Likely PathogenicLikely Pathogenic0.073Likely Benign-1.60Neutral0.462Possibly Damaging0.227Benign4.19Benign0.00Affected4.3210.14830.167120-1.319.05
c.195C>A
H65Q
2D
AIThe SynGAP1 missense variant H65Q is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33425803‑C‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM‑Consensus as “Likely Benign,” and Foldetta results are unavailable. Based on the overall distribution of predictions, the variant is most likely benign, and this assessment does not contradict the ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.411940Structured0.476188Uncertain0.4580.7580.1256-33425803-C-A16.20e-7-2.966Likely Benign0.953Likely PathogenicAmbiguous0.035Likely Benign-1.46Neutral0.462Possibly Damaging0.227Benign4.19Benign0.00Affected4.3210.10590.290003-0.3-9.01
c.1964T>C
L655P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L655P is catalogued in gnomAD (ID 6‑33441223‑T‑C) but has no ClinVar entry. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, SIFT, and FATHMM, whereas pathogenic calls are made by Rosetta, Foldetta, both polyPhen‑2 versions, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX and premPS are uncertain. High‑accuracy assessments give AlphaMissense‑Optimized as pathogenic, Foldetta as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive. Overall, the majority of evidence points to a pathogenic effect. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.015344Structured0.268808Uncertain0.9610.2740.0006-33441223-T-C16.20e-7-9.771Likely Pathogenic0.982Likely PathogenicLikely Pathogenic1.33Ambiguous0.56.52Destabilizing3.93Destabilizing0.57Ambiguous0.126Likely Benign-1.36Neutral0.981Probably Damaging0.772Possibly Damaging3.47Benign0.32Tolerated3.39240.35980.1274-3-3-5.4-16.04
c.1966G>C
E656Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E656Q is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441225‑G‑C). Functional prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default; Rosetta reports an uncertain result. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑2 split. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.032017Structured0.242242Uncertain0.9630.2640.000Uncertain 16-33441225-G-C16.20e-7-9.145Likely Pathogenic0.766Likely PathogenicLikely Benign-0.14Likely Benign0.0-0.81Ambiguous-0.48Likely Benign0.25Likely Benign0.249Likely Benign-2.29Neutral0.980Probably Damaging0.528Possibly Damaging3.46Benign0.02Affected3.39240.17390.6645220.0-0.98224.31.70.00.10.10.0XPotentially BenignThe carboxylate side chain of Glu656, located on an α helix (res. Ser641-Glu666), frequently forms a hydrogen bond with the nearby residue Ser659 on the same α helix. In the variant simulations, the carboxamide side chain of Gln656 alternatively forms a hydrogen bond with either Ser659 or Glu548 on an opposing helix (res. Ala533-Val560).Although the frequent interaction between Gln656 and Glu548 may strengthen or stabilize the tertiary structure assembly, the effect is likely to be marginal.
c.1979T>C
M660T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M660T is catalogued in gnomAD (ID 6‑33441238‑T‑C) but has no ClinVar entry, so its clinical status is currently unreported. In silico prediction tools largely agree that the substitution is deleterious: pathogenic predictions come from SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a benign effect. High‑accuracy assessments reinforce the pathogenic view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding result is missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.0006-33441238-T-C16.20e-7-9.791Likely Pathogenic0.989Likely PathogenicLikely Pathogenic3.62Destabilizing0.12.05Destabilizing2.84Destabilizing1.91Destabilizing0.561Likely Pathogenic-5.99Deleterious0.967Probably Damaging0.633Possibly Damaging3.36Benign0.02Affected3.38280.18110.1630-1-1-2.6-30.09
c.1991T>C
L664S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L664S is listed in ClinVar as Benign (ClinVar ID 2429773.0) and is present in gnomAD (ID 6‑33441250‑T‑C). Prediction tools that report a benign effect include only FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the overwhelming majority of pathogenic predictions—including the high‑accuracy tools—the variant is most likely pathogenic, which contradicts its ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.100716Structured0.089318Uncertain0.9370.3390.000Likely Benign 16-33441250-T-C16.20e-7-16.498Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.75Destabilizing0.23.63Destabilizing3.69Destabilizing2.77Destabilizing0.543Likely Pathogenic-5.99Deleterious1.000Probably Damaging0.996Probably Damaging2.85Benign0.00Affected3.38280.20910.0896-3-2-4.6-26.08215.550.10.00.0-0.20.2XPotentially BenignThe iso-butyl side chain of L664, located on an α-helix (res. Ser641-Glu666), hydrophobically interacts with residues in the inter-helix space between three helices (res. Glu617-Asn635, res. Glu582-Met603, and res. Ser641-Glu666), such as Ile589, Phe663, and Met660. In the variant simulations, the hydroxyl group of Ser664 forms hydrogen bonds with the backbone carbonyl oxygen of another helix residue, such as Met660 or Gln661. This interaction is known to destabilize hydrogen bonding in the α-helix, but this effect was not observed in the simulations. Additionally, Ser664 occasionally forms hydrogen bonds with the carboxylate group of Asp586 on another α-helix (res. Glu582-Met603), which could minimally influence the tertiary structure assembly. Despite these interactions, no major negative effects on the protein structure were observed during the simulations.
c.1994A>G
Y665C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y665C is listed in ClinVar with no assertion (status: None) and is present in gnomAD (ID 6‑33441253‑A‑G). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. FoldX, Rosetta, and Foldetta give uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is also unavailable. Overall, the evidence is mixed, but the majority of high‑confidence tools lean toward a benign interpretation. Thus, the variant is most likely benign based on current predictions, and this does not contradict the ClinVar status, which remains unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.098513Structured0.086641Uncertain0.9220.3610.0006-33441253-A-G16.20e-7-9.007Likely Pathogenic0.261Likely BenignLikely Benign1.05Ambiguous0.11.60Ambiguous1.33Ambiguous1.12Destabilizing0.210Likely Benign-3.22Deleterious1.000Probably Damaging0.981Probably Damaging3.45Benign0.14Tolerated3.38280.25620.2019-203.8-60.04
c.2030G>A
S677N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S677N is catalogued in gnomAD (6‑33441289‑G‑A) but has no ClinVar entry. Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while premPS and ESM1b are uncertain. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is benign. Thus, all available evidence supports a benign classification, and there is no conflict with ClinVar status (which is absent). The variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.194234Structured0.115685Uncertain0.5550.3380.1256-33441289-G-A16.20e-7-7.955In-Between0.111Likely BenignLikely Benign0.17Likely Benign0.5-0.15Likely Benign0.01Likely Benign0.89Ambiguous0.079Likely Benign-2.05Neutral0.038Benign0.007Benign3.28Benign0.15Tolerated3.41230.17630.568811-2.727.03
c.2033G>A
S678N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678N is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID 6‑33441292‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Overall, the variant is most likely benign, and this conclusion does not contradict ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.301917Structured0.123585Uncertain0.6600.3210.0006-33441292-G-A16.20e-7-3.355Likely Benign0.139Likely BenignLikely Benign-0.10Likely Benign0.1-0.47Likely Benign-0.29Likely Benign0.38Likely Benign0.067Likely Benign-0.63Neutral0.001Benign0.002Benign3.43Benign0.14Tolerated3.43190.14350.486311-2.727.03
c.2041G>C
G681R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681R is listed in gnomAD (6-33441300-G-C) but has no ClinVar entry. In silico predictors largely converge on a deleterious effect: benign calls are limited to FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—report pathogenicity. premPS is inconclusive. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates pathogenic folding instability. No prediction tool suggests a benign outcome, and the variant’s presence in gnomAD does not alter the consensus. Thus, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.0006-33441300-G-C16.20e-7-12.170Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.25Destabilizing1.75.46Destabilizing3.86Destabilizing0.99Ambiguous0.556Likely Pathogenic-7.98Deleterious0.999Probably Damaging0.928Probably Damaging3.42Benign0.00Affected3.43140.10220.3879-2-3-4.199.14
c.206T>C
I69T
2D
AIThe SynGAP1 missense variant I69T is listed in gnomAD (ID 6‑33425814‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as “Likely Benign” (three benign votes versus one pathogenic). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. Foldetta results are unavailable, so they do not influence the assessment. Overall, the majority of evidence points to a benign effect for I69T, and this conclusion does not contradict any ClinVar status, as none is reported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.466129Uncertain0.4370.7860.3756-33425814-T-C16.20e-7-2.978Likely Benign0.755Likely PathogenicLikely Benign0.116Likely Benign-0.79Neutral0.824Possibly Damaging0.507Possibly Damaging4.15Benign0.00Affected4.3210.10220.0891-10-5.2-12.05
c.2072C>T
T691I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T691I is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (gnomAD ID: 6‑33441331‑C‑T). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from FoldX, Foldetta, and premPS. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, while Foldetta remains uncertain. Overall, the evidence overwhelmingly indicates that T691I is most likely benign, and this conclusion does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.060549Structured0.271308Uncertain0.9410.2320.0006-33441331-C-T16.20e-7-5.857Likely Benign0.202Likely BenignLikely Benign-1.08Ambiguous0.1-2.12Stabilizing-1.60Ambiguous-0.61Ambiguous0.052Likely Benign-1.19Neutral0.040Benign0.003Benign3.49Benign0.34Tolerated3.43140.06440.5397-105.212.05
c.2089T>C
W697R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W697R is listed in ClinVar as Benign (ClinVar ID 703213.0) and is present in the gnomAD database (gnomAD ID 6‑33441348‑T‑C). Functional prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple pathogenic‑predicting tools suggests that the variant is most likely pathogenic, which contradicts its current ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.400169Uncertain0.9450.2970.000Likely Benign 16-33441348-T-C16.20e-7-10.020Likely Pathogenic0.941Likely PathogenicAmbiguous1.14Ambiguous0.11.18Ambiguous1.16Ambiguous1.25Destabilizing0.401Likely Benign-9.50Deleterious1.000Probably Damaging0.994Probably Damaging3.45Benign0.02Affected3.46130.39440.06122-3-3.6-30.03254.4-41.20.00.0-0.70.0XPotentially BenignThe indole ring of Trp697, located on the outer surface of an α-helix (res. Leu685-Val699), is not involved in any long-lasting interactions in the WT simulations. In the variant simulations, the positively charged guanidinium side chain of Arg697 occasionally forms hydrogen bonds with nearby residues, such as Ser722 and Asn719. However, similar to Trp697 in the WT, Arg697 does not form any long-lasting interactions and thus does not induce any negative structural effects in the simulations.
c.208C>G
R70G
2D
AIThe SynGAP1 missense variant R70G is listed in gnomAD (ID 6‑33425816‑C‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar) and SIFT. AlphaMissense‑Default is uncertain, and Foldetta (FoldX‑MD/Rosetta stability assessment) has no result for this variant. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also indicates a likely benign outcome; Foldetta data are unavailable. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the absence of a ClinVar pathogenic classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.458981Uncertain0.3920.7930.3756-33425816-C-G16.20e-7-3.555Likely Benign0.430AmbiguousLikely Benign0.095Likely Benign-0.61Neutral0.962Probably Damaging0.726Possibly Damaging4.11Benign0.00Affected4.3210.30780.3194-2-34.1-99.14
c.209G>A
R70Q
2D
AIThe SynGAP1 missense variant R70Q is reported in gnomAD (variant ID 6-33425817‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: the majority (REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a benign effect, while a minority (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT) predict pathogenicity. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized classifies the variant as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as Likely Benign. No Foldetta stability data are available, so it does not influence the conclusion. Overall, the preponderance of evidence from both general and high‑accuracy predictors points to a benign impact. This assessment is not in conflict with ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.458981Uncertain0.3920.7930.3756-33425817-G-A16.20e-7-3.399Likely Benign0.180Likely BenignLikely Benign0.109Likely Benign-0.04Neutral0.983Probably Damaging0.602Possibly Damaging4.25Benign0.00Affected4.3210.25120.2506111.0-28.06
c.2113A>C
K705Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K705Q missense variant (ClinVar ID 3699560.0) is listed as “Uncertain” in ClinVar and is present in gnomAD (variant ID 6‑33441372‑A‑C). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (benign), FATHMM (benign), and PROVEAN (benign)—also yields a benign classification; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the preponderance of evidence supports a benign impact for K705Q, and this conclusion does not contradict the ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.134866Structured0.379324Uncertain0.9220.3640.000Uncertain 16-33441372-A-C16.20e-7-5.787Likely Benign0.436AmbiguousLikely Benign-0.10Likely Benign0.00.33Likely Benign0.12Likely Benign-0.02Likely Benign0.142Likely Benign-0.24Neutral0.997Probably Damaging0.969Probably Damaging3.42Benign0.78Tolerated3.47100.30630.1014110.4-0.04
c.2119G>A
A707T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A707T is reported in gnomAD (ID 6‑33441584‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also benign. The Foldetta stability prediction is inconclusive and therefore not considered evidence. Overall, the consensus of available predictions indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.203355Structured0.371229Uncertain0.9270.3650.0006-33441584-G-A16.20e-7-0.836Likely Benign0.175Likely BenignLikely Benign0.50Ambiguous0.02.36Destabilizing1.43Ambiguous0.10Likely Benign0.252Likely Benign-0.57Neutral0.980Probably Damaging0.947Probably Damaging3.52Benign0.44Tolerated3.5090.08800.433001-2.530.03
c.2120C>T
A707V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A707V variant is not reported in ClinVar (no ClinVar ID) but is present in gnomAD (variant ID 6‑33441585‑C‑T). Functional prediction tools largely agree on a benign effect: REVEL, FoldX, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign classification. Only three tools—Rosetta, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar—predict pathogenicity, while Foldetta reports an uncertain stability change. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM‑Consensus is benign, and Foldetta remains uncertain. Overall, the majority of evidence supports a benign impact for A707V, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.203355Structured0.371229Uncertain0.9270.3650.0006-33441585-C-T16.20e-7-6.479Likely Benign0.277Likely BenignLikely Benign0.05Likely Benign0.02.17Destabilizing1.11Ambiguous-0.30Likely Benign0.212Likely Benign-1.62Neutral0.991Probably Damaging0.912Probably Damaging3.45Benign1.00Tolerated3.5090.07940.4048002.428.05
c.212A>G
D71G
2D
AIThe SynGAP1 missense variant D71G is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33425820‑A‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.456046Uncertain0.3500.7990.3756-33425820-A-G16.20e-7-3.136Likely Benign0.439AmbiguousLikely Benign0.111Likely Benign-1.82Neutral0.171Benign0.021Benign4.03Benign0.00Affected4.3210.38020.5704-113.1-58.04
c.2131C>G
L711V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L711V is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441596‑C‑G). Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. The majority of other in silico predictors—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify the change as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as likely pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect, which does not conflict with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000Uncertain16-33441596-C-G16.20e-7-10.045Likely Pathogenic0.709Likely PathogenicLikely Benign3.48Destabilizing0.12.22Destabilizing2.85Destabilizing1.40Destabilizing0.170Likely Benign-2.59Deleterious0.992Probably Damaging0.970Probably Damaging3.34Benign0.00Affected3.5090.13180.3010120.4-14.03
c.2134G>T
G712C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712C is catalogued in gnomAD (6‑33441599‑G‑T) but has no ClinVar entry. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.0006-33441599-G-T16.20e-7-11.376Likely Pathogenic0.829Likely PathogenicAmbiguous2.54Destabilizing0.05.72Destabilizing4.13Destabilizing0.56Ambiguous0.516Likely Pathogenic-7.75Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.00Affected3.5090.15130.3947-3-32.946.09
c.2135G>A
G712D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G712D is catalogued in gnomAD (ID 6‑33441600‑G‑A) but has no ClinVar entry. In silico predictors show mixed results: benign calls come from REVEL, SIFT, and FATHMM, while pathogenic calls are made by FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Uncertain predictions are reported by premPS and AlphaMissense‑Optimized. The high‑accuracy consensus tools give a pathogenic verdict: AlphaMissense‑Optimized is inconclusive, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Overall, the majority of reliable predictors and the consensus methods lean toward a pathogenic effect, and this assessment does not conflict with ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.0006-33441600-G-A16.20e-7-8.211Likely Pathogenic0.946Likely PathogenicAmbiguous2.87Destabilizing0.15.37Destabilizing4.12Destabilizing0.90Ambiguous0.320Likely Benign-5.69Deleterious1.000Probably Damaging0.999Probably Damaging3.67Benign0.12Tolerated3.5090.21460.2533-11-3.158.04
c.2143C>T
P715S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P715S is listed in ClinVar as pathogenic (ClinVar ID 1804065.0) and is present in gnomAD (ID 6‑33441608‑C‑T). Functional prediction tools that agree on a benign effect are REVEL and FATHMM. Those that predict a pathogenic effect include FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. Predictions that are inconclusive are Rosetta, premPS, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of evidence points to a pathogenic impact, which is consistent with the ClinVar classification and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.243554Structured0.409757Uncertain0.9560.3620.000Likely Pathogenic 16-33441608-C-T16.20e-7-7.635In-Between0.787Likely PathogenicAmbiguous3.54Destabilizing0.00.81Ambiguous2.18Destabilizing0.94Ambiguous0.277Likely Benign-7.17Deleterious1.000Probably Damaging0.998Probably Damaging3.43Benign0.01Affected3.5090.29770.37551-10.8-10.04231.8-14.0-0.10.0-0.80.1XUncertainPro715, along with Gly712 and Pro713, are located in a hinge region of an α-helix making a ~90-degree turn (res. Lys705-Leu725). In the WT simulations, the pyrrolidine side chain of Pro715, lacking the backbone amide groups altogether, forces the tight helix turn to take place while also hydrophobically packing with nearby residues (e.g., Leu700, Leu708, Leu714, and Leu718). Leu715, with a normal amide backbone, could potentially affect protein folding and turn formation, although this was not observed in the variant simulations. Additionally, the hydroxyl group of the Ser715 side chain can form hydrogen bonds with the backbone carbonyl group of Gly712 and disrupt the hydrophobic packing arrangement of the leucine residues from the neighboring α-helices, impacting the GAP domain tertiary assembly.
c.214C>T
R72W
2D
AIThe SynGAP1 missense variant R72W is catalogued in gnomAD (ID 6‑33425822‑C‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions are reported by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized scores the variant as benign, and the SGM‑Consensus also indicates a likely benign outcome. The Foldetta stability analysis is unavailable, providing no additional evidence. Overall, the preponderance of computational evidence points to a benign effect for R72W, and this conclusion is not contradicted by any ClinVar classification (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.497853Structured0.455349Uncertain0.3550.8190.3756-33425822-C-T16.20e-7-5.546Likely Benign0.430AmbiguousLikely Benign0.145Likely Benign-1.82Neutral0.994Probably Damaging0.689Possibly Damaging4.07Benign0.00Affected4.3210.16010.3652-323.630.03
c.2165G>C
S722T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S722T is reported in gnomAD (6‑33441630‑G‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only polyPhen‑2 HumDiv predicts it as pathogenic, while FoldX is uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. No prediction or stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.468512Structured0.457186Uncertain0.9500.4310.3756-33441630-G-C16.20e-7-5.734Likely Benign0.202Likely BenignLikely Benign0.53Ambiguous0.0-0.32Likely Benign0.11Likely Benign-0.12Likely Benign0.118Likely Benign-0.57Neutral0.921Possibly Damaging0.414Benign2.57Benign1.00Tolerated3.5080.13570.4363110.114.03
c.2181C>A
N727K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N727K is catalogued in gnomAD (ID 6‑33441646‑C‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, SIFT, and the protein‑folding stability method Foldetta; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the consensus score SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain, SGM Consensus indicates likely pathogenic, and Foldetta reports benign stability. Overall, the majority of evidence points to a pathogenic effect, and this conclusion is not contradicted by ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.538167Disordered0.442107Uncertain0.8430.5420.6256-33441646-C-A16.19e-7-10.601Likely Pathogenic0.884Likely PathogenicAmbiguous-0.12Likely Benign0.2-0.44Likely Benign-0.28Likely Benign0.86Ambiguous0.148Likely Benign-3.82Deleterious0.998Probably Damaging0.994Probably Damaging2.18Pathogenic0.12Tolerated3.5970.20020.559001-0.414.07
c.2182C>T
P728S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P728S is not reported in ClinVar and is present in gnomAD (ID 6‑33441647‑C‑T). Functional prediction tools that agree on a benign effect include REVEL, whereas the majority of tools predict pathogenicity: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain results from FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized are treated as unavailable. High‑accuracy consensus methods give a Likely Pathogenic verdict from the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and an Uncertain outcome from AlphaMissense‑Optimized; Foldetta also reports Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for P728S, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.632174Disordered0.434760Uncertain0.7250.5670.6256-33441647-C-T16.20e-7-9.047Likely Pathogenic0.897Likely PathogenicAmbiguous0.89Ambiguous0.00.98Ambiguous0.94Ambiguous0.54Ambiguous0.280Likely Benign-6.38Deleterious1.000Probably Damaging0.998Probably Damaging0.68Pathogenic0.00Affected3.5970.35710.3571-110.8-10.04
c.2186A>C
N729T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N729T is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID 6‑33441651‑A‑C). Consensus among the majority of in‑silico predictors is benign: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign”; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yields an uncertain result. Overall, the evidence strongly supports a benign effect, and this conclusion does not contradict ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.426547Uncertain0.6510.5830.6256-33441651-A-C16.20e-7-1.952Likely Benign0.103Likely BenignLikely Benign0.52Ambiguous0.31.73Ambiguous1.13Ambiguous-0.34Likely Benign0.052Likely Benign-0.52Neutral0.123Benign0.042Benign3.33Benign1.00Tolerated3.5970.12010.4805002.8-13.00
c.2186A>T
N729I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N729I is listed in gnomAD (ID 6‑33441651‑A‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, premPS, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic effect are PROVEAN and polyPhen‑2 HumDiv. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicting benign, while Foldetta’s stability analysis is inconclusive. Overall, the majority of evidence points to a benign impact. There is no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.426547Uncertain0.6510.5830.6256-33441651-A-T16.20e-7-3.308Likely Benign0.234Likely BenignLikely Benign0.54Ambiguous0.60.79Ambiguous0.67Ambiguous0.29Likely Benign0.043Likely Benign-2.96Deleterious0.506Possibly Damaging0.243Benign3.26Benign0.13Tolerated3.5970.06250.4698-3-28.0-0.94
c.2194A>G
R732G
2D
AIThe SynGAP1 R732G missense variant is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (ID 6‑33441659‑A‑G). Prediction tools that agree on a benign effect include REVEL, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, whereas tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 benign vs. 2 pathogenic), and Foldetta results are unavailable. Overall, the majority of standard predictors lean toward pathogenicity, while the most accurate single predictor (AlphaMissense‑Optimized) suggests a benign outcome. Given the lack of ClinVar evidence, there is no contradiction; the variant is most likely pathogenic based on the collective predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.846163Disordered0.412403Uncertain0.4270.6730.7506-33441659-A-G16.20e-7-9.348Likely Pathogenic0.295Likely BenignLikely Benign0.145Likely Benign-2.98Deleterious1.000Probably Damaging0.982Probably Damaging2.56Benign0.03Affected3.5970.30800.2942-2-34.1-99.14
c.2214T>G
S738R
2D
AIThe SynGAP1 missense variant S738R is listed in ClinVar (ID 1592652.0) as Benign and is present in gnomAD (variant ID 6‑33441679‑T‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to Likely Benign (three benign votes versus one pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Benign; Foldetta’s protein‑folding stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, aligning with the ClinVar designation and not contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.812494Disordered0.441162Uncertain0.2840.8270.875Benign 16-33441679-T-G16.20e-7-4.241Likely Benign0.570Likely PathogenicLikely Benign0.068Likely Benign-1.55Neutral0.473Possibly Damaging0.193Benign2.69Benign0.01Affected4.3220.08870.28910-1-3.769.11
c.2225G>C
R742P
2D
AIThe SynGAP1 missense variant R742P is catalogued in gnomAD (6-33441690‑G‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign or likely benign outcome. Only SIFT classifies the change as pathogenic, representing the sole discordant prediction. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise reports likely benign. The Foldetta protein‑folding stability analysis is not available for this variant. Overall, the preponderance of evidence points to a benign impact, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.871313Disordered0.509587Binding0.3090.8560.8756-33441690-G-C16.20e-7-2.920Likely Benign0.112Likely BenignLikely Benign0.081Likely Benign-0.51Neutral0.001Benign0.004Benign2.84Benign0.03Affected4.3220.25980.3637-202.9-59.07
c.2227C>T
P743S
2D
AIThe SynGAP1 missense variant P743S is listed in gnomAD (ID 6‑33441692‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the change as benign. Only SIFT predicts a pathogenic outcome. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is “Likely Benign.” No Foldetta stability data are available, so it does not influence the assessment. Overall, the preponderance of evidence indicates that P743S is most likely benign, and this conclusion is not contradicted by any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.852992Disordered0.526809Binding0.3170.8620.8756-33441692-C-T16.19e-7-4.286Likely Benign0.063Likely BenignLikely Benign0.085Likely Benign-0.33Neutral0.021Benign0.015Benign2.93Benign0.00Affected4.3220.30870.3948-110.8-10.0410.1016/j.ajhg.2020.11.011
c.2228C>T
P743L
2D
AIThe SynGAP1 missense variant P743L is listed in gnomAD (ID 6‑33441693‑C‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; a Foldetta stability analysis is not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status, as none is reported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.852992Disordered0.526809Binding0.3170.8620.8756-33441693-C-T16.19e-7-4.838Likely Benign0.081Likely BenignLikely Benign0.112Likely Benign-2.21Neutral0.801Possibly Damaging0.192Benign2.73Benign0.00Affected4.3220.21660.5533-3-35.416.04
c.222C>A
S74R
2D
AIThe SynGAP1 missense variant S74R is catalogued in gnomAD (ID 6‑33425830‑C‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all report benign or likely benign. Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments confirm the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus, derived from the majority of the high‑confidence predictors, is benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that S74R is most likely benign, and this assessment does not contradict any ClinVar status, as none is reported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.505461Disordered0.450156Uncertain0.2940.8310.5006-33425830-C-A16.20e-7-3.271Likely Benign0.418AmbiguousLikely Benign0.070Likely Benign-1.34Neutral0.361Benign0.019Benign4.08Benign0.00Affected4.3210.09430.3562-10-3.769.11
c.2233C>T
P745S
2D
AIThe SynGAP1 missense variant P745S is reported in gnomAD (variant ID 6-33441698-C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence from multiple prediction algorithms and consensus methods points to a benign effect for P745S, and this conclusion is not contradicted by any ClinVar classification (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.791621Disordered0.558331Binding0.3410.8600.8756-33441698-C-T16.19e-7-4.300Likely Benign0.077Likely BenignLikely Benign0.160Likely Benign-2.32Neutral1.000Probably Damaging0.999Probably Damaging2.54Benign0.05Affected4.3220.33970.3882-110.8-10.04
c.2236G>C
V746L
2D
AIThe SynGAP1 missense variant V746L is catalogued in gnomAD (ID 6‑33441701‑G‑C) but has no ClinVar entry. Across a broad panel of in silico predictors, every tool reports a benign effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. No tool in the set predicts pathogenicity, so the pathogenic group is empty. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta results are not available for this variant. Taken together, the computational evidence overwhelmingly supports a benign effect, and this conclusion does not conflict with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.808535Disordered0.576597Binding0.3360.8670.8756-33441701-G-C16.19e-7-3.260Likely Benign0.086Likely BenignLikely Benign0.015Likely Benign-0.68Neutral0.002Benign0.003Benign2.82Benign0.08Tolerated4.3220.08960.506512-0.414.03
c.2243T>C
L748P
2D
AIThe SynGAP1 missense variant L748P is reported in gnomAD (ID 6‑33441708‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions are made by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments reinforce the benign view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields benign. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy tools indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.611637Binding0.3390.8630.7506-33441708-T-C16.20e-7-2.732Likely Benign0.129Likely BenignLikely Benign0.075Likely Benign-0.69Neutral0.912Possibly Damaging0.611Possibly Damaging2.69Benign0.02Affected4.3220.35030.1399-3-3-5.4-16.04
c.2252C>G
P751R
2D
AIThe SynGAP1 missense variant P751R is catalogued in gnomAD (ID 6‑33441717‑C‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN and polyPhen‑2 HumDiv. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, SGM‑Consensus is likely benign, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.618285Disordered0.667683Binding0.3860.8660.6256-33441717-C-G16.20e-7-5.646Likely Benign0.296Likely BenignLikely Benign0.157Likely Benign-2.61Deleterious0.719Possibly Damaging0.295Benign2.68Benign0.06Tolerated3.9950.13900.3644-20-2.959.07
c.225G>C
E75D
2D
AIThe SynGAP1 missense variant E75D is reported in gnomAD (6‑33425833‑G‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only SIFT predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is “Likely Benign.” No Foldetta stability prediction is available. Overall, the preponderance of evidence indicates that E75D is most likely benign, and this conclusion is not contradicted by ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.595080Disordered0.443881Uncertain0.3030.8220.5006-33425833-G-C16.20e-7-3.710Likely Benign0.073Likely BenignLikely Benign0.058Likely Benign-0.27Neutral0.001Benign0.000Benign4.25Benign0.00Affected4.3210.20260.3833230.0-14.03
c.226T>G
S76A
2D
AIThe SynGAP1 missense variant S76A is reported in gnomAD (ID 6‑33425834‑T‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.444487Uncertain0.2790.8260.5006-33425834-T-G16.20e-7-3.230Likely Benign0.072Likely BenignLikely Benign0.048Likely Benign-1.10Neutral0.643Possibly Damaging0.277Benign3.86Benign0.00Affected4.3210.45430.3619112.6-16.00
c.2273A>C
Y758S
2D
AIThe SynGAP1 missense variant Y758S is reported in gnomAD (variant ID 6‑33441738‑A‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 (HumDiv and HumVar) predict it to be pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (majority‑vote) is benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the preponderance of evidence points to a benign impact, and this assessment does not contradict any ClinVar classification (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.856063Binding0.2890.8710.3756-33441738-A-C16.20e-7-1.912Likely Benign0.215Likely BenignLikely Benign0.110Likely Benign-0.54Neutral0.912Possibly Damaging0.629Possibly Damaging2.75Benign0.06Tolerated3.9950.53770.1663Weaken-2-30.5-76.10
c.2277G>A
M759I
2D
AIThe SynGAP1 missense variant M759I is listed in ClinVar (ID 3686687.0) with an “Uncertain” status and is present in gnomAD (variant ID 6‑33441742‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.879389Binding0.2990.8640.375Uncertain 16-33441742-G-A16.20e-7-4.058Likely Benign0.393AmbiguousLikely Benign0.075Likely Benign-0.88Neutral0.454Possibly Damaging0.192Benign2.83Benign0.34Tolerated3.9950.12350.3129122.6-18.03
c.2279T>C
M760T
2D
AIThe SynGAP1 missense variant M760T is reported in gnomAD (ID 6‑33441744‑T‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; AlphaMissense‑Default is uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates Likely Benign. Foldetta results are unavailable, so they do not influence the assessment. Overall, the consensus of available predictions indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.893402Binding0.3460.8650.3756-33441744-T-C16.20e-7-2.365Likely Benign0.519AmbiguousLikely Benign0.096Likely Benign-1.56Neutral0.425Benign0.252Benign2.71Benign0.41Tolerated3.9950.25150.2875-1-1-2.6-30.09
c.2281C>T
R761W
2D
AIThe SynGAP1 missense variant R761W is listed in gnomAD (ID 6‑33441746‑C‑T) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus remains Likely Pathogenic; Foldetta results are unavailable. Overall, the majority of tools (six pathogenic vs. four benign) suggest a pathogenic effect, and this conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.538167Disordered0.900613Binding0.3530.8650.2506-33441746-C-T16.20e-7-9.248Likely Pathogenic0.665Likely PathogenicLikely Benign0.193Likely Benign-3.52Deleterious1.000Probably Damaging0.987Probably Damaging2.66Benign0.06Tolerated3.9950.10180.3668-323.630.03
c.2282G>C
R761P
2D
AIThe SynGAP1 missense variant R761P is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33441747‑G‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions point to a benign impact, and this is consistent with the ClinVar “Uncertain” designation rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.538167Disordered0.900613Binding0.3530.8650.250Uncertain 36-33441747-G-C16.20e-7-5.091Likely Benign0.640Likely PathogenicLikely Benign0.201Likely Benign-1.89Neutral0.999Probably Damaging0.968Probably Damaging2.69Benign0.38Tolerated3.9950.19980.44490-22.9-59.07
c.2296T>C
S766P
2D
AIThe SynGAP1 missense variant S766P is reported in gnomAD (ID 6‑33442454‑T‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Optimized all classify the change as benign, while SIFT uniquely predicts it as pathogenic. The remaining tools, ESM1b and AlphaMissense‑Default, are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta stability analysis is unavailable. Overall, the preponderance of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.405110Structured0.923125Binding0.3380.8740.2506-33442454-T-C11.28e-6-7.343In-Between0.374AmbiguousLikely Benign0.193Likely Benign-0.91Neutral0.006Benign0.013Benign4.07Benign0.01Affected3.6460.22160.5862-11-0.810.04
c.2314T>C
F772L
2D
AIThe SynGAP1 missense variant F772L is listed in gnomAD (6‑33442472‑T‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus score (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the absence of a ClinVar pathogenic classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.450668Structured0.922662Binding0.3290.8840.2506-33442472-T-C11.28e-6-1.751Likely Benign0.762Likely PathogenicLikely Benign0.161Likely Benign-0.47Neutral0.508Possibly Damaging0.786Possibly Damaging4.31Benign1.00Tolerated3.6460.16610.3033021.0-34.02
c.2318T>C
M773T
2D
AIThe SynGAP1 missense variant M773T is listed in gnomAD (ID 6‑33442476‑T‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only polyPhen‑2 HumVar predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.408655Structured0.916222Binding0.3250.8930.2506-33442476-T-C11.28e-6-4.225Likely Benign0.377AmbiguousLikely Benign0.112Likely Benign-1.63Neutral0.106Benign0.471Possibly Damaging4.22Benign0.06Tolerated3.6460.21960.1586-1-1-2.6-30.09
c.2318T>G
M773R
2D
AIThe SynGAP1 missense variant M773R is listed in gnomAD (ID 6‑33442476‑T‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates benign. No Foldetta (FoldX‑MD/Rosetta stability) result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.408655Structured0.916222Binding0.3250.8930.2506-33442476-T-G11.28e-6-4.340Likely Benign0.597Likely PathogenicLikely Benign0.183Likely Benign-1.87Neutral0.220Benign0.471Possibly Damaging4.18Benign0.02Affected3.6460.17780.0800-10-6.424.99
c.2321C>T
A774V
2D
AIThe SynGAP1 missense variant A774V is catalogued in gnomAD (ID 6‑33442479‑C‑T) but has no ClinVar entry. Across the spectrum of in‑silico predictors, every tool listed—REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently scores the variant as benign. No pathogenic predictions are reported. Grouping by agreement, the benign‑predicting tools comprise the entire set, while the pathogenic group is empty. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Benign.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.450668Structured0.905168Binding0.3360.8970.2506-33442479-C-T11.28e-6-3.075Likely Benign0.108Likely BenignLikely Benign0.055Likely Benign-0.73Neutral0.000Benign0.003Benign4.20Benign1.00Tolerated3.6460.10700.6659002.428.05
c.2326G>A
G776S
2D
AIThe SynGAP1 missense variant G776S is reported in ClinVar as “Not submitted” and is present in gnomAD (variant ID 6-33442484-G-A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus likewise indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of predictive evidence points to a benign effect, and this conclusion does not contradict the ClinVar status, which currently contains no pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.377384Structured0.886983Binding0.2960.8880.2506-33442484-G-A11.28e-6-3.334Likely Benign0.147Likely BenignLikely Benign0.163Likely Benign-1.21Neutral0.997Probably Damaging0.992Probably Damaging4.28Benign0.13Tolerated3.6460.25390.578501-0.430.03
c.2333A>G
N778S
2D
AIThe SynGAP1 missense variant N778S is reported in gnomAD (ID 6‑33442491‑A‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools—polyPhen‑2 HumDiv and HumVar—predict pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.494003Structured0.853922Binding0.2880.8870.5006-33442491-A-G11.28e-6-2.711Likely Benign0.097Likely BenignLikely Benign0.137Likely Benign-0.61Neutral0.843Possibly Damaging0.893Possibly Damaging4.32Benign0.86Tolerated3.6460.42850.6890112.7-27.03
c.2338T>C
S780P
2D
AIThe SynGAP1 missense variant S780P is reported in gnomAD (ID 6‑33442890‑T‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.599170Disordered0.812415Binding0.2830.8830.5006-33442890-T-C16.22e-7-6.055Likely Benign0.234Likely BenignLikely Benign0.088Likely Benign-1.11Neutral0.995Probably Damaging0.892Possibly Damaging2.64Benign0.30Tolerated3.6460.20860.6171-11-0.810.04
c.2342T>C
M781T
2D
AIThe SynGAP1 missense variant M781T is catalogued in gnomAD (ID 6‑33442894‑T‑C) and has no ClinVar entry. Across the evaluated in‑silico tools, every predictor classifies the substitution as benign: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return benign scores. No tool reports a pathogenic or likely pathogenic outcome. The high‑accuracy consensus methods reinforce this view: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta, a protein‑folding stability predictor, has no available result for this variant. Based on the unanimous benign predictions and the lack of any ClinVar pathogenic annotation, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.580690Disordered0.792850Binding0.3420.8890.6256-33442894-T-C16.21e-7-3.774Likely Benign0.310Likely BenignLikely Benign0.175Likely Benign-0.86Neutral0.015Benign0.037Benign2.75Benign0.59Tolerated3.6460.22670.1599-1-1-2.6-30.09
c.2343G>C
M781I
2D
AIThe SynGAP1 missense variant M781I is catalogued in gnomAD (ID 6‑33442895‑G‑C) but has no ClinVar entry. Functional prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all score the substitution as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no reported result for this variant, so its status is unavailable. Overall, the consensus of all available predictions is benign, and this is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.580690Disordered0.792850Binding0.3420.8890.6256-33442895-G-C16.21e-7-2.484Likely Benign0.323Likely BenignLikely Benign0.101Likely Benign0.05Neutral0.000Benign0.001Benign2.89Benign1.00Tolerated3.6460.14050.2793122.6-18.03
c.2347A>G
M783V
2D
AIThe SynGAP1 missense variant M783V is catalogued in gnomAD (ID 6‑33442899‑A‑G) and has no ClinVar entry. All evaluated in‑silico predictors classify it as benign: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool reports a pathogenic outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign effect. Foldetta results are unavailable. Consequently, the variant is most likely benign, and this prediction does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.736850Disordered0.738119Binding0.3310.8890.6256-33442899-A-G16.21e-7-3.453Likely Benign0.086Likely BenignLikely Benign0.065Likely Benign-0.96Neutral0.072Benign0.026Benign2.85Benign0.12Tolerated3.6460.34440.3710122.3-32.06
c.2351C>G
A784G
2D
AIThe SynGAP1 missense variant A784G is reported in gnomAD (ID 6‑33442903‑C‑G) and has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Benign.” Foldetta results are unavailable. Overall, the evidence strongly suggests the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.801317Disordered0.708872Binding0.3140.8960.6256-33442903-C-G16.20e-7-3.370Likely Benign0.158Likely BenignLikely Benign0.056Likely Benign-1.24Neutral0.224Benign0.138Benign2.67Benign0.26Tolerated3.6460.23030.441801-2.2-14.03
c.2375A>C
E792A
2D
AIThe SynGAP1 missense variant E792A is catalogued in gnomAD (ID 6‑33442927‑A‑C) but has no ClinVar submission. Functional prediction tools cluster into two groups: benign (REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized) and pathogenic (PROVEAN, SIFT). The high‑accuracy AlphaMissense‑Optimized score is benign, and the SGM consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also favors benign. Foldetta, a protein‑folding stability predictor, has no available result for this residue. Overall, the preponderance of evidence points to a benign effect. This conclusion is consistent with the absence of a ClinVar pathogenic classification; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.974374Disordered0.452261Uncertain0.3520.8960.8756-33442927-A-C16.20e-7-3.248Likely Benign0.515AmbiguousLikely Benign0.060Likely Benign-3.35Deleterious0.000Benign0.001Benign3.92Benign0.01Affected3.6460.45860.7544-105.3-58.04
c.237C>A
N79K
2D
AIThe SynGAP1 missense variant N79K is listed in gnomAD (ID 6‑33425845‑C‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized scores benign and the SGM‑Consensus indicates “Likely Benign.” No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign effect for the variant, and this conclusion is not contradicted by any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.618285Disordered0.457064Uncertain0.2900.8760.3756-33425845-C-A16.20e-7-2.811Likely Benign0.422AmbiguousLikely Benign0.030Likely Benign-0.91Neutral0.001Benign0.000Benign4.22Benign0.00Affected4.3210.18830.392901-0.414.07
c.237C>G
N79K
2D
AIThe SynGAP1 missense variant N79K is listed in gnomAD (ID 6‑33425845‑C‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign impact. There is no ClinVar classification to contradict this conclusion. Thus, based on current predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.618285Disordered0.457064Uncertain0.2900.8760.3756-33425845-C-G16.20e-7-2.811Likely Benign0.422AmbiguousLikely Benign0.030Likely Benign-0.91Neutral0.001Benign0.000Benign4.22Benign0.00Affected4.3210.18830.392901-0.414.07
c.2380C>A
P794T
2D
AIThe SynGAP1 missense variant P794T is catalogued in gnomAD (ID 6‑33442932‑C‑A) but has no ClinVar entry. Functional prediction tools uniformly indicate a benign effect: SGM‑Consensus (Likely Benign), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. No tool in the dataset predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized reports a benign outcome, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a benign prediction. The Foldetta stability analysis is not available for this variant. Overall, the consensus of all available predictions is benign, and this is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.979741Disordered0.408951Uncertain0.5500.8980.8756-33442932-C-A16.20e-7-4.838Likely Benign0.060Likely BenignLikely Benign0.046Likely Benign-0.34Neutral0.245Benign0.138Benign4.25Benign0.66Tolerated4.0730.17390.6207-100.93.99
c.2383C>T
P795S
2D
AIThe SynGAP1 missense variant P795S is catalogued in gnomAD (6‑33442935‑C‑T) but has no entry in ClinVar. Across the spectrum of in‑silico predictors, every tool listed—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently scores the variant as benign. No pathogenic predictions are reported. Grouping by agreement, all available tools fall into the benign category, with no tools indicating pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely benign. Foldetta results are not provided, so they are treated as unavailable. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.972450Disordered0.410339Uncertain0.4570.9030.8756-33442935-C-T16.20e-7-5.846Likely Benign0.067Likely BenignLikely Benign0.056Likely Benign-0.23Neutral0.001Benign0.002Benign4.30Benign0.24Tolerated4.3220.35170.5766-110.8-10.04
c.239A>G
K80R
2D
AIThe SynGAP1 missense variant K80R is reported in gnomAD (ID 6‑33425847‑A‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts it to be pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.637480Disordered0.477530Uncertain0.3310.8730.5006-33425847-A-G16.20e-7-2.919Likely Benign0.146Likely BenignLikely Benign0.077Likely Benign0.11Neutral0.001Benign0.001Benign4.33Benign0.00Affected4.3210.44810.085823-0.628.01
c.2404G>A
G802S
2D
AIThe SynGAP1 missense variant G802S is catalogued in gnomAD (allele ID 6‑33442956‑G‑A) but has no entry in ClinVar. Functional prediction tools that assess evolutionary conservation and structural impact (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all uniformly predict a benign effect. No tool in the dataset indicates pathogenicity. High‑accuracy assessments further support this view: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no reported result for this variant, so it does not influence the assessment. **Overall, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.894241Disordered0.681966Binding0.2940.8980.6256-33442956-G-A16.20e-7-2.663Likely Benign0.078Likely BenignLikely Benign0.098Likely Benign0.32Neutral0.001Benign0.006Benign2.83Benign0.06Tolerated3.7750.26820.520801-0.430.03
c.2405G>A
G802D
2D
AIThe SynGAP1 missense variant G802D is listed in ClinVar with an “Uncertain” status and is present in gnomAD (6‑33442957‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—all classifying the change as benign. No tool predicts a pathogenic outcome. The high‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign effect. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of available predictions points to a benign impact, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.894241Disordered0.681966Binding0.2940.8980.625Uncertain 16-33442957-G-A16.20e-7-5.083Likely Benign0.476AmbiguousLikely Benign0.153Likely Benign-0.38Neutral0.126Benign0.138Benign2.72Benign0.09Tolerated3.7750.19930.27421-1-3.158.04
c.2411A>G
D804G
2D
AIThe SynGAP1 missense variant D804G is catalogued in gnomAD (ID 6‑33442963‑A‑G) but has no ClinVar entry. Prediction tools cluster into two groups: benign calls come from REVEL, ESM1b, and AlphaMissense‑Optimized, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.801317Disordered0.786762Binding0.2940.9000.6256-33442963-A-G16.20e-7-5.051Likely Benign0.680Likely PathogenicLikely Benign0.287Likely Benign-3.82Deleterious0.980Probably Damaging0.858Possibly Damaging1.21Pathogenic0.04Affected3.7750.38540.6488-113.1-58.04
c.2417T>C
F806S
2D
AIThe SynGAP1 missense variant F806S is catalogued in gnomAD (ID 6‑33442969‑T‑C) but has no ClinVar entry. Functional prediction tools split into two groups: benign predictions come from REVEL and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessment shows AlphaMissense‑Optimized as uncertain, whereas the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves as likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar status because none is reported. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.736850Disordered0.847454Binding0.2760.9040.5006-33442969-T-C16.20e-7-6.959Likely Benign0.911Likely PathogenicAmbiguous0.269Likely Benign-4.13Deleterious0.999Probably Damaging0.996Probably Damaging2.21Pathogenic0.00Affected3.7750.50670.0391Weaken-2-3-3.6-60.10
c.241C>A
L81M
2D
AIThe SynGAP1 missense variant L81M is listed in ClinVar with no submitted interpretation and is present in gnomAD (variant ID 6‑33425849‑C‑A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; no Foldetta stability result is available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which remains unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.632174Disordered0.502033Binding0.2910.8780.2506-33425849-C-A16.20e-7-5.351Likely Benign0.254Likely BenignLikely Benign0.039Likely Benign-0.27Neutral0.789Possibly Damaging0.165Benign3.95Benign0.00Affected4.3210.06920.243224-1.918.03
c.2420A>G
Y807C
2D
AIThe SynGAP1 missense variant Y807C is listed in ClinVar with an “Uncertain” status (ClinVar ID 2119812.0) and is present in gnomAD (ID 6‑33442972‑A‑G). Prediction tools that agree on a benign effect include REVEL, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions (five pathogenic vs. three benign) and the SGM Consensus support a pathogenic interpretation, whereas AlphaMissense‑Optimized alone suggests benign. The variant is most likely pathogenic based on the collective evidence, and this conclusion is not contradicted by the ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.699094Disordered0.853760Binding0.3360.9010.500Uncertain 16-33442972-A-G16.20e-7-7.228In-Between0.204Likely BenignLikely Benign0.243Likely Benign-3.89Deleterious0.997Probably Damaging0.934Probably Damaging2.42Pathogenic0.01Affected3.7750.31010.19070-23.8-60.04
c.2434C>T
P812S
2D
AIThe SynGAP1 missense variant P812S is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33442986‑C‑T). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. AlphaMissense‑Default remains uncertain, and no Foldetta stability result is available. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta data are missing. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.414856Structured0.842442Binding0.3880.9010.125Uncertain 16-33442986-C-T16.20e-7-5.689Likely Benign0.456AmbiguousLikely Benign0.162Likely Benign-0.62Neutral0.999Probably Damaging0.966Probably Damaging2.89Benign0.95Tolerated4.3240.34170.56991-10.8-10.04
c.2435C>T
P812L
2D
AIThe SynGAP1 P812L missense variant is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID: 6‑33442987‑C‑T). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic, and Foldetta’s protein‑folding stability analysis is unavailable. Overall, the majority of predictions lean toward pathogenicity, which is consistent with the lack of ClinVar reporting but does not contradict it. Thus, based on the available computational evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.414856Structured0.842442Binding0.3880.9010.1256-33442987-C-T16.20e-7-7.121In-Between0.591Likely PathogenicLikely Benign0.172Likely Benign-2.61Deleterious0.978Probably Damaging0.824Possibly Damaging2.76Benign0.01Affected4.3240.21310.6634-3-35.416.04
c.2452C>T
P818S
2D
AIThe SynGAP1 missense variant P818S is catalogued in gnomAD (ID 6‑33443004‑C‑T) but has no ClinVar entry. Functional prediction tools split in two groups: benign calls come from REVEL and ESM1b, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The consensus predictor SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Pathogenic.” High‑accuracy assessments are limited: AlphaMissense‑Optimized yields an uncertain result, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available prediction for this residue. Taken together, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar status because none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.715889Binding0.3710.8930.6256-33443004-C-T16.20e-7-5.740Likely Benign0.932Likely PathogenicAmbiguous0.203Likely Benign-4.38Deleterious0.989Probably Damaging0.824Possibly Damaging2.04Pathogenic0.04Affected3.7750.35810.6199-110.8-10.04
c.2453C>T
P818L
2D
AIThe SynGAP1 missense variant P818L is catalogued in gnomAD (ID 6‑33443005‑C‑T) but has no ClinVar entry. Functional prediction tools fall into two consensus groups: benign predictions come from REVEL and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). AlphaMissense‑Optimized returns an uncertain result. High‑accuracy assessments are limited: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates “Likely Pathogenic,” and Foldetta data are unavailable. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification. Thus, the variant is most likely pathogenic based on current predictive tools.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.715889Binding0.3710.8930.6256-33443005-C-T16.20e-7-6.064Likely Benign0.938Likely PathogenicAmbiguous0.285Likely Benign-5.81Deleterious0.997Probably Damaging0.954Probably Damaging1.98Pathogenic0.02Affected3.7750.23510.6951-3-35.416.04
c.2456C>T
A819V
2D
AIThe SynGAP1 missense variant A819V is catalogued in gnomAD (ID 6‑33443008‑C‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas a majority of tools predict a pathogenic outcome: polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score is uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two benign vs. two pathogenic), and Foldetta stability analysis is unavailable. Overall, the balance of evidence favors a pathogenic classification for A819V, and this assessment does not contradict any ClinVar status because the variant is not yet reported in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.694846Disordered0.707644Binding0.3170.8920.6256-33443008-C-T16.19e-7-4.944Likely Benign0.797Likely PathogenicAmbiguous0.246Likely Benign-2.40Neutral0.998Probably Damaging0.963Probably Damaging2.19Pathogenic0.01Affected3.7750.10980.6664002.428.05
c.245T>C
L82P
2D
AIThe SynGAP1 missense variant L82P is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33425853‑T‑C). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors pathogenicity. Foldetta, a protein‑folding stability method, did not provide a result for this variant. Overall, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.637480Disordered0.517720Binding0.2840.8900.3756-33425853-T-C16.20e-7-7.667In-Between0.991Likely PathogenicLikely Pathogenic0.125Likely Benign-2.73Deleterious0.939Possibly Damaging0.162Benign3.64Benign0.00Affected4.3210.34770.1118-3-3-5.4-16.04
c.2470A>G
S824G
2D
AIThe SynGAP1 missense variant S824G is listed in ClinVar with no submitted interpretation and is present in gnomAD (variant ID 6‑33443022‑A‑G). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. AlphaMissense‑Default is uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Based on the preponderance of benign predictions and the consensus from high‑accuracy tools, the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently has no pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.728858Disordered0.611272Binding0.3140.8840.7506-33443022-A-G16.20e-7-5.476Likely Benign0.543AmbiguousLikely Benign0.079Likely Benign-1.74Neutral0.992Probably Damaging0.987Probably Damaging2.60Benign0.50Tolerated3.7750.28800.5437010.4-30.03
c.2474C>T
S825L
2D
AIThe SynGAP1 missense variant S825L is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33443026‑C‑T). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” and the Foldetta stability analysis is unavailable. Overall, the preponderance of evidence points to a pathogenic effect, which is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.675549Disordered0.618614Binding0.3840.8860.750Uncertain 16-33443026-C-T16.20e-7-4.987Likely Benign0.910Likely PathogenicAmbiguous0.249Likely Benign-4.30Deleterious0.999Probably Damaging0.994Probably Damaging1.94Pathogenic0.01Affected3.7750.12520.5747-2-34.626.08
c.2482A>G
T828A
2D
AIThe SynGAP1 missense variant T828A is reported in gnomAD (variant ID 6‑33443034‑A‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also likely benign. No Foldetta stability analysis is available, so it does not influence the overall assessment. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar classification (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.604312Disordered0.631236Binding0.3210.8790.5006-33443034-A-G16.20e-7-2.974Likely Benign0.340Likely BenignLikely Benign0.197Likely Benign-2.13Neutral0.997Probably Damaging0.992Probably Damaging2.67Benign0.24Tolerated3.7750.40390.3861012.5-30.03
c.2493G>C
E831D
2D
AIThe SynGAP1 missense variant E831D is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33443045‑G‑C). All available in‑silico predictors classify the change as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool reports a pathogenic or likely‑pathogenic outcome. Grouping by agreement, the benign‑predicting tools comprise the entire set, while no pathogenic predictions are present. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a benign classification. Foldetta results are unavailable. Overall, the computational evidence strongly supports a benign effect, and this conclusion does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.626927Disordered0.617732Binding0.3190.8740.375Uncertain 16-33443045-G-C16.19e-7-3.055Likely Benign0.063Likely BenignLikely Benign0.073Likely Benign1.23Neutral0.002Benign0.002Benign2.64Benign0.77Tolerated3.7750.15370.4530320.0-14.03
c.249A>C
R83S
2D
AIThe SynGAP1 R83S missense variant has no ClinVar entry and is present in gnomAD (ID 6‑33425857‑A‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) remains Likely Benign. Foldetta results are unavailable. Overall, the predictions are split, but the consensus‑based high‑accuracy tools lean toward a benign interpretation. Thus, the variant is most likely benign based on current computational evidence, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.637480Disordered0.522784Binding0.2750.8950.2506-33425857-A-C16.20e-7-2.550Likely Benign0.999Likely PathogenicLikely Pathogenic0.094Likely Benign-1.87Neutral0.909Possibly Damaging0.587Possibly Damaging3.19Benign0.00Affected4.3210.31610.27340-13.7-69.11
c.2503C>G
L835V
2D
AIThe SynGAP1 missense variant L835V is reported in gnomAD (variant ID 6‑33443055‑C‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely benign. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict the variant to be pathogenic. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence from multiple prediction algorithms and high‑accuracy tools indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.642742Binding0.3190.8630.1256-33443055-C-G16.19e-7-3.439Likely Benign0.115Likely BenignLikely Benign0.073Likely Benign-0.70Neutral0.995Probably Damaging0.926Probably Damaging2.72Benign0.17Tolerated3.7750.14920.2886120.4-14.03
c.2509G>A
V837I
2D
AIThe SynGAP1 missense variant V837I is reported in ClinVar as “Not submitted” and is present in gnomAD (variant ID 6-33443061‑G‑A). Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 (HumDiv and HumVar) predict it to be pathogenic. When predictions are grouped by consensus, the benign group contains seven tools, while the pathogenic group contains two. High‑accuracy assessments reinforce the benign view: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also likely benign. Foldetta results are unavailable. Overall, the majority of evidence indicates that V837I is most likely benign, and this conclusion does not contradict the ClinVar status, which currently has no pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.626284Binding0.3180.8710.1256-33443061-G-A16.19e-7-4.299Likely Benign0.119Likely BenignLikely Benign0.119Likely Benign-0.51Neutral0.992Probably Damaging0.989Probably Damaging2.63Benign0.13Tolerated3.7750.08330.3848340.314.03
c.2516A>G
K839R
2D
AIThe SynGAP1 missense variant K839R is catalogued in gnomAD (ID 6‑33443068‑A‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact, while ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of evidence points to a benign effect for K839R, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.642678Disordered0.611185Binding0.2820.8650.3756-33443068-A-G16.20e-7-7.111In-Between0.162Likely BenignLikely Benign0.133Likely Benign-0.88Neutral0.972Probably Damaging0.860Possibly Damaging2.72Benign0.31Tolerated3.7750.48230.134523-0.628.01
c.2529G>A
M843I
2D
AIThe SynGAP1 missense variant M843I is catalogued in gnomAD (6‑33443081‑G‑A) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the predictions are split, with an equal number of benign and pathogenic calls; however, the majority of conventional tools lean toward benign, and the high‑accuracy consensus also favors benign. Thus, the variant is most likely benign based on current computational evidence, and this assessment does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.585406Disordered0.617934Binding0.3270.8540.3756-33443081-G-A16.20e-7-6.219Likely Benign0.983Likely PathogenicLikely Pathogenic0.209Likely Benign-1.97Neutral0.925Possibly Damaging0.954Probably Damaging2.66Benign0.03Affected3.7750.14970.3630122.6-18.03
c.2543G>T
G848V
2D
AIThe SynGAP1 missense variant G848V is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33443095‑G‑T). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, and the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign effect. No Foldetta stability prediction is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar status, which currently contains no pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.724957Disordered0.563942Binding0.2870.8160.5006-33443095-G-T16.20e-7-4.445Likely Benign0.255Likely BenignLikely Benign0.218Likely Benign-1.39Neutral0.977Probably Damaging0.856Possibly Damaging2.57Benign0.02Affected4.3240.11840.4336-3-14.642.08
c.2555G>A
G852D
2D
AIThe SynGAP1 missense variant G852D is catalogued in gnomAD (ID 6‑33443107‑G‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report benign or tolerated outcomes, while the single pathogenic signal comes from SIFT. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates a benign likelihood; Foldetta results are not available. Overall, the preponderance of evidence points to a benign impact for G852D, and this conclusion is not contradicted by any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.506063Binding0.2760.8160.6256-33443107-G-A16.20e-7-5.588Likely Benign0.203Likely BenignLikely Benign0.154Likely Benign0.67Neutral0.001Benign0.005Benign4.18Benign0.01Affected3.7750.18550.2175-11-3.158.04
c.256G>C
V86L
2D
AIThe SynGAP1 missense variant V86L is reported in ClinVar as “not listed” and is present in the gnomAD database (ID 6‑33425864‑G‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely benign. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains benign; Foldetta stability analysis is unavailable. Overall, the balance of evidence favors a benign interpretation, and this conclusion does not contradict the ClinVar status, which currently contains no pathogenic assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.685117Disordered0.552911Binding0.2950.8870.5006-33425864-G-C16.20e-7-3.658Likely Benign0.965Likely PathogenicLikely Pathogenic0.081Likely Benign-0.84Neutral0.267Benign0.097Benign3.85Benign0.00Affected4.3210.11210.538612-0.414.03
c.2596G>T
V866L
2D
AIThe SynGAP1 missense variant V866L is listed in ClinVar (ID 469150.0) with an “Uncertain” clinical significance and is present in gnomAD (6‑33443148‑G‑T). All evaluated in‑silico predictors classify the substitution as benign: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool reports a pathogenic outcome. High‑accuracy assessments corroborate this benign prediction: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, did not provide a result for this variant. Overall, the computational evidence strongly supports a benign effect, and this conclusion does not contradict the current ClinVar status of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.599170Disordered0.638070Binding0.2660.7880.250Uncertain 16-33443148-G-T16.20e-7-3.352Likely Benign0.148Likely BenignLikely Benign0.046Likely Benign-0.97Neutral0.217Benign0.229Benign2.71Benign0.21Tolerated3.8240.08360.466021-0.414.03
c.2597T>C
V866A
2D
AIThe SynGAP1 missense variant V866A is reported in gnomAD (ID 6‑33443149‑T‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 (HumDiv and HumVar) predict it to be pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (majority‑vote) is benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact, and this assessment does not contradict any ClinVar status (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.599170Disordered0.638070Binding0.2660.7880.2506-33443149-T-C16.20e-7-1.805Likely Benign0.101Likely BenignLikely Benign0.054Likely Benign-1.27Neutral0.889Possibly Damaging0.682Possibly Damaging2.87Benign0.37Tolerated3.8240.34410.251200-2.4-28.05
c.2599G>C
G867R
2D
AIThe SynGAP1 missense variant G867R is catalogued in gnomAD (6‑33443151‑G‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus score, whereas pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized reports a benign effect, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign status. No Foldetta stability analysis is available for this residue. Overall, the majority of evidence points to a benign effect for G867R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.657954Binding0.2850.8010.2506-33443151-G-C16.20e-7-3.569Likely Benign0.755Likely PathogenicLikely Benign0.131Likely Benign-1.76Neutral0.997Probably Damaging0.943Probably Damaging2.70Benign0.05Affected3.8240.08860.4494-2-3-4.199.14
c.2602G>C
D868H
2D
AIThe SynGAP1 missense variant D868H is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (variant ID 6‑33443154‑G‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs. 2 pathogenic), and Foldetta results are unavailable. Overall, the majority of predictions lean toward a benign impact, and this is not contradicted by ClinVar status. Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.525368Disordered0.676362Binding0.2620.8150.2506-33443154-G-C16.20e-7-3.358Likely Benign0.763Likely PathogenicLikely Benign0.212Likely Benign-2.34Neutral1.000Probably Damaging0.983Probably Damaging2.49Pathogenic0.08Tolerated3.8240.22580.7837-110.322.05
c.2613C>G
H871Q
2D
AIThe SynGAP1 missense variant H871Q is reported in gnomAD (ID 6‑33443165‑C‑G) and has no ClinVar entry. Functional prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. No tool predicts pathogenicity. The high‑accuracy consensus methods corroborate this: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta, a protein‑folding stability predictor, was not available for this variant. Overall, the evidence strongly supports a benign impact. This conclusion is consistent with the absence of a ClinVar pathogenic classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.480142Structured0.679301Binding0.2790.8580.2506-33443165-C-G16.20e-7-4.049Likely Benign0.140Likely BenignLikely Benign0.061Likely Benign-0.67Neutral0.255Benign0.113Benign2.69Benign0.17Tolerated3.8830.13840.335703-0.3-9.01
c.2619C>G
S873R
2D
AIThe SynGAP1 missense variant S873R is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33443171‑C‑G). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic versus two benign votes), and Foldetta stability analysis is unavailable. Overall, the balance of evidence favors a pathogenic effect, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.414856Structured0.649816Binding0.2830.8660.125Uncertain 16-33443171-C-G16.20e-7-5.856Likely Benign0.976Likely PathogenicLikely Pathogenic0.192Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging2.67Benign0.06Tolerated3.7750.09700.36670-1-3.769.11
c.2623G>A
A875T
2D
AIThe SynGAP1 missense variant A875T is listed in ClinVar with an “Uncertain” status and is present in gnomAD (variant ID 6‑33443175‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact, which is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.632173Binding0.2730.8720.250Uncertain 16-33443175-G-A16.20e-7-3.793Likely Benign0.179Likely BenignLikely Benign0.110Likely Benign-1.56Neutral0.972Probably Damaging0.864Possibly Damaging2.72Benign0.26Tolerated3.7750.14380.751801-2.530.03
c.2627C>G
S876W
2D
AIThe SynGAP1 missense variant S876W is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID: 6‑33443179‑C‑G). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). The high‑accuracy AlphaMissense‑Optimized result is uncertain, and the SGM‑Consensus indicates a likely pathogenic classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the preponderance of pathogenic predictions and the SGM‑Consensus, the variant is most likely pathogenic; this assessment does not contradict ClinVar status, as no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.549308Disordered0.631130Binding0.2800.8720.2506-33443179-C-G16.20e-7-9.305Likely Pathogenic0.829Likely PathogenicAmbiguous0.291Likely Benign-3.72Deleterious1.000Probably Damaging0.999Probably Damaging2.54Benign0.01Affected3.7750.09640.6700-3-2-0.199.14
c.2636C>A
A879E
2D
AIThe SynGAP1 missense variant A879E is reported in gnomAD (variant ID 6‑33443188‑C‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar. AlphaMissense‑Default is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. High‑accuracy predictions specifically show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta data is missing. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar status because none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.622695Binding0.2770.8740.2506-33443188-C-A16.20e-7-3.786Likely Benign0.503AmbiguousLikely Benign0.070Likely Benign-0.27Neutral0.872Possibly Damaging0.659Possibly Damaging2.70Benign0.27Tolerated3.7750.11200.1903-10-5.358.04
c.2636C>G
A879G
2D
AIThe SynGAP1 missense variant A879G is reported in gnomAD (variant ID 6-33443188-C-G) but has no ClinVar entry. Functional prediction tools uniformly classify the change as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a benign effect. No tool predicts pathogenicity. The high‑accuracy consensus methods corroborate this: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta results are not available, so they do not influence the assessment. Based on the collective predictions, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.622695Binding0.2770.8740.2506-33443188-C-G16.20e-7-3.924Likely Benign0.085Likely BenignLikely Benign0.054Likely Benign-0.43Neutral0.001Benign0.007Benign2.69Benign0.43Tolerated3.7750.22140.436201-2.2-14.03
c.2639C>T
A880V
2D
AIThe SynGAP1 missense variant A880V is reported in gnomAD (variant ID 6‑33443191‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv flags the change as pathogenic, creating a single discordant prediction. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign impact for A880V, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.621441Binding0.3090.8740.2506-33443191-C-T16.20e-7-5.440Likely Benign0.121Likely BenignLikely Benign0.095Likely Benign-0.11Neutral0.761Possibly Damaging0.399Benign2.58Benign1.00Tolerated3.7750.09470.5362002.428.05
c.2654C>G
P885R
2D
AIThe SynGAP1 missense variant P885R is reported in gnomAD (ID 6‑33443206‑C‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign impact, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.690604Disordered0.636133Binding0.3440.9170.2506-33443206-C-G16.20e-7-4.166Likely Benign0.308Likely BenignLikely Benign0.072Likely Benign-1.99Neutral0.586Possibly Damaging0.377Benign2.84Benign0.00Affected4.3240.13110.3505-20-2.959.07
c.2662G>A
A888T
2D
AIThe SynGAP1 missense variant A888T is catalogued in gnomAD (6‑33443214‑G‑A) but has no ClinVar entry. In silico assessment shows a consensus of benign predictions: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a neutral effect. Only SIFT predicts a deleterious outcome. High‑accuracy tools reinforce the benign consensus: AlphaMissense‑Optimized reports benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also classifies the variant as likely benign. Foldetta data are unavailable. Overall, the preponderance of evidence supports a benign classification, and this is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.784345Disordered0.575860Binding0.3520.9280.6256-33443214-G-A16.20e-7-4.792Likely Benign0.084Likely BenignLikely Benign0.059Likely Benign-1.11Neutral0.001Benign0.002Benign2.62Benign0.00Affected4.3240.15480.711501-2.530.03
c.2663C>T
A888V
2D
AIThe SynGAP1 missense variant A888V is catalogued in gnomAD (ID 6‑33443215‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report benign or tolerated outcomes, while the single pathogenic signal comes from SIFT. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates a benign likelihood. Foldetta results are unavailable, so they do not influence the assessment. Overall, the preponderance of evidence points to a benign impact for A888V, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.784345Disordered0.575860Binding0.3520.9280.6256-33443215-C-T16.20e-7-4.241Likely Benign0.106Likely BenignLikely Benign0.034Likely Benign-0.91Neutral0.000Benign0.001Benign2.78Benign0.00Affected4.3240.12850.7056002.428.05
c.2665G>A
G889R
2D
AIThe SynGAP1 missense variant G889R is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (ID 6‑33443217‑G‑A). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized; pathogenic predictions come from SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign effect, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta results are unavailable. Overall, the majority of evidence (six benign vs three pathogenic) supports a benign impact. This conclusion does not contradict ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.690604Disordered0.552581Binding0.3310.9280.6256-33443217-G-A16.20e-7-3.357Likely Benign0.685Likely PathogenicLikely Benign0.070Likely Benign-1.96Neutral0.027Benign0.009Benign2.38Pathogenic0.02Affected4.3240.09250.4165-2-3-4.199.14
c.2666G>C
G889A
2D
AIThe SynGAP1 missense variant G889A is listed in gnomAD (6‑33443218‑G‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the change as benign or likely benign. Only FATHMM predicts a pathogenic outcome, representing a single dissenting signal. High‑accuracy assessments confirm the benign consensus: AlphaMissense‑Optimized reports a benign effect, and the SGM‑Consensus likewise indicates a likely benign status. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the preponderance of evidence supports a benign classification, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.690604Disordered0.552581Binding0.3310.9280.6256-33443218-G-C16.20e-7-4.580Likely Benign0.099Likely BenignLikely Benign0.063Likely Benign-1.49Neutral0.245Benign0.096Benign2.47Pathogenic0.76Tolerated4.3240.38380.4902012.214.03
c.2674T>C
S892P
2D
AIThe SynGAP1 missense variant S892P is reported in gnomAD (ID 6‑33443226‑T‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while only SIFT predicts it to be pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the consensus of the majority of prediction tools and the high‑accuracy methods points to a benign impact. This conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.754692Disordered0.473390Uncertain0.3190.9260.8756-33443226-T-C16.20e-7-3.247Likely Benign0.222Likely BenignLikely Benign0.041Likely Benign-0.87Neutral0.057Benign0.047Benign2.60Benign0.01Affected4.3240.22300.5251-11-0.810.04
c.2678A>C
Q893P
2D
AIThe SynGAP1 missense variant Q893P is reported in gnomAD (ID 6‑33443230‑A‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 HumDiv and SIFT predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates benign. No Foldetta stability data are available, so it does not influence the assessment. Overall, the majority of predictions, including the high‑confidence tools, support a benign classification, and this is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.754692Disordered0.447267Uncertain0.3100.9250.7506-33443230-A-C16.20e-7-2.463Likely Benign0.072Likely BenignLikely Benign0.084Likely Benign-0.70Neutral0.802Possibly Damaging0.432Benign2.69Benign0.05Affected4.3240.22710.5151-101.9-31.01
c.2681G>C
G894A
2D
AIThe SynGAP1 missense variant G894A is reported in gnomAD (ID 6‑33443233‑G‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely benign. Only two tools—polyPhen‑2 HumDiv and HumVar—predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the preponderance of evidence indicates the variant is most likely benign, and this conclusion does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.425700Uncertain0.3100.9250.7506-33443233-G-C16.20e-7-3.997Likely Benign0.267Likely BenignLikely Benign0.180Likely Benign-1.26Neutral0.999Probably Damaging0.999Probably Damaging2.69Benign0.97Tolerated4.3240.38570.4670012.214.03
c.2683A>C
S895R
2D
AIThe SynGAP1 missense variant S895R is reported in ClinVar as not yet classified and is present in gnomAD (ID 6‑33443235‑A‑C). Consensus from multiple in silico predictors shows a split: benign calls come from REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic calls arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. When grouping by agreement, the benign group contains five tools, whereas the pathogenic group contains four. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts pathogenicity, whereas the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points toward a benign effect, and this conclusion does not conflict with the current ClinVar status, which remains unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.7506-33443235-A-C16.20e-7-4.746Likely Benign0.973Likely PathogenicLikely Pathogenic0.167Likely Benign-1.72Neutral0.997Probably Damaging0.995Probably Damaging2.64Benign0.10Tolerated4.3240.09490.4046-10-3.769.11
c.2684G>C
S895T
2D
AIThe SynGAP1 missense variant S895T is reported in gnomAD (variant ID 6-33443236‑G‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign, and AlphaMissense‑Optimized also scores benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect. The variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.788093Disordered0.414977Uncertain0.2940.9250.7506-33443236-G-C16.20e-7-5.515Likely Benign0.199Likely BenignLikely Benign0.132Likely Benign-1.14Neutral0.979Probably Damaging0.982Probably Damaging2.75Benign0.26Tolerated4.3240.14050.6392110.114.03
c.2687G>T
G896V
2D
AIThe SynGAP1 missense variant G896V is reported in gnomAD (6-33443239-G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign outcome. Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect for G896V, and this conclusion is not contradicted by any ClinVar classification (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.412816Uncertain0.3140.9230.6256-33443239-G-T16.20e-7-2.936Likely Benign0.285Likely BenignLikely Benign0.165Likely Benign-1.96Neutral0.997Probably Damaging0.912Probably Damaging2.46Pathogenic0.30Tolerated4.3240.12640.4026-3-14.642.08
c.268G>A
V90M
2D
AIThe SynGAP1 missense variant V90M is listed in gnomAD (6‑33425876‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status, as none is reported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.542047Binding0.3430.8730.5006-33425876-G-A16.20e-7-5.017Likely Benign0.463AmbiguousLikely Benign0.053Likely Benign-0.15Neutral0.872Possibly Damaging0.162Benign3.98Benign0.00Affected4.3210.12210.439312-2.332.06
c.2693C>G
S898C
2D
AIThe SynGAP1 missense variant S898C is catalogued in gnomAD (ID 6‑33443245‑C‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM, while ESM1b remains uncertain. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign, and the SGM Consensus also indicates benign. Foldetta, a protein‑folding stability predictor that integrates FoldX‑MD and Rosetta outputs, did not return a result for this variant, so its stability impact is unavailable. Overall, the preponderance of evidence points to a benign effect, and this assessment does not conflict with ClinVar, which currently has no classification for S898C.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.690604Disordered0.426070Uncertain0.3050.9220.5006-33443245-C-G16.20e-7-7.007In-Between0.257Likely BenignLikely Benign0.146Likely Benign-2.43Neutral0.999Probably Damaging0.986Probably Damaging2.43Pathogenic0.01Affected4.3240.14870.6166-103.316.06
c.2707G>A
G903S
2D
AIThe SynGAP1 missense variant G903S is reported in gnomAD (variant ID 6-33443259‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which labels the variant as “Likely Benign.” Pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates likely benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for G903S, and this conclusion is not contradicted by ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.680603Disordered0.549818Binding0.2910.9170.3756-33443259-G-A16.20e-7-3.451Likely Benign0.154Likely BenignLikely Benign0.091Likely Benign-1.37Neutral0.989Probably Damaging0.871Possibly Damaging2.40Pathogenic0.04Affected3.7750.24470.477401-0.430.03
c.2713C>A
R905S
2D
AIThe SynGAP1 missense variant R905S is catalogued in gnomAD (ID 6‑33443265‑C‑A) but has no ClinVar entry. Consensus from multiple in‑silico predictors shows a split: benign‑oriented tools—REVEL, PROVEAN, SIFT, ESM1b, and FATHMM—all classify the change as benign, while pathogenic‑oriented tools—polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default—label it pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign status. High‑accuracy assessments are mixed: AlphaMissense‑Optimized returns an uncertain result, SGM‑Consensus remains likely benign, and Foldetta data are unavailable. Overall, the majority of evidence points toward a benign effect, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.671169Disordered0.618085Binding0.2910.9200.2506-33443265-C-A16.20e-7-2.382Likely Benign0.903Likely PathogenicAmbiguous0.133Likely Benign-1.39Neutral0.999Probably Damaging0.962Probably Damaging2.71Benign0.15Tolerated3.7750.28060.4124-103.7-69.11
c.2724G>C
Q908H
2D
AIThe SynGAP1 missense variant Q908H is listed in ClinVar (ID 436926.0) with an “Uncertain” status and is present in gnomAD (variant ID 6‑33443276‑G‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This consensus does not contradict the ClinVar “Uncertain” classification, which remains inconclusive.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.678728Binding0.2750.9170.250Conflicting 46-33443276-G-C16.20e-7-4.658Likely Benign0.311Likely BenignLikely Benign0.112Likely Benign-0.74Neutral0.996Probably Damaging0.995Probably Damaging2.58Benign0.05Affected3.7750.12930.3597300.39.01
c.2729G>C
G910A
2D
AIThe SynGAP1 missense variant G910A is listed in ClinVar with an “Uncertain” status (ClinVar ID 2091237.0) and is present in gnomAD (6‑33443281‑G‑C). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar. The remaining predictions are uncertain: AlphaMissense‑Default is inconclusive, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.762850Disordered0.707319Binding0.2640.9170.250Uncertain 16-33443281-G-C16.20e-7-3.587Likely Benign0.361AmbiguousLikely Benign0.209Likely Benign-1.43Neutral0.999Probably Damaging0.999Probably Damaging2.78Benign0.10Tolerated3.7750.37530.4544102.214.03
c.2729G>T
G910V
2D
AIThe SynGAP1 missense variant G910V is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33443281‑G‑T). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta results are unavailable. Overall, the majority of tools (five pathogenic vs. four benign) predict a pathogenic impact. This prediction does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.762850Disordered0.707319Binding0.2640.9170.2506-33443281-G-T16.20e-7-4.362Likely Benign0.724Likely PathogenicLikely Benign0.237Likely Benign-2.69Deleterious1.000Probably Damaging1.000Probably Damaging2.73Benign0.02Affected3.7750.11790.3662-3-14.642.08
c.273G>C
E91D
2D
AIThe SynGAP1 missense variant E91D is reported in gnomAD (variant ID 6‑33425881‑G‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT predict a pathogenic impact. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; no Foldetta stability data are available. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.533667Binding0.3030.8750.5006-33425881-G-C16.20e-7-3.160Likely Benign0.293Likely BenignLikely Benign0.095Likely Benign-0.84Neutral0.880Possibly Damaging0.636Possibly Damaging3.98Benign0.00Affected4.3210.20000.5219230.0-14.03
c.2743G>T
G915C
2D
AIThe SynGAP1 missense variant G915C is listed in ClinVar with no submitted interpretation and is present in gnomAD (variant ID 6-33443295-G‑T). Functional prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.657645Disordered0.808641Binding0.3020.8800.3756-33443295-G-T16.20e-7-6.446Likely Benign0.185Likely BenignLikely Benign0.103Likely Benign-2.84Deleterious1.000Probably Damaging0.989Probably Damaging2.64Benign0.01Affected3.7750.10230.4471-3-32.946.09
c.2749C>G
P917A
2D
AIThe SynGAP1 missense variant P917A is not reported in ClinVar and is present in gnomAD (ID 6‑33443301‑C‑G). Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all classify the change as benign or likely benign. Only SIFT predicts a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized reports benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the collective predictions point to a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for P917A.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.599170Disordered0.863949Binding0.3140.8620.3756-33443301-C-G16.20e-7-3.681Likely Benign0.062Likely BenignLikely Benign0.053Likely Benign-1.33Neutral0.065Benign0.037Benign2.72Benign0.00Affected3.7750.34580.4772-113.4-26.04
c.2749C>T
P917S
2D
AIThe SynGAP1 missense variant P917S is catalogued in gnomAD (ID 6‑33443301‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report benign. Only SIFT predicts pathogenicity. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as “Likely Benign.” High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (majority vote) is benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no reported result for this variant, so it provides no additional evidence. Overall, the preponderance of predictions indicates that P917S is most likely benign, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.599170Disordered0.863949Binding0.3140.8620.3756-33443301-C-T16.20e-7-3.562Likely Benign0.073Likely BenignLikely Benign0.056Likely Benign-0.54Neutral0.003Benign0.002Benign2.70Benign0.00Affected3.7750.34780.5121-110.8-10.04
c.274G>A
G92R
2D
AIThe SynGAP1 missense variant G92R is listed in gnomAD (6-33425882‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM‑Consensus as “Likely Benign,” and Foldetta results are unavailable. Taken together, the preponderance of evidence from multiple independent predictors and the consensus score points to a benign classification. This conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.537848Binding0.3370.8740.6256-33425882-G-A16.20e-7-2.909Likely Benign0.876Likely PathogenicAmbiguous0.139Likely Benign-2.38Neutral0.999Probably Damaging0.979Probably Damaging4.01Benign0.00Affected4.3210.10410.4605-2-3-4.199.14
c.2752G>A
A918T
2D
AISynGAP1 missense variant A918T is listed in ClinVar with an uncertain significance (ClinVar ID 3964538.0) and is present in gnomAD (6‑33443304‑G‑A). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions are reported by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely benign. Foldetta stability analysis is unavailable. Overall, the preponderance of evidence points to a benign effect, which is consistent with the ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.632174Disordered0.891459Binding0.3170.8600.250Uncertain 16-33443304-G-A16.20e-7-4.139Likely Benign0.083Likely BenignLikely Benign0.065Likely Benign-1.09Neutral0.980Probably Damaging0.721Possibly Damaging2.64Benign0.03Affected4.3240.17420.643001-2.530.03
c.2756A>T
Q919L
2D
AIThe SynGAP1 missense variant Q919L is reported in gnomAD (ID 6‑33443308‑A‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as “Likely Benign.” High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.618285Disordered0.911223Binding0.2990.8410.2506-33443308-A-T16.20e-7-4.492Likely Benign0.252Likely BenignLikely Benign0.175Likely Benign-2.13Neutral0.891Possibly Damaging0.596Possibly Damaging2.40Pathogenic0.04Affected4.3240.07710.6454-2-27.3-14.97
c.2762T>C
L921P
2D
AIThe SynGAP1 missense variant L921P is recorded in gnomAD (ID 6‑33443314‑T‑C) but has no ClinVar submission. Functional prediction tools cluster into two groups: benign calls from REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized; pathogenic calls from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. AlphaMissense‑Default is uncertain. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive because the votes are split (two benign, one pathogenic, one uncertain). Foldetta, a protein‑folding stability predictor that combines FoldX‑MD and Rosetta outputs, has no reported result for this variant. Consequently, the evidence is evenly divided, with high‑accuracy tools not providing a decisive verdict. The variant is therefore inconclusive; it does not contradict ClinVar status, which currently has no entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.608892Disordered0.943282Binding0.3110.8450.3756-33443314-T-C16.20e-7-2.087Likely Benign0.393AmbiguousLikely Benign0.215Likely Benign-1.83Neutral0.998Probably Damaging0.958Probably Damaging2.39Pathogenic0.00Affected3.7750.35810.1343-3-3-5.4-16.04
c.2767A>G
I923V
2D
AIThe SynGAP1 missense variant I923V is reported in gnomAD (ID 6‑33443319‑A‑G) and has no ClinVar entry. Functional prediction tools uniformly classify the substitution as benign: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a benign effect. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, has no available result for this variant. Overall, the consensus of all available predictions is benign, and this is consistent with the absence of a ClinVar pathogenic classification. Therefore, the variant is most likely benign, with no conflict with ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.562014Disordered0.964857Binding0.2920.8520.2506-33443319-A-G16.20e-7-2.010Likely Benign0.113Likely BenignLikely Benign0.059Likely Benign0.05Neutral0.028Benign0.009Benign2.76Benign1.00Tolerated3.7750.15890.406034-0.3-14.03
c.2783A>G
Q928R
2D
AIThe SynGAP1 missense variant Q928R is listed in gnomAD (ID 6‑33443335‑A‑G) but has no ClinVar entry. Functional prediction tools fall into two consensus groups: benign predictions come from REVEL and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). AlphaMissense‑Optimized returns an uncertain result, and no Foldetta (FoldX‑MD/Rosetta stability) data are available. High‑accuracy assessments therefore indicate a likely pathogenic outcome (SGM‑Consensus) with no contradictory evidence from ClinVar. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not conflict with the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.497853Structured0.986260Binding0.3240.8520.2506-33443335-A-G16.20e-7-4.089Likely Benign0.826Likely PathogenicAmbiguous0.290Likely Benign-2.91Deleterious0.994Probably Damaging0.988Probably Damaging1.58Pathogenic0.00Affected4.3240.13570.345311-1.028.06

Found 8751 rows. Show 800 rows per page. Page 10/11 « Previous | Next »